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  Foreword 
 
 
Chapter I of the 2007 report of the International Narcotics Control Board contains a 
discussion on the principle of proportionality and drug-related offences. The 
principle has ancient origins, such as the Code of Hammurabi, with its rules of 
retributive justice (“an eye for an eye”, “a tooth for a tooth” and “a bone for a 
bone”) to curb excessive punishment by victims or the State.  
The human sense of how best to address wrongdoing in a proportionate manner has 
evolved considerably since the time of Hammurabi. However, there are still 
differences between countries and regions concerning how best to respond to 
offences and offenders.  
The United Nations Convention against Illicit Traffic in Narcotic Drugs and 
Psychotropic Substances of 1988 addresses in a general manner responses to drug-
related crime. Those responses serve as a guide, as any response adopted by a party 
is subject to its constitutional principles and its domestic law. 
The 1988 Convention provides that sanctions take into account whether an offence 
is of a grave or minor nature. There is a wide variety of sanctions, ranging from 
imprisonment or other forms of deprivation of liberty to measures such as the 
education, rehabilitation or social reintegration of drug-abusing offenders. 
The 1988 Convention recognizes that, to be effective, a State’s response to an 
offence committed by a drug abuser must address both the offence and the 
underlying cause, namely drug abuse. More scrupulous application of the provisions 
of the 1988 Convention by Governments will ensure that serious offences are not 
committed with impunity and that those who commit them are not treated more 
leniently than is reasonably justifiable and do not escape justice entirely. 
The Board is of the opinion that the nature and severity of penalties and sanctions 
for enforcement are useful in assessing whether the principle of proportionality is 
met. Full compliance with the principle of proportionality implies mutual respect for 
national sovereignty, for the various constitutional and other fundamental principles 
of domestic law – practice, judgements and procedures – and for the rich diversity 
of peoples, cultures, customs and values served by those different legal systems.  
A close look at the world’s drug problem reveals two developments of particular 
concern. First, criminal organizations are taking advantage of loopholes in the 
control systems in Africa for chemicals used in illicit drug manufacture and are in 
the process of establishing in that region trafficking hubs for chemicals. Numerous 
suspicious shipments of precursor chemicals to Africa have been identified. Also of 
concern is the establishment of routes for smuggling cocaine between countries in 
South America and Africa. Countries affected by those developments should 
introduce appropriate measures to prevent their territory from being targeted for 
such criminal activity. 
It has now been almost 10 years since the General Assembly adopted the 
Declaration on the Guiding Principles of Drug Demand Reduction. The time has 
come to reflect on investments made by Governments in reducing the demand for 
illicit drugs. Although many Governments have made considerable efforts, more 
needs to be done. Governments should recognize that reducing illicit drug demand 
and reducing illicit drug supply are complementary and mutually reinforcing. 
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To suggest that the legalization of drugs would “solve” the world drug problem is to 
ignore historical facts. The first international controls over narcotic drugs, 
introduced in 1912, helped to reduce the scourge of opium addiction in some Asian 
countries. Some 60 years later, accession to the Convention on Psychotropic 
Substances of 1971 contributed to a significant decline in the abuse of psychotropic 
substances, which had created serious health problems in the 1950s and 1960s. 
Given those and other experiences, any suggestion to legalize the use of illicit drugs 
seems rather simplistic and misplaced. There are no “quick fix” solutions to the 
drug problem. Governments should continue to take action to address drug abuse 
and illicit drug trafficking in a comprehensive, sustained and concerted manner. 
That is where the solution to the world drug problem lies. To do nothing is not an 
option.  
 
 Philip O. Emafo 
 President of the International Narcotics Control Board 
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Explanatory notes 
 
The following abbreviations have been used in this report: 
ACCORD ASEAN and China Cooperative Operations in Response to 
Dangerous Drugs 
ADD  attention deficit disorder 
AIDS acquired immunodeficiency syndrome 
ARCOS Automation of Reports and Consolidated Orders System (United 
States of America) 
ASEAN Association of Southeast Asian Nations 
ASEANAPOL ASEAN Chiefs of Police 
ATS  amphetamine-type stimulant 
BKA  Federal Criminal Police Office (Germany) 
BZP  N-benzylpiperazine 
CARDIN Central Asian Regional Drug Information Network 
mCCP 1-(3-chlorophenyl)piperazine 
CICAD Inter-American Drug Abuse Control Commission 
CIS  Commonwealth of Independent States 
CNCN National Council against Drug Trafficking (Honduras) 
CNTF Counter-Narcotics Trust Fund (Afghanistan) 
CONSEP National Narcotic and Psychotropic Substances Control Board 
(Ecuador) 
CSTO Collective Security Treaty Organization 
DARE Drug Abuse Resistance Education 
DEA  Drug Enforcement Administration (United States of America) 
DEVIDA National Commission for Development and Life without Drugs 
(Peru) 
Europol European Police Office 
FUNDASALVA Anti-Drugs Foundation of El Salvador 
GAFISUD Financial Action Task Force of South America against Money 
Laundering 
GBL  gamma-butyrolactone 
GHB  gamma-hydroxybutyric acid 
HIV  human immunodeficiency virus 
 Interpol International Criminal Police Organization 
LSD  lysergic acid diethylamide 
MDA methylenedioxyamphetamine 
MDBP 1-(3,4-methylenedioxybenzyl)piperazine 
MDMA methylenedioxymethamphetamine 
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3,4-MDP-2-P 3,4-methylenedioxyphenyl-2-propanone 
MeOPP 1-(4-methoxyphenyl)piperazine 
MINUSTAH United Nations Stabilization Mission in Haiti 
NATO North Atlantic Treaty Organization 
NPP  N-phenethyl-4-piperidone 
OAS  Organization of American States 
OID  Inter-American Observatory on Drugs 
P-2-P phenyl-2-propanone 
PEN Online Pre-Export Notification Online 
SAARC South Asian Association for Regional Cooperation 
SARPCCO South African Regional Police Chiefs Cooperation Organization 
SCO  Shanghai Cooperation Organization 
TFMPP 1-(3-trifluoromethylphenyl)piperazine 
THC  tetrahydrocannabinol 
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 The designations employed and the presentation of the material in this 
publication do not imply the expression of any opinion whatsoever on the part of the 
Secretariat of the United Nations concerning the legal status of any country, 
territory, city or area or of its authorities, or concerning the delimitation of its 
frontiers or boundaries.  
 Countries and areas are referred to by the names that were in official use at the 
time the relevant data were collected. 
 
Data reported later than 1 November 2007 
could not be taken into consideration in 
preparing this report. 
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 I. The principle of proportionality and drug-related offences 
 
 
1. Over 95 per cent of the Member States of the 
United Nations are now parties to the international 
drug control conventions. The conventions contain the 
basic legal structure, obligations, tools and guidance 
that are needed for all States to achieve the main aims 
of the international drug control system: controlled 
universal availability of narcotic drugs and 
psychotropic substances for medical and scientific 
purposes only; prevention of drug abuse, drug 
trafficking and other forms of drug-related crime; and 
the undertaking of effective remedial action when 
prevention does not fully succeed. As such, the 
conventions constitute the world’s agreed proportionate 
response to the global problems of illicit drug abuse 
and trafficking and the world’s agreed legal framework 
for international drug control.  
2. The conventions set minimum standards only. If 
those standards are met and not undermined, each State 
has discretion to transpose the provisions of the 
conventions into domestic law and practice in line with 
its own legal system and principles. Each State can 
also apply more strict or severe measures if it considers 
them desirable or necessary for the protection of public 
health and welfare or for the prevention and 
suppression of illicit traffic.  
3. There are wide differences between countries and 
regions in community tolerance or intolerance towards 
drug-related offences and offenders, and those 
differences have an impact on the way the conventions 
are implemented. Penalties for similar offences may 
seem severe in some places, but lenient in others. Also 
the nature and extent of the drug problem appears to 
vary from one country or region to another.1 States 
therefore attempt to address the drug problem based on 
their perception of the reality and extent of the 
problem, as well as on the resources available for 
addressing it. Some States target major drug traffickers 
and dismantle their networks, while others deal only 
with small cases. People who divert internationally 
controlled substances to illicit markets may avoid 
sanctions in one place but go to prison and lose their 
business in another. A prominent citizen may be 
__________________ 
 1  Due to factors such as whether it is mainly a drug-
producing, transit or consumer country or region, the 
prevalence of drug abusers, the types of drugs abused, 
and other variables such as crime rates. 
reprimanded for systematically laundering drug money, 
while a poor person in the same country may be jailed 
for shoplifting. Some States imprison drug-abusing 
offenders without providing any treatment or 
rehabilitation. Others provide both treatment and 
rehabilitation, with or without prison.  
4. Some of the differences in national approaches to 
dealing with offenders, protecting public safety and 
repairing any harm caused to victims and the 
community flow from the different legal systems of the 
States parties to the conventions. They in turn reflect 
underlying differences concerning, for example: 
(a)  how best to deal with unlawful behaviour by 
offenders; (b) how best to promote a sense of 
responsibility on the part of offenders and their 
acknowledgement of the harm they have done to 
victims and the community; (c) how best to deter them 
and others from offending in the future; (d) what 
constitutes “fair punishment”; (e) when and in what 
circumstances to separate offenders from society; and 
(f) how best to rehabilitate them. Ultimately, the 
differences reflect what comes from the depths of each 
country’s culture and value system about drug-related 
behaviour, crime, punishment and rehabilitation.  
5. Some of the differences have a positive impact on 
the implementation of a convention; for example, they 
may encourage new and improved ways to reduce 
drug-related crime, drug abuse and repeat offending. 
Other differences may have the reverse effect; for 
example, they may give rise to perceptions of profound 
injustice, generate tension or confusion between 
countries, hamper international cooperation or simply 
limit the range of problem-solving options considered 
by a Government – particularly if it considers that its 
own national drug control system is better than those 
of other countries or that little can be learned from 
others. The conventions permit some of the 
differences, but also set clear limits on them. The 
conventions do not, for example, allow a party to 
choose whatever interpretation of a provision suits its 
particular culture, value system or view of 
proportionality, in order to justify policies and 
practices that may undermine the aims of the 
conventions. The International Narcotics Control 
Board, in line with its mandate under the conventions, 
has expressed its views on several occasions when 
E/INCB/2007/1  
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such cases were brought to its attention and will 
continue to do so whenever appropriate.  
6. Proportionality has also become an important 
issue in its own right since the Board first touched on 
that issue in its 1996 review of drug abuse and the 
criminal justice system.2 Eleven years later, there is 
still much room for improvement. The Board has 
chosen the principle of proportionality and drug-related 
offences as its special theme for the present report to 
put greater focus on the issue and to help improve the 
proportionality of responses by States to drug-related 
offences, so that the implementation of the conventions 
can be even more effective.  
 
 
 A. The principle of proportionality 
 
 
7. Transposing the international drug control 
conventions into domestic law is subject to the 
internationally recognized principle of proportionality. 
The principle requires a State’s response to anything 
that may harm peace, order or good governance to be 
proportionate. In a narrower, criminal justice sense, the 
principle permits punishment as an acceptable response 
to crime, provided that it is not disproportionate to the 
seriousness of the crime. Variants of the broad 
principle are often enshrined in States’ constitutions, 
with specific rules set out in more detailed national 
law. International and regional human rights 
instruments3 and crime prevention and criminal justice 
instruments often develop or set the standards. 
8. The principle of proportionality has ancient 
origins. Its first recorded formulations date back over 
4,000 years. One of the earliest was the Code of 
Hammurabi, with its rules of retributive justice to curb 
excessive punishment by victims or the State (“an eye 
for an eye”, “a tooth for a tooth” and “a bone for a 
bone”). Some punishments applied equally to all 
wrongdoers. Others depended on the respective status 
of the wrongdoer and the victim in Mesopotamian 
society: if the victim was “socially superior”, 
punishment could be excessive but within fixed limits; 
if the victim was an “equal”, the punishment could be 
__________________ 
 2  International Narcotics Control Board Report for 1996 
(United Nations publication, Sales No. E.97.XI.3), 
paras. 1-6, 21-31 and 36-37. 
 3  For example, the Universal Declaration of Human Rights 
(General Assembly resolution 217 A (III)). 
no worse than the crime; and if the victim was 
“socially inferior”, fixed compensation could be 
specified. Since the introduction of the Code of 
Hammurabi, there have been considerable 
developments, particularly regarding how to better 
make the offender accountable, restore public peace, 
remedy the victim’s loss or the damage and, when 
appropriate, ultimately enable the rehabilitation and 
social reintegration of the offender.  
9. Whether or not a State’s response to drug-related 
offences is proportionate depends in turn on how its 
legislative, judicial and executive arms of government 
respond in both law and practice. For example:  
 (a) Is the particular response necessary?  
 (b) To what extent can the response result in the 
achievement of the desired objectives?  
 (c) Does the response legitimately go beyond 
what is needed?  
 (d) Does the response comply with 
internationally accepted norms concerning the rule of 
law?4  
 (e) When the offences have international 
aspects, is there effective international casework 
cooperation between the regulatory, law enforcement, 
prosecution and judicial services of all the countries 
concerned, for example, in obtaining relevant 
intelligence and evidence, tracing and ultimately 
confiscating criminal wealth and returning fugitives of 
justice? If the answer to the above questions is no, 
justice may not be done, making the response to the 
offending manifestly disproportionate. 
10. In the Board’s view, whether or not the principle 
of proportionality is satisfied in any State’s drug-
related casework depends on whether or not the cases 
are dealt with fully in accordance with the conventions 
and the rule of law. 
 
 
__________________ 
 4  These include the absolute supremacy of laws seeking to 
achieve good over the arbitrary power of individuals and 
institutions; upholding law and order; the equality and 
accountability of everyone before the law for every act 
done without legal justification; well-functioning courts 
providing predictable and efficient judgements; and 
upholding the rights and duties of individuals under the 
country’s constitutional law. 
 E/INCB/2007/1
 
 3 
 
 B. Proportionality and the international 
drug control conventions  
 
 
11. As indicated in paragraph 1 above, there is now 
almost universal adherence to the international drug 
control conventions. The United Nations Convention 
against Illicit Traffic in Narcotic Drugs and 
Psychotropic Substances of 19885 is the most recent, 
most specific and most prescriptive of those 
conventions. It is mainly designed to promote more 
clarity, homogeneity and effective implementation by 
law enforcement, prosecution and judicial services of 
States in dealing with drug-related crime at the national 
and international levels. Proportionality is an important 
principle in effectively implementing the provisions of 
the conventions. As formal legal agreements, the 
conventions reflect compromises (in some cases, 
compromises reached after long, hard-fought 
negotiation) on the essential mandatory measures and 
actions that parties to the conventions are required to 
take and the results that they are expected to 
accomplish. The fact that so far over 95 per cent of all 
States have chosen to become parties to the 
conventions is evidence that those binding legal 
instruments represent a proportionate response to 
global drug problems. Some of the main 
proportionality provisions of the conventions 
encourage and facilitate proportionate responses by 
States to drug-related offences. Other provisions seek 
to limit disproportionate responses. The main 
proportionality provisions are discussed below. 
12. To ensure that narcotic drugs and psychotropic 
substances are indeed available for medical and 
scientific purposes only, States must control all drugs 
under international control with different levels of 
strictness, depending on the therapeutic usefulness, 
public benefits and risks associated with their use. 
Accordingly, the Single Convention on Narcotic Drugs 
of 1961 as amended by the 1972 Protocol6 and the 
Convention on Psychotropic Substances of 19717 each 
classifies the drugs to which it applies into four groups, 
for which it respectively provides four general control 
regimes of differing strictness. The convention 
schedule in which a drug is listed determines the 
particular control regime governing the drug, which the 
__________________ 
 5  United Nations, Treaty Series, vol. 1582, No. 27627. 
 6  Ibid., vol. 976, No. 14152. 
 7  Ibid., vol. 1019, No. 14956. 
parties must then apply. The manufacture, distribution 
or use of or trade in drugs classified as having little or 
no therapeutic value and liable to cause the most 
serious health and social problems if abused must be 
prohibited or very strictly controlled. For drugs 
classified in other groups, the greater their therapeutic 
value and the less serious the problems resulting from 
their abuse, the less strict the controls that apply to 
them.  
13. The conventions generally require parties to 
establish a wide range of drug-related activities as 
criminal offences under their domestic law but permit 
parties to respond to them proportionately. The 
1988  Convention covers drug-related activities not 
specifically envisaged in the earlier treaties, such as 
the organization, management and financing of drug 
trafficking, money-laundering, trafficking in precursor 
chemicals, and a range of other enabling, facilitating or 
supporting activities. The 1988 Convention also 
generally requires States to establish as a criminal 
offence the possession, purchase or cultivation of drugs 
for non-medical personal consumption.  
14. In requiring parties to establish as offences 
certain drug-related activities, the conventions permit 
parties to define all offences and defences using the 
framework and terminology of their national legal 
systems. Subject to the convention limits summarized 
below, parties are also permitted to deal with offenders 
in conformity with their own national laws. This 
includes (again, subject to those limits), the different 
legal, moral and cultural traditions reflected in those 
laws. 
15. The 1988 Convention requires parties to take a 
range of special measures to ensure that offences of a 
serious kind or nature are not committed with 
impunity.8 Perpetrators should not be treated more 
leniently than reasonably justified or are not able to 
escape justice entirely. Because serious offences 
typically pose significant risks to public health and 
safety, and offenders profit from the misery of others, 
parties must deal with serious offences more severely 
and extensively than offences of a less grave nature. 
For such serious offences, the 1988 Convention 
requires parties to make the commission of such 
__________________ 
 8  In the present chapter, “serious offence” means any 
offence referred to in article 3, paragraph 1, of the 
1988 Convention. 
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serious offences liable to sanctions that take into 
account the grave nature of those offences, such as 
imprisonment, other forms of deprivation of liberty, 
pecuniary sanctions and confiscation. By way of 
exception or qualification, if all the facts and 
circumstances surrounding the commission of such an 
offence nevertheless indicate that it is an appropriate 
case of a minor nature, the 1988 Convention permits 
parties to provide alternatives to conviction or 
punishment, such as education, rehabilitation or social 
reintegration.  
16. To help ensure that serious offence cases have 
serious consequences in all countries and not just in 
some, the 1988 Convention seeks to limit the 
possibility of unduly lenient responses to serious 
offences and offenders. For example, it requires parties 
to ensure that their courts take into account 
aggravating circumstances when sentencing offenders. 
The circumstances listed are illustrative, not 
exhaustive.9 Any discretionary powers to prosecute 
those offences must be exercised to maximize the 
effectiveness of law enforcement and with due regard 
to deter their commission. Parties must ensure that 
courts and other competent authorities bear in mind the 
serious nature of those offences and any aggravating 
circumstance when considering early release or parole 
of convicted offenders. Where prosecution for a serious 
offence must take place within a fixed period after the 
commission of the offence, the time limit must be 
longer if the alleged offender has evaded the 
administration of justice.  
17. The 1988 Convention seeks to put an end to safe 
havens abroad for persons committing serious drug-
related crimes. It requires parties to establish wide 
extraterritorial jurisdiction to make offenders 
accountable for serious offences wherever they are 
committed; to confiscate wealth derived from such 
offences, wherever those offences have been 
committed and wherever such wealth is held; to give 
and receive assistance from each other in serious 
offence investigations, prosecutions and judicial 
proceedings; and to investigate serious offences 
__________________ 
 9  They include factors such as involvement in the offence 
of any organized criminal group to which the offender 
belongs, the use of violence or arms, any victimization 
or use of minors, and commission of the offence in or 
around places used by students or children for education, 
sports or social activities. 
committed at home or abroad (with the other States’ 
agreement) using, for example, controlled delivery,10 
undercover operations,11 joint investigation teams and 
maritime cooperation.12  
18. The conventions differentiate sharply between 
offences related to drug trafficking and offences related 
to personal use of illicit drugs and between offences 
committed by drug abusers and those committed by 
others. Under the 1988 Convention, drug abusers who 
commit offences may be required to undergo treatment, 
education, aftercare, rehabilitation or social 
reintegration, in addition to being convicted or 
punished, providing that the facts and circumstances 
surrounding the commission of the offence indicate it 
to be an offence of a minor nature. However, with 
offences involving the possession, purchase or 
cultivation of illicit drugs for the offender’s personal 
use, the measures can be applied as complete 
alternatives to conviction and punishment, and none of 
the convention obligations referred to in 
paragraphs  15-17 above apply to such offences. As 
such, the conventions recognize that, to be truly 
effective, a State’s response to offences by drug 
abusers must address both the offences and the abuse 
of drugs (the underlying cause). 
 
 
__________________ 
 10  Controlled delivery is the investigative technique of 
allowing illegal or suspicious consignments of, for 
example, illicit drugs (sometimes other substances are 
substituted for the illicit drugs), to pass out of, through 
or into one or more countries with the knowledge or 
under the supervision of their competent authorities with 
a view to identifying those involved in the commission 
of serious offences. 
 11  Undercover operations involve allowing law 
enforcement to operate covertly outside their agencies 
(for example, buying illicit drugs) but under the 
supervision of their competent authorities with a view to 
catching persons committing serious offences. 
 12  Maritime cooperation is used to address the problem of 
drug smuggling by sea, with a view to allowing the 
authorities of an intervening State to board and search a 
vessel when there are reasonable grounds to suspect that 
it is engaged in trafficking; if evidence is found, the 
intervening State may be authorized to take appropriate 
action with respect to the vessel and the persons and 
cargo on board. 
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 C. Proportionate prosecution, sentencing 
and alternatives  
 
 
19. Prior to the adoption of the 1988 Convention, 
some States were considered safe havens for traffickers 
or their criminally derived wealth. The agreed aims of 
the 1988 Convention include giving urgent attention 
and the highest priority to the suppression of drug 
trafficking as an international criminal activity, 
eliminating the main incentive for it by depriving 
traffickers and their helpers of the large financial 
profits and wealth generated by it and coordinated 
action to eradicate it (a collective responsibility of 
States). Central to achieving those aims is the 
proportionate use of the penalties and sanctions 
referred to in the convention, such as deprivation of 
liberty, non-custodial penalties (for example, fines) and 
sanctions (for example, confiscation). The convention 
aims to ensure that the measures will be implemented 
more strictly against those whose authority, functions, 
share of profits and criminal culpability are considered 
the most serious. As control, authority, profit-sharing 
and overall criminal culpability diminish down the line 
and the scope of operations is reduced from the 
international level to the national and local 
(community) levels, the penalties and sanctions may 
progressively be reduced to the end-user. The 
convention treats end-users as accountable criminal 
offenders and, as indicated in paragraph 18 above, in 
terms of penalties and sanctions, treats offences related 
to personal use as less serious offences than offences 
related to drug trafficking. 
20. The growing complexity and international scale 
of serious crime have forced criminal justice officials 
to fundamentally rethink traditional approaches and 
processes and expand their case disposal options. Other 
factors behind that development have been the demand 
for new, better and more flexible ways to deal with 
growing socio-economic phenomena such as drug 
abuse and the recognition that criminal law alone 
cannot adequately control all criminal activities 
associated with drug abuse. Growing backlogs in 
justice system casework, overcrowded prisons, human 
rights concerns and demand for government services to 
make better use of resources have added to the 
pressure. 
21. As a result, most societies now expect that 
anyone accused of a crime will be dealt with 
proportionately and in full compliance with the rule of 
law and human rights standards. To that end, appeal 
courts are increasingly correcting injustice and curbing 
excessive punishment in most countries. More 
authorities now prioritize their casework so that not 
only street offenders, but also crime bosses whose 
hands never touch the trafficked drugs are brought to 
justice. More States enable their authorities to apply a 
range of custodial and non-custodial sanctions for 
drug-related offences to fit the particular crime and the 
particular offender, rather than operate on the basis of 
“one size fits all”. Those sanctions may be 
correctional, restorative or both.  
22. Some States have also changed their laws, 
practices or procedures to help their criminal justice 
systems to achieve more effective case outcomes and 
not just more efficient case processing; to become 
more forward-looking; to be more focused on problem-
solving and reducing future offending, instead of being 
focused on punishment alone; to be more interest- or 
need-based, instead of being just rights-, claim- or 
case-oriented; and to be more interdependent and 
collaborative in working with other authorities, 
agencies and communities affected by cases. Those 
reforms have helped to make responses to some 
offences more proportionate, particularly certain lower-
level offences committed by drug abusers. 
Nevertheless, disproportionate responses remain; some 
examples in relation to drug-related offences are 
described below. 
 
  Prisons  
 
23. According to data collected between the 
beginning of 2004 and the end of 2006, over 
9.2  million people are held in penal institutions 
throughout the world for criminal offences, whether 
drug-related or not, mostly as pretrial detainees but 
also as sentenced prisoners. Prison population rates 
vary widely between countries and regions from the 
global average of 139 per 100,000 total population. In 
most countries, prison occupancy rates exceed 
available prison capacity. In most countries, the prison 
population is growing; in some countries, however, it 
has fallen.13 
__________________ 
 13  Roy Walmsley, World Prison Population List, 7th ed. 
(London, International Centre for Prison Studies, Kings 
College, 2006). 
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24. The international drug control conventions 
require parties to make the commission of serious 
offences liable to sanctions such as imprisonment or 
other forms of deprivation of liberty, pecuniary 
sanctions and confiscation – sanctions that take into 
account the grave nature of those offences. The list of 
sanctions is illustrative (not exhaustive) and alternative 
(not cumulative). The conventions do not oblige parties 
to make the commission of a specific offence liable to 
imprisonment, another offence liable to a fine, another 
liable to confiscation or yet another liable to all three. 
They rightly leave the choice to States because 
criminal responsibility and the scale, severity and 
impact of different offences always vary according to 
the facts and circumstances of each case. 
25. In meeting the conventions’ aims of suppressing 
illicit drug trafficking and depriving those involved of 
the profits, a sanction such as imprisonment will be 
appropriate in many cases, but it may be inappropriate 
in others. For example, the organization, management 
and carrying out of large-scale trafficking in illicit 
drugs and precursors, money-laundering and related 
serious offences should normally result in substantial 
prison sentences and confiscation. However, there is no 
universal moral instinct about what is right or wrong 
when it comes to punishment in less serious cases. The 
conventions expressly permit but do not oblige each 
party to punish an offender if its domestic authorities 
consider the offence an appropriate case of a minor 
nature or, in the case of a drug-abusing offender, if the 
offence is the possession, purchase or cultivation of 
illicit drugs for personal use. Thus, provided the 
minimum convention requirements are met, the 
decision to make any such offence punishable in those 
circumstances, particularly by imprisonment, is left to 
the discretion of each State.14 
26. Nevertheless, many States do impose 
unconditional imprisonment on drug abusers for such 
lesser offences, and such offenders typically account 
for a significant proportion of the growing prison 
__________________ 
 14  For example, under United States federal law, unlawful 
possession of illicit drugs for a defendant’s own use is 
subject to mandatory minimum terms of imprisonment 
under 21 U.S.C. § 844(a). In Brazil, under Law 
No. 11.343 of 23 August, 2006, a person who unlawfully 
buys, holds, stores, transports or carries illicit drugs for 
personal use is subject to warning, educational measures, 
community service and, in certain cases, fines, but not 
imprisonment. 
population in some of those countries. Contrary to the 
United Nations standards and norms in crime 
prevention and criminal justice, (in particular, the 
United Nations Standard Minimum Rules for the 
Administration of Juvenile Justice (the Beijing 
Rules))15 young drug offenders and first offenders are 
sent to prison not as a last resort but as a first resort; 
young prisoners are not kept separate from adult 
prisoners, nor are untried offenders kept separate from 
sentenced prisoners; places where prisoners live or 
work may be overcrowded and have poor lighting, 
ventilation, sanitation or hygiene facilities; and the 
services of at least one qualified doctor and adequate 
pharmaceutical supplies and psychiatric services may 
not be available. Moreover, unless closely supervised, 
prisons can become markets for illicit drugs and 
consequently increase the scale and severity of drug 
abuse, as well as the incidence of HIV and other 
diseases. Governments have a responsibility to reduce 
the availability of illicit drugs in prisons, provide 
adequate services for drug offenders (whether in 
treatment services or in prison) and minimize the 
possibility of some penal institutions functioning 
unintentionally as informal learning centres from 
which inmates leave with greater criminal expertise 
than when they entered.16 
 
  Proportionality and prosecution decision-
making 
 
27. When the Board addressed implementation issues 
with drug abuse and the criminal justice system in its 
report for 1996,17 some of its suggestions and 
recommendations indirectly touched on decisions of 
whether to investigate and prosecute a drug offence 
case or to dispose of it in some other way. Those 
decisions are among the most important and sensitive 
to be made. Each has an impact on the proportionality 
of a State’s response to drug offences in general and to 
each offence and offender in each particular case. 
__________________ 
 15  General Assembly resolution 40/33, annex. 
 16  For example, paragraph 9 of the Basic Principles for the 
Treatment of Prisoners (General Assembly 
resolution 45/111, annex) states that prisoners should 
have access to the health services available in the 
country without discrimination on the grounds of their 
legal situation. 
 17  Report of the International Narcotics Control Board for 
1996 …, paras. 22 and 24. 
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28. Under the basic legal system of some countries, 
all offences must be automatically prosecuted if there 
is enough evidence (strict legality systems). Police 
must report all cases to prosecutors, and prosecutors 
refer all prosecutable cases to the courts. In other 
countries, the police may have some discretion about 
possible further action,18 though those police powers 
are not always used.19 Some States that did not 
previously allow discretion now do so.20 Prosecuting 
or judicial authorities have wider discretion to take no 
further action, initiate or divert from prosecution or 
take other action, such as reducing charges or 
discontinuing prosecution (expediency systems). If 
they decide not to prosecute, they can impose 
conditions on offenders.21 If those conditions are not 
met, prosecution may resume. Many ministries of 
justice and prosecution services and some international 
organizations have issued decision-making guidelines 
for prosecution and diversion-related decisions. 
__________________ 
 18  Prosecution-related decisions are taken not just on the 
basis of evidence of a prosecutable case, but also after 
carefully weighing all relevant factors for and against 
prosecution, which normally include the nature and 
seriousness of the offence, the interests of any victims 
and the wider community and the circumstances of the 
offender. The relevance and weight given to each factor 
normally depend on all the facts and circumstances of 
each case. 
 19  As in, for example, Finland and Sweden, perhaps 
because of the perceived deterrent effect of prosecution 
and the higher level of social sanction against drug 
abuse (European Monitoring Centre for Drugs and Drug 
Addiction, Prosecution of Drug Users in Europe: 
Varying Pathways to Similar Objectives EMCDDA 
Insights Series, No. 5 (Luxembourg, Office for Official 
Publications of the European Communities, 2002), 
p. 20). 
 20  In Belgium, for example, the principle of expediency has 
operated since its introduction in 1998. In practice, the 
police exercise discretionary powers to divert drug users 
from the system at the earliest point in Germany, the 
Netherlands, Portugal and Spain, stipulating that the 
public prosecutor, taking into account the criminal 
policy guidelines of the Minister of Justice and the 
Board of Prosecutors-General, must decide the 
expediency of prosecution (European Monitoring Centre 
for Drugs and Drug Addiction, Prosecution of Drug 
Users in Europe …, pp. 20 and 86-87). 
 21  For example, to refrain from using illicit drugs, 
frequenting specified kinds of places or associating 
unnecessarily with specified persons and to undergo 
medical, psychiatric or psychological treatment, 
including treatment for drug dependency. 
29. There are advantages and disadvantages to both 
discretionary and non-discretionary prosecution 
systems. Non-discretionary prosecution systems can be 
simpler to operate, give more consistent and 
predictable case outcomes and reduce the risk of 
corruption. As all cases must be prosecuted, however, 
minor cases can drive up costs, overload the justice 
system and divert resources from cases with potentially 
higher impact. Discretionary systems give flexibility to 
deal with cases cost-effectively with higher overall 
impact. But uncontrolled discretion can reduce 
predictability and consistency and tempt decision 
makers not to prosecute when they should.22 
Discretion can also lead to systematic administrative 
non-enforcement action23 or legislative action to curb 
administrative or judicial discretion and ensure more 
strict or uniform interdiction and sentencing of 
offenders.24 Both discretionary and non-discretionary 
systems can produce disproportionate outcomes.25 
__________________ 
 22  For example, due to corruption or to avoid either 
paperwork or the painstaking forensic work that 
effective investigation, prosecution and trial entail. 
 23  In the Netherlands, for example, the police do not 
normally investigate cases involving possession of 
cannabis for personal use, as possession of cannabis in 
small quantities is tolerated in coffee shops, in certain 
conditions. 
 24  In the United States, for example, there is the Sentencing 
Reform Act of 1984. The United States Congress enacted 
mandatory minimum sentencing laws, under which 
judicial authorities must order fixed sentences for those 
convicted of offences largely involving drug and 
weapons and for recidivist offenders, regardless of 
culpability or other mitigating factors. Mandatory drug 
sentences are determined on the basis of three factors: 
the type of drug, the weight of the drug mixture (or the 
alleged weight in conspiracy cases) and the number of 
prior convictions. Judges are unable to consider other 
important factors such as the offender’s role, motivation 
and the likelihood of recidivism. A defendant may 
reduce the mandatory minimum by providing the 
prosecutor with “substantial assistance” (information 
that aids the Government in prosecuting other 
offenders). 
 25  For example, in a discretionary system, a government 
leader caught accepting bribes from a drug trafficker 
may keep the bribes and escape prosecution because 
improper pressure is brought to bear on the decision 
maker. In a non-discretionary system, a student caught 
experimenting with drugs may forfeit his or her future 
professional career if the law offers no options other 
than arrest, pretrial detention, prosecution and 
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30. All responses to drug-related offences by States 
must comply with the conventions and not result in any 
weakening of the implementation of the conventions. 
Whether States have discretionary or non-discretionary 
prosecution systems, the minimum convention 
requirements should be met in all cases. For the 
response to be proportionate in the context of the 
international drug control conventions, prosecutable 
serious offence cases should in general be prosecuted, 
unless the circumstances indicate that a case is of a 
minor nature. If it is a case of a minor nature or a case 
involving an offence related to personal use, it should 
be either prosecuted or conditionally disposed of using 
alternatives to formal trial and adjudication. Any 
discretionary decision of whether or not to prosecute 
should be governed by a legal or regulatory framework 
that guides the exercise of discretion to ensure fairness 
and consistency, so that all people are equal before the 
law and are treated equally when suspected of 
committing a criminal offence. 
 
  Proportionate sentencing and alternative 
disposal of drug-related casework 
 
31. The nature and severity of the penalties and 
sanctions applied by a State are therefore critical in 
assessing whether the principle of proportionality is 
satisfied in the State’s response to drug-related 
offences in general or to any particular case. As 
indicated in paragraphs 13-18 above, trafficking-
related offences must be treated as offences of a grave 
nature, with sanctions that adequately reflect the 
seriousness of those offences. The international drug 
control conventions do not specify what precise 
procedure or process each party should follow or what 
particular penalty, sanction or alternative to apply to a 
particular offender in a particular case. Providing the 
aims and requirements of the conventions are met, 
States can generally use their own processes and 
procedures and apply the different penalties, sanctions 
and alternatives they determine – according to their 
own laws, moral and cultural traditions, legal systems 
and the facts and circumstances of each case. 
32. The internationally recognized United Nations 
standards and norms in the treatment of prisoners, 
alternatives to imprisonment, the use of force by the 
police, juvenile justice and the protection of victims 
provide useful guidance for States in deciding what 
__________________ 
unconditional prison. 
custodial and non-custodial penalties and sanctions to 
adopt and apply, for what offences, to which offenders, 
in what circumstances and at what stage of the criminal 
justice process. The United Nations Standard Minimum 
Rules for Non-custodial Measures (the Tokyo Rules)26 
are the agreed international standards in setting and 
appropriately applying penalties, sanctions and non-
custodial alternatives, and the United Nations Standard 
Minimum Rules for the Administration of Juvenile 
Justice (the Beijing Rules)27 deal specifically with 
those and other issues in the juvenile justice context. 28 
33. At the pretrial stage, the Tokyo Rules provide 
that, where appropriate and compatible with the legal 
system, the police, prosecution service or other 
authorized agency should be empowered to discharge 
the offender if they consider it is unnecessary to 
proceed with the case for the protection of society, 
crime prevention or the promotion of respect for the 
law and the rights of victims. Criteria should be 
developed within each legal system to guide decisions 
on appropriateness of discharge or determination of the 
proceedings. For minor cases, the prosecutor may 
impose suitable non-custodial measures, as appropriate 
(rule 5.1). Pretrial detention should be used as a means 
of last resort in criminal proceedings, with due regard 
for the investigation of the alleged offence and for the 
protection of society and the victim. Alternatives to 
pretrial detention should be employed at as early a 
stage as possible and pretrial detention should last no 
longer than necessary (rule 6.2).  
34. At the sentencing stage, the authorities may 
dispose of cases by custodial sentence or, where 
appropriate, a non-custodial alternative. For custodial 
sentences and fines for serious drug-related offences, a 
range of variable severity is often set – usually with a 
maximum and sometimes also with a mandatory 
minimum. The penalties and sanctions may vary 
according to the specific drug or class of drugs used, 
along the lines of the calibrated risk-benefit drug 
classification system of the conventions (see 
__________________ 
 26 General Assembly resolution 45/110, annex. 
 27 General Assembly resolution 40/33, annex. 
 28 This may require innovative risk management. For 
example, where a suspect has no readily identifiable 
place of residence, the community may be able to take 
greater responsibility for ensuring that he or she 
complies with the release conditions and does not flee 
from justice. 
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paragraph  12 above), so that higher penalties and 
sanctions apply for strictly controlled drugs and lower 
ones for less strictly controlled drugs. To be reliable 
and fair, quantity-based sentencing systems must be 
supported by appropriate technical facilities and 
adequate financial and human resources.  
35. Non-custodial sanctions at the sentencing stage 
under the Tokyo Rules include deprivation of liberty 
while the offender continues to live in the 
community.29 Economic sanctions and monetary 
penalties such as fines may be imposed, which if 
unpaid may lead to imprisonment. Finally, at any stage, 
non-custodial sanctions may include verbal sanctions 
such as admonition, reprimand and warning. 
36. The demand for Governments to be more 
effective in their drug control work is difficult to meet, 
especially when resources are limited. In some 
countries, justice, health-care, education and social 
systems often struggle to provide basic public services. 
There may not be enough courts, judges, lawyers, 
support staff or equipment to promptly and 
__________________ 
 29 For example, a sentence may be imposed and recorded 
but suspended for a specified time. An offender may also 
be conditionally discharged (that is, acquitted and not 
punished), provided that he or she complies with certain 
conditions: the offender may be allowed to continue to 
live in the community under the supervision of a judicial 
authority, probation service or other similar body, 
provided that he or she attends a certain course, therapy 
or treatment programme. A decision may be taken not to 
pass sentence on condition that the offender undertakes 
some action, such as undergoing treatment for 
alcoholism or drug addiction or receiving psychological 
counsel. The offender may be placed under house arrest 
and obliged to live in a certain place (normally his or her 
place of residence) under the supervision of a 
specialized agency and cannot change his or her place of 
residence, work or education without the permission of 
the supervising body. Curfews and other restrictions may 
be imposed on the offender’s travel, movement or right 
to associate with particular individuals. Restrictions may 
be placed on other rights, such as the right to take up 
certain types of employment or to occupy specific 
positions in government. The judge may order the 
offender to work without compensation, usually in an 
agency or organization, for the benefit of the community. 
The court may also direct an offender to spend a fixed 
number of hours each day in an attendance centre for a 
specified period undertaking a structured programme to 
address his or her offending behaviour in a group 
environment. 
independently confirm that each detention is lawful 
and appropriate and that each offender is either tried 
within a reasonable period or released. The trial court 
may lack access to legislation, case law, information to 
guide sentencing and other basic materials. If the trial 
eventually takes place, offenders might be without a 
defence lawyer. If a prison sentence is imposed, 
community care standards might not be followed in the 
prison. If imprisoned drug-abusing offenders are 
returned to the community, they might pose an even 
greater criminal threat and become even more 
problematic drug abusers. Meanwhile, many of the 
United Nations standards and norms in crime 
prevention and criminal justice, particularly those 
outlined in paragraph 26 above, may manifestly not be 
met. 
 
 
 D. Equality before the law 
 
 
37. Equality before the law is a universal human 
right.30 As everyone has duties to the community, 
article 29 of the Universal Declaration of Human 
Rights permits the exercise of human rights and 
freedoms to be limited, but only by law, solely for the 
purpose of securing due recognition of the rights and 
freedoms of others and of meeting the just 
requirements of morality, public order and the general 
welfare in a democratic society. 
38. Due respect for universal human rights, human 
duties and the rule of law is important for effective 
implementation of the international drug control 
conventions. Non-respect for them can prejudice the 
ability of the criminal justice system to enforce the 
law, can lead to discriminatory disproportionate 
responses to drug offending and can undermine the 
conventions.31 Presented below, is a review of several 
__________________ 
 30 Universal Declaration of Human Rights, articles 7 and 
10; and International Covenant on Civil and Political 
Rights (General Assembly resolution 2200 A (XXI), 
annex), articles 2, 3 and 26. 
 31 For example, if human rights are not properly respected 
by the police, public trust may erode to the point that 
proactive community policing initiatives against local 
drug problems become impossible. The loss of 
cooperation and vital information from the community 
may reduce the ability of the justice system to 
successfully disrupt the operations of the drug 
trafficking groups involved. 
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situations where some drug offenders can be treated 
more or less equally than others before the law.  
 
  Higher-level offenders 
 
39. Because of their resources, some powerful drug 
criminals have been able to compromise justice 
systems. In its report for 1996, the Board touched on 
how that could lead to a sense of injustice in the 
community and undermine public confidence in the 
criminal justice system.32 In too many places, such 
powerful drug crime figures can easily cross borders, 
cover their tracks, set different justice systems against 
each other and kill, bully and corrupt in the process. 
40. Bringing to justice powerful drug traffickers and 
dismantling their networks are resource-intensive, 
painstaking and dangerous undertakings. The 
traffickers are usually careful never to touch the drugs 
and are difficult to convict unless they are caught red-
handed. The cases can be complex to investigate; they 
often involve transactions made abroad in an effort to 
disguise or hide wealth derived from drug trafficking. 
Strong laws targeting criminal associations and 
conspiracies are usually needed to ensure the 
conviction of the persons involved and the confiscation 
of their criminally derived wealth. Such cases can also 
require substantial international law enforcement and 
justice system cooperation because of all the sensitive 
intelligence, evidence and operational action needed 
for success. By comparison, smaller cases involving 
drug trafficking are typically more easily proved and 
less ably defended than cases involving major drug 
traffickers. Add to all that demands on justice systems 
to be more accountable for their budgets and 
performance, and the result can be strong pressure on 
the authorities to focus more on low-level offenders 
and less on persons higher up in the drug trafficking 
chain. 
41. A month before he was killed in Medellin, the 
Colombian drug dealer Pablo Escobar was ranked as 
one of the richest men in the world. At the height of his 
power, his Medellin cartel controlled 80 per cent of the 
world’s cocaine market and was estimated to be 
receiving billions of dollars annually from its cocaine 
operations. Escobar ruthlessly applied a strategy of 
plata o plomo (accept a bribe or face assassination) to 
__________________ 
 32 Report of the International Narcotics Control Board for 
1996 …, para. 4-6. 
intimidate politicians, government officials and judges. 
Anyone viewed as a threat was executed. As a result, 
hundreds were killed; some were killed by Escobar 
himself. In 1991, Escobar reached an agreement with 
the Colombian authorities whereby, in return for 
turning himself in and discontinuing his drug 
trafficking activities, he would: receive a guarantee 
that he would not be extradited to the United States of 
America; and he would spend five years in a prison in 
Colombia that he would build for himself. After 
pictures of his luxurious prison residence were 
published, Escobar escaped, fearing that he would be 
extradited to the United States. Without the agreement, 
Escobar might never have been held accountable in any 
way for his actions. Colombia’s drug control efforts 
have accomplished much since then. Although now 
only of historical significance, the Escobar case 
typifies some of the major problems still faced by 
many States in bringing to justice powerful drug 
traffickers and their supporters.  
42. In Afghanistan, drug warlords still operate with 
relative impunity. Afghanistan produces some 92 per 
cent of the world’s illicit opium,33 and has a virtual 
monopoly over the world’s illicit market for opiates, 
valued at billions of dollars.34 Attempts to hold 
Afghanistan’s drug traffickers and their foreign 
partners accountable have been mainly limited to 
domestic and international security efforts and some 
international law enforcement efforts. Those efforts 
have been hampered within Afghanistan by the security 
situation, lack of effective control in several important 
parts of the country beyond the capital and 
compromises made in the system of justice. But 
political and security responses or alliances alone 
cannot be effective against major drug traffickers, their 
operations and their assets. As a result, little has been 
achieved in efforts to counter drug trafficking in 
Afghanistan. The Board has, in its reports, urged those 
supporting Afghanistan to increase their assistance to 
the country to achieve greater success.  
__________________ 
 33 World Drug Report 2007 (United Nations publication, 
Sales No. E.07.XI.5), fig. 13. 
 34 UNODC estimated the global illicit market for opiates, 
measured at wholesale prices, to be US$ 20.6 billion in 
2003 (US$ 64.8 billion measured at retail prices) (World 
Drug Report 2005 (United Nations publication, Sales 
No. E.05.XI.10), vol. 1, p. 17). 
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43. A number of other countries have difficulty 
holding accountable major drug traffickers. Experience 
has shown that all major drug traffickers, including 
those who are warlords, take sophisticated steps 
wherever needed to distance themselves from their 
crimes and their ownership of wealth. 
44. In the Board’s view, when a State cannot fully 
deal with the situation in its entire territory concerning 
major drug traffickers, much more could be done by all 
other States in which the traffickers hide their 
criminally derived wealth. Those States could take 
collective responsibility and, together with the 
trafficker’s home State, take steps to trace, freeze, 
seize and ultimately confiscate such wealth, regardless 
of where in the world it is held. That would require 
determined, secure and well-coordinated action by 
their law enforcement, financial and criminal justice 
authorities, particularly in sharing intelligence and 
evidence with States in a position to take effective 
action to confiscate such wealth. States might also give 
consideration to sharing such confiscated property with 
other parties, pursuant to article 5, paragraph 5 (b) (ii), 
of the 1988 Convention.  
 
  Lower-level offenders 
 
45. In its report for 1996, the Board called on 
Governments to take a more strategic approach to 
tackling drug trafficking, in order to prevent their 
justice and prison systems from being overloaded by 
low-level offender casework and to ensure that major 
drug trafficking operations were disrupted and put out 
of business.35 At the time, the Board noted that many 
law enforcement agencies did not have the resources or 
skills to do more than apprehend street sellers and 
individual drug abusers, leaving intact the structure, 
financing and management of the illicit drug 
production chain. Eleven years later, that still appears 
to be the case in many countries.  
46. Appropriate enforcement of the law in cases 
involving minor offences can also prevent minor crime 
from escalating into major crime (the “broken window 
principle”).36 However, enforcing the law against 
__________________ 
 35 Report of the International Narcotics Control Board for 
1996 …, para. 6. 
 36 The “broken window principle” became a metaphor for a 
successful strategy to prevent vandalism, by fixing the 
crime problems when they are still small, before the 
problems escalate. According to the principle, if a vandal 
minor offenders only is contrary to the conventions, 
and contrary to the principle of proportionality.  
 
  Celebrity drug offenders  
 
47. More people than ever before can now routinely 
follow, through the media, the behaviour of 
well-known public figures from the world of sport or 
the entertainment industry or the performing arts. In 
general, the more iconic a person is in his or her 
culture and the more dramatic the behaviour, the higher 
the level of interest of the media and the public. 
48. When such celebrities use illicit drugs, they break 
the law. Depending on how the authorities respond in 
the case, the media reports and associated Internet 
chatter often reflect or generate perceptions that the 
system has treated the celebrity concerned, by virtue of 
his or her celebrity status, more leniently than others.  
49. Celebrity drug offenders can profoundly 
influence public attitudes, values and behaviour 
towards drug abuse, particularly among young people 
who have not yet taken a firm and fully informed 
position on drug issues. Cases involving celebrity drug 
offenders can also profoundly affect public perceptions 
about the fairness and proportionality of the response 
of the justice system, especially if there is a less lenient 
response to similar or lesser offences committed by 
non-celebrities. 
 
 
 E. Teamwork involving the justice and 
health-care systems 
 
 
50. The principle of proportionality applies to all 
aspects of a country’s response to drug abuse problems, 
including the prevention and treatment of drug abuse. 
When prevention and treatment do not succeed and 
drug abusers come into contact with the criminal 
justice system, proportionality requires an 
interdisciplinary response. Although drug addiction is a 
recognized medical condition brought on by use, it is 
not a legal excuse for committing crime.  
51. An addicted person will do almost anything, even 
commit crime, to obtain the drug. Therefore, responses 
__________________ 
who breaks a window is caught and made to repair the 
broken window within a short time, say, within a week, 
the vandal is much less likely to break more windows or 
do further damage. 
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by States need to address both the offending and the 
drug abuse (the underlying cause). Anything less does 
not meet the aims and requirements of the conventions 
and does not satisfy the principle of proportionality.  
52. Drug-related crime committed by drug abusers 
needs to be addressed in an integrated and 
individualized way:37 integrated because such crime is 
inextricably linked to drug abuse; and individualized 
because there is no single treatment that is appropriate 
for all individuals. No single justice system measure 
can prevent reoffending. No justice, health-care, 
education, social or employment system alone has the 
remit or resources to deliver both; however, by 
working together with all relevant actors in the public, 
private and community sectors, it can be done. It is 
best done when there are clear and detailed guidelines 
for action that are integrated and coordinated 
vertically, as well as horizontally, among the various 
actors.  
53. In the Board’s view, the work and impact of drug 
treatment courts, as one example, confirm the value of 
the integrated approach with certain types of offences 
and offenders that justice and health-care systems 
agree are appropriate for diversion to treatment. Drug 
treatment courts aim to stop drug abuse and related 
criminal activity of offenders through court-directed 
treatment and rehabilitation programmes. Eligible 
participants undergo treatment and rehabilitation 
programmes instead of traditional final sanctions such 
as imprisonment. The programmes demand a high level 
of accountability on the part of the offender, and 
potential participants often prefer imprisonment, as it 
is the less demanding alternative. The court’s 
multidisciplinary team (from the justice and health-
care systems), led by the judge, oversees each 
participant’s progress throughout the programme. 
Programme compliance is objectively monitored by 
__________________ 
 37 In its report for 1996, the Board reiterated that drug 
abuse must be dealt with simultaneously from the 
different perspectives of law enforcement, prevention, 
treatment and rehabilitation. The Board expressed its 
belief that increased cooperation between the judicial, 
health and social authorities is a necessity to provide a 
bridge between the penal and health systems and called 
on Governments to examine more closely the 
alternatives to prison developed in different parts of the 
world, bearing in mind the different legal philosophies 
and systems (Report of the International Narcotics 
Control Board for 1996 …, paras. 24 and 26). 
frequent substance-abuse testing. Compliance is 
rewarded and non-compliance is sanctioned. Relapse 
into drug abuse is not usually punished because some 
relapse can occur on the long journey towards 
sustained recovery. However, any dishonesty on the 
part of the offender about relapse is sanctioned. Such 
sanctioning may be in the form of a very short 
custodial sanction aimed at helping the offender to 
focus on and address any lingering failure to take 
responsibility for his or her own recovery – a key 
obstacle to making real progress towards sustained 
recovery. Successful completion may lead to 
suspension or dismissal of the criminal case, a non-
custodial sentence or probation. Repeat offending or 
other serious programme non-compliance usually leads 
to expulsion, and the offender is then dealt with in the 
traditional manner in the criminal justice system. 
54. In a growing number of countries,38 courts apply 
key principles in court-directed treatment and 
rehabilitation programmes. The courts do not all 
operate the same way, and what works best in one 
place may not work in another. Some are separate, 
newly established courts, while others are existing 
courts with specially adjusted procedures. There is no 
single, universal model, and they have evolved in 
different forms to suit different needs, legal systems, 
localities and available resources. Key differences 
include eligibility to participate, when the case is 
diverted, and programme outcomes; however, the core 
characteristics are the same.  
55. Applying the principles of drug treatment courts 
increases the cost of dealing with drug-abusing 
offenders (because of the court’s monitoring of 
programme compliance), and the cost of treatment. 
However, evaluation of the work and impact of such 
courts shows that they are generally better at retaining 
drug-abusing offenders in treatment and at reducing 
recidivism and are often more cost-effective than other 
alternatives.39 Success factors appear to include 
effective judicial leadership of the drug treatment court 
team; strong interdisciplinary team collaboration, with 
__________________ 
 38 For example, in Australia, Barbados, Bermuda, Brazil, 
Canada, Chile, Ireland, Jamaica, New Zealand, Norway, 
Trinidad and Tobago and the United States. 
 39 United States, Government Accountability Office, Adult 
Drug Courts: Evidence Indicates Recidivism Reductions 
and Mixed Results for Other Outcomes, GAO report 
GAO-05-219 (Washington, D.C., 2005). 
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each team member maintaining professional 
independence; among the team members from the 
justice system, good knowledge of addiction, treatment 
and recovery; among the team members from the 
health-care system, good knowledge of criminality; an 
operational manual for consistency and efficiency; 
clear criteria for the eligibility of participants, with 
objective screening of potential participants; detailed 
assessment of each potential participant; fully informed 
and documented consent of each participant to be 
admitted to the drug treatment court programme; 
speedy referral of participants to treatment and 
rehabilitation following arrest; swift, certain and 
consistent sanctions for programme non-compliance 
and rewards for compliance; ongoing programme 
evaluation and willingness to make improvements; 
sufficient, sustained and dedicated drug treatment court 
funding; and changes in the underlying substantive or 
procedural law, if necessary or appropriate. 
56. Treatment, rehabilitation and reintegration of 
drug-abusing offenders are effective and sustainable 
only when well tailored to ensure the offender’s 
recovery and non-recidivism. The Board notes that 
programmes for the treatment of drug abuse need 
careful policy consideration, clearly articulated 
programme objectives and a built-in evaluation 
component. The programmes need to include relapse 
prevention and aftercare following primary treatment. 
Success will also depend on the expertise of those 
conducting the programmes, the availability of places 
in suitable facilities and close cooperation between the 
criminal justice and health agencies. Adequate 
resources need to be allocated to maximize the chances 
of success. Treatment services for drug abuse should 
also be made available within the prison system.40 
57. The Board notes that although the provision of 
treatment for drug abusers on a voluntary basis is 
desirable, such treatment does not need to be voluntary 
to be effective. Strong motivation can facilitate the 
treatment process. The Board has emphasized that a 
drug-abusing offender’s encounter with the criminal 
justice system can provide a valuable opportunity to 
motivate the person to undergo treatment.41 The 
conventions permit the courts to use their authority and 
sanctioning powers creatively in an appropriate case to 
__________________ 
 40 Report of the International Narcotics Control Board for 
1996 …, paras. 29-31. 
 41 Ibid., para. 30. 
help retain an offender in treatment, improve the 
prospects of the treatment succeeding and strengthen 
public safety by reducing the offenders drug abuse and 
propensity to reoffend. Finally, the Board notes the 
good results achieved in some countries where the 
justice and health-care systems cooperate closely to 
provide mandatory treatment for drug abusers in 
prisons.  
 
 
 F. Recommendations 
 
 
58. The international drug control conventions 
encourage and facilitate proportionate responses by 
States to drug-related offences and offenders. 
Disproportionate responses undermine the aims of the 
conventions and undermine the rule of law. 
59. While many countries have made progress since 
the Board last addressed proportionality issues in its 
report for 1996, more remains to be done, particularly 
in targeting and dismantling major drug trafficking 
organizations. In several countries, there is a need to 
better balance law enforcement efforts, so that lower-
level offenders do not bear the brunt of justice while 
higher-level offenders are not brought to trial.  
60. In order to ensure more effective implementation 
of the conventions, the Board recommends that 
Governments that have not already done so should take 
the following measures:  
 (a) Law enforcement. Governments should 
ensure that law enforcement and justice systems give 
high priority to investigating, prosecuting and 
convicting those who control, organize, manage or 
provide production for major drug trafficking 
organizations. Services to counter money-laundering 
are also important in this regard. While close attention 
should also be paid to street-level trafficking and to 
crimes involving possession of illicit drugs, they 
should not be the only focus of law enforcement and 
judicial action; 
 (b) Assets of crime. Governments should ensure 
that appropriate legislation is in place to allow 
authorities to freeze and seize property and assets of 
drug traffickers and that the authorities give priority to 
such action. Cooperation among States and 
asset-sharing in cross-border cases should be 
emphasized in order to effectively dismantle the 
operations of major drug trafficking organizations; 
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 (c) Alternative sentencing. Governments should 
consider widening the range of custodial and non-
custodial options for drug-related offences by illicit 
drug users so that authorities can respond 
proportionately to the circumstances of each case. In 
some cases drug courts focusing on persons who 
frequently relapse into high-risk lifestyles and 
mandatory treatment programmes can offer drug-
abusing offenders effective alternatives to 
imprisonment; 
 (d) Penal and health-care systems. 
Governments should widen the availability of health-
care programmes and treatment programmes for drug 
abuse in prisons, many of which have been shown to 
be quite cost-effective and useful in decreasing 
recidivism. It is of the utmost importance that access to 
illicit drugs in prisons be terminated; 
 (e) Offences by public celebrities. The 
authorities of criminal justice and treatment 
programmes should ensure that public celebrities who 
violate drug laws are made accountable for their 
offences. Cases involving drug-abusing celebrities who 
are treated more leniently than others breed public 
cynicism and may lead to youth adopting a more 
permissive attitude towards illicit drugs; 
 (f) Mutual legal assistance. Governments 
should review and, if necessary, revise their laws, 
policies, procedures, resource allocations, priorities 
and infrastructures regarding international justice 
system cooperation. The practical results should be that 
States receiving requests for international justice 
system cooperation or assistance dealt with those 
requests as quickly, thoroughly and usefully as they 
would want their own requests to be treated by States. 
Requests should be limited to the essential assistance 
needed, so as not to unreasonably burden the receiving 
State that has to execute the request. To improve the 
quality, speed and effectiveness of the request-making 
process, the Board recommends that Governments, 
when appropriate, should make use of the Mutual 
Legal Assistance Request Writer Tool and the 
forthcoming extradition request writer tool of UNODC, 
as well as the UNODC guides on best practices in 
extradition, mutual legal assistance and confiscation 
casework; 
 (g) Resources. Governments should review 
their drug-related casework priorities, practices and 
procedures to ensure that resources for law 
enforcement, prosecution, court, and prison and 
correctional facilities are adequate for proportionate, 
effective action against drug-related crime. 
Governments should also consider increasing their 
support to help Governments of developing countries 
to enable their justice and health-care systems to deal 
more effectively with their drug-related offence 
casework; 
 (h) Information policies. Governments should 
ensure that the public and the media have access to 
facts and statistics concerning the use of the criminal 
justice system in response to drug trafficking and drug 
abuse. It is particularly important that the public be 
informed about effective treatment programmes for 
drug abuse and that health authorities make 
information widely available concerning the means and 
methods of treatment in order to encourage recidivist 
offenders to enter such programmes. 
61. In the light of the recommendations made in its 
report for 1996 and the recommendations above, the 
Board calls on Governments to comprehensively 
review the responses by their legislative, judicial and 
executive arms of government to drug-related offences, 
in order to ensure that they are proportionate, and to 
make appropriate changes to correct any shortcomings. 
The Board would appreciate receiving feedback from 
States on any such changes. 
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 II. Operation of the international drug control system 
 
 A. Narcotic drugs 
 
 
  Status of adherence to the Single Convention on 
Narcotic Drugs of 1961 and that Convention as 
amended by the 1972 Protocol 
 
62. Since the publication of the report of the Board 
for 2006, Andorra and the Democratic People’s 
Republic of Korea have become parties to the 
1961 Convention as amended by the 1972 Protocol. As 
at 1 November 2007, the number of States parties to 
the Single Convention on Narcotic Drugs of 196142 or 
that Convention as amended by the 1972 Protocol 
stood at 186. Of those States, 183 were parties to the 
1961 Convention as amended by the 1972 Protocol. 
Afghanistan, Chad and the Lao People’s Democratic 
Republic continue to be parties to the 1961 Convention 
in its unamended form only. The Board once again 
calls on those three States to accede to the 
1972  Protocol amending the 1961 Convention43 as 
soon as possible. A total of eight States have not yet 
become parties to the 1961 Convention: one State in 
Africa (Equatorial Guinea), one in Asia (Timor-Leste) 
and six in Oceania (Cook Islands, Kiribati, Nauru, 
Samoa, Tuvalu and Vanuatu). The Board reiterates its 
request to those States to become parties to the 
1961 Convention without further delay. 
 
  Cooperation with Governments 
 
  Submission of annual and quarterly statistical 
reports on narcotic drugs 
 
63. In performing the tasks assigned to it under the 
1961 Convention, the Board maintains a continuous 
dialogue with Governments. The statistical data and 
other information received from them are used by the 
Board in assessing the licit manufacture of, trade in 
and consumption of narcotic drugs worldwide, with a 
view to determining the extent of Governments’ 
compliance with treaty provisions requiring them to 
limit to medical and scientific purposes the licit 
manufacture of, trade in and use of narcotic drugs, 
while at the same time ensuring their availability for 
legitimate purposes. 
__________________ 
 42  United Nations, Treaty Series, vol. 520, No. 7515. 
 43  Ibid., vol. 976, No. 14151. 
64. Parties to the 1961 Convention have an obligation 
to furnish to the Board annual statistical reports on 
production, manufacture, consumption, stocks and 
seizures of narcotic drugs. They also have an 
obligation to submit to the Board quarterly statistics on 
imports and exports of narcotic drugs. As at 
1 November 2007, a total of 172 States and territories 
had submitted annual statistics on narcotic drugs for 
2006. That accounts for 82 per cent of the 211 States 
and territories required to furnish such statistics. A 
total of 187 States and territories provided quarterly 
statistics of imports and exports of narcotic drugs for 
2006; that figure represents 89 per cent of the 
211 States and territories requested to furnish those 
statistics. Details of the statistical data received, 
including the status of compliance by individual parties 
with their reporting obligations, are included in the 
2007 technical report of the Board on narcotic drugs.44  
65. The vast majority of States regularly submit the 
mandatory annual and quarterly statistics. However, 
the Board is concerned that many States, including 
some that are major manufacturers, importers, 
exporters or users of narcotic drugs, such as Ireland, 
Japan, the Netherlands and the United States, did not 
provide in 2007 the requested information in a timely 
manner. The late submission of reports affects the 
ability of the Board to monitor licit activities related to 
narcotic drugs and delays the analysis by the Board of 
the worldwide availability of narcotic drugs for 
medical purposes, as well as its analysis of the global 
balance between the supply of opiate raw materials and 
the demand for opiates. 
66. In some countries, the delay in the submission of 
statistical data to the Board is the result of 
Governments providing insufficient resources to the 
authorities responsible for the control of licit activities 
related to narcotic drugs. The Board calls upon the 
Governments concerned to provide adequate resources 
to ensure the compliance of those authorities with all 
the reporting obligations under the 1961 Convention 
(see also paragraphs 236-241 below). 
__________________ 
 44  Narcotic Drugs: Estimated World Requirements for 
2008; Statistics for 2006 (United Nations publication, 
Sales No. E/F/S.08.XI.2). 
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67. When examining the statistics received from 
Governments, the Board brings to the attention of the 
Governments concerned inconsistencies observed in 
their reports and requests them to rectify such 
inconsistencies and resolve the problems that have led 
to those inconsistencies.  
68. The Board is always ready to assist Governments 
in complying with their reporting obligations under the 
1961 Convention. In 2007, as in previous years, the 
Board provided to several Governments, at their 
request, explanations on issues regarding reporting 
requirements. 
69. The Board prepared detailed training material on 
the control of narcotic drugs and guidelines on 
reporting on those drugs for use by national competent 
authorities. Those training materials are available on 
the website of the Board (www.incb.org). The methods 
of reporting were included in the training of national 
drug control administrators (see paragraph 185 below) 
and were dealt with during an informal consultation on 
reporting, organized for selected Governments by the 
Board during the fiftieth session of the Commission on 
Narcotic Drugs, in March 2007. 
70. All Governments are encouraged to seek from the 
Board any information that they may require 
regarding  the control of narcotic drugs under the 
1961 Convention, including reporting requirements. 
 
  Estimates of requirements for narcotic drugs 
 
71. The universal application of the system of 
estimates is essential to the functioning of the 
international control system for narcotic drugs. When 
Governments establish estimates that are too low, they 
run the risk of not having sufficient drugs available for 
medical treatment. Conversely, estimates that are 
inappropriately high may result in quantities of drugs 
being available in a country in excess of current 
requirements for medical use, which could facilitate 
the inappropriate use of drugs or even their diversion 
into illicit channels.  
72. The majority of Governments furnished to the 
Board by 1 November 2007 their estimated 
requirements for narcotic drugs for 2008. However, for 
a number of States and territories that did not provide 
their estimates in time for examination and 
confirmation, the Board had to establish estimates in 
accordance with article 12, paragraph 3, of the 
1961 Convention. The estimates for all countries and 
territories are published by the Board in its technical 
report on narcotic drugs. The updates of those 
estimates, which reflect, inter alia, supplementary 
estimates furnished by Governments, are made 
available on the website of the Board. 
73. The estimates established by the Board are based 
on the estimates and statistics reported in the past by 
the respective Governments. For Governments that 
have not provided estimates and statistics for several 
years, the estimates established by the Board are in 
some cases considerably lower than the estimates 
furnished by those Governments in the past, as a 
precaution in view of the risk of diversion. Therefore, 
the Governments concerned are urged to examine their 
requirements for narcotic drugs for 2008 and furnish 
their own estimates to the Board for confirmation, in 
order to prevent any possible difficulties in importing 
the quantities of narcotic drugs required for medical 
use in their countries.  
74. The Board examines the estimates received from 
Governments, including supplementary estimates, with 
a view to limiting the use of narcotic drugs to the 
amount required for medical and scientific purposes 
and ensuring adequate availability of those drugs for 
such purposes. When the estimates appear to be 
inadequate, the Governments concerned are requested 
to adjust their estimates. In 2007, most Governments 
promptly adjusted their estimates when the Board 
requested them to do so. 
75. The Board requests all Governments to determine 
their annual estimates of requirements for narcotic 
drugs as accurately as possible, so that resorting to 
supplementary estimates is reserved for unforeseen 
circumstances or when developments in medical 
treatment, including the use of new medications and 
scientific research, result in additional requirements for 
narcotic drugs. 
 
  Deficiencies in reporting statistics and estimates 
 
76. Problems encountered by Governments in 
furnishing adequate statistics and/or estimates to the 
Board are often an indication of deficiencies in their 
national control mechanisms for narcotic drugs and/or 
the health-care systems in the countries concerned. 
Such deficiencies often reflect problems in the 
implementation of the treaty provisions in those 
countries, for example lacunae in national laws or 
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administrative regulations or the failure of some 
licensees to comply with their obligations under 
national legislation, including their obligation to 
provide to the national authorities timely and accurate 
reports on their transactions involving narcotic drugs. 
The Board invites all Governments concerned to find 
the causes for deficiencies in reporting statistics and/or 
estimates to the Board, with a view to resolving those 
problems and ensuring adequate reporting. 
 
  Prevention of diversion into the illicit traffic 
 
  Diversion from international trade 
 
77. The system of control measures laid down in the 
1961 Convention provides effective protection of 
international trade in narcotic drugs against attempts at 
their diversion into illicit channels. In 2007, as in 
recent years, no cases of diversion of narcotic drugs 
from licit international trade into the illicit traffic were 
detected.  
78. The effective control of international trade in 
narcotic drugs depends to a large extent on the 
vigilance of exporting countries and their observance 
of the limits set in the system of estimates for narcotic 
drugs for the importing countries. While most 
Governments are fully implementing the system of 
estimates and the import and export authorization 
system, the Board identified in 2007 a few cases in 
which exports of narcotic drugs were authorized in 
excess of the estimates of the respective importing 
countries. Such exports did not comply with the 
provisions of article 31 of the 1961 Convention and 
could have resulted in the diversion of narcotic drugs 
into illicit channels. The Board has reminded the 
Governments concerned of their obligation to comply 
with the provisions of article 31 and has advised them, 
when authorizing exports of narcotic drugs in the 
future, to always consult the annual estimates of 
requirements for narcotic drugs for each importing 
country and territory, which are published by the 
Board. 
 
  Diversion from domestic distribution channels 
 
79. The diversion of pharmaceutical preparations 
containing narcotic drugs from domestic distribution 
channels and the subsequent abuse of those diverted 
preparations have become serious problems in many 
countries. The narcotic drugs most often diverted and 
abused include codeine, dextropropoxyphene, 
dihydrocodeine, fentanyl, hydrocodone, methadone, 
morphine, oxycodone, pethidine and trimeperidine. 
Data received from Governments suggest that in some 
countries there is a strong correlation between the most 
abused pharmaceutical preparations containing narcotic 
drugs and the availability of those preparations on the 
licit market. The Board calls on all Governments 
concerned to take effective measures to counter the 
diversion and abuse of pharmaceutical preparations 
containing narcotic drugs.  
80. Diverted pharmaceutical preparations containing 
narcotic drugs are also smuggled, for example, out of 
countries in Asia into the United States and into 
countries in Europe, where there is illicit demand for 
such preparations. Governments of countries in which 
those preparations are diverted from the domestic 
distribution channels should critically examine their 
estimates so that there is no excess of narcotic drugs, 
which could be diverted. 
81. In some countries, the abuse of pharmaceutical 
preparations containing narcotic drugs surpasses the 
abuse of illicitly manufactured drugs. For example, in 
the United States, the level of misuse of OxyContin® 
(containing oxycodone) reported in the 2006 National 
Survey on Drug Use and Health is more than twice as 
high as the reported level of abuse of heroin. The 
Board is particularly concerned about the high number 
of adolescents abusing those narcotic drugs. In the 
United States, about 10 per cent of students in their 
final year of secondary school (aged 17-18) reported 
having abused pharmaceutical preparations such as 
Vicodin® (containing hydrocodone) and OxyContin® in 
2006 (see also paragraph 98 below). The widespread 
prescription of those pharmaceutical preparations has 
contributed to the belief that those drugs might be safer 
than the illicitly manufactured drugs. The Board calls 
on the Government of the United States to give high 
priority in its drug abuse prevention programmes to 
preventing the abuse of pharmaceutical preparations 
containing narcotic drugs and to bring to the attention 
of adolescents the high risks associated with such 
abuse.  
 
  Scope of control 
 
  Control of oripavine 
 
82. On the recommendation by the World Health 
Organization (WHO), the Commission on Narcotic 
Drugs adopted decision 50/1, in which it decided to 
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include oripavine in Schedule I of the 1961 Convention 
and that Convention as amended by the 1972 Protocol. 
The Secretary-General, in his note verbale dated 
27 June 2007, informed all States that, pursuant to the 
provisions of article 3, paragraph 7, of the 
1961  Convention, Commission decision 50/1 had 
become effective with respect to each party on the date 
of its receipt of that note. The Board requests all States 
to implement without delay the provisions of the 
1961 Convention with respect to oripavine, including 
by complying with the system of estimates and 
providing statistical reports to the Board. 
 
  Ensuring the availability of drugs for medical 
purposes 
 
  Demand for and supply of opiates 
 
83. Pursuant to the 1961 Convention and relevant 
Economic and Social Council resolutions, the Board 
examines on a regular basis issues affecting the supply 
of, and demand for, opiates used for medical and 
scientific purposes. In cooperation with Governments, 
the Board strives to maintain a balance between supply 
of and demand for opiates for legitimate uses. A 
detailed analysis of the current situation with regard to 
supply of and demand for opiates for medical and 
scientific purposes worldwide is contained in the 
2007 technical report of the Board on narcotic drugs.45  
84. The Board recommends that global stocks of 
opiate raw materials be maintained at a level sufficient 
to cover global demand for about one year, in order to 
ensure the availability of opiates for medical needs in 
case of an unexpected shortfall of production and to 
reduce the risk of diversion associated with excessive 
stocks. Since the entry into force of the 
1961 Convention, Governments of producing countries 
have cooperated with the Board in seeking to maintain 
global stocks of the opiate raw materials at the level 
recommended by the Board. In the period 1999-2003, 
total production of opiate raw materials considerably 
exceeded global demand, resulting in stock levels that 
were higher than necessary. The Board, therefore, 
invited producing countries to reduce the production of 
opiate raw materials to prevent a further increase in 
global stocks. The Board appreciates that producing 
countries have adhered to its advice and contributed to 
the reduction of stocks. 
__________________ 
 45  Ibid. 
85. Stocks of opiate raw materials rich in morphine, 
which, at the end of 2005, had been higher than global 
demand for two years, were reduced to a level 
sufficient to cover global demand for about 21 months 
at the end of 2006.  
86. In 2006, there was an increase in stocks of 
thebaine and opiates derived from thebaine. At the end 
of 2006, global stocks of opiate raw materials rich in 
thebaine were sufficient to cover global demand for 
about eight months; in addition, stocks of thebaine and 
opiates derived from thebaine were sufficient to cover 
global demand for about 30 months. 
87. According to information available to the Board, 
in 2007, some of the excessive stocks of opiate raw 
materials will be used to cover global demand, which 
will be more than total production. For 2008, 
Governments of some producing countries are planning 
to increase the area cultivated with opium poppy, in 
order to cover increasing demand and to replenish 
stocks of opiate raw materials, where necessary. The 
total supply of opiate raw materials will continue to be 
sufficient to cover the demand. The Board urges 
Governments of producing countries to maintain the 
future production at the levels currently planned. 
88. Global demand continues to increase for both 
opiate raw materials rich in morphine and those rich in 
thebaine. It is anticipated that, as a result of the 
activities of the Board and WHO to ensure the 
adequate use of opioid analgesics, global demand for 
opiates and for opiate raw materials will rise further 
(see paragraphs 208-213 below). 
 
  Prevention of the proliferation of production of 
opiate raw materials 
 
89. Pursuant to the relevant Economic and Social 
Council resolutions, the Board calls upon all 
Governments to contribute to the maintenance of a 
balance between the licit supply of and demand for 
opiate raw materials and to cooperate in preventing the 
proliferation of sources of production of opiate raw 
materials. Most recently, in its resolution 2007/9 of 
25 July 2007, the Economic and Social Council urged 
the Governments of all countries where opium poppy 
had not been cultivated for the licit production of 
opiate raw materials to refrain from engaging in the 
commercial cultivation of opium poppy, in order to 
avoid the proliferation of supply sites. The Board 
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would welcome the cooperation of all Governments in 
complying with Council resolution 2007/9. 
 
  Informal consultation on supply of and demand 
for opiates for medical and scientific purposes 
 
90. Pursuant to Economic and Social Council 
resolution 2006/34 of 27 July 2006, the Board 
convened an informal consultation on the supply of 
and demand for opiates for medical and scientific 
purposes during the fiftieth session of the Commission 
on Narcotic Drugs, in March 2007. During that 
meeting, the Governments of major producers and 
importers of opiate raw materials examined recent 
developments affecting global production of and 
demand for opiate raw materials and discussed the 
various policies applied in their countries with respect 
to those raw materials. 
 
  Cultivation and utilization of Papaver bracteatum 
as a raw material for the manufacture of opiates 
 
91. Papaver bracteatum is a variety of poppy for 
which no control provisions are contained in the 
1961  Convention as amended by the 1972 Protocol. 
The Board notes that in some countries there has been 
an interest in conducting scientific research on the 
cultivation of Papaver bracteatum for the extraction of 
alkaloids, in particular thebaine. In one country, there 
is a proposal to begin commercial cultivation of 
Papaver bracteatum for the extraction of alkaloids.  
92. The cultivation and utilization of Papaver 
bracteatum for the commercial extraction of alkaloids 
were contemplated by some Governments in the 1970s, 
when there was a temporary shortage in the supply of 
opiate raw materials. Papaver bracteatum was 
considered as a possible source of thebaine for 
conversion into codeine. At that time, the Board 
concluded that the cultivation of Papaver bracteatum 
for commercial purposes and the resulting production 
of poppy straw must be taken into consideration when 
balancing the supply of and demand for opiate raw 
materials. The Board also concluded that Papaver 
bracteatum should be placed under international 
control once its commercial cultivation had started.46  
__________________ 
 46  Demand and Supply of Opiates for Medical and 
Scientific Needs (United Nations publication, Sales No. 
E.82.XI.4), paras. 357-358. 
93. In its resolution 1982/12 of 30 April 1982, at a 
time when large stocks of opiate raw materials were 
held by the traditional supplier countries, the Economic 
and Social Council appealed to Governments that had 
not cultivated Papaver bracteatum to consider 
refraining from embarking on its commercial 
cultivation. Pursuant to that resolution, no Government 
started the commercial cultivation of Papaver 
bracteatum. 
94. Since then, the international market for opiate 
raw materials has changed, and new varieties of opium 
poppy (Papaver somniferum) rich in thebaine have 
been developed for commercial use to satisfy the 
growing demand for opiate raw materials rich in 
thebaine. The Board invites all the Governments 
concerned, in particular major producers and users of 
opiate raw materials and countries in which research 
on Papaver bracteatum is being conducted, to 
examine, in cooperation with the Board, the possible 
impact of the commercial cultivation of Papaver 
bracteatum on the global supply of opiate raw 
materials and the steps to be taken in that connection to 
ensure that there is a balance between the supply of 
and demand for opiate raw materials. The Board will 
contact the Governments concerned on that matter.  
95. The Board wishes to remind all Governments that 
the Commission on Narcotic Drugs, in its resolution 2 
(XXIX), urged parties engaged in the cultivation of 
Papaver bracteatum for the production of thebaine or 
thebaine derivatives to voluntarily report to the Board 
statistics on the area cultivated and production. 
 
  Consumption of narcotic drugs 
 
96. Global consumption of opioid analgesics for the 
treatment of moderate to severe pain (expressed in 
defined daily doses for statistical purposes) increased 
by more than two and one half times during the past 
decade. However, the increase in consumption 
occurred mainly in countries in Europe and North 
America. In 2006, for example, countries in those two 
regions together accounted for almost 96 per cent of 
global consumption of fentanyl, 89 per cent of global 
consumption of morphine and 97 per cent of global 
consumption of oxycodone.  
97. The low levels of consumption of opioid 
analgesics for the treatment of pain in many countries, 
in particular in developing countries, continue to be a 
matter of serious concern to the Board. The Board 
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again urges all Governments concerned to identify the 
impediments in their countries to adequate use of 
opioid analgesics for the treatment of pain and to take 
steps to improve the availability of those narcotic 
drugs for medical purposes, in accordance with the 
pertinent recommendations of WHO. The Board trusts 
that the Access to Controlled Medications Programme, 
the framework of which was prepared by WHO in 
cooperation with the Board, will provide effective 
assistance to Governments in that regard (see 
paragraphs 208-213 below). 
98. Governments should be aware that increased 
availability of narcotic drugs for legitimate medical 
purposes may raise the risk of diversion and abuse of 
those drugs. In the United States, the most frequently 
diverted and abused pharmaceutical preparations are 
those containing hydrocodone and oxycodone (see 
paragraph  81 above). In 2006, the United States 
accounted for 99 per cent of global consumption of 
hydrocodone and 80 per cent of global consumption of 
oxycodone. The medical use of hydrocodone reached 
19 defined daily doses for statistical purposes (S-DDD) 
per 1,000 inhabitants per day, and the medical use of 
oxycodone reached 4 S-DDD per 1,000 inhabitants per 
day. In the United States, the consumption of 
hydrocodone increased by 70 per cent and the 
consumption of oxycodone by 55 per cent during the 
past five years. The Board wishes to remind all 
Governments of the need to closely monitor trends in 
the consumption of pharmaceutical preparations 
containing narcotic drugs and to adopt measures to 
counter their diversion and abuse, as necessary. 
99. Global consumption of methadone has increased 
more than three times over the past decade. Methadone 
is used in several countries for the treatment of pain, 
but the sharp upward trend in its consumption is 
mainly attributable to its growing use in maintenance 
treatment related to opioid dependency. In 2006, the 
countries using the largest quantities of methadone 
were (in descending order) the United States, Spain, 
Germany, the United Kingdom of Great Britain and 
Northern Ireland, Italy, the Islamic Republic of Iran 
and Canada; those countries together accounted for 
83 per cent of global consumption. The Board requests 
the authorities of those and other countries where 
methadone is used for medical purposes to be vigilant 
with regard to possible methadone diversion, 
trafficking or abuse and to take effective 
countermeasures, if necessary. 
 B. Psychotropic substances 
 
 
  Status of adherence to the Convention on 
Psychotropic Substances of 1971 
 
100. Since the publication of the report of the Board 
for 2006, Andorra, the Democratic People’s Republic 
of Korea and Nepal have become parties to the 
Convention on Psychotropic Substances of 1971. Thus, 
as at 1 November 2007, the number of States parties to 
the 1971 Convention stood at 183. Of the 11 States that 
have yet to become parties to the 1971 Convention, 
there are two in Africa (Equatorial Guinea and 
Liberia), one in the Americas (Haiti), one in Asia 
(Timor-Leste) and seven in Oceania (Cook Islands, 
Kiribati, Nauru, Samoa, Solomon Islands, Tuvalu and 
Vanuatu). The Board calls on those States which have 
not yet become parties to the 1971 Convention to 
accede to that Convention without further delay.  
 
  Cooperation with Governments 
 
  Submission of annual and quarterly statistical 
data 
 
101. Parties to the 1971 Convention have an obligation 
to furnish annual statistical reports on psychotropic 
substances to the Board. In its resolutions 1985/15 of 
28  May 1985 and 1987/30 of 26 May 1987, the 
Economic and Social Council requested Governments 
to voluntarily provide to the Board information on the 
countries of origin of imports and the countries of 
destination of exports of substances listed in 
Schedules III and IV of the 1971 Convention. Details 
of the statistical data received, including the status of 
reporting by Governments, and the analysis of such 
data are included in the technical publication of the 
Board on psychotropic substances.47 
102. The majority of States regularly submit the 
mandatory and voluntary statistical reports, and most 
of the statistical reports are submitted in a timely 
manner. By 1 November 2007, a total of 155 States and 
territories had submitted to the Board annual statistical 
reports on psychotropic substances for 2006 in 
conformity with the provisions of article 16 of the 
__________________ 
 47  Psychotropic Substances: Statistics for 2006; 
Assessments of Annual Medical and Scientific 
Requirements for Substances in Schedules II, III and IV 
of the Convention on Psychotropic Substances of 1971 
(United Nations publication, Sales No. E/F/S.08.XI.3). 
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1971 Convention. That accounts for 73 per cent of the 
States and territories required to furnish such statistics. 
A total of 133 Governments voluntarily provided 
details on the countries of origin of imports and the 
countries of destination of exports of substances listed 
in Schedules III and IV of the 1971 Convention. In 
addition, for the year 2006, 110 Governments 
submitted voluntarily all four quarterly statistical 
reports on imports and exports of substances in 
Schedule II of the 1971 Convention. 
103. The late submission of mandatory annual 
statistical reports creates difficulties for the 
international control of psychotropic substances. The 
Board regrets that some countries, including the main 
manufacturing and exporting countries, such as 
Ireland, Japan, the Netherlands and Switzerland, did 
not submit their annual statistical reports on 
psychotropic substances for 2006 in a timely manner. 
In addition, some Governments did not provide details 
on the countries of origin of imports or countries of 
destination of exports of substances in Schedules III 
and IV of the 1971 Convention, pursuant to Economic 
and Social Council resolutions 1985/15 and 1987/30. 
Incomplete, late or no reporting may indicate 
deficiencies in the national control system. The Board 
reiterates its request to all States that experience 
difficulties in complying in a timely manner with their 
reporting obligations to take the appropriate measures 
to ensure that national controls are applied as 
necessary and that the statistical reports on 
psychotropic substances are submitted within the 
deadline (before 30 June), pursuant to the 
1971 Convention and relevant Economic and Social 
Council resolutions. The Board stands ready to assist 
the competent authorities in complying with their 
reporting obligations under the 1971 Convention.  
 
  Assessments of requirements for psychotropic 
substances 
 
104. Governments are requested to provide to the 
Board assessments, also called simplified estimates, of 
annual domestic medical and scientific requirements 
for psychotropic substances, pursuant to Economic and 
Social Council resolution 1981/7 of 6 May 1981 with 
respect to substances in Schedule II of the 
1971  Convention and pursuant to Council resolution 
1991/44 of 21 June 1991 with respect to substances in 
Schedules III and IV of that Convention. The 
assessments are collated and communicated to the 
competent authorities of all States and territories, to be 
used as a guide in approving exports of psychotropic 
substances. By 1 November 2007, the Governments of 
almost all countries had submitted to the Board at least 
once their assessments of annual medical and scientific 
requirements for psychotropic substances. The Board 
established annual assessments for Montenegro.48 The 
Board urges the Government of Montenegro to review 
those assessments as soon as possible with a view to 
amending them as necessary, so as to be able to import 
psychotropic substances to meet medical needs.  
105. The Board has recommended that Governments 
review and, if necessary, update the assessments of 
their annual medical and scientific requirements for 
psychotropic substances at least every three years. In 
January 2007, all Governments were asked to review 
and, if necessary, update the assessments of their 
annual medical and scientific requirements for 
psychotropic substances. By 1 November 2007, 
97  Governments had submitted to the Board a full 
revision of the assessments of their requirements for 
psychotropic substances.  
106. However, the Board is concerned that 
19 Governments have not revised their requirements 
for psychotropic substances in the past three years. 
Those assessments may no longer reflect the actual 
medical and scientific requirements for psychotropic 
substances in the countries concerned. Assessments 
that are lower than the actual legitimate requirements 
may delay the importation of psychotropic substances 
needed for medical or scientific purposes in the 
country in question, owing to the need to verify the 
legitimacy of import orders. Assessments that are 
significantly higher than the actual legitimate needs 
may increase the risk of psychotropic substances being 
diverted into illicit channels. The Board encourages all 
Governments to ensure that their assessments are 
regularly updated and that the Board is informed of any 
modifications.  
 
__________________ 
 48  Prior to 2006, assessments for Montenegro were 
included in the assessments of Serbia and Montenegro 
(see the Report of the International Narcotics Control 
Board for 2006 (United Nations publication, Sales 
No. E.07.XI.11), para. 73). 
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  Prevention of diversion of psychotropic 
substances into the illicit traffic 
 
  Diversion from international trade 
 
107. While, in the past, diversion of substances in 
Schedules III and IV of the 1971 Convention from licit 
international trade was one of the main sources used to 
supply illicit markets, no diversion of substances in 
Schedule I has ever been reported to the Board and no 
diversion from licit international trade of substances in 
Schedule II has been reported since 1990. Those 
successes are the result of a well-functioning 
international control regime for psychotropic 
substances in Schedules I and II. 
108. Licit international trade in psychotropic 
substances in Schedule I of the 1971 Convention has 
been limited to a small number of transactions 
involving quantities of only a few grams, because of 
the very limited use of such substances. While there 
have been isolated attempts over the years to divert 
substances in Schedule I, no actual diversion into illicit 
channels has ever taken place, because of the strict 
international control mechanism for those substances, 
in particular the requirement in article 7, paragraph (a), 
of the 1971 Convention to prohibit all use of those 
substances except for scientific and very limited 
medical purposes. The Board calls upon all 
Governments to remain vigilant and ensure that their 
industries, as well as authorized traders, are fully 
aware of all restrictions in place concerning trade in 
and use of substances in Schedule I of the 
1971 Convention. 
109. Of the substances in Schedule II of 
the   1971   Convention, only amphetamines and 
methylphenidate are manufactured and traded in large 
quantities. Methylphenidate is used mostly in the 
treatment of attention deficit disorder (ADD). 
Amphetamines, which are mostly used in industrial 
processes, are also used in the treatment of ADD. The 
implementation of treaty-based control measures (the 
import and export authorization system) and other 
measures recommended by the Board and endorsed by 
the Economic and Social Council, such as assessments 
and quarterly statistical reports, have virtually 
eliminated the diversion of those substances. 
Preparations containing hallucinogens, fenetylline and 
methaqualone, which are found on illicit markets in 
some regions, are almost exclusively illicitly 
manufactured, while methylphenidate found on illicit 
markets is believed to have been diverted from 
domestic distribution channels. 
110. Licit international trade in substances in 
Schedules III and IV of the 1971 Convention consists 
of thousands of individual transactions each year. The 
Board analyses data on international trade in those 
psychotropic substances and, when in doubt, requests 
the Governments concerned to initiate investigations of 
suspicious transactions. While, until a decade ago, the 
diversion of substances in Schedules III and IV from 
licit international trade had occurred frequently, 
involving quantities of up to hundreds of kilograms, 
nowadays almost all attempts at diverting such 
substances are discovered and the very rare successful 
diversions involve only small quantities of substances. 
That positive development is attributable to the fact 
that the majority of Governments, as recommended by 
the Board and requested by the Economic and Social 
Council, have extended the additional controls over 
international trade (using, for example, the import and 
export authorization system, the assessment system and 
the detailed reporting system) to include most of the 
substances in Schedules III and IV as well.  
111. However, there continue to be attempts to divert 
substances in Schedules III and IV of the 
1971 Convention. The method used most in attempted 
diversions, the falsification of import authorizations, 
was used in two major diversion attempts reported to 
the Board in 2007. The first case involved the 
attempted diversion of 3 tons of phenobarbital, a 
substance in Schedule IV of the 1971 Convention, from 
China to Afghanistan. The second case involved the 
attempted diversion of 250,000 pentazocine injections 
from India to Nigeria. Pentazocine is an opioid 
analgesic in Schedule III of the 1971 Convention, with 
actions similar to those of morphine; it is widely 
abused in Nigeria. In both cases, the exportation did 
not take place. 
112. The Board invites all Governments to continue to 
be vigilant with respect to orders for psychotropic 
substances and, if necessary, to confirm with the 
Governments of the importing countries the legitimacy 
of such orders prior to approving the export of such 
substances. The Board is prepared to facilitate such 
confirmations. Furthermore, the Board encourages the 
national competent authorities of exporting countries to 
regularly check import orders against the assessments 
of the actual requirements for psychotropic substances 
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of the relevant importing countries when verifying the 
legitimacy of trade transactions. Such checks are 
especially important in the case of orders placed by 
companies in the few countries that have not yet 
introduced mandatory import authorizations for all 
psychotropic substances.  
 
  Diversion from domestic distribution channels 
 
113. The diversion of psychotropic substances from 
domestic distribution channels continues and, in some 
cases, relatively large quantities of psychotropic 
substances are involved. Information available on the 
abuse and seizure of psychotropic substances indicates 
that the diversion of pharmaceutical preparations 
containing such substances from licit distribution 
channels is the most important source used by illicit 
drug suppliers. The two most abused groups of 
psychotropic substances are benzodiazepines and 
amphetamine-type stimulants (ATS). In a number of 
developing countries, certain benzodiazepines such as 
diazepam (often sold under the brand name Valium®) 
and chlordiazepoxide (often sold under the brand name 
Librium®) can be easily obtained on the street, whereas 
in developed countries, notably Canada, the United 
States and certain European countries, there have been 
reports of the misuse or abuse of stimulants, 
barbiturates and benzodiazepines obtained without 
prescription through illegally operating Internet 
pharmacies. The Board calls on Governments to 
monitor the consumption levels of prescription drugs 
containing psychotropic substances, to identify 
possible diversions and to raise awareness about the 
consequences of the abuse of such drugs. 
114. Recently, the diversion from licit distribution 
channels of preparations containing the analgesic 
buprenorphine has become a matter of growing 
concern. The diversion and abuse of such preparations 
have been reported in a number of countries, mainly in 
Europe, where buprenorphine is used also for the 
treatment of opioid addicts, but also in other regions, 
such as East Africa and West Asia. Because of those 
diversions, the Board has requested the governments of 
all the countries and territories that have been reporting 
licit consumption of buprenorphine (a total of 
47  countries and territories) to provide it with 
information on the control status of buprenorphine in 
their respective territory. So far, the Governments of 
25   countries49 have furnished the requested 
information. According to that preliminary 
information, Governments of many developed 
countries have subjected buprenorphine to the same 
control measures that are applied to narcotic drugs in 
their countries. In addition, the importation of 
buprenorphine preparations in Mauritius, has been 
prohibited since 1999 as it is being used illicitly as the 
main substitute for heroin in that country. The Board 
calls on the competent authorities of all countries 
concerned to increase their vigilance with regard to the 
diversion and abuse of and trafficking in 
buprenorphine and to inform the Board of new 
developments. The Board encourages all Governments 
concerned to consider enhancing existing mechanisms 
for control over that substance, as necessary. 
115. Details on the diversion and abuse of 
pharmaceutical preparations, including the methods 
used to divert pharmaceutical preparations from licit 
distribution channels, and the measures to be taken by 
Governments to counter such illicit activities can be 
found in paragraphs 282-290 below. 
 
  Smuggling and abuse of counterfeit preparations 
 
116. Pharmaceutical preparations containing 
psychotropic substances found on the illicit market are 
not necessarily always diverted from licit manufacture 
and trade. In some cases, increased demand on illicit 
markets for a specific pharmaceutical preparation 
containing a psychotropic substance has led to the 
illicit manufacture of counterfeit preparations. 
117. While there were numerous cases involving the 
diversion of licitly manufactured Captagon® and/or the 
base substance fenetylline in the late 1980s, the 
adoption of enhanced control measures in the 1990s 
has put an end to such diversion. As fenetylline can no 
longer be obtained from licit sources, traffickers have 
resorted to producing counterfeit Captagon containing 
mainly amphetamines. Large seizures of such 
counterfeit Captagon tablets continue to be made in 
countries in West Asia. In 2006, over 2 million 
counterfeit Captagon tablets were seized in Saudi 
__________________ 
 49  Australia, Austria, Belgium, Canada, China, Czech 
Republic, Denmark, El Salvador, Estonia, France, 
Greece, Iceland, Indonesia, Ireland, Israel, Latvia, 
Malaysia, the Netherlands, Poland, Portugal, 
the Republic of Korea, the Russian Federation, Spain, 
Sweden and the United Kingdom. 
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Arabia and about 8 million were seized in the Syrian 
Arab Republic, as well as 193,000 tablets containing 
other psychoactive substances. Furthermore, in the 
same year, a single consignment containing 
45,000 counterfeit Captagon tablets from the Syrian 
Arab Republic was seized in the United Arab Emirates. 
The Board notes the steps taken by the Government of 
the Syrian Arab Republic to combat trafficking in those 
tablets and encourages the Governments of all the 
countries concerned in the region to follow suit, as 
appropriate.  
118. Pharmaceutical preparations containing 
psychotropic substances have become major drugs of 
abuse. For example, Rohypnol,® a pharmaceutical 
preparation containing flunitrazepam, is being 
counterfeited to be sold on the illicit market. 
Flunitrazepam, a benzodiazepine-type sedative-
hypnotic in Schedule III, is one of the most frequently 
misused or abused benzodiazepines. Diversion of 
flunitrazepam from both international trade and 
domestic distribution channels was significantly 
reduced during the past decade by the adoption and 
implementation of strict control policies for that 
substance. It would appear that the majority of the 
Rohypnol® tablets seized since then have been 
counterfeit products, although reliable information on 
the share of counterfeit tablets among all seized 
Rohypnol® tablets is not available. In order to be able 
to accurately determine illicit drug manufacture and 
trafficking trends involving Rohypnol,® the Board 
wishes to encourage all Governments concerned to test 
seized Rohypnol® tablets, whenever possible, to 
determine if they are counterfeit. The Board also 
encourages Governments to share information on the 
physical appearance of seized Rohypnol® tablets with 
other interested Governments through a profiling 
network and to report their findings to the Board. 
 
  Control measures 
 
  Assistance to Governments in verifying the 
legitimacy of import transactions 
 
119. The Governments of many exporting countries 
continue to request the assistance of the Board in 
verifying the legitimacy of import authorizations for 
psychotropic substances. In order to be able to better 
assist Governments in verifying the authenticity of 
import documents for narcotic drugs, psychotropic 
substances and precursor chemicals, the Board 
maintains a collection of samples of official import 
certificates and authorizations in use by national 
authorities. The Board calls on all Governments that 
have not yet provided it with such samples to do so 
without further delay. 
120. The Board notes with concern that, in certain 
cases, responses to its requests for confirmation of the 
legitimacy of import orders are unduly delayed. The 
Board wishes to draw the attention of the Governments 
concerned to the importance of responding in a timely 
manner to enquiries made by the Board. Failure to 
cooperate with the Board may hinder the investigation 
of diversion attempts and/or may cause delays in 
legitimate trade in psychotropic substances and impede 
the availability of psychotropic substances for 
legitimate purposes. 
 
  National control measures regarding international 
trade 
 
121. The Board notes with appreciation that, in 2007, 
Georgia extended the system of import and export 
authorizations to include all substances in 
Schedules  III and IV of the 1971 Convention. In 
addition, El Salvador, Myanmar, Pakistan, the 
Philippines and Saudi Arabia extended that system to 
include some substances that had previously not been 
covered. At present, export and import authorizations 
for substances in Schedules III and IV are required by 
national law in more than 160 countries and territories. 
122. The Board requests the Governments of all 
countries that do not yet control the import and export 
of all psychotropic substances by the system of import 
and export authorizations, regardless of whether they 
are parties to the 1971 Convention or not, to introduce 
such controls. Experience has shown that countries that 
are involved in international commerce but do not have 
such controls are at particular risk of being targeted by 
traffickers. The Board therefore urges the Governments 
of Ireland and Singapore, which are major importers 
and exporters of psychotropic substances, to extend 
such controls to include all substances listed in 
Schedules III and IV of the 1971 Convention. 
123. Governments should also carefully examine the 
“table showing the countries in which national 
legislation requires the issuing of import authorizations 
for substances in Schedules III and IV of the 
1971 Convention”, which is circulated twice a year to 
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all Governments, and inform the Board of any 
revisions of the requested information.  
124. The system for the assessment of medical and 
scientific needs of psychotropic substances, established 
by the authorities of each country and territory, is 
another important control measure applied to 
international trade in psychotropic substances. 
Experience has shown that the diversion of 
psychotropic substances can be prevented if exporting 
countries verify whether the quantities ordered by 
importing countries are within the assessments of their 
medical and scientific needs. The Board appreciates 
the cooperation of exporting countries that contact it 
when they receive authorizations for imports of 
psychotropic substances in excess of the assessed 
legitimate requirements. The Board notes, however, 
that seven countries issued import authorizations 
during 2006 for sizeable quantities of benzodiazepines 
in Schedule IV, without having established assessments 
for the substances concerned. Moreover, some 
countries, including countries that are major 
manufacturers, importers and exporters of psychotropic 
substances, such as Belgium, Germany, the 
Netherlands, Spain, Switzerland and the United 
Kingdom, issued import authorizations for substances 
in Schedules II, III or IV in quantities exceeding their 
assessments. The Board reiterates its request to all 
Governments to establish a mechanism for ensuring 
that their assessments correspond to their actual 
legitimate needs and that no imports exceeding the 
assessments are authorized. 
 
  Consumption of psychotropic substances  
 
125. The consumption levels of psychotropic 
substances continue to differ widely depending on the 
country and region, as shown in previous reports of the 
Board. While such differences can often be explained 
by cultural diversity in medical practice and variations 
in prescription patterns, the issue of excessively high 
or low levels of drug consumption merits special 
attention. High levels of consumption of psychotropic 
substances that are not medically justified are a matter 
of concern to the Board, as they may lead to abuse and 
diversion of the substances in question, as shown in the 
examples below. Low levels of consumption of 
psychotropic substances in some countries may reflect 
the fact that the substances are almost inaccessible by 
some segments of the population in those countries, 
which may lead to parallel markets offering those 
substances or counterfeit medicaments allegedly 
containing those substances. The Board invites the 
Governments of all countries to compare their 
consumption patterns with those in other countries and 
regions, to identify unusual trends requiring attention 
in their territory, as recommended in the report of the 
Board for 2000,50 and to promote rational use of those 
substances. 
 
  Buprenorphine 
 
126. Buprenorphine, listed in Schedule III since 1989, 
is used mainly as an opioid analgesic. In several 
countries, buprenorphine is also used in the 
detoxification and substitution treatment of opioid 
dependence. Since new preparations containing high 
doses of buprenorphine (Subutex®) or buprenorphine 
with naloxone (Suboxone®) have been introduced in 
several countries for the treatment of drug dependence, 
global manufacture and consumption of buprenorphine 
have increased substantially and the use of 
buprenorphine has been reported in an increasing 
number of countries. For instance, since 2000, the 
number of countries reporting imports of 
buprenorphine has more than doubled. Total 
manufacture of the substance increased steadily from 
1993 onwards, reaching an average of nearly 2 tons in 
the period 2003-2006, which is double the amount 
manufactured in the late 1990s, when the substance 
started to be used in higher doses for the treatment of 
opioid addiction.  
127. The increased use of buprenorphine for medical 
purposes has been accompanied by increased diversion 
of buprenorphine preparations. The Board reiterates its 
request to all Governments that experience such 
problems to strengthen the control measures applied to 
buprenorphine, in order to stop the diversion of that 
substance from licit distribution channels. 
 
  Stimulants in Schedule II of the 1971 Convention 
used for the treatment of attention deficit disorder 
 
128. Methylphenidate, amphetamine and 
dexamphetamine, substances in Schedule II of the 
1971 Convention, are used mainly for the treatment of 
ADD, primarily in children, and for the treatment of 
__________________ 
 50  Report of the International Narcotics Control Board for 
2000 (United Nations publication, Sales No. E.01.XI.1), 
chap. I. 
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narcolepsy. The use of those substances is considerably 
higher in the Americas than elsewhere. The use of 
methylphenidate increased significantly in the 1990s, 
mainly as a result of developments in the United 
States, where the substance is frequently publicized, 
including in advertisements directed at potential 
consumers. The United States accounted for over 
80  per cent of the calculated worldwide use of 
methylphenidate in 2006. However, since the late 
1990s, the use of methylphenidate for the treatment of 
ADD has risen sharply in many other countries as well, 
such as Canada, Germany, Iceland, Spain and 
Switzerland. Global calculated consumption of the 
substance increased significantly, from 22 to 36 tons, 
in the period 2002-2006. 
129. The Board reiterates its concern that, in some 
countries with high prescription levels for stimulants in 
Schedule II of the 1971 Convention, the diversion and 
abuse of those substances have been noted (see 
paragraphs 282-290 below). The Board requests all 
Governments to ensure that the control measures 
foreseen in the 1971 Convention are applied to 
stimulants in Schedule II that are used for the treatment 
of ADD and appeals to the Governments concerned to 
increase their vigilance with regard to the diversion of, 
trafficking in and abuse of stimulants in Schedule II. 
The Board requests Governments to inform it of any 
new development in that area.  
 
  Stimulants in Schedule IV of the 1971 Convention 
that are used as anorectics 
 
130. The stimulants in Schedule IV of the 
1971 Convention are mostly used as anorectics. The 
Board has closely followed developments in the 
consumption of those substances, with a view to 
identifying consumption levels that may be 
inappropriate for medical purposes and might therefore 
lead to the diversion and abuse of the substances in 
question. Of those substances, phentermine is the one 
used the most, followed by fenproporex, amfepramone 
and phendimetrazine. 
131. Consumption of stimulants in Schedule IV 
continued to increase significantly in some countries in 
the Americas, such as Argentina, Brazil and the United 
States, which are also the countries with the highest 
calculated rate of use of the central nervous system 
stimulants listed in Schedule IV worldwide. Overall, 
per capita consumption of those stimulants in the 
Americas was three times more than in other regions. 
Whereas consumption levels for those substances fell 
in Europe and Oceania, the level of consumption 
increased in countries in Asia, in particular in the 
Republic of Korea.  
132. The Board reiterates its appeal to Governments 
reporting high levels of consumption of stimulants in 
Schedule IV of the 1971 Convention to monitor their 
trend of use, to identify possible overprescribing of 
anorectics and to ensure that domestic distribution 
channels are adequately controlled. 
 
 
 C. Precursors 
 
 
  Status of adherence to the United Nations 
Convention against Illicit Traffic in Narcotic 
Drugs and Psychotropic Substances of 1988 
 
133. All States that are major manufacturers, exporters 
and importers of scheduled chemicals are now parties 
to the 1988 Convention. The Board welcomes the 
accession of the Democratic People’s Republic of 
Korea and Liechtenstein to the 1988 Convention 
during the period under review. As at 1 November 
2007, a total of 182 States, plus the European 
Community (extent of competence: article 12), were 
parties to the 1988 Convention. A total of 12 States 
have not yet become parties to the 1988 Convention: 
3 States in Africa (Equatorial Guinea, Namibia and 
Somalia), 1 in Asia (Timor-Leste), 1 in Europe (the 
Holy See) and 7 in Oceania (Kiribati, the Marshall 
Islands, Nauru, Palau, Papua New Guinea, Solomon 
Islands and Tuvalu). The Board urges all those States 
to implement the provisions of article 12 and to 
become parties to the 1988 Convention as soon as 
possible. 
 
  Cooperation with Governments 
 
  Submission of statistical data on seizures 
 
134. Reporting on information on substances 
frequently used in the illicit manufacture of narcotic 
drugs and psychotropic substances is an obligation 
under article 12 of the 1988 Convention. By 
1  November 2007, such information had been 
submitted for 2006 by a total of 141 States and 
territories, as well as the European Community (on 
behalf of its member States). The rate of submission is 
similar to that of previous years. Of the States parties 
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to the 1988 Convention that failed to submit such 
information for a number of years, Pakistan and the 
Sudan have resumed providing that information to the 
Board. In addition, Namibia, which is not yet a party to 
the 1988 Convention and had never submitted such 
information, provided the information for 2006. The 
Board urges those parties to the 1988 Convention 
which have not submitted such information to provide 
the required information as soon as possible. 
135. Thirty-two Governments have reported their 
seizures of precursors for 2006. The Board appreciates 
the fact that 17 of those Governments provided 
additional information on non-scheduled chemicals, 
methods of diversion and stopped shipments. The 
Board calls upon all competent authorities effecting 
seizures or intercepting shipments of precursors to 
thoroughly investigate those cases and to report the 
results of those investigations to the Board, as that 
information is essential to the identification of new 
trends in illicit drug manufacture and trafficking in 
precursors. 
 
  Annual submission of information on the licit 
trade in and uses of substances in Tables I and II 
of the 1988 Convention 
 
136. Since 1995, in accordance with Economic and 
Social Council resolution 1995/20 of 24 July 1995, the 
Board has been requesting Governments to provide, on 
a voluntary basis, data on licit trade in, uses of and 
requirements for scheduled substances. It is crucial for 
all Governments to be well informed of trade in and 
licit requirements for substances in Tables I and II of 
the 1988 Convention, in order to be able to identify 
unusual transactions at an early stage and thus prevent 
the diversion of those substances. 
137. As at 1 November 2007, a total of 109 States and 
territories had submitted data for 2006 on the licit 
movement of precursors and 97 Governments had 
furnished information for 2006 on licit uses of and 
requirements for such substances. All of the major 
manufacturing and exporting countries have continued 
to furnish comprehensive information on licit trade in 
scheduled substances. As Pakistan, a country importing 
large quantities of substances in Table I, has resumed 
providing data on its licit trade in scheduled 
substances, all major importing countries now provide 
data on licit trade. The major exporting countries and 
territories continued to provide information on 
individual exports through pre-export notifications 
pursuant to article 12, paragraph 10 (a), of the 
1988 Convention and in compliance with the voluntary 
measures promoted by two international initiatives to 
address the diversion of chemicals used in the illicit 
manufacture of drugs: Project Cohesion, targeting 
heroin and cocaine; and Project Prism, targeting ATS. 
 
  Control measures 
 
138. Having in place an adequate legislative basis or 
system for precursor control is essential to preventing 
the diversion of precursors into illicit channels. The 
Board notes that, during the reporting period, the 
Governments of a number of countries, including 
Australia, Chile, Peru and the Russian Federation, in 
addition to member States of the European Union, 
introduced new or strengthened existing controls over 
precursors. 
139. Despite the recent introduction of new laws and 
regulations in Mexico to restrict the import of 
ephedrine and pseudoephedrine and regulate their sale 
and despite the ban on ephedra, the Board remains 
concerned that those substances continue to be 
smuggled into Mexico. The Board is also concerned by 
the lack of adequate legislation in place in the Syrian 
Arab Republic and the United Arab Emirates to prevent 
the diversion of precursors, particularly in the form of 
pharmaceutical preparations. 
 
  Estimates of legitimate requirements for 
precursors 
 
140. In its resolution 49/3, entitled “Strengthening 
systems for the control of precursor chemicals used in 
the manufacture of synthetic drugs”, the Commission 
on Narcotic Drugs requested Member States to provide 
to the Board annual estimates of their legitimate 
requirements for four precursor chemicals: ephedrine, 
pseudoephedrine, 3,4-methylenedioxyphenyl-2-
propanone (3,4-MDP-2-P) and phenyl-2-propanone 
(P-2-P). As at 1 November 2007, a total of 101 States 
had provided those estimates to the Board, which is an 
improvement compared with the total of 80 States in 
2006. Those estimates have been published in the 
200651 and 200752 reports of the Board on the 
__________________ 
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implementation of article 12 of the 1988 Convention. 
In addition, a table showing the reported annual 
legitimate requirements for substances frequently used 
in the manufacture of ATS is available on the website 
of the Board (www.incb.org); the table is updated 
regularly. The Board again requests all competent 
authorities to provide information on annual legitimate 
requirements of the four precursor chemicals 
mentioned above, to review the reported information 
and to amend it as necessary. The Board also invites 
competent authorities to inform the Board of any 
methodologies that they have found useful for 
estimating their national requirements for those 
precursor chemicals. 
 
  Online system of pre-export notifications 
 
141. The Board notes that, as at 1 November 2007, 
92  countries and territories had registered to use 
Pre-Export Notification Online (PEN Online), the 
automated online system for the exchange of pre-
export notifications, and that over 11,000 pre-export 
notifications had been sent to 164 countries and 
territories over the PEN Online portal since the 
introduction of the system in 2006. As the system has 
facilitated communication among Governments and 
has been instrumental in identifying suspicious 
transactions and preventing diversion, the Board 
encourages all Governments that have not yet done so 
to register to use PEN Online. 
142. The Board has found that the time taken to reply 
to pre-export notifications is often too long. Importing 
countries should adhere to the deadlines set by 
exporting countries for providing feedback on pre-
export notifications, in order to prevent unwanted 
shipments. If an importing country needs more time to 
verify the legitimacy of a consignment, that should be 
__________________ 
Control Board for 2006 on the Implementation of 
Article 12 of the United Nations Convention against 
Illicit Traffic in Narcotic Drugs and Psychotropic 
Substances of 1988 (United Nations publication, Sales 
No. E.07.XI.12), annex V. 
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Substances: Report of the International Narcotics 
Control Board for 2007 on the Implementation of 
Article 12 of the United Nations Convention against 
Illicit Traffic in Narcotic Drugs and Psychotropic 
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indicated immediately to the Board and the exporting 
country in question. Doing so might significantly 
reduce unnecessary delays in legitimate trade. 
 
  Prevention of diversion of precursors into the 
illicit traffic 
 
143. The Board has continued to serve as the 
international focal point for the rapid exchange of 
information and the verification of transactions in 
precursor chemicals, particularly within the framework 
of Project Prism and Project Cohesion. During the 
reporting period, the Board has made a number of 
observations and has recommended to Governments 
action to address existing problems in international and 
national precursor control. 
144. As highlighted in the 2007 report of the Board 
on   the implementation of article   12 of the 
1988   Convention,53 diversion from domestic 
distribution channels and smuggling across borders are 
the most common methods used by traffickers to obtain 
chemicals for illicit drug manufacture. That has been 
for quite some time a trend in trafficking in precursors 
of heroin and cocaine. However, the Board has also 
observed that, with respect to the diversion of 
precursors of ATS, with the exception of ephedrine and 
pseudoephedrine, there have been few if any cases 
involving such diversions in international trade. For 
example, no cases have been reported involving the 
diversion from licit trade of 3,4-MDP-2-P, a key 
chemical used in the manufacture of 
methylenedioxymethamphetamine (MDMA, commonly 
known as “ecstasy”). It is believed that, as the 
monitoring of shipments of the relevant chemicals in 
international trade has been strengthened worldwide, 
traffickers obtain chemicals from domestic distribution 
channels and then smuggle those substances, often 
across international borders, to the illicit drug 
manufacturing areas. In order to address that 
development, the Board recommends that Governments 
should take additional measures to monitor more 
closely the manufacture and domestic distribution of 
precursor chemicals. Those additional measures could 
include verifying the legitimacy of the end-use of the 
chemical concerned, ensuring the proper registration 
__________________ 
 53  Precursors and Chemicals Frequently Used in the Illicit 
Manufacture of Narcotic Drugs and Psychotropic 
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and auditing of operators, inspecting records that are 
maintained and preventing accumulation of the 
chemicals in quantities that exceed licit market 
requirements. 
145. Seizures of acetic anhydride in and around 
Afghanistan are very limited. The Board recommends 
to the Project Cohesion Task Force to take urgent 
measures to intercept consignments of acetic anhydride 
that are being smuggled into Afghanistan and to 
identify the sources of the chemical. The Board urges 
the Governments of Afghanistan and its neighbouring 
countries to cooperate fully with the Task Force in such 
endeavours. 
146. Governments of Latin American countries are 
having serious difficulties preventing chemicals, 
including potassium permanganate, from reaching 
cocaine manufacturing areas. The Project Cohesion 
Task Force needs to devise strategies to address the 
problem by identifying the origins of the chemicals, in 
particular, of the potassium permanganate seized in 
areas where cocaine is illicitly manufactured. 
147. The Board appreciates the results achieved under 
Project Prism, in particular in connection with 
Operation Crystal Flow, which was conducted from 
1  January to 30 June 2007. The monitoring of 
1,400   individual shipments of ephedrine and 
pseudoephedrine has led to the identification of 
35 suspicious transactions and prevented the diversion 
of a total of 52 tons of the substances, which would 
have been sufficient to manufacture 48 tons of 
methamphetamine; Mexico was the declared or 
intended country of destination of about half of the 
suspicious shipments identified. 
148. The Board is concerned by some of the trends 
identified or confirmed during Operation Crystal Flow. 
Africa and West Asia in particular are being targeted 
by traffickers in their efforts to divert ephedrine. As 
highlighted in the 2007 report of the Board on the 
implementation of article 12 of the 1988 Convention,54 
traffickers have particularly targeted Burundi, the 
Democratic Republic of the Congo, Egypt, Ethiopia, 
Ghana, Iran (Islamic Republic of), Kenya, Nigeria, 
Somalia, South Africa, the Sudan, the Syrian Arab 
Republic, the United Arab Emirates and the United 
Republic of Tanzania. The Board calls on the 
Governments of all countries in Africa and West Asia 
__________________ 
 54  Ibid. 
to strengthen their control over the importation and 
movement within their territory of the precursors, 
including by allocating additional resources to the 
competent national authorities and to training. 
Countries and territories exporting ephedrines are 
urged not to release any shipments of ephedrine, 
pseudoephedrine or preparations containing those 
substances to any country until the legitimacy of such 
shipments is duly confirmed by the Governments of the 
countries to which those chemicals are being exported. 
149. Activities undertaken within the framework of 
Project Prism have also confirmed that, in most parts 
of the world, traffickers are increasingly trying to 
obtain large amounts of pharmaceutical preparations 
containing ephedrine or pseudoephedrine through licit 
trade at the national and international levels. The 
Board again recommends that all Governments control 
such preparations the same way as they control the raw 
chemicals ephedrine and pseudoephedrine. 
Governments are encouraged to use pre-export 
notifications for shipments of such preparations. 
150. The strengthened monitoring of precursors has 
resulted in trafficking organizations looking for non-
scheduled substances as alternative substances for use 
in the illicit manufacture of ATS. In that connection, 
the Board has updated its limited international special 
surveillance list of non-scheduled substances. The 
Board encourages Governments to put in place 
effective mechanisms, which would allow them to 
identify and investigate suspicious transactions 
involving such substances. It is important that the 
Board is provided with detailed information on such 
cases so that it may alert all relevant competent 
authorities of the latest trends in diversion and 
trafficking. 
151. Full details on the activities undertaken by 
Governments and the Board in precursor control are 
contained in the 2007 report of the Board on the 
implementation of article 12 of the 1988 Convention. 
 
 
 D. Promoting universal application of the 
international drug control treaties 
 
 
152. In discharging its mandate under the international 
drug control treaties, the Board maintains a dialogue 
with Governments through, for example, regular 
consultations and country missions. That dialogue is 
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aimed at assisting Governments in their efforts to 
comply with the provisions of the treaties. 
153. By analysing the information it receives, the 
Board is able to determine whether the international 
drug control treaties are being implemented by 
Governments as effectively as possible. On the basis of 
its continuous evaluation of national efforts, the Board 
is able to recommend action to Governments and 
relevant international organizations and suggest 
adjustments to the international and national control 
regimes. 
 
  Evaluation of overall treaty compliance by 
selected Governments 
 
154. The Board reviews, on a regular basis, the drug 
control situation in various countries and 
Governments’ overall compliance with the provisions 
of the international drug control treaties. The review 
covers various aspects of drug control, including the 
functioning of national drug control administrations, 
the adequacy of national drug control legislation and 
policy, measures taken by Governments to combat drug 
trafficking and abuse, and Governments’ fulfilment of 
their reporting obligations under the international drug 
control treaties. 
155. The findings of the review, as well as the Board’s 
recommendations for remedial action, are conveyed to 
the Governments concerned as part of the ongoing 
dialogue between the Board and Governments to 
ensure that the international drug control treaties are 
fully implemented. 
156. The Board, while reviewing the drug control 
situation in various countries, adopts, when necessary, 
positions on particular drug control issues. Those 
positions are based on the Board’s interpretation of the 
provisions of the international drug control treaties and 
are conveyed to the Governments concerned and, when 
appropriate, made public by the Board through its 
annual report. The Board notes that the vast majority of 
Governments comply with the Board’s 
recommendations and with their obligations under the 
international drug control treaties. 
157. In 2007, the Board reviewed the drug control 
situation in Canada, the Democratic People’s Republic 
of Korea and Turkmenistan, as well as measures taken 
by those Governments to implement the international 
drug control treaties. In doing so, the Board paid 
particular attention to new developments in drug 
control in those countries. 
 
  Canada 
 
158. The Board notes that, following its mission to 
Canada in October 2003 and its continuous dialogue 
with the Government over the past few years, the 
Government has significantly improved its level of 
cooperation with the Board and intensified its efforts to 
curb illicit drug manufacture, trafficking and abuse. 
The Government has refrained from pursuing cannabis 
decriminalization and, in October 2007, launched the 
new National Anti-Drug Strategy, allocating 
63.8 million Canadian dollars over two years on three 
priority areas: combating illicit drug production, 
preventing illicit drug use and treating drug-dependent 
persons. 
159. The Board notes that, as part of the National 
Anti-Drug Strategy, the Government of Canada will 
enhance its law enforcement efforts to combat illicit 
use of drugs and increase the capacity of the criminal 
justice system to investigate, interdict and prosecute 
offenders. The Government is also planning to 
implement a national campaign for the prevention of 
drug abuse aimed at young people and their parents, to 
provide treatment services for drug abusers and to 
support referral and treatment programmes for young 
people with drug-related problems at the various stages 
of the criminal justice system. 
160. Efforts have also been made by the Government 
of Canada to address prescription drug abuse: initial 
steps have been taken to identify problematic use of 
pharmaceuticals and to develop strategies to detect, 
prevent and treat the abuse of prescription drugs and 
over-the-counter drugs. Furthermore, an ongoing 
general population survey, the Canadian Alcohol and 
Drug Use Monitoring Survey, has been developed with 
a view to tracking trends in the abuse of drugs, 
including prescription drugs. The Board encourages the 
Government to continue its efforts in this area, 
particularly with regard to the setting up of a national 
standardized monitoring system that would 
systematically report on the prevalence and nature of 
drug abuse nationwide. 
161. The Board, while taking note of the 
Government’s views on the drug injection room in 
Vancouver, wishes to reiterate its position on that issue 
as expressed directly to the Government and in its 
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annual reports,55 namely that the provision of rooms 
for the abuse of drugs is contrary to the international 
drug control treaties, particularly article 4 of the 
1961 Convention, which obligates State parties to 
ensure that the production, manufacture, import, export 
and distribution of, trade in and use and possession of 
drugs are limited exclusively to medical and scientific 
purposes. The Board trusts that the Government will 
reach a decision that will be in compliance with the 
provisions of the international drug control treaties. 
 
  Democratic People’s Republic of Korea 
 
162. In recent years, there has been increased 
cooperation between the Board and the Government of 
the Democratic People’s Republic of Korea, as well as 
progress made by the Government in the 
implementation of the Board’s recommendations 
following its two missions to the country in 2002 and 
2006. 
163. In particular, the Board notes that in August 2003, 
the Supreme People’s Assembly of the Democratic 
People’s Republic of Korea adopted a new law on the 
administration of narcotic drugs, which brings its 
national legislation fully in line with the international 
drug control treaties. In February 2005, the 
Government of the Democratic People’s Republic of 
Korea established an inter-ministerial committee with a 
view to ensuring effective coordination of drug control 
activities and adequate implementation of drug control 
legislation at the national level. In March 2007, the 
Government of the Democratic People’s Republic of 
Korea acceded to the three international drug control 
conventions. 
164. The Board notes, however, that the Government’s 
capacity for the implementation of the international 
drug control treaties remains limited. The Board 
encourages the Government of the Democratic 
People’s Republic of Korea to continue seeking 
international assistance in various areas of drug control 
and, at the same time, to take an active part in 
addressing drug trafficking and abuse at the regional 
and international levels. The Government should 
develop a long-term national drug control strategy, in 
view of the increasing illicit manufacture of ATS in 
East and South-East Asia, and should take preventive 
__________________ 
 55  See, for example, Report of the International Narcotics 
Control Board for 2006 …, paras. 175-179, 328 and 648. 
measures against drug trafficking and abuse on its 
territory. 
 
  Turkmenistan 
 
165. Since 1997, the Board has maintained a close 
dialogue with the Government of Turkmenistan, with a 
view to improving the Government’s implementation 
of the international drug control treaties and its 
cooperation with the Board. In particular, the Board, 
following its most recent mission to the country in 
2003, invited a Government delegation from 
Turkmenistan to its session in February 2005, in order 
to continue the dialogue on issues of concern to the 
Board. 
166. The Board notes that the Government of 
Turkmenistan has established the State Coordinating 
Committee to Combat Drug Addiction under the 
Cabinet of Ministers of Turkmenistan to coordinate 
drug control activities among Government agencies 
involved in drug control. Furthermore, the national 
programme to combat illicit drug trafficking and to 
provide assistance to persons dependent on narcotic 
drugs and psychotropic substances for the period 2006-
2010 was adopted by presidential decree in April 2006. 
167. The Board remains concerned about the 
continued limited information on drug trafficking and 
seizures in Turkmenistan, particularly in view of the 
country’s geographical proximity to Afghanistan. The 
Government is invited to respond regularly to the 
Board’s queries about the drug control situation in the 
country and the Government’s measures against drug 
trafficking and abuse. 
168. The Board wishes to emphasize that 
Turkmenistan, together with other countries sharing 
borders with Afghanistan, has an important role to play 
in preventing the trafficking in opium and heroin from 
Afghanistan. As the vast majority of the world’s illicit 
opium production takes place in Afghanistan, stronger 
efforts on the part of Turkmenistan towards fulfilling 
its obligations and in cooperating with the Board 
would have a positive impact on the global efforts 
against trafficking in illicit drugs, in particular heroin. 
The Board urges the Government of Turkmenistan to 
take effective measures to intensify its drug law 
enforcement efforts and make further progress in 
complying with the international drug control treaties. 
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  Evaluation of the implementation by 
Governments of recommendations made by the 
Board following its country missions 
 
169. The Board undertakes an average of 20 country 
missions a year and sends to the Governments of the 
countries visited recommendations on improving the 
drug control situation in those countries. As part of its 
ongoing dialogue with Governments, the Board also 
conducts an evaluation of the implementation of those 
recommendations, two years after each mission. 
170. In 2007, the Board invited the Governments of 
the following eight countries to provide information on 
the implementation of the Board’s recommendations 
following its missions to those countries in 2004: 
Belgium, Indonesia, Madagascar, Pakistan, Portugal, 
South Africa, Thailand and Timor-Leste. The 
Governments of the selected countries were requested 
to provide information on progress made in the 
implementation of the Board’s recommendations, 
including any achievements made and difficulties 
encountered. 
171. The Board expresses its appreciation to the 
Governments of Belgium, Madagascar and Portugal for 
their timely submission of the information, which 
greatly facilitated the Board’s assessment of the drug 
control situation in those countries and the 
Governments’ compliance with the international drug 
control treaties. Information provided by the 
Governments of Indonesia, Pakistan and Thailand was 
received too late to be included in the present report 
and will therefore be reported on in the report of the 
Board for 2008. 
172. The Board regrets that no information was 
received from the Governments of South Africa and 
Timor-Leste. The Board requests those Governments to 
provide the requested information without further 
delay. 
 
  Belgium 
 
173. In 2003, the Government of Belgium adopted a 
revision to its national legislation on drug-related 
offences, in particular offences involving cannabis. The 
Board notes that Belgian authorities plan to collect 
information on drug abuse in a nationwide health 
survey in 2008. The Board expects that the 
Government will conduct an evaluation of the impact 
of the implementation of the revision on demand 
reduction and any consequences it may have had for 
the abuse of drugs, in particular cannabis, in the 
country. 
174. The Government of Belgium has acted on the 
Board’s recommendation regarding the use of seized 
cocaine. The Board noted that the Government had 
allowed a private firm to use seized cocaine to 
manufacture pharmaceutical preparations for export. 
Pursuant to the Board’s recommendation to explore 
other solutions, Belgium stopped using confiscated 
cocaine in 2005 and since then has been using raw 
cocaine imported from Peru. 
175. The Government of Belgium, in cooperation with 
other Governments, has strengthened law enforcement 
efforts against the illicit manufacture of MDMA. As 
noted in the report of the Board for 2006,56 in 2005, 
the law enforcement authorities in the Netherlands 
were able to dismantle the largest illicit MDMA 
laboratory ever found in that country, as a result of an 
investigation involving the cooperation of their 
counterparts in Belgium and Germany. The Board 
urges the Government of Belgium to continue its 
efforts in that area and to take measures to address the 
illicit manufacture of synthetic drugs, particularly 
MDMA. 
 
  Madagascar 
 
176. The Board notes that some progress has been 
made by the Government of Madagascar in some areas 
of drug control. Following the decentralization reforms 
undertaken in the past few years, the inter-ministerial 
commission for coordinating the fight against drugs 
has been restructured, which has resulted in 
improvement in its efficiency. In addition, Madagascar 
has put in place appropriate legislation in drug control, 
thus bringing its national legislation in line with the 
international drug control treaties and ensuring its 
compliance with treaty obligations. 
177. The Government of Madagascar has acted on the 
Board’s recommendations on demand reduction, in 
particular with regard to training and drug awareness 
campaigns in the local media. The Government has 
also included in the national budget, under the heading 
“Programmes of public interest”, a dedicated budget 
line to conduct drug-related activities. The Board 
__________________ 
 56  Report of the International Narcotics Control Board for 
2006 …, para. 602. 
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encourages the Government to continue its efforts in 
those areas. 
178. The Board notes, however, that there appears to 
be lack of progress in the implementation of its 
recommendations on the control measures related to 
psychotropic substances. The Board urges the 
Government of Madagascar to take the necessary steps 
to ensure adequate implementation of the provisions of 
the 1971 Convention, particularly with regard to the 
application of import authorization requirements to 
psychotropic substances, in accordance with the 
provisions of that Convention and relevant Economic 
and Social Council resolutions. 
 
  Portugal 
 
179. The Board notes the efforts made by the 
Government of Portugal to implement its 
recommendations following the 2004 mission of the 
Board to that country. In particular, the Board notes 
that the Government of Portugal has conducted an 
evaluation of the national drug control strategy and has 
carried out a survey of services for the treatment of 
drug-dependent persons. The results of the evaluation 
were taken into consideration in developing a new 
national drug control strategy, covering the period 
2005-2012, and a national plan against drugs and drug 
addiction, covering the period 2005-2008. Measures 
are also being taken to improve precursor control: new 
administrative structures are being created and new 
legislation is being drafted in accordance with 
European Union guidelines. 
180. While recognizing the positive developments in 
drug control in Portugal, the Board is concerned that 
the national plan on drugs and drug addiction 
envisages the establishment, by 2008, of a room for the 
abuse of drugs and that the municipal government of 
Lisbon has submitted a proposal to set up the facility. 
The Board wishes to reiterate that rooms for the abuse 
of drugs, regardless of whether they are under the 
direct or indirect supervision of the Government, are 
contrary to the international drug control treaties, 
particularly article 4 of the 1961 Convention, which 
obligates State parties to ensure that the production, 
manufacture, import, export, distribution of, trade in, 
use and possession of drugs are limited exclusively to 
medical and scientific purposes. The Board urges the 
Government to ensure that any measures to address 
drug abuse and the spread of HIV/AIDS are in 
compliance with the provisions of the international 
drug control treaties. 
181. Pursuant to the Board’s recommendation on the 
high level of consumption of psychotropic substances, 
mainly benzodiazepines, the Government of Portugal 
conducted a study in June 2005 that confirmed that 
there are chronic users of benzodiazepines, although 
the numbers of those users appear to be decreasing. 
The Board encourages the Government to introduce 
measures to better control the prescription of 
benzodiazepines and to conduct campaigns to raise the 
awareness of health-care professionals, so as to ensure 
the rational use of those substances. 
 
  Questionnaire on the evaluation of the 
implementation of the international drug 
control treaties 
 
182. A questionnaire entitled “Evaluation of the 
implementation of the international drug control 
treaties” was sent to the governments of all countries 
and territories in January 2007 for completion. The 
purpose of the review was to highlight government 
efforts in the implementation of the international drug 
control treaties, to identify weaknesses and loopholes 
in drug control at the national and international levels 
and to provide recommendations for national and 
international drug control regimes. 
183. The Board is pleased to note that, as at 
1  November 2007, a total of 142 countries and 
territories had returned the completed questionnaire. 
The Board appreciates the cooperation of all the 
governments that have submitted the required 
information as part of efforts to promote universal 
application of the international drug control treaties. 
184. The information submitted by governments in the 
questionnaire, once it has been processed and analysed, 
will be reviewed by the Board. A report on the findings 
of the evaluation will be published for consideration by 
governments. 
 
  Assistance in increasing national capacity to 
comply with treaty obligations 
 
  Ongoing training opportunities 
 
185. At the request of Governments, the secretariat of 
the Board organizes in Vienna training for national 
drug control administrators to improve the functioning 
of national drug control administrations. During 2007, 
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the Board offered such training to national drug control 
administrators from a number of countries, including 
Canada, Cuba, Ghana, Jordan and the United States, as 
well as to representatives of the United Nations Interim 
Administration Mission in Kosovo. 
186. The training provided national drug control 
administrators with an opportunity to obtain a better 
understanding of the functioning of the international 
drug control system and to discuss some of the 
problems and difficulties encountered in the 
implementation of the international drug control 
treaties. The Board trusts that the training will enhance 
the capacity of the national drug control 
administrations to comply with the provisions of the 
treaties in those countries. 
187. The Board also used various opportunities to 
provide ad hoc advice to national drug control 
administrators on treaty requirements for reporting on 
narcotic drugs, psychotropic substances and precursors. 
Such advice was provided through communications, 
individual meetings, during the country missions of the 
Board and in an informal consultation on reporting 
organized by the Board during the fiftieth session of 
the Commission on Narcotic Drugs. 
188. To facilitate full compliance with reporting 
obligations as required under the international drug 
control treaties, the Board has also made available 
online, detailed training material on the control of 
narcotic drugs, psychotropic substances and precursors, 
as well as guidelines for reporting on those 
substances.57  
 
  Training seminar in Beijing 
 
189. At the request of the Government of the 
Democratic People’s Republic of Korea, the Board, in 
cooperation with the Government of China, organized 
a training seminar in Beijing from 26 to 30 June 2007. 
Participants in the seminar were officials from various 
Government ministries responsible for drug control in 
the Democratic People’s Republic of Korea. 
190. The Democratic People’s Republic of Korea 
acceded to the three international drug control 
conventions in March 2007. The training seminar was 
aimed at improving the understanding of the 
__________________ 
 57  The training material can be found on the website of the 
Board (http://www.incb.org/incb/index.html). 
Government officials of how provisions of those 
conventions are implemented. The seminar covered 
both national and international aspects of drug control, 
focusing on Governments’ obligations under the 
international drug control treaties. 
191. Officials from the Office of China’s National 
Narcotics Control Commission and other relevant 
ministries participated as resource persons and gave 
briefings on various areas of drug control in China, 
particularly on the Government’s measures in the area 
of implementation of the international drug control 
treaties and on its cooperation with the Board. The 
seminar was intended to provide an opportunity for 
officials from the Government of the Democratic 
People’s Republic of Korea to learn from the 
experiences of the Government of China in national 
drug control. 
192. The Board underlines the importance of accession 
to the international drug control treaties by the 
Government of the Democratic People’s Republic of 
Korea. The Board urges the Government to continue its 
efforts and take the steps necessary to fully comply 
with its obligations under the international drug control 
treaties. 
193. The Board wishes to express its appreciation for 
the assistance received from the Government of China 
in organizing the seminar. 
 
 
 E. Measures to ensure the implementation 
of the international drug control 
treaties 
 
 
  Action of the Board taken pursuant to article 14 
of the 1961 Convention and article 19 of the 
1971 Convention 
 
194. Article 14 of the 1961 Convention as amended by 
the 1972 Protocol and article 19 of the 
1971 Convention set out measures that the Board may 
take to ensure the execution of the provisions of those 
conventions. The Board has invoked such measures 
vis-à-vis a limited number of States for their persistent 
failure to bring their control measures in line with the 
respective conventions, to submit information to the 
Board as required under those conventions and to 
respond to enquiries of the Board. Most of those States 
have taken remedial measures, which has led to the 
Board’s decision to terminate action under article 14 of 
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the 1961   Convention and article 19 of the 
1971 Convention vis-à-vis those States. 
 
  Consultation with the Government of 
Afghanistan pursuant to article 14 of the 1961 
Convention 
 
195. As part of the continuing consultations under 
article 14 of the 1961  Convention, a Government 
delegation from Afghanistan attended the session of the 
Board in May 2007 at the request of the Board. The 
delegation, headed by the Vice-Minister of Counter 
Narcotics, gave a presentation on the current drug 
control situation in Afghanistan and measures taken by 
the Government in the area of drug control, underlining 
the Government’s resolve to strengthen its compliance 
with the international drug control treaties and its 
cooperation with the Board. 
196. The Board notes with serious concern that, in 
2007, the illicit cultivation of opium poppy in 
Afghanistan reached an unprecedented level for the 
second consecutive year, the area under opium poppy 
cultivation rising to 193,000 hectares, an increase of 
17 per cent compared with the level in 2006. As a 
result of that increase, combined with a higher opium 
yield, total opium production is expected to be about 
8,200 tons, more than one third over the level of 2006. 
197. The illicit cultivation of opium poppy is 
particularly widespread in the southern and western 
parts of Afghanistan, where such cultivation has 
increased in virtually every province. Much of the most 
fertile areas in the south have been used for illicit 
opium poppy cultivation. In Helmand, illicit opium 
poppy cultivation has increased by 48 per cent, 
accounting for more than 50 per cent of the entire 
opium poppy crop in the country. More than 75 per 
cent of the opium poppy cultivation in that province in 
2007 did not exist in 2005. Despite the fact that 
Helmand had more resources than any other province, 
the opium poppy eradication efforts in Helmand fell far 
short of expectations. 
198. The Board, while recognizing the difficulties 
encountered by the Government of Afghanistan, notes 
that one of the continuing major obstacles to the 
eradication of illicit opium poppy cultivation is the 
widespread drug-related corruption among officials at 
various levels of government. Such corruption has 
impeded progress in the elimination of the drug 
problem, as evidenced by the significant increase in the 
illicit opium poppy cultivation in the country over the 
past two years. Despite increased eradication efforts in 
2007, most of the provinces have failed to significantly 
reduce opium poppy cultivation. 
199. The Board wishes to emphasize that the 
Government of Afghanistan must take firm measures 
against corrupt officials at any level of government 
who are involved in illicit drug activities. The 
elimination of illicit drug activities, particularly the 
illicit cultivation of opium poppy, is the responsibility 
of the Government of Afghanistan, which must be held 
accountable at all levels. 
200. The upward trend in cannabis cultivation in 
Afghanistan is another worrying development, one that 
requires urgent action. According to UNODC, the area 
under cannabis cultivation has increased constantly 
over the past two years, reaching 70,000 hectares in 
2007, compared with 30,000 hectares in 2005 and 
50,000  hectares in 2006. Cannabis cultivation takes 
place mainly in the southern provinces but also in some 
areas that were declared poppy-free in 2007. Cannabis 
cultivation is increasing among farmers who do not 
cultivate opium poppy, mainly due to increased 
cannabis prices and, compared with opium, the higher 
yield and lower investment required. Under article 14 
of the 1961 Convention, the Government of 
Afghanistan is responsible for taking measures to 
ensure that illicit activity related to any controlled 
substance, including cannabis, is dealt with in 
accordance with the provisions of the international 
drug control treaties. 
201. The Board notes that the control of licit activities 
related to narcotic drugs and psychotropic substances 
need to be strengthened in Afghanistan. The 
Government continues to have difficulty in complying 
with the reporting obligations required under the 
international drug control treaties. The Government has 
yet to put in place adequate systems for preventing the 
diversion of controlled substances from licit sources 
into illicit channels and for ensuring that legitimate 
requirements for controlled substances are met. The 
Board urges the Government to take steps to ensure the 
effective functioning of the newly established Drug 
Regulation Committee. 
202. The Board notes that efforts have been made by 
the Government to address the growing problem of 
drug abuse in Afghanistan, following the first 
nationwide survey, conducted in 2005. According to 
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the Ministry of Counter Narcotics, the number of 
treatment and rehabilitation facilities for drug addicts 
in the country has increased. In view of the fact that 
the majority of drug addicts live in rural areas, the 
Ministry of Public Health is currently seeking 
assistance in funding a pioneering project, aimed at 
integrating the treatment of drug addicts into its 
primary health-care system, so that the necessary 
services can be provided to drug addicts at local 
hospitals. The Board welcomes that initiative and 
encourages the Government to take a comprehensive 
approach towards addressing drug abuse and 
HIV/AIDS in the country. 
203. In recent years, there has been continuous 
advocacy and pressure by some non-governmental 
organizations and others of the legalization of opium 
poppy cultivation in Afghanistan, based on the 
assumption that the opium produced in Afghanistan 
could be exported and utilized to manufacture opiates 
to help meet world demand while, at the same time, 
helping to curb illicit drug activities by organized 
criminal groups. The Board reminds those involved in 
such advocacy that the licit cultivation of opium poppy 
and the production of opiate raw materials are subject 
to control measures imposed pursuant to the provisions 
of the 1961 Convention and that Convention as 
amended by the 1972 Protocol. 
204. The Board believes that, until such time as the 
Government is able to put in place credible and 
sustainable control measures and to effectively 
exercise control over narcotic drugs, psychotropic 
substances and precursors, an enforceable ban on 
opium poppy cultivation in Afghanistan is the most 
suitable and realistic measure to address the drug 
problem in the country. The Board commends the 
decision of the Government of Afghanistan to reject 
the proposal to legalize illicit opium cultivation in the 
country. The Government has affirmed its commitment 
to fulfilling the obligations under the international drug 
control treaties, particularly the obligations under 
article 22 of the 1961 Convention as amended by the 
1972 Protocol. 
205. As the Board has emphasized over the years in its 
technical report on narcotic drugs, global demand for 
opiate raw materials for medical and scientific 
purposes as requested by Governments has been fully 
met. Currently, global stocks of opiate raw materials 
are sufficient to cover global demand for more than 
one year. The often expressed view that there is a 
global shortage of opiates for medical and scientific 
purposes, which is often used to advocate legalization 
of opium poppy cultivation in Afghanistan, is not based 
on hard facts. 
206. The Board is also concerned that precursor 
chemicals, in particular acetic anhydride, continue to 
be available for the illicit manufacture of heroin in 
Afghanistan. Projected opium production in that 
country increased in 2007, and illicit demand for acetic 
anhydride is expected to increase proportionally. In 
that connection, the Board reminds all Governments 
that Afghanistan has no licit requirements for acetic 
anhydride. Any order or request involving the shipment 
of acetic anhydride to that country should be reported 
to the Board. 
207. The Board notes that in the Afghanistan 
Compact58 an effective mechanism was established for 
coordinating Afghan and international efforts for the 
coming years. The Board calls upon the Government of 
Afghanistan, the United Nations and the rest of the 
international community to cooperate closely in 
achieving the goals set out in the Compact. Bearing in 
mind the overarching objective of the National Drug 
Control Strategy of Afghanistan,59 the Government of 
Afghanistan, with assistance from the international 
community, should, without further delay, take 
measures to achieve a substantial, sustainable decrease 
in opium poppy cultivation and in opium production, 
trafficking and abuse in the country. 
 
 
 F. Special topics 
 
 
  Access to opioid analgesics 
 
208. The Board has brought to the attention of the 
international community the fact that the levels of 
consumption of opioid analgesics for the treatment of 
moderate to severe pain were low in a number of 
countries. The Board welcomed the adoption of 
__________________ 
 58  “Letter dated 9 February 2006 from the Permanent 
Representative of Afghanistan to the United Nations 
addressed to the President of the Security Council” 
(S/2006/90), annex. 
 59  “Letter dated 14 February 2006 from the Permanent 
Representative of Afghanistan to the United Nations 
addressed to the President of the Security Council” 
(S/2006/106), annex. 
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Economic and Social Council resolution 2005/25 of 
22 July 2005, entitled “Treatment of pain using opioid 
analgesics”, in which the Council called upon Member 
States to remove barriers to the medical use of such 
analgesics, taking fully into account the need to 
prevent their diversion for illicit use. 
209. Also in its resolution 2005/25, the Economic and 
Social Council invited the Board and WHO to examine 
the feasibility of a possible assistance mechanism that 
would facilitate the adequate treatment of pain using 
opioid analgesics. The Board and WHO submitted a 
joint report on the examination of that matter to the 
Commission on Narcotic Drugs at its fiftieth session, 
in March 2007, and to the World Health Assembly at 
its sixtieth session, in May 2007. 
210. The Board and WHO reviewed documents and 
studies on the availability of opioid analgesics at the 
national level and examined the activities undertaken 
and planned by various bodies to assist Governments 
in ensuring the availability of those drugs for medical 
use. The Board and WHO observed that, although there 
was no shortage of licitly produced opioid analgesic 
raw materials worldwide and there had been a 
substantial increase in the global consumption of 
opioids in the past two decades, access to opioid 
analgesics continued to be difficult in some countries. 
The difficulties in having access to opioid analgesics 
are due to various interrelated factors, such as 
inadequate medical education and lack of knowledge 
and skills in pain management, public attitude, 
regulatory impediments and economic constraints. 
211. The Board and WHO concluded that a 
mechanism for facilitating the adequate treatment of 
pain using opioid analgesics would be feasible. 
Therefore, WHO started the preparation of an 
assistance programme called Access to Controlled 
Medications Programme and elaborated a framework 
document for that programme, in consultation with the 
Board. 
212. Activities of the Access to Controlled 
Medications Programme will address all the identified 
impediments, focusing on regulatory, attitude and 
knowledge impediments. The programme will be 
implemented by WHO, in cooperation with 
Governments, WHO partners and collaborating centres. 
The Board will provide expertise to WHO in those 
areas of the programme related to the mandate of the 
Board. 
213. The Board encourages all Governments and the 
international organizations concerned, such as the 
United Nations Office on Drugs and Crime (UNODC), 
to cooperate with WHO in the implementation of the 
programme, with a view to promoting rational use of 
opioid analgesics by health-care professionals. The 
Board calls on Governments to provide resources to 
WHO for the implementation of the programme. 
 
  Cultivation of coca bush and uses of coca leaf 
under the international drug control treaties 
 
214. The Board is concerned that the cultivation of 
coca bush for purposes that are not in line with the 
1961 Convention is continuing in some countries. Uses 
of coca leaves contrary to the provisions of the 
1961 Convention are also continuing, and some of 
those uses are even being expanded. 
215. The Board reminds all Governments concerned 
that coca leaf is a narcotic drug in Schedule I of the 
1961 Convention as amended by the 1972 Protocol. 
Governments should ensure that the production, 
export, import, distribution, use and possession of, as 
well as trade in, coca leaf are limited to medical and 
scientific purposes, just as they would be limited in the 
case of any other narcotic drug. In addition, coca 
leaves may also be used for the preparation of a 
flavouring agent that should not contain any alkaloids, 
and, to the extent necessary for such use, production, 
trade in and possession of such leaves may be 
permitted. Governments permitting the cultivation of 
coca bush should set up an agency to carry out certain 
functions, as required under articles 23 and 26 of the 
1961 Convention. 
216. The practice of chewing coca leaves continues in 
Bolivia and Peru and, on a limited scale, in some other 
countries. The Board wishes to point out that, within 
25  years following the entry into force of the 
1961 Convention, coca leaf chewing should have been 
abolished in those countries where it was taking place. 
As the 1961 Convention came into force in 1964, coca 
leaf chewing should have come to an end in 1989. 
217. In addition, coca leaf is used in Bolivia and Peru 
for the manufacture and distribution of mate de coca 
(coca tea). Such use is also not in line with the 
provisions of the 1961 Convention. The Board again 
calls on the Governments of Bolivia and Peru to 
consider amending their national legislation so as to 
abolish or prohibit activities that are contrary to the 
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1961 Convention, such as coca leaf chewing and the 
manufacture of mate de coca (coca tea) and other 
products containing coca alkaloids for domestic use 
and export.60 
218. The Board reminds all Governments that 
importation of coca leaf for purposes other than 
medical and scientific purposes or the preparation of a 
flavouring agent is contrary to the provisions of the 
1961 Convention. 
219. The 1988 Convention requires Governments to 
establish as criminal offences under domestic law, 
when committed intentionally, activities involving coca 
leaf that are contrary to the provisions of the 
1961 Convention. The activities include, among other 
things, the production, offering for sale, distribution, 
sale, delivery on any terms whatsoever, brokerage, 
dispatch, transport, importation or exportation of coca 
leaf contrary to the provisions of the 1961 Convention. 
Subject to its constitutional principles and the basic 
concepts of its legal system, each party to the 
Convention should establish as a criminal offence, 
when committed intentionally, the possession and 
purchase of coca leaf for personal consumption 
contrary to the provisions of the 1961 Convention. 
Governments should establish as criminal offences 
under its domestic law, when committed intentionally, 
the cultivation of coca bush for the purpose of the 
production of narcotic drugs contrary to the provisions 
of the 1961 Convention. 
220. The provisions of the 1988 Convention, including 
reservations made under that Convention, do not 
absolve a party of its rights and obligations under the 
other international drug control treaties. It is therefore 
important that States fulfil their obligations under those 
treaties in spite of any reservations they may have 
made. Should a State require assistance from the 
international community to enable it to comply with 
any of its treaty obligations, it should make a formal 
request for such assistance. 
221. The Board calls upon the Governments of Bolivia 
and Peru to initiate action without delay with a view to 
eliminating uses of coca leaf that are contrary to the 
1961 Convention and to strengthen their efforts against 
trafficking in cocaine in the region. The Board calls on 
__________________ 
 60  Report of the International Narcotics Control Board for 
1993 (United Nations publication, Sales No. E.94.XI.2), 
para. 211. 
the international community to provide assistance to 
those countries towards achieving those objectives. 
 
  Ketamine 
 
222. The Board welcomes the adoption of Commission 
on Narcotic Drugs resolution 50/3, in which the 
Commission encouraged Member States to pay 
particular attention to the emerging problem of 
widespread abuse and diversion of ketamine and to 
consider adopting a system of precautionary measures 
for use by their Government agencies to facilitate the 
timely detection of the diversion of ketamine. The 
Board calls on all Governments to implement that 
resolution without delay. The Board, together with the 
Commission, looks forward to the updated review of 
ketamine by WHO. 
223. Since 2004, the Board has drawn the attention of 
Governments to the problem of trafficking in and abuse 
of ketamine, a substance currently not under 
international control.61, 62, 63 Ketamine abuse 
continues to be reported in a number of countries, 
particularly in the Americas, East and South-East Asia, 
South Asia and Oceania. 
224. For 2006, the abuse of ketamine was reported in 
France, Greece, the Hong Kong Special Administrative 
Region (SAR) of China, Israel, Peru, South Africa and 
the United Kingdom. Seizures of that substance 
effected in 2006 were reported in Argentina, Australia, 
Hungary, the Macao SAR of China, Malaysia, 
Myanmar and the Philippines. In addition, the 
competent authorities of France have informed the 
Board of an armed robbery involving ketamine and 
tiletamine (an anaesthetic used in veterinary medicine) 
that took place in France in 2007, at the premises of a 
company trading in pharmaceutical raw materials. 
225. The Board is pleased to note that ketamine is 
controlled in a number of countries where it has been 
found to be abused. In 2007, the Governments of Chile 
and France provided to the Board information on the 
__________________ 
 61  Report of the International Narcotics Control Board for 
2004 (United Nations publication, Sales No. E.05.XI.3), 
para. 390. 
 62  Report of the International Narcotics Control Board for 
2005 (United Nations publication, Sales No. E.06.XI.2), 
paras. 385, 431, 471 and 641. 
 63  Report of the International Narcotics Control Board for 
2006 …, paras. 199-204 and 457-458. 
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national control measures put in place in their 
countries pursuant to Commission on Narcotic Drugs 
resolution 49/6, in which the Commission called upon 
Member States to consider controlling the use of 
ketamine by placing it on the list of substances 
controlled under their national legislation, where the 
domestic situation so required, and encouraged 
Member States to consider adopting a system of import 
and export authorizations for use by their government 
agencies. The Board again requests all Governments 
that have not yet done so to furnish it with information 
on their national regulatory control measures that have 
been put in place for ketamine. In addition, the Board 
again requests all Governments to provide to it and to 
WHO all available information on the abuse of 
ketamine in their countries in order to assist WHO in 
its evaluation of ketamine for possible scheduling 
under the 1971 Convention.64  
 
  Piperazine-derived compounds 
 
226. During the past several years, the Board has 
noted with concern reports of the abuse of and 
trafficking in piperazine-derived compounds, among 
them N-benzylpiperazine (BZP), 1-(3-
trifluoromethylphenyl)piperazine (TFMPP),  
1-(3-chlorophenyl)piperazine (mCPP), 1-(4-
methoxyphenyl)piperazine (MeOPP) and 1-(3,4-
methylenedioxybenzyl)piperazine (MDBP). 
227. There are no current therapeutic uses of the 
above-mentioned piperazine-derived compounds in 
humans. Such substances are available primarily for 
use as intermediates in the manufacture of chemicals 
and pharmaceuticals and are used in neurochemical 
and psychiatric research as pharmacological probe 
drugs for drug discrimination procedures in animals. 
The effects of most of those piperazines have never 
been scientifically investigated, but they are 
understood to act directly on central monoamine 
receptors in a complex manner, with specific actions 
depending on the substance in question. They are also 
metabolites of substances with different psychoactive 
properties. They are widely available (they can be 
obtained through commercial chemical suppliers) and 
relatively inexpensive. 
228. Piperazine-derived compounds are taken orally, 
but they can also be smoked or snorted. A few cases of 
__________________ 
 64  Ibid., paras. 202-204. 
injecting drug abuse of mCPP have been reported in 
France, in abusers who usually inject MDMA. 
Piperazine-derived substances are also frequently 
encountered in mixtures with other substances. 
229. The subjective effects of BZP are described as 
stimulant-like, similar to the effects of amphetamines. 
The substance roughly mimics the psychoactive effects 
of d-amphetamine, although at a higher dosage. 
TFMPP produces a hallucinogen-like effect, mimicking 
some of the psychoactive effects of MDMA. The 
subjective effects of mCPP are described as similar to 
those produced by lysergic acid diethylamide (LSD) or 
mescaline. mCPP has been shown to produce stimulant 
and hallucinogenic effects similar to MDMA. Panic 
attacks have also been reported. 
230. The abuse of BZP and TFMPP was first reported 
in the United States (California) in 1996 and in Sweden 
in 1999. Since then, the abuse of those substances has 
spread rapidly to other countries. Since the late 1990s, 
the abuse of BZP and TFMPP has increasingly been 
reported in venues similar to those where MDMA is 
abused. Their growing popularity is evidenced by the 
fact that seizures of those substances have increased in 
the United States since 2000. Numerous seizures of 
BZP have also been effected in Europe. In early 2007, 
eight European Union member States reported seizures 
of BZP to the European Police Office (Europol), 
including a seizure of 64,900 tablets in the United 
Kingdom.65 
231. mCPP is available on illicit markets in many 
European countries, such as Austria, the Netherlands 
and Sweden, and its availability in Europe as a whole 
is increasing. The size of individual seizures of mCPP 
have ranged from a few tablets to 30,000 tablets. 
Significant mCPP seizures were reported to Europol 
and the European Monitoring Centre for Drugs and 
Drug Addiction by Belgium, Estonia, Finland, France, 
Germany, Greece, Hungary, Malta, the Netherlands, 
Slovakia, Spain and the United Kingdom. Several other 
European Union member States have reported minor 
seizures of mCPP tablets. More than 800,000 mCPP 
tablets were seized in the European Union in 2006. In 
the  Netherlands, 255,000 mCPP tablets were seized. 
__________________ 
 65  European Police Office, Amphetamine-type Stimulants in 
the European Union 1998-2007: Europol Contribution to 
the Expert Consultations for the UNGASS Assessment 
(The Hague, July 2007). 
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Furthermore, the size of the seizures and the discovery 
of traces of mCPP in major MDMA production and 
tabletting sites in the Netherlands strongly suggest the 
involvement of organized criminal groups.66 
232. The authorities in a number of countries have 
already placed some of those substances under national 
control or are considering doing so. For instance, most 
piperazines are already under national control in 
Australia, Japan and New Zealand, BZP is under 
national control in Belgium, Denmark, Greece, Malta, 
Spain, Sweden and the United States and mCPP has 
been placed under national control in Finland and 
Greece, whereas the introduction of controls for mCPP 
is being considered in Belgium, Germany and Latvia. 
Furthermore, the European Union has taken steps to 
ensure that BZP is placed under control in all member 
States. 
233. In view of those developments, the Board 
requested WHO in March 2007 to consider reviewing 
piperazine-derived compounds for possible scheduling 
under the 1971 Convention. The Board urges all 
Governments to report to WHO, as well as to the 
Board, any information on the emerging abuse of and 
trafficking in those substances. 
 
  Information on the specific requirements for 
travellers who carry medical preparations 
containing controlled substances for personal 
use 
 
234. The Commission on Narcotic Drugs, in its 
resolutions 45/5, 46/6 and 50/2, encouraged States 
parties to the 1961 Convention, that Convention 
as   amended by the 1972 Protocol and the 
1971  Convention to notify the Board of restrictions 
currently applicable in their territory to travellers under 
medical treatment with preparations containing 
substances under international control. The Board has 
received from 73 Governments information on the 
legal provisions and/or administrative measures 
currently applicable in their countries to travellers 
carrying medical preparations containing narcotic 
drugs or psychotropic substances for personal use. The 
Board, in cooperation with those Governments, has 
been putting the information received into a standard 
format so that travellers may receive comprehensive 
information on the requirements in their countries of 
__________________ 
 66  Ibid. 
destination.67 The Board urges Governments that have 
not yet done so to examine the standardized 
information on their national requirements and to 
inform the Board immediately of their approval of that 
information. Once approved, the standardized 
information will be posted on the website of the Board 
and will also be disseminated on a regular basis to all 
Governments. 
235. The Board calls on all Governments that have not 
yet done so to submit to it their current national 
regulations and restrictions applicable to international 
travellers carrying medical preparations containing 
internationally controlled substances for personal use, 
pursuant to Commission on Narcotic Drugs 
resolutions   45/5, 46/6 and 50/2. In addition, 
Governments should notify the Board of any changes 
in their national jurisdictions in the scope of control of 
narcotic drugs and psychotropic substances relevant to 
travellers under medical treatment with internationally 
controlled substances, in accordance with Commission 
resolution 50/2. 
 
  Inadequate resources for Governments’ 
regulatory agencies for national drug control 
 
236. In accordance with the provisions of the 
1961  Convention, the 1971 Convention and the 
1988 Convention, Governments are required, inter alia, 
to cooperate with the Board in the administration of the 
system of estimates and statistical returns for narcotic 
drugs and the submission of statistical reports on 
psychotropic substances. 
237. The Board is aware that drug control authorities 
have other tasks besides reporting to the Board. The 
Board is also aware that the duties of drug regulatory 
agencies are manifold and include licensing and 
inspection of manufacturers and traders, issuing export 
and import authorizations and ensuring adequate drug 
supply. The Board recognizes that, without the 
cooperation of the different agencies, the competent 
national authorities would not be able to report 
adequately and in a timely manner to the Board. Such 
internal cooperation may require adequate funding. 
238. The Board notes with concern that the control of 
licitly manufactured drugs is receiving decreasing 
attention by many Governments, despite the growing 
__________________ 
 67  See also Report of the International Narcotics Control 
Board for 2005 …, paras. 214-215. 
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abuse of those drugs. Investigation by the Board has 
shown that lack of resources is at the root of the 
difficulties Governments have in complying with their 
treaty obligations, including difficulties in fulfilling 
their treaty obligations to report to the Board. A 
number of countries that are major manufacturers and 
traders in narcotic drugs and psychotropic substances 
are furnishing too late or not at all their mandatory 
statistical reports to the Board (see paragraphs 65, 66, 
76, 103 and 106 above). 
239. The Board carries out its obligations under the 
international drug control treaties in part on the basis 
of data provided by Governments. If the Board does 
not receive the data required in a timely manner or 
there are deficiencies in the quality of the data 
submitted, the Board will not be in a position to fully 
accomplish its obligations and the international drug 
control system will not be performing to its full 
capacity. 
240. Governments are reminded that the international 
control system for narcotic drugs and psychotropic 
substances functions as good as the quality and 
timeliness of the information collected and supplied by 
Governments and the good cooperation of 
Governments with the Board.  
241. Governments should be aware that a lack of 
adequate resources allocated to the competent 
authorities responsible for national control of narcotic 
drugs and psychotropic substances and for cooperation 
with the Board seriously affects the functioning of the 
international drug control system. The Board therefore 
urges all Governments to always allocate adequate 
resources to their national competent authorities to 
meet their treaty obligations by submitting the 
statistical data to the Board in a timely manner and in 
the quality required. 
 
  Trafficking in and abuse of fentanyl 
 
242. In its report for 2006, the Board alerted 
Governments to the increasing trafficking in and abuse 
of fentanyl and to the dangers related to the very high 
potency of fentanyl and its analogues, which increases 
the risk of their overdose and other health problems 
related to the abuse of opioids. The Board is concerned 
that trafficking in and abuse of fentanyl continue to 
pose problems in some countries, in particular in the 
United States. Recently, the Russian Federation 
has   reported seizures of illicitly manufactured 
3-methylfentanyl, an analogue of fentanyl. In most 
countries, relatively little is known about trafficking in 
and abuse of fentanyl. That lack of information may, 
however, in some cases be related to the fact that 
clandestinely manufactured fentanyl is often sold as 
heroin and therefore appears on the illicit market as 
heroin. The Board invites the Governments of 
countries in all regions to remain vigilant with regard 
to trafficking in and abuse of fentanyl and its 
analogues.  
243. In the United States, most of the fentanyl seized 
consists of clandestinely manufactured fentanyl. In 
addition, a smaller number of seizures of other fentanyl 
analogues have been reported. In the period 2005-
2007, trafficking in fentanyl and its analogues occurred 
in the north-eastern part of the United States. The 
distribution of illicitly manufactured fentanyl 
combined with heroin or cocaine has resulted in 
hundreds of suspected fentanyl-related overdoses and 
over 1,000 confirmed fentanyl-related deaths in that 
part of the country.  
244. A small number of clandestine laboratories 
manufacturing fentanyl, including one laboratory in 
Toluca, Mexico, dismantled by the Mexican authorities 
in May 2006, were involved in the outbreak of fentanyl 
abuse in 2005 and 2006 in the United States. As a 
result of measures adopted by the authorities of the 
United States, trafficking in fentanyl decreased in 
2007.  
245. Since April 2007, N-phenethyl-4-piperidone 
(NPP), a substance identified as a precursor of 
fentanyl, was placed under control in the United States 
as a “List I chemical” under the Controlled Substances 
Act. 
246. In the Russian Federation, the vast majority of 
seizures involve clandestinely manufactured 
3-methylfentanyl. In 2006, the total number of seizures 
represented more than 1.3 billion single doses of that 
narcotic drug. The seizures were mainly effected in the 
central and north-western parts of the country and in 
the area of Kaliningrad. The Board calls upon the 
authorities of the Russian Federation to continue to 
take vigorous measures with a view to eliminating 
trafficking in and abuse of 3-methylfentanyl. 
247. Some other countries in Europe, including 
Belarus, Estonia and Lithuania, reported seizures of 
fentanyl or 3-methylfentanyl in 2006 and 2007. The 
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Board calls upon those States to systematically collect 
data on the extent of the problem and to adopt 
measures to counter trafficking in and abuse of those 
drugs, as necessary. The Board encourages those and 
the other countries concerned in the region to exchange 
all relevant information and to cooperate with each 
other, in order to prevent the smuggling and abuse of 
fentanyl and its analogues. 
248. The Board remains concerned that trafficking in 
and abuse of fentanyl may not be recognized as a 
problem in some countries due to insufficient 
laboratory analysis and/or inadequate reporting. The 
Board reaffirms its request to the Governments of 
countries in which there has been a sudden increase in 
opioid overdoses to determine whether those overdoses 
were caused by the abuse of fentanyl and its analogues. 
The Board encourages Governments to ensure that 
forensic laboratories include in their programmes the 
analysis of fentanyl and its analogues. 
249. The Board notes with concern that a growing 
number of Governments are reporting the abuse of 
diverted pharmaceutical preparations containing 
fentanyl. Such abuse often involves fentanyl patches 
diverted from licit channels, including used and 
discarded patches. As the used and discarded patches 
contain significant quantities of fentanyl, specific 
measures for the disposal of such patches are 
recommended. The Board calls upon the Governments 
of countries in which fentanyl patches are 
manufactured to examine, in cooperation with the 
pharmaceutical industry, possible ways to address this 
issue without impeding access to an otherwise useful 
medicine. The Board requests the Governments of all 
countries in which fentanyl patches are used to take 
care with regard to the disposal of used patches, in 
order to prevent them from being diverted for abuse. 
 
  Internet 
 
250. In its resolution 50/11, the Commission on 
Narcotic Drugs recognized that the illegal distribution 
via the Internet of internationally controlled licit 
substances was an escalating problem. The 
unsupervised use by the general public, in particular 
underage persons, of pharmaceutical preparations 
containing such substances purchased through the 
Internet constitutes a serious risk to health worldwide. 
In its resolution 50/11, the Commission encouraged 
Member States to notify the Board, in a regular and 
standardized manner, of seizures of licit substances 
under international control ordered via the Internet and 
delivered through the mail, in order to fully assess 
trends relevant to that issue, and encouraged the Board 
to continue its work with a view to raising awareness 
of and preventing the misuse of the Internet for the 
illegal supply, sale and distribution of such substances. 
The Board is alarmed by the continuing rise in Internet 
sales of internationally controlled substances without 
valid prescriptions. 
251. According to information from countries in which 
activities of illegal Internet pharmacies are closely 
investigated, the very high volume of transactions 
carried out by individual Internet pharmacies is a 
matter of serious concern. For example, in the United 
States, it was found that, in 2006, 34 illegal Internet 
pharmacies dispensed more than 98 million dosage 
units of hydrocodone products. Since individuals 
ordering from illicit Internet pharmacies can obtain 
quantities of about 100-200 tablets per order, the 
quantities of controlled drugs dispensed illegally over 
the Internet have contributed significantly to the 
availability of the prescription drugs abused. 
According to studies carried out by the National Center 
on Addiction and Substance Abuse at Columbia 
University, the number of websites advertising or 
selling controlled prescription drugs increased by 
70  per cent in 2007 compared with 2006. Of the 
187  websites analysed in 2007, 84 per cent sold 
prescription drugs containing controlled substances 
without requiring the patient to provide a valid 
prescription. Because of the high rate of abuse of 
certain prescription drugs by teenagers, it is of 
particular concern that there are no mechanisms in 
place for preventing young people from purchasing 
controlled prescription drugs through the Internet. 
252. In August 2007, a report by an enterprise brand 
protection company showed that the majority of 
websites from which prescription drugs were 
obtainable were operating without proper credentials. 
Only 4 of the 3,160 online pharmacy websites studied 
were accredited as Verified Internet Pharmacy Practice 
Sites™ (VIPPS®), the industry credential that assures 
consumers of the legitimacy of the online pharmacy 
operations. Most of those Internet pharmacy websites 
were based in the United States, followed by the 
United Kingdom. The websites had a high visitor rate: 
the most frequented websites were visited by an 
average of 32,000 visitors a day. The prices (in some 
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cases, one fifth of the official retail price) and the 
quantities traded indicated that the pharmaceutical 
preparations sold were questionable (that is, they were 
expired, stolen, diluted or counterfeit).  
253. Internet pharmacies continue to operate from 
countries not only in North America and Europe but 
also in South Asia, South-East Asia and West Asia, 
from where large quantities of controlled prescription 
drugs are illegally shipped to customers in North 
America and Europe. In addition, the Internet 
continues to be used as a source for chemicals required 
for the illicit manufacture of drugs. For example, 
Canadian authorities have discovered that gamma-
butyrolactone (GBL), the precursor of gamma-
hydroxybutyric acid (GHB), was obtained from 
Canadian or other sources in “GHB manufacturing 
kits” ordered via the Internet.68 An Internet company 
based in the United Kingdom supplied more than 
360 kg of chemicals to clandestine methamphetamine 
laboratories in the United States in 2006 and 2007. 
254. In response to that worrying development, the 
United States authorities have introduced new tools, 
such as the Automation of Reports and Consolidated 
Orders System (ARCOS), to identify consignments 
with high or excessive volumes. ARCOS supports 
efforts to identify retail pharmacies and practitioners 
who might be connected with illegal sales of controlled 
substances via the Internet. In addition, the United 
States Drug Enforcement Administration (DEA) 
launched in 2006 an initiative to provide educational 
information to DEA-registered Internet distributors of 
controlled substances. DEA has established 
cooperation with other businesses and industries whose 
services are misused by illegally operating Internet 
pharmacies, such as Internet service providers, express 
package delivery companies and financial service 
companies. 
255. The Royal Pharmaceutical Society of Great 
Britain has developed a pilot project that will give 
persons placing orders through Internet pharmacies 
direct access to its website to enable them to verify 
whether an Internet pharmacy is duly registered with 
the Society, which is required of all pharmacies based 
in England, Scotland or Wales. Visitors of the website 
can verify the registration details of both the pharmacy 
__________________ 
 68  Royal Canadian Mounted Police, Drug Situation Report 
2005, p. 19. 
and the pharmacist, thereby ensuring that they are 
ordering medicines from a bona fide pharmacist. 
256. The Board calls upon all Governments to accord 
adequate importance to the detection and investigation 
of illegal sales of prescription drugs containing 
internationally controlled substances and to undertake 
all measures necessary to ensure that legislative and 
regulatory provisions are in force in their territory to 
effectively counteract such illegal transactions. 
Governments should also ensure that customers of 
Internet pharmacies are made aware of the potential 
health risk involved in consuming prescription drugs 
obtained from illegal Internet pharmacies. In addition, 
Governments should seek the cooperation of 
professional and consumer interest groups in 
identifying and implementing measures to counteract 
illegal activities of Internet pharmacies. 
257. The Board continues to collect information from 
Governments on national legislation related to Internet 
services and sites, national cooperation mechanisms 
and practical experience in the control and 
investigation of illegal Internet pharmacies. In 
addition, the Board collects contact details of national 
focal points for activities related to illegal Internet 
pharmacies in order to facilitate international 
cooperation. The Board encourages all Governments 
that have not yet done so to provide it with the required 
information. 
258. The Board is in the process of finalizing 
guidelines on matters related to Internet sites illegally 
selling internationally controlled substances. The 
guidelines are intended to provide guidance to national 
authorities in formulating national legislation and 
policies for prescribers, pharmacists, law enforcement 
authorities, regulatory authorities and the public with 
regard to the use of the Internet for dispensing, 
purchasing or importing internationally controlled 
substances. 
 
  Operations of courier services and drug control 
 
259. Alerted by reports received from some 
Governments, the Board has initiated a review into the 
compliance of courier services69 with control 
__________________ 
 69  For the purpose of the present report, courier services 
are defined as companies offering customized pickup, 
sorting, transport and delivery (domestic or 
international) of letters, parcels (mail type) and packages 
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provisions on international shipments of narcotic drugs 
and psychotropic substances. The Board has begun 
analysing information on the misuse of courier services 
for smuggling illicit drugs and drugs licitly 
manufactured and subsequently diverted. 
260. According to the preliminary analysis of 
information received by the Board from several 
Governments, the legal situation with regard to the use 
of courier services to transport consignments of 
internationally controlled substances differs from 
country to country. While in some countries such 
shipping is regulated under specific laws, in other 
countries the general provisions regarding the 
transporting of narcotic drugs and psychotropic 
substances apply also to their shipment using courier 
services. In most countries, postal laws apply to the 
sending of letters and parcels through courier services. 
261. The information received so far does not indicate 
any major problems regarding legitimate shipments of 
narcotic drugs and psychotropic substances by courier 
services. Reports of the diversion of consignments of 
narcotic drugs and psychotropic substances while they 
are being transported are very rare. However, in a few 
cases, the non-compliance of courier services with 
control provisions on transporting consignments of 
narcotic drugs and psychotropic substances has been 
detected. 
262. In Sweden, guidelines on the transportation of 
pharmaceuticals that are especially liable to theft were 
developed by the Swedish Association of the 
Pharmaceutical Industry, wholesalers and pharmacies, 
in cooperation with the Medical Products Agency of 
Sweden. The authorities intend to make the application 
of the guidelines mandatory for all shipments of 
narcotic drugs, including those sent by courier 
services. 
263. The smuggling of narcotic drugs and 
psychotropic substances using shipments registered 
through various courier services was reported in 
several countries in different regions. The drugs are 
either sent in misdeclared consignments or are 
concealed in consignments of legitimate goods. In a 
few countries, the misuse of courier services was 
identified as a major modus operandi for drug 
smuggling. 
__________________ 
in fast delivery time. The companies operate outside the 
scope of universal service obligation. 
264. The experience of law enforcement authorities in 
some countries, including Poland and Venezuela 
(Bolivarian Republic of), indicates that drug trafficking 
organizations have realized that using courier services 
is a relatively secure method of illegal drug 
transportation; it allows criminals involved in drug 
trafficking to maintain their anonymity and it keeps the 
risks to a minimum and the operational costs low. 
According to law enforcement authorities in those and 
other countries, using the technique of controlled 
delivery is the most effective way to counteract such 
smuggling, since it makes possible the identification of 
both the senders and the recipients of illicit drug 
consignments. 
265. The law enforcement authorities of several 
countries consider their cooperation with the staff of 
courier services to be an important tool for detecting 
drug smuggling. Law enforcement authorities in India, 
for example, have been training the staff of courier 
services to identify suspicious shipments. Several 
seizures of narcotic drugs and psychotropic substances 
have been made in India on the basis of information 
provided by the staff of courier services to the customs 
authorities. Cooperation between the law enforcement 
authorities and courier services is also taking place in 
Lithuania and Malaysia. 
266. The Board will continue gathering information on 
the misuse of courier services in relation to trafficking 
in internationally controlled drugs, with a view to 
developing countermeasures in that area for adoption 
by Governments. The Board invites all Governments 
and the relevant international organizations to provide 
it with pertinent information and their views on that 
subject. 
 
  Problems in precursor control in Africa 
 
267. Operation Crystal Flow (a six-month operation 
used to track orders for shipments of ephedrine and 
pseudoephedrine to countries in Africa, the Americas 
and West Asia) has helped in identifying the trends in 
trafficking operations using Africa and West Asia as 
transit areas as part of efforts to divert ephedrines. As 
highlighted in the 2007 report of the Board on the 
implementation of article 12 of the 1988 Convention,70 
__________________ 
 70  Precursors and Chemicals Frequently Used in the Illicit 
Manufacture of Narcotic Drugs and Psychotropic 
Substances: Report of the International Narcotics 
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countries being targeted for the diversion of precursors 
of ATS include Burundi, the Democratic Republic of 
the Congo, Ethiopia, Ghana, Iran (Islamic Republic 
of), Kenya, Nigeria, Somalia, South Africa, the Sudan, 
the Syrian Arab Republic, the United Arab Emirates 
and the United Republic of Tanzania. The Board calls 
on the Governments of all countries in Africa and West 
Asia to strengthen their controls over the import and 
movement within their territory of those precursors. 
268. During the period 2006-2007, participants in 
Project Prism (the international initiative to address the 
diversion of chemicals used in the illicit manufacture 
of ATS) and in Operation Crystal Flow identified 
shipments to Africa to be diverted within the region 
and to the Americas. In total, over 75 tons of ephedrine 
and pseudoephedrine were prevented from being 
diverted to or through the region. The Democratic 
Republic of the Congo alone was the destination of 
seven stopped shipments involving a total of 23 tons of 
pseudoephedrine during 2007. Traffickers are taking 
advantage of the often less stringent or non-existing 
national controls over pharmaceutical preparations 
containing ephedrine or pseudoephedrine, which are 
not currently under international control, to smuggle 
such consignments into African countries. 
269. One of the most commonly used methods of 
diversion in Africa was the falsification of import 
permits. The Board notes with concern that several 
African countries are not in a position to respond in a 
timely manner to pre-export notifications and to 
inquiries about suspicious chemical shipments. The 
Governments of those countries should allocate 
adequate resources to staff development to enable the 
competent authorities to perform their regulatory and 
enforcement roles efficiently. The competent 
authorities of countries and territories exporting 
ephedrines are urged to confirm the legitimacy of 
shipments of ephedrine, pseudoephedrine or 
preparations containing those substances to any 
country before releasing such shipments. 
270. The Board is concerned by recent developments 
in which Africa has become one of the main regions 
used for the diversion of precursors of ATS. In 
particular, the Board is concerned that the significant 
number of identified diversions and attempted 
diversions to and through Africa is in sharp contrast 
__________________ 
Control Board for 2007 … . 
with the limited number of seizures made by 
Governments of countries in the region. Between 2000 
and 2006, ephedrine and pseudoephedrine seizures in 
the entire region amounted to only 242 kg, with South 
Africa accounting for most of those seizures. The 
Board calls on the Governments of countries in Africa 
to take adequate measures to ensure that their territory 
is not used for the trans-shipment of precursor 
chemicals. 
 
  Demand reduction 
 
271. Pursuant to article 38 of the 1961 Convention as 
amended by the 1972 Protocol and article 20 of the 
1971 Convention, parties are required to take all 
practicable measures for the prevention of abuse of 
narcotic drugs and psychotropic substances and for the 
early identification, treatment, education, aftercare, 
rehabilitation and social reintegration of the persons 
involved. Article 14, paragraph 4, of the 
1988  Convention states that parties shall adopt 
appropriate measures aimed at eliminating or reducing 
illicit demand for narcotic drugs and psychotropic 
substances, with a view to reducing human suffering 
and eliminating financial incentives for illicit traffic. 
272. The Board has addressed the issue of drug 
demand reduction in a number of its annual reports. In 
its report for 1993,71 the Board underlined the 
importance of demand reduction as an essential part of 
global and national efforts against drug abuse. The 
Board invited Governments to consider making 
demand reduction a priority in their drug control 
efforts, stressing the inextricable relationship between 
demand reduction and supply reduction. That 
connection was further analysed by the Board in its 
report for 2004,72 in which the Board stated that 
neither demand reduction programmes nor supply 
reduction programmes alone had been fully successful 
in addressing the drug abuse problem and indicated 
that, to reduce drug abuse effectively, Governments 
needed to implement supply and demand reduction 
policies concurrently. In its report for 1996,73 the 
Board highlighted the added value that the criminal 
__________________ 
 71  Report of the International Narcotics Control Board for 
1993 …, paras. 13-31. 
 72  Report of the International Narcotics Control Board for 
2004 …, para. 7. 
 73  Report of the International Narcotics Control Board for 
1996 …, paras. 1-37. 
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justice system could offer in reducing drug demand and 
the Board stressed that providing alternative measures 
in the areas of treatment and rehabilitation, in addition 
to, or instead of, imposing fines or handing down 
prison sentences, could be a valuable instrument for 
reducing drug abuse. In its report for 1997, the Board 
observed that some segments of popular culture, in 
particular music, promoted lifestyles in which the use 
of illicit substances was trivialized or even encouraged. 
The Board urged Governments to counter those 
messages by using new forms of communication, 
including the Internet, to disseminate messages 
underlining the negative consequences of drug abuse. 
In addition, the Board brought to the attention of 
Governments their obligation under article 3, 
paragraph 1 (c) (iii), of the 1988 Convention in relation 
to the public by inciting or inducing others to illicitly 
use narcotic drugs or psychotropic substances.74 
273. In 1998, the General Assembly at its twentieth 
special session adopted the Declaration on the Guiding 
Principles of Drug Demand Reduction (Assembly 
resolution S-20/3, annex), in which States Members of 
the United Nations pledged their commitment to 
investing in demand reduction programmes. The 
measures recommended in the Declaration included: 
regularly assessing the nature and magnitude of drug 
abuse; ensuring that demand reduction programmes 
covered all areas of prevention, from discouraging 
initial use to reducing the negative consequences of 
drug abuse; forging partnerships among the 
stakeholders involved at the national and local levels; 
tailoring approaches to different target groups, in 
particular youth; ensuring that disseminated 
information was correct and reliable; and ensuring that 
experience acquired in demand reduction was 
preserved and utilized. 
274. In 2007, the Executive Director of UNODC made 
an assessment of the progress in drug control since the 
adoption of the Declaration. All Governments were 
requested to supply information on their efforts to 
implement the international drug control conventions, 
including their demand reduction programmes. 
Information was collected on demand reduction 
through a questionnaire issued every two years after 
1998, focusing on prevention, treatment and 
__________________ 
 74  Report of the International Narcotics Control Board for 
1997 (United Nations publication, Sales No. E.98.XI.1), 
paras. 1-42. 
rehabilitation, as well as reducing the negative health 
and social consequences of drug abuse. 
275. Based on the information submitted by 
Governments on the questionnaire, the Executive 
Director of UNODC ascertained that the overall level 
of coverage in prevention efforts increased in six of the 
nine regions (Central, South and South-West Asia; 
Central and Western Europe; Latin America and the 
Caribbean; North Africa and the Middle East; North 
America; and Oceania) in the period 2004-2006, 
compared with the periods 2000-2002 and 2002-2004. 
North America and Oceania showed high levels of 
implementation of prevention interventions. In the 
other regions, the implementation levels were much 
lower, even though results per country differed 
significantly from the regional average. Although 
globally prevention interventions are being expanded 
and maintained at that higher level, effective demand 
reduction requires substantially higher coverage of 
interventions.75 
276. According to a report of the Executive Director,76 
detoxification remains the most prevalent treatment 
intervention method. The coverage of detoxification 
has increased in all regions except in Sub-Saharan 
Africa and in Eastern and South-Eastern Europe. 
Substitution treatment is the least employed 
intervention strategy and its coverage has reached high 
levels in North America and in Oceania. In most other 
regions, small increases or even declines have been 
reported. The coverage of non-pharmacological 
treatment showed a minor increase since the period 
2002-2004. In Oceania, it remained the most common 
intervention strategy. Interventions in the area of social 
reintegration received largely the same coverage during 
the period 2004-2006 as in the period 2002-2004, 
registering small increases in most regions, with small 
decreases in Sub-Saharan Africa and in North Africa 
and the Middle East. 
277. In his report, the Executive Director also focused 
on interventions to reduce the negative health and 
social consequences of drug abuse, mainly aimed at 
preventing the spread of infectious diseases such as 
__________________ 
 75  “Drug demand reduction: fourth biennial report of the 
Executive Director” (E/CN.7/2007/2/Add.1), paras. 33 
and 34. 
 76  “Drug demand reduction: fourth biennial report of the 
Executive Director” (E/CN.7/2007/2/Add.1), paras. 43-
45. 
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HIV/AIDS and hepatitis B and C. Interventions ranged 
from the dissemination of information, peer outreach, 
condom distribution, substitution treatment, 
counselling and HIV-testing to programmes for the 
exchange of needles and syringes. North America and 
Oceania had the widest coverage of the combined 
intervention strategies. Central and Western Europe 
had medium coverage of such interventions, while 
interventions in all other regions were limited, even 
though individual States within regions might have had 
higher coverage.77 
278. As underlined earlier, reducing illicit supply and 
reducing demand have a mutually reinforcing effect. 
However, both objectives require essentially different 
approaches. Supply reduction interventions must be 
implemented uniformly to ensure the functioning of the 
international drug control system. Consequently, the 
legal framework for measures countering illicit drug 
manufacture, production, trafficking and diversion 
must be established at the international level. However, 
preventing drug abuse mostly involves communicating 
messages that should take into account the cultural, 
social and economic backgrounds of target groups. In 
addition, the provision of treatment and rehabilitation 
for drug abusers can only take place in the socio-
cultural context of each country. Consequently, demand 
reduction entails policies and interventions that should 
be developed at the national and local levels to achieve 
the desired results.  
279. The Board recognizes that demand reduction is a 
policy objective requiring a wide variety of complex 
measures, in particular because effective interventions 
often need to be tailored to specific target groups. In 
addition, interventions must be sustained over a long 
period and the results of some might be difficult to 
measure. However, the Board stresses the importance 
of drug demand reduction as an essential component of 
the global response to the drug problem. Without 
concerted efforts towards drug demand reduction at the 
national and local levels, reducing the illicit use of 
drugs cannot be accomplished. 
280. In developing and implementing demand 
reduction policies, proper statistical data and expert 
analysis are indispensable. The Board calls upon every 
__________________ 
 77  “Drug demand reduction: fourth biennial report of the 
Executive Director” (E/CN.7/2007/2/Add.1), paras. 48-
57. 
Government that has not yet done so to establish an 
information system that can assess the drug abuse 
situation in its country. Demand reduction programmes 
also require constant monitoring and a built-in 
evaluation process. The Board encourages 
Governments to make national and local experiences 
with demand reduction interventions accessible to drug 
control authorities in other regions or countries. The 
sharing of information and experiences can contribute 
to improving the demand reduction strategies in 
countries that do not have established monitoring and 
evaluation systems. 
281. The Board reminds Governments of their 
obligations under the drug control conventions, as well 
as their commitments made in the Declaration on the 
Guiding Principles of Drug Demand Reduction. The 
Board calls upon Governments to implement the 
provisions of the conventions and to carry out the 
action called for in the Declaration. Governments 
should make it a priority to increase their demand 
reduction interventions in a comprehensive manner, on 
the basis of reliable information on drug abuse and 
paying due attention to the specific characteristics of 
target groups, such as their age and gender. 
 
  Abuse of narcotic drugs and psychotropic 
substances diverted from domestic distribution 
channels 
 
282. Diversion of pharmaceutical preparations 
containing narcotic drugs and psychotropic substances 
from domestic distribution channels has become the 
main source of those substances found on illicit drug 
markets. 
283. In some countries, the abuse of pharmaceutical 
preparations containing controlled substances is second 
only to the abuse of cannabis. The pharmaceutical 
preparations diverted and abused contain various 
opioids, benzodiazepines and ATS. Among the opioids, 
preparations containing buprenorphine, codeine, 
dextropropoxyphene, fentanyl, hydrocodone, 
methadone, morphine, oxycodone and trimeperidine 
account for the largest quantities diverted (see 
paragraph 79 above). 
284. Data collected by Governments on the patterns of 
abuse of pharmaceutical preparations suggest that 
those patterns are related to the overall availability of 
the preparations. For example, to a considerable extent, 
the increasing abuse of pharmaceutical preparations 
E/INCB/2007/1  
 
48  
 
containing narcotic drugs or psychotropic substances in 
Canada and the United States is attributed to the 
extensive licit supply of controlled substances in those 
countries. From 2002 to 2006, the licit use of narcotic 
drugs increased by more than 80 per cent in Canada 
and by more than 60 per cent in the United States, two 
countries that had already in 2002 ranked among the 
highest consumers of narcotic drugs worldwide. In the 
same period, the consumption of amphetamines in 
Schedule II of the 1971 Convention doubled in Canada 
and increased by 42 per cent in the United States. That 
trend in consumption clearly indicates the importance 
of monitoring and providing education on the 
appropriate use of narcotic drugs and psychotropic 
substances. The Board requests the Governments 
concerned to promote the rational use of narcotic drugs 
and psychotropic substances and to adopt prescription 
procedures that promote the rational use of drugs.  
285. Some countries in South Asia and South-West 
Asia are witnessing increasing abuse of various opioid 
analgesics, including codeine preparations, and 
benzodiazepines as preferred drugs. In a number of 
countries in Africa, certain benzodiazepines such as 
chlordiazepoxide, diazepam, lorazepam and nitrazepam 
can be obtained easily and without prescription and on 
street markets. In Nigeria, pentazocine, an opioid 
analgesic in Schedule III of the 1971 Convention, is 
the second most commonly abused drug among 
persons who abuse drugs by injection. Oxycodone, 
hydrocodone and methadone are the narcotic drugs 
most often mentioned as being responsible for the 
increasing number of fatalities in Australia, Canada 
and the United States, as well as in a number of 
European countries. 
286. The abuse of pharmaceutical preparations 
containing narcotic drugs or psychotropic substances 
has become part of and has contributed to the problem 
of increasing polydrug abuse. The increasing 
prescription of opioids, such as buprenorphine and 
methadone, for substitution treatment also contributes 
to the problem of polydrug abuse, as well as the 
problem of diversion. Some addicts illegally sell their 
prescribed pharmaceutical preparations so that they can 
purchase their drugs of choice, such as heroin. 
Significant amounts of those substances are diverted to 
supply the growing illicit markets for those substances, 
not only in the country in which they are diverted but 
also in other countries, into which they are smuggled. 
In Mauritius, for example, there has been a significant 
increase in the number of seizures of buprenorphine 
smuggled out of countries such as France. 
287. However, despite increasing abuse of 
pharmaceutical preparations, most national drug abuse 
monitoring systems are not sensitive to the 
phenomenon of abuse of prescription drugs. Prescribed 
opioids, benzodiazepines and stimulants are rarely 
included in drug abuse surveys and in data collected by 
law enforcement authorities on trafficking. That is just 
one of the reasons why the dimensions of the problem 
are unknown and inadequately assessed. 
288. The United States (in the National Survey on 
Drug Use and Health) systematically collects data on 
the abuse of specific prescription drugs. A number of 
other countries, while not systematically collecting 
such information, include prescription drugs in studies 
on the extent and patterns of drug abuse. The Board 
notes that the All Party Parliamentary Group on Drug 
Misuse in the United Kingdom launched in July 2007 
an inquiry into the scale and nature of the abuse of 
prescription drugs and over-the-counter drugs in that 
country. The Board welcomes that initiative and invites 
the Governments of other countries where that is not 
already done to examine the issue of the diversion and 
abuse of pharmaceutical preparations containing 
narcotic drugs and psychotropic substances and to 
adopt adequate countermeasures, as appropriate. 
289. The traditional methods of diversion include the 
use of stolen or forged prescriptions, burglary of 
pharmaceutical establishments and “doctor shopping”. 
In addition, diversions occur as a result of poor 
prescription practices by medical doctors and disregard 
for prescription requirements in pharmacies. Those 
diversion methods are often used to supply individual 
drug abusers. Larger-scale theft, from factories and 
wholesalers and pretended exports, are diversion 
methods used by drug traffickers. In such cases, the 
diverted drugs are abused within the country of 
diversion or smuggled into other countries. In some 
countries, the diversion of pharmaceutical drugs has 
been identified by some criminal groups as a lucrative 
activity. 
290. In countries experiencing a particularly negative 
development in the abuse of prescribed opioids, the 
authorities should consider increasing the regulatory 
control of such substances. The Board in its annual 
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reports78, 79 has encouraged the Government of the 
United States to review the controls applicable to 
preparations containing hydrocodone with a view to 
preventing their diversion and abuse. Considering the 
particularly worrying trend of the abuse of 
hydrocodone among youth (see paragraphs 81 and 98 
above), the Board again urges the authorities of the 
United States to examine the appropriateness of current 
control measures for preventing the diversion and 
abuse of that narcotic drug. If necessary, the authorities 
should adopt stricter control measures for 
hydrocodone. 
__________________ 
 78  Report of the International Narcotics Control Board for 
2005 …, para. 72. 
 79  Report of the International Narcotics Control Board for 
2006 …, para. 56. 
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III. Analysis of the world situation 
 
 
 A. Africa 
 
 
  Major developments 
 
291. The main development causing concern in Africa 
is the rapid increase in the smuggling of cocaine from 
Latin America through West and Central Africa and 
into Europe. According to Interpol estimates, 
200-300 tons of cocaine is smuggled into Europe each 
year; a growing proportion of that cocaine is passing 
through West Africa, where it is stockpiled and re-
packaged before being transported to Europe. There is 
some concern that West African countries are not 
adequately equipped to forestall that development. 
292. Africa is also being increasingly used by 
traffickers as a trans-shipment area for the diversion of 
precursors, particularly ephedrine and 
pseudoephedrine. As most countries in Africa do not 
have the legislative and institutional framework in 
place to combat trafficking in precursor chemicals, 
traffickers are increasingly turning to countries in the 
region in their efforts to obtain the chemicals they need 
for illicit drug manufacture.  
293. Cannabis remains the main illicit drug of concern 
in Africa. Cannabis illicitly cultivated in Africa is 
abused locally or smuggled through the region and into 
Europe and North America. 
294. The abuse of ATS and other psychotropic 
substances takes place in many African countries 
because the drug control systems in those countries are 
not functioning properly. There continues to be a lack 
of appropriate mechanisms and skilled human 
resources to control and prevent drug trafficking, and 
the provision of counselling, treatment and 
rehabilitation facilities for drug abusers remains 
inadequate. 
 
  Regional cooperation 
 
295. The Commission of the African Union has 
elaborated a new action plan on drug control and crime 
prevention for the period 2007-2010. The new action 
plan covers a wide range of issues, including drug 
trafficking and drug demand reduction, and is to be 
adopted at the 2008 Summit of Heads of State and 
Government of the African Union. The Commission of 
the Economic Community of West African States 
(ECOWAS) is currently developing an integrated plan 
of action against drugs and crime. The plan will 
address drug control issues, including the improvement 
of national forensic capabilities, as well as emerging 
and existing threats in West Africa. 
296. The Seventeenth Meeting of Heads of National 
Drug Law Enforcement Agencies, Africa, held in 
Nairobi in September 2006, was attended by heads of 
national law enforcement agencies from countries 
throughout Africa, representatives of international drug 
law enforcement agencies and experts from UNODC. 
Participants shared information on major regional drug 
trafficking trends, and discussed action taken by 
Governments to enhance regional and subregional 
cooperation in law enforcement training, experiences 
with drug trafficking countermeasures, the effective 
implementation of controlled delivery operations, 
efforts to mobilize community support for law 
enforcement anti-drug strategies, and inter-agency 
cooperation and the role of forensic laboratories in 
combating drug trafficking. 
297. The twenty-first conference on anti-narcotics 
policy and strengthening Arab cooperation was held in 
Tunis in June 2007. The conference, which was 
attended by representatives of North African countries 
and other member States of the League of Arab States, 
addressed developments such as drug trafficking 
through the Internet and the smuggling of drugs by 
express mail, which has emerged in recent years in 
several Arab countries. Recommendations related to 
the creation of additional drug rehabilitation centres 
and action against money-laundering were adopted.  
298. The eighth Interpol Meeting of Heads of African 
National Drugs Services, held in Arusha in June 2007, 
discussed drug control strategies and promoting 
cooperation to combat drug trafficking in Africa 
through, for example, the incident response teams80 
and the global police communications system81 of 
__________________ 
 80 The incident response teams have been created by 
Interpol to rapidly assist developing countries that 
unexpectedly make exceptional drug seizures. 
 81 The global police communications system of Interpol  
(I-24/7) connects law enforcement officials in all 
Interpol member States and provides them with a means 
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Interpol. With Somalia joining that communications 
system in July 2007, all African countries are now 
connected to it. 
299. In July 2007, UNODC launched a three-year 
project that uses law enforcement cooperation and the 
exchange of intelligence to curb the smuggling of 
cocaine from Latin America into West Africa. The 
project is aimed at establishing a multiregional 
mechanism for intelligence exchange in the area of 
drug interdiction and to promote intelligence-led drug 
investigations in Latin America, West Africa and 
Europe. The initiative, which is financed by the 
European Commission and Spain, will provide training 
and equipment to law enforcement and intelligence 
services in Latin American and West African countries 
that cooperate with each other through the gathering 
and sharing of intelligence. Seven countries in Latin 
America and the Caribbean82 and six countries in West 
Africa83 have been selected to participate in the 
project. 
300. In 2007, a joint port control unit, comprised of 
police and customs officers, was established in Ghana, 
in the port of Tema, under the Container Control 
Programme of UNODC and the World Customs 
Organization. The programme, which was launched in 
Ecuador and Ghana in November 2004, is addressing 
the problem of drug trafficking by commercial sea 
freight container. Plans are under way to extend the 
programme to include ports in countries in East and 
Southern Africa. 
301. The fourth regional working group on drug abuse 
and HIV/AIDS, organized by UNODC, the Joint 
United Nations Programme on HIV/AIDS (UNAIDS) 
and the World Health Organization (WHO), was held 
in Cairo in November 2006. The workshop focused on 
building the capacity to use a comprehensive approach 
to reduce the spread of HIV/AIDS among persons who 
abuse drugs by injection in countries on the Arabian 
peninsula and in North Africa. The workshop brought 
together representatives of law enforcement agencies, 
national AIDS programmes and non-governmental 
organizations, and United Nations entities, as well as 
researchers, community representatives and people 
__________________ 
of sharing crucial police information. 
 82 Bolivia, Brazil, Colombia, Ecuador, Peru, Trinidad and 
Tobago and Venezuela (Bolivarian Republic of). 
 83 Cape Verde, the Gambia, Ghana, Guinea-Bissau, Senegal 
and Togo. 
living with HIV. The North African countries 
represented in the workshop were Algeria, Egypt, the 
Libyan Arab Jamahiriya, Morocco and Tunisia. 
302. At the subregional level, cooperation among drug 
law enforcement agencies continues to be 
strengthened. In East Africa, cooperation among drug 
control police in Kenya, Rwanda, Uganda and the 
United Republic of Tanzania is being strengthened 
through meetings held twice a year to discuss regional 
narcotics issues. In 2007, the Southern African 
Regional Police Chiefs Cooperation Organization 
(SARPCCO) launched a project on the identification of 
illicit drugs and chemical equipment. A working group 
on the eradication of cannabis in Southern Africa has 
also been established within SARPCCO. 
 
  National legislation, policy and action 
 
303. The Board notes that a number of African 
countries are currently updating national drug control 
legislation. The Government of Guinea-Bissau, a 
country that has recently been targeted by international 
networks smuggling cocaine from Latin America into 
Europe, is revising its national legislation to 
incorporate the provisions of the international drug 
control treaties. In Malawi, Uganda and the United 
Republic of Tanzania, current drug control legislation 
is being upgraded with a view to strengthening drug 
law enforcement and to increasing penalties for 
drug-related crime. 
304. Efforts are being undertaken by the Governments 
of Egypt, Kenya and Nigeria to draft or update national 
drug control plans. In Egypt, the National Council 
against Addiction and Drug Control has started to 
update the national drug control strategy. Similarly, in 
Kenya, a multisectoral drug control master plan is 
being developed, with special emphasis on law 
enforcement activities and the strengthening of the 
capacity of judicial authorities to investigate drug 
offences and combat drug-related money-laundering. 
The Government of Nigeria has developed a drug 
control master plan for the period 2007-2011, which is 
expected to be officially released at the end of 2007.  
305. The national drug law enforcement agency of the 
Libyan Arab Jamahiriya will organize, in cooperation 
with the Universal Postal Union (UPU) and UNODC, a 
regional seminar on countering drug trafficking and 
money-laundering using the mail, to be held in Tripoli 
in November 2007. It is expected that during the 
E/INCB/2007/1  
 
52  
 
seminar, a draft regional action plan will be developed 
to foster bilateral and multilateral cooperation aimed at 
curbing the smuggling of drugs using the courier 
system. 
306. The Egyptian Anti-Narcotics General 
Administration continued to provide support, including 
in the form of border control and computer network 
training, to other national drug law enforcement 
agencies in countries in North Africa. South Africa has 
provided advisory support and training to law 
enforcement agencies of countries in East and Southern 
Africa. Botswana, Ethiopia, Mauritius, Mozambique, 
Swaziland and Zimbabwe recently received training 
and advice from South Africa on the establishment of 
forensic science laboratories. Moreover, the dog 
training school in Roodeplaat, South Africa, has 
provided training to dog handlers and delivered sniffer 
dogs, trained to detect drugs, to other African 
countries, including Botswana, Lesotho, Malawi, 
Nigeria and the United Republic of Tanzania. 
307. The Government of Morocco recently launched 
an initiative against drug-related corruption. 
Investigations following the arrest of a drug baron in 
Morocco in 2006 resulted in the arrest of more than a 
dozen high-ranking Government, judicial, military and 
law enforcement officials in connection with 
drug-related corruption. 
308. In many countries in Africa, treatment and 
rehabilitation programmes and facilities for drug-
dependent persons are often inadequate or lacking. The 
Board has repeatedly encouraged the Governments 
concerned to take the measures necessary to ensure 
that adequate treatment is available to such persons. 
The Board notes the recent opening of treatment and 
rehabilitation centres for drug-dependent persons in 
Benin, Kenya and Togo. It is also noted that a number 
of African countries, including Algeria, Côte d’Ivoire, 
Egypt, Kenya, the Libyan Arab Jamahiriya, Mali, 
Morocco, Nigeria, Senegal and the United Republic of 
Tanzania, have taken measures to develop drug abuse 
prevention programmes and treatment and 
rehabilitation programmes for drug-dependent youth 
and prison inmates. 
309. The Governments of Ethiopia, Kenya and Uganda 
are intensifying activities in the area of countering 
money-laundering. A workshop organized in 
cooperation with Interpol was held in Nairobi in 
December 2006 to provide investigators with case 
studies on how to investigate money-laundering cases. 
The Government of Malawi, having adopted legislation 
against money-laundering, in line with relevant 
recommendations of the Financial Action Task Force 
on Money Laundering, is in the process of establishing 
a financial intelligence unit. New legislation against 
money-laundering is expected to be adopted soon in 
Ghana and the United Republic of Tanzania. In all 
West African countries except Ghana, there are laws 
criminalizing money-laundering even if they do not 
always fully comply with international standards. 
Proper financial investigation units and mechanisms 
are in place in Nigeria and Senegal (and, to a lesser 
extent, in Cape Verde and the Niger). In May 2007, 
Nigeria became the first country in the West African 
subregion to be admitted as a full member of the 
Egmont Group of Financial Intelligence Units. 
 
  Cultivation, production, manufacture, 
trafficking and abuse 
 
  Narcotic drugs 
 
310. Cannabis is illicitly cultivated throughout Africa 
and is abused locally or smuggled within the region 
and into Europe. Cannabis production and trafficking 
are reported in practically all African countries. The 
largest cannabis producers in the region are countries 
in West Africa (Benin, Ghana, Nigeria and Togo), 
Southern Africa (the Democratic Republic of the 
Congo, Malawi, South Africa, Swaziland and Zambia) 
and East Africa (Comoros, Ethiopia, Kenya, 
Madagascar, Uganda and the United Republic of 
Tanzania). Increasing amounts of South African 
cannabis are being seized in countries in Europe, 
particularly Ireland and the United Kingdom. In 
August 2007, a ton of cannabis was discovered in 
Ireland in a container originating in South Africa. 
Cannabis is also found in mail leaving South Africa, 
especially for Italy and the United Kingdom. 
311. The production of cannabis resin takes place in 
countries in North Africa, mainly Morocco. The Board 
notes that the Government of Morocco has intensified 
its efforts to counter the illicit cultivation of cannabis 
plants and the illicit production of cannabis resin, 
which has resulted in a decline in the illicit production 
of cannabis resin in that country. It appears that that 
has resulted in the decline of seizures of cannabis resin 
in Europe, the largest market for cannabis resin in the 
world. Despite decreases in recent years in the total 
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area under cannabis cultivation in Morocco, that 
country remains one of the world’s main producers and 
suppliers of cannabis resin. A route used for smuggling 
cannabis resin from Morocco through Mauritania, 
Mali, the Niger and Chad and into either Egypt or the 
Sudan was identified in early 2007. A total of 5.7 tons 
of cannabis resin was seized in five seizures in the 
Niger in the period 2006-2007. 
312. While global cannabis abuse seems to have 
stabilized, in Africa the abuse of cannabis continues to 
increase. Annual prevalence of cannabis abuse in 
Africa is 7.7 per cent of the population aged 15-
64 years. Among the subregions in Africa, the highest 
rate of cannabis abuse is in West and Central Africa 
(13 per cent), followed by Southern Africa (8.5 per 
cent).84 The abuse of cannabis continues to be 
widespread in East Africa as well. 
313. Large illicit consignments of cocaine are 
transported from countries in Latin America (from 
Colombia through Brazil and Venezuela (Bolivarian 
Republic of)) to the coastal areas of West Africa (on 
board ships, private yachts and, more recently, private 
airplanes) and then to Europe. In addition, large 
quantities of cocaine, most of which is destined for 
Portugal and Spain, are shipped to the waters off the 
coast of Cape Verde and Guinea. During the first eight 
months of 2007, significant quantities of cocaine were 
seized in Benin, Cape Verde, Guinea-Bissau, 
Mauritania and Senegal. In Africa, cocaine is repacked 
in small quantities and smuggled into Europe by air, 
using locally recruited couriers. In order to avoid 
detection, cocaine traffickers frequently change the 
airports from which they depart and their routes. In 
West Africa, the main airports used by couriers 
smuggling cocaine into Europe are in Dakar, Conakry, 
Freetown, Banjul, Accra and Lagos. In addition to 
direct routes leading to Europe, new cocaine 
trafficking routes through North Africa and the Arabian 
peninsula have appeared. With the increased 
availability of cocaine in West Africa, organized 
trafficking networks have developed that are able to 
acquire and redistribute hundreds of kilograms of 
cocaine. Cocaine is transported by air also to countries 
in Southern Africa, notably South Africa (where it is 
abused locally), either directly from South America or 
via West Africa, using couriers, air freight services or 
express mail services. 
__________________ 
 84 World Drug Report 2007 …, p. 114-115. 
314. Cocaine abuse has increased in Africa, notably in 
countries in West and Southern Africa, as well as in the 
coastal area of North Africa, albeit from low levels. 
Annual prevalence of cocaine abuse in Africa stood at 
slightly over 1 million, in 2005;85 in other words, 
cocaine abusers in Africa represent about 7.6 per cent 
of all the cocaine abusers in the world. In South Africa, 
data from treatment centres indicate that cocaine abuse 
is increasing throughout the country. 
315. Heroin trafficking and abuse are on the increase 
in some countries in Africa. Heroin is smuggled by air 
from South-West Asia through East Africa and West 
Africa into Europe and through West Africa into North 
America, usually by courier. In 2006, the World 
Customs Organization reported heroin trafficking 
routes leading from Afghanistan and Iran (Islamic 
Republic of) through Qatar to Kenya and from the 
Islamic Republic of Iran through the United Arab 
Emirates to South Africa and the United Republic of 
Tanzania. Data of seizures of heroin in many countries 
in Africa seem to suggest an increasing presence of 
heroin on illicit markets in the region. The main transit 
countries used by heroin traffickers in the various 
African subregions are as follows: Ethiopia, Kenya and 
United Republic of Tanzania in East Africa; 
Côte d’Ivoire, Ghana and Nigeria in West Africa; and 
South Africa in Southern Africa. Heroin is smuggled 
through major international airports in West Africa by 
couriers on direct flights from countries in East Africa 
(Ethiopia and Kenya) and on the Arabian peninsula and 
from Pakistan. West Africa serves as a corridor for 
heroin smuggled into North America and Europe. 
Parcel post is another means by which heroin is 
smuggled into countries in Africa, mainly Nigeria and 
South Africa but also Côte d’Ivoire, the Democratic 
Republic of the Congo, Mali and Mozambique. 
316. The level of heroin abuse in Africa remains low. 
According to the World Drug Report 200786 of 
UNODC, in 2005 it was estimated that 
980,000 persons in Africa (or 0.2 per cent of the total 
population aged 15-64) were heroin abusers. Although 
heroin abuse seems to be confined to areas along 
trafficking routes, it is reported to have increased 
sharply in countries in East Africa (notably Kenya, 
Mauritius and the United Republic of Tanzania) and 
Southern Africa (notably Mozambique and South 
__________________ 
 85 Ibid., p. 82. 
 86 Ibid., table 4. 
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Africa). In countries in West Africa, such as 
Côte d’Ivoire and Senegal, and in countries in North 
Africa, such as Morocco, there have also been reports 
of sharply increased heroin abuse, a development that 
is probably linked to the fact that heroin trafficking 
routes pass through those countries. 
317. Heroin is abused in Africa primarily by smoking. 
However, the abuse of heroin by injection is spreading 
in Kenya, Mauritius and the United Republic of 
Tanzania, particularly in urban areas; in those 
countries, the authorities are concerned about the high 
prevalence of HIV/AIDS among injecting drug 
abusers. 
 
  Psychotropic substances 
 
318. In many countries in Africa, the diversion of 
pharmaceutical preparations containing psychotropic 
substances from licit distribution channels into parallel 
markets continues to be a cause for concern. The sale 
of such substances without medical prescription by 
street vendors and health-care providers continues to 
pose a major problem throughout the region. 
319. Methaqualone has, for years, been the preferred 
drug of abuse in South Africa; however, according to 
the South African Community Epidemiology Network 
on Drug Use,87 its abuse appears to be on the decline. 
Methaqualone, which is generally smoked together 
with cannabis, is not only manufactured locally in 
clandestine laboratories in South Africa, but also 
smuggled into the country out of China, India and 
other countries. In 2006, South African authorities 
detected over 1 ton of methaqualone in a sea freight 
consignment originating in China and intercepted 
30 kg of methaqualone from Zambia that was entering 
South Africa through Zimbabwe. 
320. Illicit manufacture of ATS, mostly 
methamphetamine and methcathinone, is taking place 
in Southern Africa. In addition, methamphetamine 
continues to be smuggled into South Africa, mainly out 
of China. In South Africa, both the illicit manufacture 
and abuse of ATS have increased. The substances 
ephedrine and pseudoephedrine, which are used for the 
__________________ 
 87 Charles Parry, Andreas Plüddemann and Arvin Bhana, 
“Alcohol and drug abuse trends: July-December 2006 
(phase 21)”, South African Community Epidemiology 
Network on Drug Use (SACENDU) Update (Cape 
Town), 15 May 2007. 
illicit manufacture of those ATS, are smuggled into 
South Africa out of China and India or are diverted 
from licit channels. Illicit manufacture of several types 
of synthetic drugs seems to have increased, as shown 
by the growing number of clandestine laboratories that 
have been dismantled in South Africa. For example, 
between 1995 and 1999, South Africa reported, on 
average, the dismantling of one clandestine laboratory 
per year; that figure increased to 46 in 2006. Because 
of intensified law enforcement activities, such 
laboratories are increasingly being established on 
remote farms, making it more difficult for the police to 
find and destroy them. 
321. MDMA (commonly known as “ecstasy”) 
continues to be smuggled out of Europe into South 
Africa, to be sold on the illicit market in that country. 
In June 2007, 70,000 “ecstasy” tablets were intercepted 
at the airport at Brussels; the tablets were destined for 
Cape Town. 
322. In Mauritius, buprenorphine (Subutex®) is abused 
as a substitute for heroin, either alone or in 
combination with other drugs. During 2006, about 
520  seizures of small quantities of Subutex® were 
effected in that country; in most of those cases, the 
substance was found on drug addicts. In addition, two 
cases involving the large-scale smuggling of Subutex® 
were reported in Mauritius, the most recent one 
involving 50,000 tablets from France. 
 
  Precursors 
 
323. The Board is concerned that Africa is 
increasingly being targeted by traffickers as a trans-
shipment point for the diversion of precursors, 
particularly ephedrine and pseudoephedrine.88 During 
the period 2006-2007, a large number of suspicious 
shipments of ephedrine and pseudoephedrine, as well 
as preparations containing those substances, were 
identified; all of the shipments were destined for 
African countries such as Burundi, the Democratic 
Republic of the Congo, Egypt, Ethiopia, Ghana, 
Kenya, Mozambique, Nigeria, Somalia, South Africa 
and the United Republic of Tanzania. During that 
period, a total of over 75 tons of the two substances 
__________________ 
 88 For a detailed description, see Precursors and Chemicals 
Frequently Used in the Illicit Manufacture of Narcotic 
Drugs and Psychotropic Substances: Report of the 
International Narcotics Control Board for 2007 … . 
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were prevented from being diverted to or through the 
region, which represents the highest amount ever 
recorded for Africa. The Democratic Republic of the 
Congo was the destination of seven stopped shipments 
containing a total of 23 tons of pseudoephedrine 
during 2007. 
324. As precursor control legislation is inadequate or 
non-existent in many African countries and as 
monitoring and control mechanisms are weak, 
traffickers have been placing orders for such 
substances to be delivered to countries in Africa, from 
where the consignments are to be smuggled into North 
America or other regions. In most of the identified 
diversion attempts, forgery of import permits was the 
prevailing method used. Another matter of concern is 
that the authorities of many African countries do not 
respond to pre-export notifications and to inquiries 
about the legitimacy of shipments of precursors in a 
timely manner. The Board therefore urges the 
Governments of the African countries affected by such 
transit traffic to put in place, as a matter of priority, the 
necessary legislative and institutional framework to 
effectively combat the smuggling of precursors through 
their territories. 
 
  Missions 
 
325. The Board sent a mission, for the first time, to the 
Congo in February 2007. The Board notes that the 
Government of the Congo, by acceding to the three 
international drug control treaties in 2004, has 
demonstrated its political will and determination to 
combat drug trafficking and abuse, in cooperation with 
the international community. However, the 
Government is not able to fully comply with its treaty 
obligations. The Board therefore encourages the 
Government to give drug control issues the highest 
possible priority and to strengthen its commitment to 
the objectives of the international drug control treaties. 
326. The national drug control legislation of the 
Congo is outdated; it needs to be revised to ensure 
effective control over narcotic drugs, psychotropic 
substances and precursors. The Board urges the 
Government of the Congo to give priority to updating 
its national drug control legislation. Moreover, the 
administrative mechanism for monitoring and 
exercising control over those substances needs to be 
strengthened so that the Government may fulfil its 
obligations under the international drug control 
treaties. To that end, the Government may wish to avail 
itself of the legal assistance of UNODC. 
327. Effective drug interdiction in the Congo is 
hampered by the fact that trained law enforcement 
officers and the necessary equipment are lacking. The 
Board is concerned that the Congo is at risk of being 
used as a transit country for drug trafficking, which 
could have spillover effects, such as increased drug 
abuse. The Board urges the Government of the Congo 
to give priority to further strengthening the drug 
interdiction capacity of the law enforcement 
authorities, including the customs authorities, by 
providing the necessary training and equipment. To 
that end, the Government may wish to request the 
support of other Governments and UNODC. 
328. The Board carried out a mission to Liberia in 
March 2007. While Liberia is party to the 
1961 Convention and the 1988 Convention, it has not 
ratified the 1971 Convention (it is the only State in 
West Africa that is not yet a party to that treaty). The 
Board therefore requests Liberia to ratify the 
1971  Convention as soon as possible. In addition, 
Liberia should take the measures necessary to ensure 
its full compliance with the reporting obligations of the 
international drug control treaties. 
329. Drug trafficking and abuse are major challenges 
that the Government of Liberia is facing after a 
protracted civil war. It is important for the Government 
to adopt appropriate national legislation to address 
drug trafficking and abuse. The Board therefore urges 
the Government to adopt adequate drug control 
legislation without further delay. To that end, the 
Government may wish to seek legal assistance from 
UNODC. 
330. The Board notes that there are at least nine law 
enforcement agencies in Liberia that have a mandate to 
act against drug trafficking. The mandates of the 
agencies in question appear to be overlapping, which 
may result in duplication of activities. It is imperative 
for the Government to resolve that issue as soon as 
possible. In addition, the ability of the Government to 
correctly identify drugs being trafficked is limited. The 
Board notes the initial assessment made by UNODC to 
assist the Government in establishing laboratory 
capabilities in Liberia.  
331. Drugs are believed to be widely abused in 
Liberia. However, there has never been a systematic 
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assessment of the nature, extent and patterns of drug 
abuse in that country. The Government should 
therefore give priority to conducting a rapid 
assessment of drug abuse in the country. Such an 
assessment is essential to the development of policy 
and the designing of appropriate programmes for the 
prevention of drug abuse and treatment and 
rehabilitation of the drug abusers. 
 
 
 B. Americas 
 
 
  Central America and the Caribbean 
 
 
  Major developments 
 
332. The region of Central America and the Caribbean 
continues to be used as a transit and trans-shipment 
area for consignments of illicit drugs, primarily 
cocaine from countries in South America, mainly 
Colombia, bound for the United States and Europe. It 
is estimated that 88 per cent of the cocaine entering the 
United States has passed through Central America, 
while about 40 per cent of the cocaine entering Europe 
has passed through the Caribbean. In some countries in 
the region, the involvement of international and 
national criminal groups in drug trafficking is 
increasing and the rule of law is being undermined. 
The existence of youth gangs, or maras, involved and 
often in control of the street-level distribution of 
cocaine hydrochloride and “crack” cocaine, continues 
to be a problem in countries in the region such as 
El Salvador, Guatemala and Honduras. 
333. Most illicit drugs are transported through 
Caribbean and Pacific waters, usually using fast boats 
in the Caribbean and larger craft in the Pacific. Despite 
the huge amount of cocaine passing through Central 
America and the Caribbean, the level of drug abuse in 
the region remains relatively low. However, the 
increasing quantities of drugs being trans-shipped 
through the countries in the region can, in the longer 
term, lead to growing illicit markets and increasing 
drug abuse levels in the transit countries. 
334. While the production of cannabis for the illicit 
markets in North America and Europe has decreased, 
cannabis abuse and trafficking within Central America 
and the Caribbean continue to pose problems. The 
significant increase in seizures of MDMA reflects the 
intensified use of the region as a transit area and the 
related problem of growing drug abuse. 
335. The control of precursor chemicals in Central 
America and the Caribbean appears weak. The Board 
encourages countries in the region to put in place an 
adequate system for the control of precursors, in order 
to prevent the region from being used for the diversion 
and smuggling of precursor chemicals into other 
regions, for use in the illicit manufacture of 
methamphetamine. 
 
  Regional cooperation 
 
336. Member States of the Organization of American 
States (OAS) are using the Multilateral Evaluation 
Mechanism to monitor and evaluate individual and 
collective efforts in addressing the drug problem. The 
Inter-American Drug Abuse Commission (CICAD) 
employs the results of the evaluation to make periodic 
recommendations to member States on improving their 
capacity to control illicit drug trafficking and abuse 
and enhance multilateral cooperation. Although not all 
recommendations have been fully implemented, 
substantial progress has been made. Through the 
Multilateral Evaluation Mechanism, three evaluations 
have been conducted and recommendations have been 
made to Governments. The responses from 
Governments have been very positive: 76 per cent of 
recommendations had been implemented by 
Governments in the first round, 85 per cent in the 
second round and 81 per cent in the third round. 
337. Drug control efforts of countries in Central 
America and the Caribbean are often hampered by lack 
of funding. The Secretary-General of OAS invited the 
States in the region to adopt laws that would, on a 
regular and permanent basis, allocate up to 1 per cent 
of the drug-related assets seized to drug control 
programmes and organizations. Recognizing the 
important role that sea transport plays in drug 
trafficking in the region, the Board encourages the 
Governments of countries in the region to follow the 
recommendation of OAS on implementing measures to 
deter, thwart and dismantle criminal organizations 
using the sea to transport narcotic drugs, arms and 
materials used in processing drugs. 
338. Drug abuse prevention programmes continue to 
expand in the region. Such programmes include a 
programme on school drug abuse prevention 
guidelines, training teachers under the sponsorship of 
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CICAD and life skills programmes. In addition, the 
University of the West Indies launched in 2007 an 
online programme in the Caribbean for the prevention 
and treatment of substance abuse. The online 
programme marks the conclusion of a two-year 
partnership between CICAD and the University of the 
West Indies, undertaken at the request of national drug 
control commissions of Caribbean countries. 
339. OAS and the Commission of the European Union 
launched an initiative in February 2007 to link cities in 
Europe with cities in Latin America and the Caribbean 
in order to create associations to improve, at the 
municipal level, the rehabilitation and treatment of 
drug abusers. Furthermore, the Governments of 
Canada, France, the Netherlands, Spain, the United 
Kingdom and the United States provided assistance in 
combating drug trafficking activities. 
340. The Regional Security System of the 
Organization of Eastern Caribbean States has among its 
main objectives the prevention and interdiction of 
trafficking in illicit narcotic drugs. The countries that 
are members of the Regional Security System (Antigua 
and Barbuda, Barbados, Dominica, Grenada, Saint 
Kitts and Nevis, Saint Lucia and Saint Vincent and the 
Grenadines) continued in 2006 to support efforts to 
counteract the smuggling of drugs through the eastern 
part of the Caribbean. 
341. A seminar was held in Mexico City in May 2006 
to provide training for police, customs and officials 
from the ministries of health of El Salvador, 
Guatemala, Nicaragua and Panama in improving the 
current system for the control of precursors in those 
countries. The training focused on bringing national 
legal frameworks in line with the international drug 
control treaties, on diversion techniques and on the 
implementation of UNODC electronic tools for drug 
control. Similar training was offered for police, 
customs and Government officials from Belize, 
Costa Rica and Honduras in October 2007. 
342. The Board would welcome the disruption, as a 
result of the ongoing cooperation among countries in 
the region, of operations involving trafficking in drugs 
and precursor chemicals. 
 
  National legislation, policy and action  
 
343. In Belize, the National Coast Guard Service, with 
full responsibility for law enforcement and safety at 
sea, was established in 2006 to deter trans-shipping of 
narcotic drugs. The National Coast Guard Service 
patrols the Belizean coastline and conducts operations 
to combat drug trafficking.  
344. In 2006, the Costa Rican Institute on Drugs 
enhanced its coordination efforts in the areas of 
intelligence-gathering, demand reduction, the seizure 
of assets and the licensing of precursor chemicals. In 
2006, Costa Rica also adopted legislation against illicit 
enrichment and reported the results of the evaluation of 
several drug abuse prevention programmes. 
Programmes targeting universities, adults, the 
workplace and prison inmates are included in the 
strategy “Promoting Healthy Lifestyles”. The Board 
encourages the Government of Costa Rica to ratify the 
multilateral Agreement concerning Cooperation in 
Suppressing Illicit Maritime and Air Trafficking in 
Narcotics Drugs and Psychotropic Substances in the 
Caribbean Area. 
345. In El Salvador, the Anti-Narcotics Division of the 
National Police is responsible for preventing drug 
trafficking by land, sea and air. It is also responsible 
for preventing the smuggling of drugs using mail 
delivery services. With regard to drug abuse prevention 
efforts, the Government of El Salvador is working with 
the Anti-Drugs Foundation of El Salvador 
(FUNDASALVA), a non-governmental organization, to 
increase public awareness of substance abuse and to 
provide counselling, rehabilitation and reintegration 
services (including job training) for drug-dependent 
persons. In 2007, UNODC, in collaboration with the 
United States Centers for Disease Control and 
Prevention conducted studies on the prevalence of drug 
abuse by injection, high-risk behaviour and HIV/AIDS 
in treatment centres in El Salvador and Guatemala. 
UNODC provided to El Salvador, Guatemala, 
Nicaragua and Panama support in publishing and 
promoting recently approved or revised minimum 
standards for the treatment of drug abusers. 
346. In 2006, Guatemala enacted a law against 
organized crime, authorizing wiretaps, undercover 
operations and controlled deliveries. The Executive 
Secretariat of the Commission against Addictions and 
Illicit Drug Trafficking of Guatemala continues to 
implement the Comprehensive National Program on 
Prevention Education. Using the “train-the-trainer” 
concept, the Government of Guatemala trained a 
sufficient number of teachers so that courses on drug 
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abuse prevention could be taught in schools. 
Corruption remains a problem in Guatemala, despite 
efforts by the Government of Guatemala and the 
enforcement of a zero-tolerance policy on corruption in 
the National Police. 
347. In 2006, Honduras adopted the Law on 
Transparency and Access to Information, giving public 
access to information about activities of the 
Government, in particular its ministries and agencies. 
Congress is expected to adopt in 2007 a plan to revise 
the police law and to reorganize the national police and 
law enforcement efforts to combat drug trafficking. In 
order to improve the work of the national police, plans 
are being made to increase the number of police 
officers and to reorganize the police command. 
348. While Panama is not a major producer or 
consumer of chemicals used in the illicit manufacture 
of drugs, there are reports that significant quantities of 
chemicals pass through the Colón Free Zone to other 
countries. Legislation to strengthen the chemical 
control regime in Panama was adopted in April 2005. 
In 2006, emphasis was placed on building capacity to 
implement the new legislation, for example by creating 
a chemical control unit at the Joint Intelligence 
Coordination Center. 
349. The Information Advisory Committee of the 
National Drug Council of Antigua and Barbuda has 
started to evaluate currently used methods for data 
collection and analysis. With technical assistance from 
CICAD, Antigua and Barbuda has carried out a 
national survey in secondary schools to determine the 
nature and extent of drug use in secondary schools and 
the attitudes of youth towards the use of drugs.  
350. In Barbados, the National Council on Substance 
Abuse, in cooperation with non-governmental 
organizations, carries out drug abuse prevention and 
education programmes, such as the Drugs and 
Decisions programme in 45 primary schools, the Drug 
Abuse Resistance Education (DARE) programme and 
the Parents’ Resource Institute for Drug Education 
programme. 
351. In Cuba, rehabilitation programmes for drug-
dependent persons are carried out by State-run 
organizations ensuring the implementation of minimum 
care standards. In order to prevent the diversion of 
pharmaceuticals containing internationally controlled 
substances, only one port and one airport are 
authorized to function as gateways for the import and 
export for controlled substances. 
352. The Ministry of Health of Dominica has 
established a series of community-based prevention 
programmes, including the DARE programme. The 
Board encourages Dominica to adopt the principle of 
minimum standards of care in drug dependency 
treatment as defined by CICAD. 
353. The Dominican Republic has strengthened 
domestic law enforcement and has identified activities 
against money-laundering that are to be given priority. 
Corruption continues to undermine drug control 
activities, despite efforts by the Government to deal 
with that problem. 
354. The Board notes that in Grenada the 2005 draft 
precursor chemical bill has not yet been adopted. The 
Board encourages the Government of Grenada to adopt 
legislation on precursor control that is in conformity 
with the provisions of the international drug control 
treaties. 
355. The Observatoire haïtien des drogues (Haitian 
drug monitoring centre) is not functioning properly 
because of lack of human resources and equipment. 
The national police reached an agreement in August 
2006 with the United Nations Stabilization Mission in 
Haiti (MINUSTAH) on procedures for checking all 
police officers for criminal records. In 2006, 
500   officers were dismissed for misconduct. 
Corruption is so prevalent in the country that it often 
hinders drug and crime control efforts. Anti-corruption 
measures introduced by the Government have met with 
limited success. The Board requests the Government to 
curb the influence of organized crime on Government 
activities and to fight corruption at all levels. The 
Board is concerned that the lack of resources to 
adequately patrol the borders and coast of Haiti has 
resulted in the country becoming a major drug 
trafficking hub in Central America and the Caribbean.  
356. In 2006, the Government of Jamaica announced 
security and legislative and policy initiatives to combat 
drug trafficking, corruption and trafficking in humans. 
The initiatives called for measures such as forfeiture, 
port security and digital fingerprinting measures. 
However, the legislation did not go beyond the initial 
stages. The adoption of the Proceeds of Crime Act, 
which would facilitate seizures and forfeitures, was 
stalled in Parliament. Legislation to criminalize the 
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manufacture, sale, transport and possession of 
“ecstasy”, methamphetamine and precursors of those 
drugs was drafted in 2006 and scheduled to be 
presented to Parliament in 2007. The Board urges the 
Government of Jamaica to adopt the two laws as soon 
as possible. 
357. In 2006, the National Drug Council of Trinidad 
and Tobago enhanced the capacities of the Special 
Anti-Crime Unit, which carries out operations to 
counter drug trafficking and kidnapping. In 2006, 
crime control and law enforcement bills were passed in 
Trinidad and Tobago, streamlining the police service 
and holding it more accountable, in addition to 
increasing the penalties for certain offences, including 
offences related to drug trafficking. 
 
  Cultivation, production, manufacture, 
trafficking and abuse 
 
  Narcotic drugs 
 
358. The region of Central America and the Caribbean 
is used by drug traffickers as a major transit and trans-
shipment area. Cooperation increased between criminal 
groups in the region, and more complex cooperation 
mechanisms have been established between criminal 
groups. Drug trafficking accounts for a large part of the 
organized criminal activities in the region. Some 
countries, such as the Dominican Republic, Haiti and 
Jamaica, are major hubs for drug trafficking groups 
shipping drugs to the United States and countries in 
Europe. In 2005, about 10 tons of cocaine were 
transported through Jamaica, and 20 tons of cocaine 
passed through the Dominican Republic or Haiti. The 
Caribbean islands continue to form part of the main 
routes used for smuggling cocaine into Europe: the 
Netherlands Antilles is used for shipments to the 
Netherlands, Jamaica for shipments to the United 
Kingdom and French-speaking Caribbean islands are 
used for shipments to France. The authorities in the 
Netherlands believe that the 100 per cent control 
strategy for passengers flying from the Netherlands 
Antilles, Suriname and Venezuela (Bolivarian Republic 
of) to the Netherlands has significantly reduced the 
flow of illicit drugs through Schiphol airport, near 
Amsterdam.  
359. While the Caribbean route is preferred by 
Colombian drug traffickers, Mexican criminal groups 
engaged in drug trafficking prefer the Central 
American corridor. As the Mexican criminal groups 
have replaced Colombian drug trafficking groups in the 
United States (see paragraph 397 below), part of the 
transit traffic in illicit drugs appears to have shifted to 
Central America. Some less policed areas in Central 
America, such as the national park Laguna del Tigre in 
Guatemala, Mosquitia in Honduras and the Atlantic 
coast of Nicaragua, are used by drug traffickers for 
refuelling planes and vessels and for repackaging and 
storing drugs. The share of cocaine shipments 
accounted for by Central American countries and 
Mexico increased from about 50 per cent in 1999 to 
88 per cent in 2005. Guatemala is used as a landing 
area for private aircraft smuggling cocaine from 
Colombia into the United States. Guatemala is also 
used as a trans-shipment area for cocaine consignments 
transported by sea to Europe. Because of its extensive 
unpatrolled areas, drug traffickers are also using 
Guatemala as a storage area for drugs being 
transported to Mexico.  
360. During 2006, joint operations of Costa Rican and 
United States authorities led to the seizure of more 
than 25 tons of cocaine. One growing problem is the 
use of Costa Rican fishing vessels for smuggling 
narcotic drugs and refuelling “go-fast” boats 
transporting drugs. In 2006, over 36 tons of cocaine 
were seized in Panama. 
361. In Central America and the Caribbean, the level 
of abuse of narcotic drugs is relatively low. For 
example, the annual prevalence of abuse of narcotic 
drugs appears to range from 0.1 per cent in Antigua 
and Barbuda to 1.3 per cent in Aruba; the majority of 
countries have an annual prevalence rate of less than 
1 per cent. 
362. In the Caribbean, Jamaica continues to be the 
main producer of cannabis and the only significant 
exporter of cannabis to other regions, but its cannabis 
production has decreased. There is substantial cannabis 
production in Central American countries, mostly for 
domestic use or trafficking within the region. Jamaica 
has the highest annual prevalence of cannabis abuse, 
with 10 per cent of all persons aged 15-64 abusing 
cannabis. In all countries in Central America except 
Belize and Guatemala the annual prevalence is less 
than 5 per cent. The cannabis abuse level is higher in 
most countries in the Caribbean but still significantly 
lower than in Jamaica, ranging from 1.9 per cent in the 
Dominican Republic to 7.3 per cent in Barbados. 
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363. Substantial amounts of heroin originating in 
Colombia and Mexico have been seized in countries in 
the Caribbean (Aruba, Bermuda, the Dominican 
Republic, the Netherlands Antilles, Puerto Rico and 
Trinidad and Tobago) and in Central America 
(Costa  Rica, El Salvador, Nicaragua and Panama). 
Guatemala has reported large seizures of opium poppy 
capsules but only sporadic seizures of heroin. In 
September 2006, the Government of Guatemala 
reported having eradicated 27  million opium poppy 
plants, indicating an increase in illicit opium poppy 
cultivation to its previous peak level. 
364. The annual prevalence rate of abuse of opiates is 
low in most countries in the region, ranging from 
0.04  per cent in Honduras to 0.3 per cent in 
El Salvador. 
 
  Psychotropic substances 
 
365. The transit traffic in psychotropic substances 
appears to be increasing in the Caribbean. In 2006, the 
authorities in the Dominican Republic seized 
363,434 tablets of MDMA (“ecstasy”). A large part of 
the seized drugs were destined for the illicit market in 
North America. Increasing trafficking is contributing to 
a rise in the abuse of psychotropic substances such as 
MDMA in the Dominican Republic. According to 
authorities, about half of all the MDMA trafficked in 
the Dominican Republic is abused in the country. In 
Jamaica, there is evidence that MDMA from the 
Netherlands is increasingly becoming available on the 
illicit markets, mostly for tourists. The annual 
prevalence of abuse of amphetamines is highest in 
El Salvador (3 per cent), followed by the Dominican 
Republic (1.1 per cent). Synthetic drugs also originate 
in the region, although to a lesser extent. A laboratory 
manufacturing LSD was dismantled on the island of 
St. Maarten. 
 
  Precursors 
 
366. Because of improved control over imports of 
ephedrine and pseudoephedrine, in Mexico, there have 
been fewer attempts to illegally import those 
substances into that country and drug traffickers have 
therefore found a new route for smuggling ephedrine 
and pseudoephedrine through Central American 
countries to clandestine laboratories in Mexico. In 
2006, Indian authorities stopped the shipment of 5 tons 
of ephedrine and 2.5 tons of pseudoephedrine to 
Belize. Attempts to divert large quantities of 
pharmaceutical preparations containing ephedrine and 
pseudoephedrine were prevented in Costa Rica and 
El Salvador. 
 
 
  North America 
 
 
  Major developments 
 
367. The increasing influence that organized criminal 
groups gained over and through drug trafficking is the 
major drug threat in the region of North America. 
Organized crime is controlling drug trafficking in 
Mexico. The role of criminal organizations in drug 
trafficking in Canada and the United States has 
expanded, providing them with financial gains that 
increase their illicit drug manufacturing capacities 
even further. Despite strong efforts by the Government 
of Mexico and bilateral efforts in cooperation with the 
United States, organized crime is engaged in open 
warfare against the authorities in order to maintain 
Mexico’s position as the primary transit corridor for 
most of the cocaine consignments destined for the 
United States while maintaining their share of the 
profits derived from the trafficking in heroin, 
methamphetamine and cannabis found on the United 
States market. 
368. In Canada, apart from motorcycle gangs involved 
in drug trafficking, various ethnic criminal groups 
engage in the large-scale illicit production of cannabis 
and illicit manufacture of and trafficking in 
methamphetamine and MDMA. In the United States, 
criminal groups originating in Colombia, the 
Dominican Republic and Mexico play a major role in 
illicit drug manufacture and trafficking. The Board, 
recognizing that national authorities in all of those 
countries are attempting to counteract those 
developments by increasing cooperation and joint 
operations, encourages the national authorities to 
intensify those efforts in order to adequately respond to 
those challenges. 
369. In Canada, the supply of “safer crack kits”, 
including the mouthpiece and screen components of 
pipes for smoking “crack”, has been authorized by the 
Vancouver Island Health Authority, in contravention of 
article 13 of the 1988 Convention. Several other cities 
in Canada, such as Ottawa and Toronto, have also 
approved programmes for the distribution of drug 
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paraphernalia, including crack pipes, to chronic drug 
users. The Board calls upon the Government of Canada 
to eliminate those programmes, as well as existing 
programmes providing drug injection sites, which are 
in violation of the international drug control treaties, to 
which Canada is a party. 
370. After years of apparent stability in the drug trade, 
significant and sustained increases in cocaine and 
methamphetamine prices occurred in the illicit drug 
market in the United States during 2007. At the same 
time, a drop in purity at the retail level was observed. 
Contributing causes of those positive developments 
seem to be: an increase in the flow of cocaine towards 
Europe; eradication campaigns in Colombia; and 
intensified efforts by the Government of Mexico, 
which have disrupted the operating environment of 
drug traffickers. 
371. As a result of those developments, the abuse of 
cocaine and “crack” in the United States has 
significantly decreased, but the abuse of prescription 
drugs has become a major problem. Illegal Internet 
pharmacies constitute a large part of that problem by 
providing prescription drugs without the required 
controls. The particularly high rates for the abuse of 
prescription drugs, the consequences of which can be 
fatal, are affecting a larger proportion of young people 
than in previous years.  
372. The United States has nearly reached its goal of 
reducing the abuse of cannabis, heroin and MDMA 
among youth by 25 per cent within five years. 
However, the decrease in the abuse of cannabis among 
youth in the United States may be offset by an increase 
in the abuse of prescription drugs. The Board, 
therefore, encourages the authorities of the United 
States to vigorously address the problem of the illegal 
sale and abuse of prescription drugs. 
 
  Regional cooperation  
 
373. Regional cooperation for drug control matters is 
well established in North America. A large number of 
bilateral investigative activities and joint operations 
have been carried out in the region, some of them 
covering the whole range of drug trafficking activities 
such as Operation All Inclusive 2005-1 and Operation 
All Inclusive 2006-1. Those two operations focused on 
South American source areas, the eastern Pacific and 
western Caribbean parts of the transit areas in Mexico 
and Central America, and mainland areas of Mexico 
and Central America, in order to target in a combined 
effort the flow of drugs, money and chemicals within 
those areas. Numerous other joint operations have 
targeted trafficking in specific drugs, including 
cocaine, methamphetamine and prescription drugs. 
374. United States law enforcement agencies provide 
the Federal Investigative Agency of Mexico with basic 
equipment and advanced contraband detection training. 
Training in the detection and dismantling of 
clandestine laboratories is also provided to law 
enforcement personnel to raise the capacity at the local 
level to bring to justice manufacturers of narcotic 
drugs and psychotropic substances, particularly 
methamphetamine. A matter of major concern to 
Mexico is the use of proceeds from drug trafficking to 
acquire weapons in the United States for use in Mexico 
by criminal organizations. 
375. The weak control of the financial system of 
Mexico is exploited by drug traffickers to launder 
money derived from drug trafficking. That has resulted 
in an increase in the number of money-laundering 
cases investigated in 2006 by the financial crime unit 
of the office of the Deputy Attorney General against 
organized crimes. In 2006, Mexico became a member 
of the Financial Action Task Force of South America 
against Money Laundering (GAFISUD). 
376. Two successful examples of cooperation between 
Canada and the United States are Project North Star, a 
mechanism for law enforcement coordination, and the 
joint Integrated Border Enforcement Team initiative. 
Canada is also cooperating with the United States 
against illicit drug trafficking along the route leading 
from South America to North America and has 
deployed “Maritime Patrol Assets” in support of the 
Joint Interagency Task Force South. The Integrated 
Marine Security Operations programme known as 
Shiprider facilitates effective maritime law 
enforcement. It allows law enforcement officers from 
one country to operate from the vessels or aircraft of 
another country, so that a single vessel can patrol both 
Canadian and United States waters and pursue suspect 
vessels. 
 
  National legislation, policy and action 
 
377. In the United States, demand reduction strategies 
targeting youth continue to be monitored in the annual 
survey “Monitoring the Future”. There has been a 
reduction in the demand for drugs that has been 
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attributed to the increasing perception of the risks of 
drug abuse by youth, strong parental disapproval and 
effective prevention messages delivered in schools. 
The National Youth Anti-Drug Media Campaign uses 
television, radio, printed matter and online 
communications to enhance young people’s ability to 
perceive the harm caused by drug abuse. 
378. The growing problem of abuse of prescription 
drugs in the United States is being addressed through 
the cooperation of government offices, research 
institutes, pharmaceutical companies, medical 
associations, schools and communities. Activities 
include educational outreach strategies covering a wide 
range of groups (including physicians, pharmacists and 
patients), as well as education, screening, intervention 
and treatment for persons who abuse prescription 
drugs, the surveillance of distribution chain integrity 
and research by the private and public sectors. In spite 
of those activities, the purchase and abuse of Vicodin® 
(containing hydrocodone) and OxyContin® (containing 
oxycodone), particularly by youth, and the illegal sale 
of those and other drugs over the Internet have become 
major problems in the United States. 
379. In the United States, the Combat 
Methamphetamine Epidemic Act of 2005 became fully 
effective in September 2006. The Act establishes a 
nationwide standard for precursor control and provides 
for severe penalties for precursor-related offences and 
provisions for enhanced international enforcement of 
laws to prevent the diversion of chemicals. Efforts are 
being carried out at the national and state levels to 
regulate more closely the sale of ephedrine and 
pseudoephedrine in retail outlets. 
380. In response to the smuggling of drugs across the 
border with Mexico, the United States Administration 
has developed the National Southwest Border 
Counternarcotics Strategy and Implementation Plan, 
which was adopted by Congress in December 2006. 
The Implementation Plan has identified the major goals 
and objectives and resource requirements for closing 
gaps in drug control capabilities along the south-west 
border of the United States. 
381. The President of Mexico has identified the fight 
against drug trafficking and organized crime as the 
most important tasks of his Government. The 
Government of Mexico has initiated plans to introduce 
innovations in law enforcement efforts to combat drug 
trafficking, through the reform of the justice system, 
the creation of a unified federal police force under a 
single command and the establishment of a unified 
criminal information system. The Government has also 
improved the investigative and analytical capabilities 
of the Federal Investigative Agency of Mexico and the 
National Centre for Analysis, Planning and Intelligence 
against Organized Crime of the Attorney General’s 
Office of Mexico. While progress appears to have been 
achieved during 2007 in the fight against drug 
traffickers and corruption, the Government has 
confirmed its commitment to adopting further 
countermeasures. The presidential veto of the planned 
changes to the national law, which would have allowed 
personal possession of drugs, was approved in April 
2007 by the commissions of justice, health and 
legislative studies of the Senate. 
382. In Mexico, the clandestine manufacture of and 
trafficking in methamphetamine have increased in the 
past few years. Legislative and administrative 
measures in Mexico have significantly reduced imports 
of ephedrine and pseudoephedrine, substances required 
for the illicit manufacture of methamphetamine (see 
also the 2007 report of the International Narcotics 
Control Board on the implementation of article 12 of 
the 1988 Convention).89 Criminal organizations have 
reacted to that development by smuggling ephedrine 
and pseudoephedrine from Central American countries 
into Mexico, to compensate for the reduced availability 
of those precursors on the Mexican market. 
383. The Board encourages the Government of Canada 
to implement as soon as possible the new National 
Anti-Drug Strategy, for combating illicit drug 
production, preventing illicit drug use and treating 
illicit drug dependence. The Board notes that the Meth 
Watch Program, implemented by the Nonprescription 
Drug Manufacturers Association of Canada, includes 
the training of retailers to identify suspicious orders for 
precursors of methamphetamine. 
384. In Canada, a bill that received final parliamentary 
approval in December 2006 will make the national 
legislation against money-laundering consistent with 
the recommendations of the Financial Action Task 
Force on Money Laundering by expanding the 
__________________ 
 89 Precursors and Chemicals Frequently Used in the Illicit 
Manufacture of Narcotic Drugs and Psychotropic 
Substances: Report of the International Narcotics 
Control Board for 2007 … . 
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coverage of the legislation to include lawyers and 
dealers in precious metal and stones. 
 
  Cultivation, production, manufacture, 
trafficking and abuse 
 
  Narcotic drugs 
 
385. North America is one of the main regions used 
for the production of cannabis. The United States, 
Mexico and Canada produce about 5,000 tons, 
4,000  tons and 800 tons of cannabis, respectively. 
Some of the cannabis produced in the United States is 
grown under hydroponic conditions, so as to increase 
the yield and the potency. 
386. The illicit market for cannabis in Canada is 
mostly supplied by domestic production. Canadian 
cannabis with high potency is grown indoors on a large 
scale under laboratory conditions using specialized 
equipment and fertilizers. The large-scale illicit 
cultivation of cannabis in Canada appears to be driven 
by the lack of strict punishment for cannabis growers. 
387. In the United States, efforts to eradicate cannabis 
have increased in recent years; in 2006, a record level 
of about 6 million cannabis plants were eradicated. The 
eradication of illicit crops remains a priority of the 
Mexican army, which eradicated nearly 30,000 
hectares of cannabis in 2006 (at least 80 per cent of the 
total cannabis crop). 
388. Cannabis is the most common illicitly used drug 
in the region. The prevalence of lifetime cannabis users 
is 40.1 per cent in the United States (according to the 
2005 national survey on drug use and health) and 
44.5 per cent in Canada (according to the 2004 report 
on the drug situation). The last survey of prevalence of 
lifetime cannabis users in Mexico (conducted in 2003) 
showed a much lower number of cannabis users 
(prevalence of 4.7 per cent). 
389. The sharp increase in cannabis potency in the 
region is a cause for serious concern. The increase has 
been attributed to the production of high-potency 
cannabis in Canada and the United States by criminal 
groups. The average potency of samples of seized 
cannabis nearly doubled from 2000 to 2005. Compared 
with the average tetrahydrocannabinol (THC) content 
of cannabis in the 1960s, the potency of cannabis has 
increased by nearly 10-fold. Mexican criminal groups 
have also started to produce higher-potency cannabis, 
derived from cannabis cultivated on outdoor plots on 
the western coast of the United States. 
390. According to the Potency Monitoring Project of 
the University of Mississippi, cannabis with higher 
potency accounts for an increasing percentage of 
samples of seized cannabis in the United States. The 
percentage of samples containing higher-potency 
cannabis (THC content of at least 5.0 per cent) 
increased from 15.8 per cent in 1989 to 60 per cent in 
2005. The highest THC content in an analysed sample 
was 32.3 per cent. According to the Treatment Episode 
Data Set, 20.1 per cent of drug abusers admitted for 
treatment in 2005 reported cannabis to be their primary 
drug of abuse (compared with 6 per cent in 1992). 
391. About 1.5 per cent of the population of the 
United States and 0.9 per cent of the population of 
Canada reported having abused heroin at least once in 
their lifetime. While heroin abuse in Mexico still seems 
to be concentrated in areas along that country’s border 
with the United States, recent surveys indicate that 
heroin abuse has expanded to other areas in Mexico 
though the prevalence rate is still quite low. In the 
United States, heroin abuse among youth has decreased 
only slightly, and no significant changes in the rate of 
heroin abuse and the number of first-time heroin 
abusers have been observed among the general 
population. 
392. Most of the heroin abused in the United States 
comes from Colombia and Mexico. While South 
American “white heroin” remains the predominant 
heroin in use in the United States, Mexican drug 
trafficking organizations have introduced “black tar” 
and “brown powder” heroin from Mexico in some of 
the south-eastern states, as well as in the Midwest, in 
the United States. A mixture of “black tar” heroin and 
Tylenol® PM (paracetamol) is increasingly being 
abused in some parts of the United States, where more 
than a dozen deaths have been reported from such 
abuse. 
393. In 2006, the Government of Mexico reported 
having eradicated opium poppy covering over 
16,831    hectares, less than the more than 
20,000 hectares reported for two of the previous three 
years. 
394. Each year, between 1 and 2 tons of heroin are 
smuggled into Canada, mostly from South-East Asia 
and South-West Asia and, to a lesser extent, Latin 
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America. According to a report from Canada, a mixture 
of heroin and ketamine is being smuggled into 
Victoria, Canada. The Board requests the Government 
of Canada to verify the authenticity of that report. 
395. In Mexico, cocaine is the second most commonly 
abused drug: lifetime prevalence of cocaine abuse (use 
of cocaine at least once in a person’s lifetime) is 
currently 1.45 per cent in that country. In Canada, 
cocaine is reported to be the third most widely abused 
drug, according to a 2004 survey; lifetime prevalence 
of cocaine abuse is 10.6 per cent in that country. In the 
United States, lifetime prevalence of cocaine abuse is 
reported to be 13.8 per cent, according to 
a 2005 survey. 
396. According to a 2005 survey, the rate of past-
month abuse of cocaine among youth in the United 
States has been stable in recent years, at about 0.6 per 
cent, which is significantly below the peak level of 
1.9 per cent in 1982. Cocaine abuse among the general 
population in the United States has also been stable. 
About 2.4 million persons have abused cocaine in the 
past month. 
397. Most of the cocaine transported to the United 
States is from countries in South America, particularly 
Colombia, which supplies about 90 per cent of the 
cocaine entering the United States, using routes that 
pass through the Mexico-Central America corridor. 
Mexican drug trafficking organizations and criminal 
groups control most of the wholesale distribution of 
cocaine in the United States. Mexican authorities 
seized more than 48 tons of cocaine between 
1 December 2006, when the new Administration took 
office, and late October 2007. That is more than double 
the amount of cocaine seized in the previous year. 
398. It is estimated that 15-25 tons of cocaine enter 
Canada every year; Colombia continues to be the 
predominant source country. Cocaine enters Canada 
largely through that country’s border with the United 
States or in shipments from the Caribbean. Canadian 
criminal organizations are involved in large-scale 
international networks facilitating the importation of 
cocaine into Canada and other countries.  
399. The abuse of prescription drugs in the United 
States is higher than the abuse of heroin, cocaine and 
methamphetamine and second only to the abuse of 
cannabis. Approximately 6.4 million people in the 
United States abuse prescription drugs containing 
controlled substances, mostly pain relievers 
(4.7 million). Nearly 10 per cent of students in their 
final year of secondary school (17-18 years old) 
reported having abused prescription drugs in the past 
year (9.7 per cent abused Vicodin® and 4.3 per cent 
abused OxyContin®). One third of all new abusers of 
prescription drugs in that country are 12-17 years old, 
and prescription drugs are the drug of choice among 
persons 12-13 years old. The Board is concerned about 
those developments. 
400. In some states in the United States, the abuse of 
prescription drugs is considered to represent a serious 
threat to the health and safety of the population. In 
Maryland, the number of deaths caused by methadone 
abuse increased by more than 25 per cent between 
2005 and 2006. Moreover, the cases involving fentanyl 
overdose and death increased significantly in 2006. 
Most of the cases involving death were not related to 
the abuse of diverted licitly manufactured fentanyl 
preparations but to the abuse of heroin or cocaine that 
had been mixed with clandestinely manufactured or 
diverted fentanyl. In May 2006, a laboratory in Mexico 
used for the clandestine manufacture of fentanyl was 
seized after having been identified as one of the main 
sources for the fentanyl that had been used as an 
adulterant for the heroin involved in the drug-related 
deaths in Maryland. 
401. The diversion and abuse of OxyContin® continue 
to take place in Canada, particularly in Nova Scotia 
and Ontario, where an increase in the number of deaths 
linked to the abuse of that drug has been noted. The 
increase in trafficking in OxyContin® is reflected in the 
increase in the samples of OxyContin® seized and 
analysed by the Public Health Agency of Canada. 
402. The increasing abuse of prescription drugs in the 
region is the result of several developments, including 
the sharply increased legitimate sale, availability and 
accessibility of such drugs, for example through 
illegally operating Internet pharmacies. From 2000 to 
2004, the sale of pharmaceuticals increased by 109 per 
cent (the sale of drugs containing oxycodone increased 
by nearly 90 per cent and the sale of drugs containing 
hydrocodone increased by nearly 70 per cent). In 2006, 
34  known or suspected illegal Internet pharmacies 
dispensed 98,566,711 dosage units of drug products 
containing hydrocodone. Individuals ordering from 
illegal Internet pharmacies have been able to obtain 
100-200 prescription drug tablets per order, much 
 E/INCB/2007/1
 
 65 
 
larger orders than they would be able to obtain legally, 
and that has contributed significantly to the increased 
availability of prescription drugs for abuse. 
 
  Psychotropic substances 
 
403. In the United States, the rate of abuse of 
methamphetamine among persons aged 12 and above 
declined from 0.7 per cent in 2002 to 0.5 per cent in 
2005. The decline was even more pronounced among 
schoolchildren aged 13-18: from 4.2 per cent in 1999 
to 2.4 per cent in 2005 and 2.0 per cent in 2006. Thus, 
the number of first-time abusers of methamphetamine 
among youth in that country also decreased in 2005, 
compared with the three previous years. In Mexico, 
however, methamphetamine abuse has been rising, 
particularly along the border of that country with the 
United States. In Canada, there has also been a 
resurgence in the popularity of methamphetamine. 
Methamphetamine tablets also continue to be one of 
the main ingredients in tablets marketed as “ecstasy”. 
It is also used by traffickers to enhance the effects of 
cannabis, cocaine, heroin and ketamine (a substance 
not under international control), possibly to accelerate 
addiction among persons abusing those substances. 
404. Reduced illicit manufacture of methamphetamine 
in the United States has been partially offset by 
increased manufacture of the drug in Mexico. About 
80  per cent of the methamphetamine in the United 
States is from larger laboratories, increasingly in 
Mexico, while the remaining 20 per cent comes from 
small home laboratories. Mexican criminal groups are 
also the main wholesale distributors in the United 
States of methamphetamine, including powder 
methamphetamine and, increasingly, “crystal” 
methamphetamine (commonly known as “ice”). 
405. Methamphetamine seizures at the border between 
Mexico and the United States increased from 777 kg in 
2000 to 2,790 kg in 2006. In 2006, Mexican authorities 
seized four clandestine laboratories capable of 
manufacturing 0.6 ton of methamphetamine. Seizure 
data indicate that extensive infrastructure for the illicit 
manufacture of methamphetamine is in place in 
Mexico and that the number of methamphetamine 
laboratories dismantled and the quantities of 
methamphetamine seized may reflect only a fraction of 
the actual illicit activity involving that drug. 
406. In Canada, methamphetamine is illicitly 
manufactured mainly in clandestine laboratories in that 
country. The involvement of organized crime in 
methamphetamine trafficking has increased the number 
of methamphetamine “super labs”, laboratories capable 
of manufacturing 5 kg or more in one 24-hour 
manufacturing cycle.90 While the quantities of 
methamphetamine smuggled out of Canada into the 
United States are considerably lower than the 
quantities of “ecstasy” smuggled in that direction, 
United States authorities fear an increase in the flow of 
methamphetamine from Canada. One growing problem 
is the smuggling of methamphetamine from Canada 
into countries overseas, mostly Japan. Seizures of 
methamphetamine of Canadian origin have also been 
reported in Australia and the Republic of Korea. 
407. In the United States, the abuse of LSD and 
MDMA by the teenage population has been declining 
since 2001, the level of abuse of MDMA decreasing by 
one half and that of LSD by nearly two thirds in the 
period 2005-2006. 
408. In Canada, illicit drug manufacturers and 
traffickers are marketing as “ecstasy” a mixture of 
MDMA and methylenedioxyamphetamine (MDA) in 
tablet, capsule or powder form. The tablets also contain 
methamphetamine, ketamine, caffeine, 
pseudoephedrine and ephedrine. 
 
  Substances not under international control 
 
409. The abuse of inhalants by young persons remains 
a problem in Mexico and the United States. In Mexico, 
inhalants, which are the third most commonly abused 
group of substances, continue to be the preferred 
substance of abuse among child workers. In the United 
States, adolescents represent the main group of 
inhalant abusers: the average age at first use of 
inhalants among recent initiates is 16 years. 
410. United States authorities are concerned about the 
growing abuse by adolescents of dextromethorphan, a 
substance commonly found in over-the-counter cough 
and cold remedies. According to the Drug Abuse 
Warning Network, adolescents accounted for nearly 
one half of all emergency room visits related to the 
abuse of that substance. 
411. In Canada, ketamine and GHB continue to be 
abused at rave parties and clubs, sometimes in 
__________________ 
 90 Ecstasy and Amphetamines: Global Survey 2003 (United 
Nations publication, Sales No. E.03.XI.15), p. 89. 
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combination with other illicit synthetic drugs. 
Ketamine found on the illicit market is obtained 
through either domestic or international channels of 
diversion. Clandestine manufacture supplies the 
Canadian market for GHB. GBL, required for the 
manufacture of GHB, is obtained from domestic or 
foreign sources in “GHB manufacturing kits” ordered 
via the Internet. 
412. Khat is smuggled mainly through the United 
Kingdom into Canada, where its abuse is mostly 
limited to groups with origins in the eastern part of 
Africa. 
413. A recently discovered drug of abuse in Canada 
has BZP as its active ingredient. The drug called “funk 
pills” has effects similar to MDMA and amphetamine. 
The Board requests the authorities of Canada to 
provide any information they may have about the abuse 
potential and prevalence of abuse of BZP to WHO, as 
that substance is under consideration for future review. 
 
 
  South America 
 
 
  Major developments 
 
414. The region of South America is suffering from 
the illicit cultivation, on a large scale, of coca bush, 
opium poppy and cannabis plant, as well as the 
manufacture and production of and trafficking in the 
illicit drugs stemming from that cultivation. During the 
past four years, the total area under illicit coca bush 
cultivation in South America was stable. In 2006, that 
total area decreased slightly compared with the 
previous year, to 156,900 hectares. In 2006, Colombia 
was the world’s leader in illicit coca bush cultivation, 
accounting for 50 per cent of global coca bush 
cultivation; it was followed by Peru (33 per cent) and 
Bolivia (17 per cent). Contrary to the situation in 2005, 
the decreased illicit cultivation of coca bush in 
Colombia in 2006 was partly offset by increased illicit 
cultivation in Bolivia and Peru. Areas under illicit coca 
bush cultivation measuring less than 100 hectares were 
found in Ecuador. Marginal illicit coca bush cultivation 
was also detected in the Bolivarian Republic of 
Venezuela. 
415. The total area of illicit coca bush cultivation 
eradicated in the three main countries producing coca 
leaf increased by 23 per cent to 231,313 hectares in 
2006, compared with 2005. In Colombia alone, the 
total area eradicated in 2006 (213,555 hectares) was 
almost three times the total area under coca bush 
cultivation (78,000 hectares), which is a reflection of 
the intensity of the eradication activity in that country. 
Priority was also given to eradicating illicit opium 
poppy cultivation. In 2006, the total area under illicit 
opium poppy cultivation in Colombia decreased to 
1,023 hectares, 48 per cent less than the level of the 
previous year and about 18 times less than the level of 
15 years ago. 
416. The continued positive developments in the 
eradication of illicit coca bush cultivation in the region 
were offset by the growers’ improved cultivation 
techniques, the planting of new varieties of coca bush 
and increased efficiency in clandestine laboratories 
processing coca leaf. As a result, potential manufacture 
of cocaine in South America remained at 
800-1,000 tons annually in the period 1997-2006. In 
2006, potential manufacture of cocaine in the region 
was 984 tons, about the same as in 2005. 
417. Although virtually all of the illicit manufacture of 
cocaine occurs in the three main countries in which 
coca bush is cultivated, all countries in South America 
are affected by trafficking in those drugs. The 
strengthened cooperation and the sharing of 
intelligence among law enforcement authorities 
contributed to an improvement of the global cocaine 
interception rate, which had risen sharply in previous 
years. According to the latest data provided by 
Governments, the amount of cocaine seized represents 
about 40 per cent of global cocaine manufacture. More 
than half of the cocaine seized worldwide was seized in 
South America. 
418. The nexus between drug trafficking, drug-related 
organized crime and violence continued to plague 
several South American countries. For example, in 
Brazil, drug-related organized crime has in recent years 
resulted in increased gang violence and murder in large 
urban areas. 
419. The primary drugs of abuse among persons 
treated for drug problems in South America are 
cocaine-type drugs (accounting for almost 50 per cent), 
followed by cannabis (26 per cent). The demand for 
treatment for the abuse of ATS and opiates is lower, 
accounting for about 1 per cent of those seeking 
treatment for abuse. Cocaine abuse continued to rise in 
all the countries covered in the latest surveys. 
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  Regional cooperation 
 
420. Representatives of 10 countries and territories, 
including Brazil, Colombia, Guyana, Suriname and 
Venezuela (Bolivarian Republic of), and six 
international organizations participated in the 
International Anti-Narcotics Conference held in 
Paramaribo in October 2006. The Conference adopted 
the Paramaribo Declaration, which contains measures 
aimed at strengthening coordination and cooperation 
among participating countries in efforts to fight drug 
and precursor trafficking and small arms trafficking 
and the criminal organizations associated with those 
activities. 
421. The sustainability and further improvement of the 
regional and international cooperation among law 
enforcement and intelligence services, as well as 
judicial authorities, of South American countries 
continued to be discussed at various meetings in South 
America. In October 2006, South American countries, 
including Argentina, Bolivia, Brazil, Chile, Colombia, 
Guyana, Paraguay, Suriname, Uruguay and Venezuela 
(Bolivarian Republic of), as well as member States of 
the European Union, Europol and Interpol were among 
those represented at the European Union-Latin 
American and Caribbean Drugs Intelligence Sharing 
Working Group, held in Rio de Janeiro, Brazil. 
Participants reported on progress made in exchange 
programmes for law enforcement officers and 
presented results of recent joint operations. States were 
invited to participate in the Europol Cocaine Logo 
System, aimed at identifying links between the drugs 
seized and the organized crime networks involved. 
422. Representatives at the Sixteenth Meeting of 
Heads of National Drug Law Enforcement Agencies, 
Latin America and the Caribbean, held in Buenos Aires 
in October 2006, reported on regional cooperation, 
including the exchange of information on the 
movement of small vessels at the international level, 
which has proved to be an effective measure against 
maritime trafficking in cocaine and other illicit drugs. 
The Meeting recommended that Governments 
organizing campaigns to eradicate illicit coca bush 
cultivation should ensure that those campaigns are 
accompanied by programmes offering viable 
commercial alternative livelihoods to assist rural 
communities in supporting themselves without having 
to return to illicit crop cultivation. 
423. At the fortieth regular session of CICAD, held in 
Santa Cruz de la Sierra, Bolivia, from 29 November to 
1 December 2006, experts reported on issues of 
common interest, including the control of precursor 
chemicals and pharmaceutical preparations, the use of 
the Internet to sell drugs and money-laundering. 
Representatives of participating countries reported on 
drug policy issues, including new drug control 
legislation (Brazil), national policy on the eradication 
of illicit crop cultivation (Colombia) and the strategy 
against drug trafficking and for the evaluation of coca 
leaf, covering the period 2007-2010 (Bolivia). 
424. During the Third Ibero-American Meeting of 
National Drug Observatories, held in Cartagena de 
Indias, Colombia, in December 2006, the subregional 
system for drug abuse information and investigation, 
linking Argentina, Bolivia, Chile, Ecuador, Peru and 
Uruguay, as well as CICAD and UNODC, was 
presented as an example of best practice in the region. 
425. In 2006, Paraguay built an operational base at its 
border with Brazil to respond to an increase in 
organized criminal activities and the presence of drug 
trafficking groups in the area. During 2006, Argentina, 
Bolivia, Brazil, Chile, Colombia, Ecuador, Paraguay, 
Peru, Venezuela (Bolivarian Republic of) and the 
United States launched the seventh phase of the 
operation Seis Fronteras, a regional initiative to control 
chemicals used in the illicit manufacture of cocaine 
and heroine. 
426. In February 2007, Colombia hosted the 
extraordinary meeting of the European Union/Latin 
America and the Caribbean Coordination and 
Cooperation Mechanism on Drugs. The meeting 
recommended the promotion and financing of 
initiatives, including preventive alternative 
development programmes, to assist in generating 
profitable and long-lasting structural changes in areas 
affected by illicit drug crop cultivation. 
427. In 2007, under the Subregional System for Drug 
Abuse Information and Investigation, an 
epidemiological study on the extent of drug abuse 
among the population was conducted simultaneously in 
Argentina, Bolivia, Chile, Ecuador, Peru and Uruguay, 
with a view to obtaining information to be used in 
support of public policies and drug demand reduction 
programmes. The countries participating in the study 
reviewed the progress made at the Technical Meeting 
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of the Subregional System for Drug Abuse Information 
and Investigation, held in Lima in March 2007. 
428. In May 2007, CICAD approved The Multilateral 
Evaluation Mechanism (MEM) Achievements: 1997-
2007, a report evaluating the main accomplishments in 
the Americas in the area of drug control. According to 
CICAD, treatment, rehabilitation and aftercare services 
for drug abusers in many countries in the region need 
to be further improved. In 2007, OAS and the 
European Commission launched an initiative to pair up 
cities in Europe with cities in Latin America and the 
Caribbean, forming partnerships to improve the 
treatment and rehabilitation of problematic drug 
abusers and address other aspects of drug dependency 
at the municipal level. The initiative will bring together 
mayors, medical and treatment personnel and judges 
from cities in both regions in a sustained program of 
exchanges aimed at sharing best practices, establishing 
long-term partnerships and developing new approaches 
to improving the treatment and rehabilitation of drug 
abusers. 
429. The Board noted that in 2007 the Governments of 
Argentina, Bolivia, Brazil, Chile, Ecuador, Paraguay 
and Peru participated in Operation Crystal Flow, which 
focused on the trade in ephedrine and pseudoephedrine, 
two key precursors of ATS. 
 
  National legislation, policy and action 
 
430. In December 2006, the Government of Bolivia 
approved the new drug policy, the strategy against drug 
trafficking and for the evaluation of coca leaf, covering 
the period 2007-2010. The goals of the strategy 
include: to reform the present legislative framework 
through the introduction of two new legal instruments, 
the regime applicable to coca and the regime 
applicable to controlled substances; to increase up to 
20,000 hectares the total area under coca bush 
cultivation permitted by Bolivian law; to industrialize 
coca leaf; and to strengthen the interdiction capacity 
and efficacy of measures to fight the drug problem. 
431. In December 2006, the Government of Bolivia, in 
line with its drug control strategy, opened one of the 
three plants envisaged for the production of coca leaf 
for industrial purposes. The Board notes with concern 
that the use of coca leaf for industrial purposes, such as 
the production of coca tea or flour, is in breach of the 
international drug control conventions. The Board 
reminds the Government of Bolivia and the 
Governments of the other countries concerned that the 
use and the importation of coca leaf, from which 
cocaine has not been extracted, for purposes other than 
those allowed under the 1961 Convention violates the 
provisions of the international drug control 
conventions. 
432. According to the Government of Bolivia, the 
abuse of illicit drugs in the country increased between 
1992 and 2005. The new drug control strategy includes 
a number of remedial measures, such as programmes 
for the prevention of drug abuse and the treatment of 
drug abusers. 
433. In Brazil, there has been an increase in drug 
trafficking and in criminal acts committed in 
combination with other serious types of crime, 
including kidnapping, extortion and arms trafficking 
organized by criminal groups, mainly in large cities. To 
tackle those serious problems, the Government of 
Brazil prepared in 2007 a new plan against crime and 
violence, focusing on the social security of police 
officers and the integration of traditional law 
enforcement action with current social policies. For 
example, in Brazil, the State of Rio de Janeiro has 
launched activities to reduce drug trafficking and 
related crime in slum areas, with a view to making 
public places safer and providing health services, 
education and safety for the local population. The 
private sector has joined forces with the local public 
institutions in Brazil to prevent drug abuse in the 
family and the community. 
434. In late 2006, Brazil promulgated decree 5.912, 
which further defines competencies of the national 
system of public policy on drugs. In Chile, a number of 
drug-related legislative instruments were adopted 
during 2006, including supreme decree No. 539 of 
18 May 2006, the regulation on the distribution of the 
Ministry of the Interior’s special fund to finance 
programmes for the prevention of drug abuse and the 
treatment and rehabilitation of drug addicts. In 
addition, the special register of users of controlled 
chemical substances, which will assist in further 
strengthening the control of precursor chemicals in the 
country, became operational in April 2007. 
435. In 2007, the Government of Colombia launched 
the Strategy for Strengthening Democracy and 
Promoting Social Development 2007-2013, also known 
as Plan Colombia Phase II, aimed at consolidating the 
results achieved during the completed Plan Colombia. 
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The Plan foresees maintaining supply reduction 
components and also emphasizes the importance of 
including social elements. 
436. In 2006, Colombia adopted resolution 15 of 
12 May 2006, establishing further measures to control 
fast boats and fishing boats in order to prevent such 
boats from being used in maritime drug trafficking. 
Following the entry into force of ministerial 
resolution  1478/2006 of 10 May 2006, Colombia 
modified regulations to improve systems for the 
control of narcotic drugs, psychotropic substances and 
precursors. The regulation extended the medical 
prescription of opioids for 30 days to facilitate the 
treatment of chronic pain. In addition, a national 
survey on the availability of opioids has been carried 
out and a programme to train doctors in palliative care 
has been launched. 
437. Following the positive results achieved by a joint 
customs and police port control unit in Guayaquil, 
Ecuador, that became operational in March 2006, a 
similar unit was established in Manta. The abuse of 
pharmaceutical preparations containing controlled 
substances is considered to be a major problem in 
Ecuador. In November 2006, the Government of 
Ecuador enacted a regulation defining procedures for 
trading in and selling pharmaceutical preparations 
containing controlled substances. 
438. In Peru, there were continued resistance and 
attacks by groups of guerrillas, as well as armed drug 
traffickers and coca growers, at the end of 2006, 
following the announcement by the Government of its 
intention to carry out a peace and development plan 
aimed at combating the remaining guerrillas and 
eradicating illicit coca bush cultivation. The 
Government responded to the attacks by expanding its 
presence in coca-growing areas. In March 2007, the 
protests against coca bush eradication efforts led to a 
controversial agreement with the coca growers on a 
temporary suspension of eradication until the growers 
registered with the national coca enterprise. The Board 
is concerned that that development may lead to a 
further increase in the number of the registered coca 
leaf producers in the country. 
439. On 22 November 2006, Peru promulgated 
supreme decree No. 84-2006-PCM to regulate the use 
of chemicals and certain finished products by retailers. 
In addition, law No. 28305 entered into force in March 
2007, providing measures for the monitoring and 
control of chemicals used in the illicit manufacture of 
drugs. 
440. In Peru, in December 2006, the National 
Commission for Development and Life without Drugs 
(DEVIDA) presented the rapid impact plan 2007, 
aimed at strengthening drug control activities in the 
country. The plan is a part of the national strategy for 
combating drugs covering the period 2007-2011, the 
goals of which include a reduction of 40 per cent in the 
total area under illicit coca bush cultivation, an 
increase in the seizures of illicit drugs and a decrease 
of 10 per cent in the rate of drug abuse (past-year 
prevalence of) among the school-age population. 
 
  Cultivation, production, manufacture, 
trafficking and abuse 
 
  Narcotic drugs 
 
441. Cannabis production takes place in practically all 
countries in South America. The largest producer in the 
region is Paraguay, followed (at a much lower level) by 
Colombia and Brazil. Decreases in cannabis production 
in Colombia in recent years appear to have been offset 
by increases in cannabis production in other countries 
in the region, notably Paraguay. 
442. Although Brazil is an important producer of 
cannabis, it does not produce enough to meet the 
demand on its illicit markets. In Brazil, most of the 
cultivation of cannabis plants takes place in fields 
resembling the fields of plantations. The Brazilian 
authorities estimate that 60 per cent of cannabis abused 
in the country is from Paraguay. In the Bolivarian 
Republic of Venezuela, the total amount of cannabis 
seized increased gradually after 2003, reaching over 
21 tons in 2006. The total amount of cannabis seized in 
2006 increased in Ecuador and Peru, but decreased in 
Chile. Almost 60 per cent of the 5 tons of cannabis 
seized in Chile originated in Paraguay. 
443. The annual prevalence of cannabis abuse among 
the general population in South America was estimated 
at 2.3 per cent, which is less than the global average. 
The results of a recent comparative study of drug abuse 
confirm that cannabis is the illicit drug of choice 
among students in secondary schools in all countries in 
South America, except Brazil, where inhalants are the 
most widely abused substance. The highest past-year 
prevalence for cannabis abuse was found in Chile 
(12.7 per cent), followed by Uruguay (8.5 per cent). In 
E/INCB/2007/1  
 
70  
 
those two countries, more than 60 per cent of students 
abuse only cannabis. The lowest abuse rates were 
found among students in Bolivia, Paraguay and Peru. 
444. In 2006, the total area under coca bush 
cultivation in South America was 156,900 hectares, 
29 per cent less than the total in 2000, which was the 
highest level in the previous 10 years. Potential illicit 
production of cocaine in 2006 was 984 tons, about the 
same amount as a year earlier. 
445. In Bolivia, the total area under coca bush 
cultivation in 2006 increased by 8 per cent, compared 
with 2005, to 27,500 hectares. In the same year, the 
total cultivated area in which coca bush was eradicated 
in that country decreased by 17 per cent, to 
5,070  hectares. That represents the smallest area 
eradicated in the previous 10 years. Due to increased 
coca bush cultivation, in particular in the Chapare area, 
where the coca leaf yields are higher than in the 
Yungas area, in the department of La Paz, potential 
production of cocaine hydrochloride in Bolivia 
increased in 2006 over the previous year by 14 tons, to 
94 tons. 
446. In Colombia, the estimated total area under illicit 
coca bush cultivation decreased in 2006 to 
78,000 hectares, which is about half of the peak level 
of 163,000 hectares reached in 2000. However, in the 
departments of Nariño and Putumayo, in a belt about 
10 km wide along the border of Colombia with 
Ecuador, total area under illicit coca bush cultivation 
increased by about 70 per cent in 2006, compared with 
2005. A record total of 213,555 hectares of illicitly 
cultivated coca bush were eradicated in Colombia in 
2006 (41,530 hectares manually and 172,025 hectares 
by aerial spraying), 26 per cent more than in 2005. 
447. According to recent estimates, about half of the 
total area in Colombia in which coca bush was 
eradicated has been replanted. Improved cultivation 
methods and intensified use of a variety of 
agrochemical products developed by growers over the 
years have contributed to a significant increase in coca 
leaf yields. In some areas, coca leaf can be harvested 
up to eight times per year. A recent coca leaf survey 
revealed that coca bush farmers in Colombia process 
three quarters of the total coca leaf production into 
coca paste or cocaine base.  
448. According to the Government of Peru, 
approximately 90 per cent of the coca leaf produced in 
the country is destined for illicit markets. After 1999, 
the total area under coca bush cultivation increased in 
Peru from a minimum of 38,700 hectares to 
51,400 hectares in 2006. The Apurimac-Ene area was 
among the areas mostly affected by the increased 
cultivation. In addition, a new coca bush cultivation 
area was identified between Brazil, Colombia and Peru 
in the Amazon basin. Based on the results of a survey 
on coca leaf and cocaine yields conducted in Peru in 
2006, potential cocaine production was estimated to be 
280 tons. 
449. In Peru, 10,136 hectares of illicitly cultivated 
coca bush were eradicated in 2006 through forced 
eradication programmes and an additional 
2,550 hectares of coca bush were eradicated as part of 
a voluntary programme. The eradication process in that 
country has been hampered by the activities of drug 
traffickers, who ambushed law enforcement officers 
and hid explosives among illicit crops to deter 
eradication efforts. The governments of the various 
regions in Peru are preparing an intervention strategy 
to address social instability, subversive action and 
crime, which have increased in recent years. 
450. According to a national illicit crop monitoring 
system, the total area under illicit coca bush cultivation 
in Ecuador was estimated at less than 100 hectares in 
2006. The illicit coca bush cultivation sites, each 
covering less than a hectare, were located mainly in the 
provinces of Esmeraldas and Sucumbíos, in the north 
of the country, not far from illicit coca bush cultivation 
areas in neighbouring Colombia. In the past five years, 
the illicit crops in the affected areas have been 
manually eradicated. In the Bolivarian Republic of 
Venezuela, 40 hectares of coca bush were eradicated 
and 18 clandestine laboratories were destroyed during 
Operation Sierra XVII. 
451. In 2006, cocaine seizures increased in Bolivia, 
Chile, Guyana, Peru and Uruguay and decreased in 
Colombia and Ecuador. 
452. In 2006, the amounts of cocaine hydrochloride 
and cocaine base seized in Bolivia increased by 22 per 
cent, to 14.1 tons. According to UNODC, between 
January and August 2007, the amount of drugs and 
precursors seized, as well as the number of destroyed 
laboratories illicitly manufacturing drugs, has 
increased, supposedly as a result of intensified drug 
control activities and increased illicit production of 
drugs in the country. The total area of illicitly 
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cultivated coca bush eradicated during the first eight 
months of 2007 was 25 per cent larger than the total 
area eradicated during the same period in 2006. 
453. The National Police of Peru reported a sharp 
increase in the total amount of coca paste and cocaine 
hydrochloride seized in 2006. The total amount of 
seized cocaine hydrochloride increased from 2.1 tons 
in 2005 to 14.7 tons in 2006. In Ecuador, a decline in 
the total amount of cocaine hydrochloride seized in 
2006 was partly offset by an increase in the total 
amount of coca paste seized. 
454. In 2006, Colombia seized 170.1 tons of cocaine 
hydrochloride and cocaine base. Though the total 
amount of those drugs seized was significantly lower 
than the amount seized in 2005, it was nevertheless 
higher than the average for the five-year period 2001-
2005. According to the Colombian authorities, the 
decline in the total amount of cocaine seized in 2006 
could be attributed to changes in trafficking patterns: 
in 2005, over 40 per cent of the cocaine seizures were 
made at sea; in 2006, however, cocaine traffickers in 
Colombia made increased use of land routes leading to 
the Bolivarian Republic of Venezuela and Ecuador and 
from there to countries in the Southern Cone, and 
Central America and the Caribbean, using different 
trafficking methods, before the cocaine consignments 
reached their final destination, mainly the United 
States and countries in Europe. 
455. Illicit cocaine shipments leaving the coasts of 
South American and Central American countries were 
also stockpiled in West African countries and trafficked 
through Africa by land before being smuggled on small 
airplanes or boats from North Africa into countries in 
Europe, in particular Spain. Commercial sea containers 
continue to be one of the main means of transport used 
to smuggle drugs. In the past few years, traffickers 
have also used submersible and semi-submersible 
vessels, constructed using the latest technology 
available in naval engineering to enable them to carry 
large cocaine consignments. 
456. In 2007, the Colombian police carried out a 
number of successful operations against drug 
traffickers. In January 2007, in Operation Mercaderes, 
the national police dismantled a major criminal 
organization, responsible for smuggling cocaine and 
heroin from Colombia into the United States, through 
Argentina, Brazil, Costa Rica, the Dominican 
Republic, Ecuador, Mexico, Nicaragua and Panama. 
Members of the organizations were arrested in 
Colombia and other countries in the Americas. During 
2007, cooperation among the law enforcement agencies 
in the region resulted in the capture, in Brazil and 
Colombia, of the two most wanted Colombian drug 
traffickers. 
457. The trafficking organizations supplying the 
growing illicit drug market in Brazil continued taking 
advantage of the geographical position of the country, 
as well as sparsely inhabited areas of the Amazon 
forest, to transport coca paste and cocaine from the 
Andean subregion through the territory of Brazil to 
Africa, Europe and North America. In particular, the 
smuggling of coca paste from Bolivia through Brazil 
increased significantly in 2006, while the smuggling of 
heroin of Colombian origin through Suriname 
decreased. The Brazilian authorities estimate that 
70 per cent of the cocaine manufactured in Bolivia is 
smuggled through the Brazilian border. 
458. Although cocaine seizures declined in Ecuador in 
2006, that country continued to be used as an important 
storage and trans-shipment area for multi-ton 
consignments of cocaine destined for illicit markets in 
Europe and North America. Cocaine and heroin are 
smuggled by sea, on fishing vessels flying the flag of 
Ecuador, as well as by air, using couriers on board 
flights passing through the international airports in 
Ecuador. 
459. According to statistics compiled by the 
Government, between 2003 and 2006, the total amount 
of cocaine seized in the Bolivarian Republic of 
Venezuela ranged from 31 to 58 tons. In mid-
September 2007, the authorities of that country seized 
another 17 tons of cocaine. Over 70 per cent of the 
cocaine consignments seized in 2006 in the Bolivarian 
Republic of Venezuela were destined for countries in 
Europe, above all, Spain, the United Kingdom and the 
Netherlands in that order. 
460. In recent years, cocaine trafficking has increased 
in Chile and Uruguay. In Uruguay, the total amount of 
cocaine seized in 2006 (471 kg) was eight times more 
than in the previous year; furthermore, by August 
2007, the amount of cocaine seized in that country had 
already exceeded the figure for the entire year 2006. 
According to the Government of Chile, the northern 
part of that country, which borders drug-producing 
countries, continues to be the main point of entry for 
the cocaine and cocaine base smuggled into the 
E/INCB/2007/1  
 
72  
 
country, mainly through areas outside the official 
crossing points.  
461. Suriname is used as a transit country for large 
shipments of cocaine and cannabis smuggled on board 
small aircraft flying from Colombia and Peru. Large 
amounts of MDMA (“ecstasy”) are smuggled in cargo 
from the Netherlands into the United States via 
Suriname. 
462. According to UNODC, between 2004 and 2005, 
laboratories illicitly manufacturing coca paste and 
cocaine were found in Argentina, Bolivia, Chile, 
Colombia, Peru and Venezuela (Bolivarian Republic 
of). In Bolivia, the number of coca paste and cocaine 
laboratories destroyed in 2006 increased over the 
previous year by more than 50 per cent, to 4,070; in 
addition, two precursor laboratories were destroyed in 
the country. The number of clandestine laboratories 
processing coca paste from Bolivia also increased in 
Brazil in 2006. 
463. In Colombia, about 2,000 of the over 
2,200 clandestine laboratories destroyed in the country 
in 2006 had been processing coca paste or cocaine base 
and the rest had been manufacturing cocaine 
hydrochloride. In 2006, the number of potassium 
permanganate laboratories destroyed in Colombia (15) 
was similar to the figure for 2005. The destruction of 
11 clandestine laboratories manufacturing cocaine 
hydrochloride and over 700 laboratories processing 
coca paste and cocaine base was reported in Peru. 
Eighteen illicit drug laboratories were found during 
Operation Sierra XVII in the Bolivarian Republic of 
Venezuela in 2006. Smaller laboratories manufacturing 
cocaine hydrochloride for personal use were found in 
Chile. 
464. In November 2006, law enforcement authorities 
in Ecuador dismantled a laboratory estimated to be 
capable of illicitly manufacturing 2-3 tons of cocaine a 
month. Ecuador is also an important source of the 
essential chemicals that sustain illicit drug manufacture 
in neighbouring Colombia. The Board notes with 
concern that the theft of petroleum ether (a chemical 
that can be misused for processing coca leaf into 
cocaine) from pipelines of the State-owned oil refinery 
in the northern province of Sucumbíos in Ecuador 
continued to be on the increase in 2005 and 2006. The 
Board urges the Government of Ecuador to adopt 
measures to prevent that negative development. 
465. In late 2006, UNODC and the Inter-American 
Observatory on Drugs (OID) of CICAD published the 
first comparative study of drug abuse in the secondary 
school student population in Argentina, Bolivia, Brazil, 
Chile, Colombia, Ecuador, Paraguay, Peru and 
Uruguay. According to the study, among students 14-
17 years old, the past-year prevalence of drug abuse 
was the highest in Chile for cannabis abuse (12.7 per 
cent); in Argentina for cocaine abuse (2.5 per cent); in 
Colombia for MDMA (“ecstasy”) abuse (3 per cent) 
and in Paraguay for the abuse of benzodiazepine-type 
tranquillizers (7.1 per cent). 
466. The age of initiation of drug abuse decreased in 
some countries in South America, including Argentina 
and Brazil. In Argentina, the abuse of “paco” (coca 
paste), a highly addictive form of cocaine, has 
increased significantly during the past two years. 
“Paco” is often abused by young people, including 
children as young as 8 or 9 years old, in the poor 
neighbourhoods of Buenos Aires. The municipal 
authorities of Buenos Aires are planning to establish 
specialized centres to provide treatment for addicts less 
than 18 years old. In Brazil, the use of “crack” cocaine 
has grown, especially among persons with low income 
in urban areas, contributing to the already high level of 
drug-related violence and health problems. 
467. The abuse of cocaine base in Chile has not 
changed significantly in the past 12 years. According 
to an epidemiological study published in July 2007, the 
abuse of cocaine hydrochloride among the general 
population in that country has remained stable and is 
estimated at 1.2 per cent. While the annual prevalence 
of cannabis abuse increased from 5.3 per cent in 2004 
to 7 per cent in 2006, the perception of the risk of such 
abuse decreased. 
468. In Colombia, as a result of the continued decrease 
in the illicit opium poppy cultivation, opium 
production decreased in 2006 to 31 tons (equivalent to 
1.3 tons of heroin). During that year, law enforcement 
agencies destroyed seven laboratories manufacturing 
heroin in the region of Colombia bordering Ecuador 
and seized over 500 kg of heroin. The price of heroin 
in Colombia in 2006 was five times higher than that of 
cocaine hydrochloride. In Ecuador, more than 200 kg 
of heroin were seized in 2006, about the same amount 
as in 2005. According to the Government of Peru, 
illicit opium poppy cultivation in that country in 2006 
did not exceed 100 hectares. In 2006, 88 hectares of 
 E/INCB/2007/1
 
 73 
 
illicit opium poppy were eradicated in Peru, 8 per cent 
less than in 2005. In 2006, a programme for monitoring 
crops by satellite was used to support Operation 
Sierra XVII in the Bolivarian Republic of Venezuela, 
during which 215 hectares of illicit crops, including 
154 hectares of opium poppy, were eradicated. 
 
  Psychotropic substances 
 
469. The abuse of sedatives and tranquillizers, the 
most widely abused drugs among the general 
population in Colombia, increased slightly in that 
country in 2006. According to a 2006 survey of 
secondary school students in nine countries in South 
America, past-year prevalence of the abuse of 
benzodiazepines, such as diazepam and alprazolam, 
was highest in Paraguay (7.1 per cent), Bolivia (7.0 per 
cent) and Colombia (6.4 per cent). 
470. In Brazil, the rate of consumption of stimulants, 
mainly as anorectics, is among the highest in the 
world. Internationally controlled substances continue 
to be diverted from licit channels and are available 
without prescription. Pharmaceutical preparations, 
including counterfeit preparations from Asian 
countries, are also smuggled into Brazil, as evidenced 
by a case involving oxycodone originating in China. In 
February 2007, the Brazilian authorities dismantled a 
laboratory used for the illicit production of tablets of 
phenproporex, a psychotropic substance in Schedule IV 
of the 1971 Convention. The Board urges the 
Government of Brazil to expedite the adoption of the 
planned measures to address the diversion and abuse of 
controlled substances, in particular stimulants. 
471. The latest data indicate that the annual prevalence 
of the abuse of MDMA (“ecstasy”) among the general 
population in South America, estimated at 0.2 per cent, 
is among the lowest in the world. The lower seizures of 
ATS in the region, compared with other types of drugs, 
corroborate those data. In 2006, the Colombian 
authorities seized 18 kg of MDMA (“ecstasy”). 
Amounts smaller than 1 kg were also seized in Chile, 
Ecuador, Peru and Venezuela (Bolivarian Republic of) 
in 2006. According to the latest UNODC data, no 
laboratories illicitly manufacturing synthetic drugs 
were reported in the period 2004-2005 in South 
America. 
472. Between 2001 and 2006, smaller amounts of LSD 
were seized in Brazil, Chile, Colombia and Uruguay. 
The latest data on seizures of precursors indicate that 
the illicit manufacture of LSD in South America cannot 
be ruled out. 
 
  Precursors 
 
473. South American countries have in place 
legislative and administrative control measures for the 
control of precursor chemicals, yet their law 
enforcement agencies continued seizing large amounts 
of solid and liquid chemicals. Moreover, there is no 
indication that those chemicals are not reaching 
clandestine cocaine laboratories. In Colombia alone, 
100-170 tons of potassium permanganate were seized 
annually between 2004 and 2006, whereas about 120-
130 tons of the substance is needed for potential annual 
manufacture of cocaine hydrochloride in the country. 
That indicates that drug traffickers have found a way to 
circumvent existing controls. The Board encourages 
the Governments concerned to initiate regional 
activities to control precursors, in particular to prevent 
the smuggling of precursors, as well as the diversion of 
precursors from licit distribution channels. 
 
  Missions 
 
474. In September 2007, a mission of the Board 
visited Bolivia to review the drug control situation in 
that country and the Government’s compliance with the 
international drug control treaties. 
475. The Board notes that the Government of Bolivia 
has adopted a national drug control strategy covering 
the period 2007-2010, which marks a significant shift 
in the political will and commitment of the 
Government to the objectives of the international drug 
control treaties. The Board appreciates that the strategy 
reaffirms the strong stand of the Government against 
the illicit manufacture of and trafficking in cocaine and 
the criminal organizations involved. The Board also 
welcomes the decision of the Government to 
strengthen the mechanism for the monitoring and 
control of coca bush cultivation.  
476. The Board notes with concern, however, that the 
strategy addresses the issue of coca leaf chewing in a 
manner that is not in line with the obligations of 
Bolivia under the international drug control treaties, to 
which Bolivia is a party. The Board requests the 
Government of Bolivia to comply with its treaty 
obligations by taking measures to prohibit the sale, use 
and attempts to export coca leaf for purposes which are 
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considered not in line with the international drug 
control treaties.  
477. The Government of Bolivia may wish to request 
assistance from its international development partners 
to put in place alternative development programmes to 
tackle the problems of poverty and hunger that prevail 
in the coca-producing areas of the country. The Board 
calls on Bolivia’s development partners to ensure that 
assistance provided to the Government of Bolivia is 
always in line with the international drug control 
treaties. 
478. The Board notes that the Government of Bolivia 
has introduced the so-called “social control” policy, 
whereby coca bush growers are in charge of 
eradication programmes. The Board notes the relative 
peaceful environment that prevails in the coca bush 
growing areas. The Board requests the Government to 
monitor closely its new policy of getting the farmers to 
cooperate in voluntary eradication efforts. However, 
consideration should be given to devising alternative 
measures where the policy does not succeed. 
479. The Board notes that the Government of Bolivia 
has established commissions to review Law 1008, the 
basic law governing drug control in the country. The 
commissions are working on two separate laws, one to 
regulate coca leaf and one to regulate controlled 
substances. The Board requests the Government to 
ensure that the laws conform with the international 
drug control treaties. 
480. The Board notes with concern that drug abuse 
among the general population, as well as among the 
student population, in Bolivia is on the rise while, at 
the same time, the age of first use of illicit drugs is 
declining. The Board requests the Government of 
Bolivia to formulate and implement education 
programmes aimed at eliminating coca leaf chewing, as 
well as other non-medical uses of coca leaf.  
481. The short-term objective of such education 
programmes should be to discourage the practice of 
coca leaf chewing while preventing the expansion of 
the practice among students and youth, drivers of 
public transport vehicles and other vulnerable groups 
in Bolivia. Such education programmes should be 
evaluated taking into account the extent and trends of 
coca leaf chewing, as well as the role that it plays in 
the progression of drug dependence. 
482. The Board notes that the existing mechanism for 
the monitoring and control of internationally controlled 
substances is not functioning adequately in Bolivia. 
The Board requests the Government of Bolivia to take 
measures to implement the recommendations made 
during its 2001 mission to that country, including the 
recommendation on providing adequate resources and 
trained personnel to all drug regulatory authorities, 
especially the Ministry of Health, to enable them to 
perform their control functions. 
483. The Board sent a mission to Brazil in December 
2006. The Board noted with concern that drug abuse 
has increased and medical overprescription of 
stimulants continue despite the recommendations of 
the Board following its previous mission to Brazil, in 
2003. The Board is also concerned about the continued 
lack of cooperation between agencies at the state level 
and those at the national level, the low level of 
resources at the national level, the slowness of the 
judicial system and reports of corruption in the police 
and the judiciary. The Board urges the Government to 
take measures to strengthen interdiction activities in 
the whole country, particularly in the border areas and 
to make every effort to ensure the expeditious and fair 
prosecution of drug-related offences. In view of the 
involvement of African criminal organizations in drug 
trafficking in Brazil, cooperation with law enforcement 
agencies in African countries should be strengthened to 
enhance the investigation and prosecution of all 
criminals involved in drug trafficking. The Board notes 
the efforts of the Government of Brazil in recent years 
to expand drug demand reduction facilities. 
Nevertheless, with regard to the new law on drug 
control, the Board is of the opinion that the provisions 
related to the treatment of drug abuse cannot be 
implemented, as services for the treatment of drug 
abusers are not yet fully available throughout the 
country. Moreover, the new law may make the 
investigation and prosecution of illicit drug activities 
more difficult and may send the message to the public 
that drug trafficking is being treated more leniently by 
the Government. 
484. The Board urges the Government of Brazil to 
enhance the inspection of domestic drug distribution 
channels and the monitoring of transport of precursor 
chemicals, particularly in areas close to sites used for 
the illicit manufacture of coca paste or cocaine, and to 
strengthen the existing control over the licit 
distribution of narcotic drugs and psychotropic 
 E/INCB/2007/1
 
 75 
 
substances, in view of the diversions to illicit channels. 
In addition, the Government should enforce the 
controls applicable to stimulants and strengthen them 
further, if necessary, to address overconsumption. The 
level of consumption of opiates used for the treatment 
of pain in Brazil continues to be low; however, the 
abuse of synthetic opioids is high, according to the 
latest household survey. The Board calls upon the 
Government of Brazil to take further steps to remove 
any perceived obstacles to the adequate treatment of 
pain in the country and to improve the rational use of 
medicines. 
485. The Board sent a mission to Colombia in April 
2007. The Board acknowledges the commitment and 
efforts of the Government of Colombia in the fight 
against illicit coca bush cultivation, drug trafficking 
and abuse. The Board notes the significant results 
achieved in the continued reduction of illicit crops and 
the significant seizures of controlled substances, 
laboratories and assets derived from drug trafficking. 
The Board appreciates that the legal framework 
currently in force in Colombia covers all areas relating 
to drug control treaties and that good coordination 
among the competent authorities concerned has 
resulted in more effective implementation of drug 
control strategies. 
486. The Board notes the difficulties encountered by 
the Government of Colombia in combating drug 
production and drug trafficking by the guerrillas and 
paramilitary groups that exist in many parts of the 
country. The Board encourages the Government to 
continue its efforts to eradicate illicitly cultivated coca 
bush and effectively introduce alternative sources of 
legitimate livelihood. In this regard, the Board 
commends the Government for the policies adopted to 
protect the forests and national parks and welcomes the 
“forest-ranger families” initiative, where families 
voluntarily become involved in the eradication of illicit 
crops, the production of economic crops and the 
protection of the forest. The Board is of the opinion 
that the Government should be assisted in its illicit 
crop eradication efforts by the international 
community, with a view to protecting the ecosystem 
from further deterioration caused by the numerous 
chemicals used to increase the coca leaf yield, as well 
as with a view to preventing deforestation, in particular 
in the Amazon area. 
487. While the mechanisms for control over the licit 
movement of narcotic drugs and psychotropic 
substances are effective, the Government of Colombia 
needs assistance to gain control over the situation with 
regard to the smuggling of precursor chemicals into the 
country. There is a need to improve regional and 
international cooperation with the Government of 
Colombia aimed at preventing the smuggling and 
diversion of chemicals used for the illicit manufacture 
of cocaine, as well as a need to draw the attention of 
Governments to the investigation and identification of 
the sources of the chemicals being smuggled into 
Colombia and the smuggling routes used. The Board 
notes that, despite the investment in controlling sea 
transportation and in aerial surveillance by the 
Government of Colombia, significant amounts of 
substitute chemicals continue to reach the country, 
replacing those currently under control. The Board is 
of the view that the authorities of Colombia and its 
neighbouring countries should work together to 
improve measures to prevent unwanted chemicals from 
reaching the Andean subregion. In addition, the 
exchange of information among those countries should 
be improved. 
488. Drug abuse surveys are being conducted and 
prevention campaigns are being organized regularly in 
Colombia. The Board encourages the Government of 
Colombia to continue improving the methodologies 
used to assess the extent of drug abuse in the country. 
The Board hopes that a comprehensive demand 
reduction policy, firmly implemented with a wide 
range of treatment and rehabilitation programmes, 
including extensive counselling and psychosocial 
assistance, will benefit the increasing number of drug 
abusers in Colombia. 
489. The Board sent a mission to Peru in 
December  2006. The Board notes with appreciation 
that the Government adopted a comprehensive and 
balanced national drug policy for the period 2007-
2011, with a view to combating drug trafficking and 
abuse, strengthened control over the licit distribution 
of narcotic drugs and psychotropic substances and 
enacted a new law for the control of precursor 
chemicals. However, the Board notes with concern that 
the vast majority of the coca leaf produced in Peru is 
diverted into illicit manufacture and that the provisions 
of the 1961 Convention concerning licit cultivation of 
coca bush and the production and use of coca leaf are 
not being implemented. The Board wishes to remind 
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the Government that the only legal uses of coca leaf 
foreseen in the 1961 Convention are for medical or 
scientific purposes or for the manufacturing of a 
flavouring agent from which all alkaloids have been 
removed. The Board requests the Government of Peru 
to take steps to abolish as soon as possible activities 
that are not in line with those provisions. 
490. The Board was impressed by the efforts 
undertaken to address the low availability of analgesics 
in Peru. The Board notes that mandatory reporting on 
the licit movement of narcotic drugs, psychotropic 
substances and precursors in Peru has improved. 
However, the Government should increase its capacity 
for inspection, in order to prevent the diversion of 
narcotic drugs and psychotropic substances from licit 
sources and improve the control of precursor chemicals 
further, in view of the continued availability of those 
substances for the illicit manufacture of drugs. With 
regard to interdiction efforts, coordination between the 
agencies involved should be strengthened. The Board 
encourages the Government to strengthen the 
cooperation of its national law enforcement agency 
with its counterparts in Africa and Europe, in view of 
the current trafficking routes and links with criminal 
organizations in those regions. With respect to demand 
reduction, the Board notes with satisfaction the action 
taken to assess the extent and type of drug abuse, to 
prevent such abuse and to treat drug abusers and 
reintegrate them into society. The Government should 
continue expanding its efforts to reverse the increasing 
trend in drug abuse, including by offering treatment 
services to the affected segments of society. 
 
 
 C. Asia 
 
 
  East and South-East Asia 
 
 
  Major developments 
 
491. The region of East and South-East Asia is no 
longer a major source of illicit opium poppy 
cultivation. However, some illicit manufacture of 
heroin remains in the region, and several laboratories 
involved in the clandestine conversion of cocaine 
hydrochloride to “crack” have been dismantled. Illicit 
manufacture of and trafficking in ATS is increasing in 
countries throughout the region, such as Cambodia, 
China and Myanmar. Large amounts of precursor 
chemicals used in the illicit manufacture of 
methamphetamine have been seized in the region. 
492. The abuse of ATS, methamphetamine in 
particular, is also increasing throughout East and 
South-East Asia. The increasing rate of abuse of heroin 
and methamphetamine by injection is contributing to 
the spread of HIV/AIDS in the region. In several 
countries in the region, a large percentage of the HIV 
infections has been attributed to drug abuse by 
injection. In order to combat the spread of HIV/AIDS 
through drug abuse by injection, Governments are 
taking action at both the national level and the regional 
level. 
 
  Regional cooperation 
 
493. The countries in East and South-East Asia 
continued to work together in the area of drug control 
through regional organizations such as the Association 
of Southeast Asian Nations (ASEAN), as well as 
through bilateral and multilateral channels. 
494. The twelfth ASEAN Summit was held in Cebu, 
Philippines, in January 2007. Participating countries 
agreed to continue to take collective action to address 
the challenges posed by regional and international 
issues such as transnational crime, including drug 
control. 
495. Task Forces of the ASEAN and China 
Cooperative Operations in Response to Dangerous 
Drugs (ACCORD) held a number of meetings in 2007: 
the Task Force on Civic Awareness and the Task Force 
on Demand Reduction held meetings in Bandar Seri 
Begawan, Brunei Darussalam, from 30 July to 
1 August; and the Task Force on Law Enforcement and 
the Task Force on Alternative Development held 
meetings in Yangon in July. The annual meetings bring 
together the ASEAN member States and China, as well 
as UNODC and the ASEAN secretariat, to share 
information, monitor progress and prioritize areas for 
future activities.  
496. Critical issues addressed at the meetings in 2007 
included ways to improve the evaluation of the impact 
of public awareness campaigns; the emergence of ATS 
as a major drug of addiction; substitution therapy for 
opioid addicts; priority issues related to drug abuse by 
injection and HIV; treatment modalities for ATS abuse 
as well as regional intelligence-sharing; clandestine 
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drug laboratory seizure and clean-up issues; and the 
cultivation of cannabis plants. 
497. The twenty-seventh annual ASEAN Chiefs of 
Police (ASEANAPOL) Conference was held in 
Singapore in June 2007. The ASEANAPOL 
Conference is the regional platform used by police 
chiefs from ASEAN member States for interaction, 
discussion, exchanging views and bringing each other 
up to date on the latest developments in law 
enforcement issues. The issues discussed during the 
Conference included drug trafficking, cybercrime, the 
provision of training, the exchange of personnel and 
the launching of the Electronic ASEANAPOL Database 
System, to facilitate the sharing of intelligence among 
the police forces of ASEAN member States. Those 
police forces signed a joint communiqué that included 
resolutions on cooperation in regional security 
concerns such as drug trafficking. In addition, in order 
to foster greater cooperation between ASEANAPOL 
and Interpol, the two organizations agreed to formalize 
collaboration involving the Electronic ASEANAPOL 
Database System and the secure global police 
communications system (I-24/7) of Interpol, which 
operates 24 hours a day, 7 days a week. 
498. Thailand hosted the 27th Meeting of ASEAN 
Senior Officials on Drug Matters in Chiang Mai in 
August 2006. Senior officials from ASEAN member 
States exchanged information on drug seizures, recent 
trends in drug trafficking, the treatment and 
rehabilitation of drug abusers, the use of alternative 
development to address the problem of illicit crop 
cultivation and progress related to the implementation 
of drug control. Participants noted with concern the 
increasing abuse of and trafficking in ketamine in 
South-East Asia and agreed to strengthen their efforts 
to control ketamine through national legislation. 
499. The seventh Ministerial Meeting of Signatory 
Countries of the 1993 Memorandum of Understanding 
on Drug Control was held in Beijing in May 2007. At 
the meeting, representatives of Cambodia, China, the 
Lao People’s Democratic Republic, Myanmar, 
Thailand and Viet Nam pledged to strengthen existing 
partnerships and commitments related to drug control. 
The importance of broadening their resource base was 
also underlined. Moreover, the sixth revised 
subregional action plan was adopted, including two 
new thematic areas: “International cooperation on 
judicial matters” and “Drugs and HIV/AIDS”. 
500. The annual study programme on drug abuse and 
narcotics control was held in Tokyo in June 2007. 
Participants from a number of countries, including 
Indonesia, Japan, Malaysia, Myanmar, the Philippines, 
Thailand and Viet Nam, exchanged information on 
recent developments in drug control in their countries. 
A study programme for drug control officials from the 
Democratic People’s Republic of Korea was organized 
by the National Narcotics Control Commission of 
China in Beijing in June 2007. Six Government 
officials from the Democratic People’s Republic of 
Korea involved in drug control were trained in various 
aspects of drug control to facilitate compliance with 
the provisions of the international drug control treaties, 
to which the Democratic People’s Republic of Korea 
had recently acceded. 
501. Japan is providing training to national and 
provincial authorities in Cambodia in matters related to 
drug control, through a project to be implemented from 
January 2007 to January 2009; the training includes the 
identification, analysis and control of drugs. Moreover, 
Japan, through its project for the period 2005-2009, is 
providing assistance in the form of improving 
infrastructure, agriculture, health and education in the 
areas of Cambodia most affected by the eradication of 
illicit opium poppy cultivation. China is supporting 
alternative development in Myanmar by providing 
10,000 tons of rice in September 2006 to farmers in the 
northern part of that country who were formerly 
involved in the illicit cultivation of opium poppy. 
Thailand continued to provide technical training in 
areas such as drug interdiction and investigation for 
law enforcement officers in Cambodia, the Lao 
People’s Democratic Republic and Myanmar. 
502. The second meeting of the Asian Collaborative 
Group on Local Precursor Control and the third 
International Forum on Control of Precursors for 
Amphetamine-type Stimulants were held in Tokyo in 
February 2007. The meetings were organized jointly by 
the Attorney-General’s Department of Australia and the 
Ministry of Health, Labour and Welfare of Japan. The 
objective of the Asian Collaborative Group is to 
promote the adoption of best practices in national 
regulatory, administrative and legislative policies and 
practices that address the threat of diversion of 
precursor chemicals in East and South-East Asia. In the 
framework of regional cooperation, the International 
Forum aims to identify and adopt measures for more 
effective control of precursors used in the illicit 
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manufacture of ATS. The meetings resulted in the 
adoption of a joint work programme of the Asian 
Collaborative Group and the International Forum 
calling for a regional response to precursor diversion, 
including the implementation of effective regulations 
and controls, the exchange of intelligence, cooperation 
with industry and the development of relevant national 
technical capacities. 
503. Cooperation among law enforcement authorities 
from China, Myanmar and Thailand, which began in 
2005, resulted in major seizures and an arrest in 
April   2006. Acting on intelligence from their 
counterparts in Thailand, the authorities in Myanmar 
seized approximately 15 million methamphetamine 
tablets, 1 ton of heroin and a significant amount of 
precursor chemicals, including 1,727 litres of acetic 
anhydride and 721 kg of ephedrine. Based on 
information provided by law enforcement authorities in 
Myanmar, the authorities in China arrested a person 
who had been under surveillance for suspected 
involvement in drug trafficking. As a result of the 
Regional Joint Action against ATS-Related Crimes 
initiative, an investigation conducted jointly by 
authorities from China and the Philippines, a 
clandestine ATS laboratory was uncovered in the 
Philippines in December 2006. Under the initiative, 
ASEAN member States and China identify ongoing 
transnational ATS-related cases, syndicates and 
fugitives for joint follow-up action. The investigation 
led to five arrests and the seizure of 30 kg of processed 
methamphetamine and 200 litres of liquid 
methamphetamine, along with a large amount of 
precursor chemicals and laboratory equipment. 
504. Although forensic laboratories in East and South-
East Asia are collaborating to some extent to improve 
the use of laboratory data for law enforcement and 
judicial purposes and for the work of regulatory and 
health authorities, there is a need for improvement of 
collaboration among the laboratories, as well as with 
regulatory and health authorities.  
 
  National legislation, policy and action 
 
505. China continued to enforce its fight against drugs 
through the implementation of national campaigns 
including components such as the prevention of drug 
abuse, the education, treatment, rehabilitation of drug 
abusers and the control of narcotic drugs, psychotropic 
substances and precursor chemicals. The Government 
of China has placed emphasis on preventing heroin 
abuse. The Government has established treatment and 
rehabilitation centres for drug abusers, including 
320  clinics that are currently providing methadone 
maintenance treatment for 38,000 patients. While the 
Board notes the efforts by the Government to provide 
treatment for drug abusers, it calls on the Government 
to ensure that such activities are comprehensive, 
evidence-based and carried out in compliance with the 
provisions of the international drug control treaties. 
506. In Cambodia, the drug control master plan for the 
period 2006-2010 is currently being implemented. The 
plan is aimed at eliminating illicit drug abuse, 
trafficking and production and the cultivation of illicit 
drug crops, improving the control of precursor 
chemicals and strengthening law enforcement. Areas 
covered by the plan include supply and demand 
reduction, law enforcement, the reduction of risks 
caused by drug abuse through a comprehensive 
approach to HIV/AIDS and the strengthening of 
international cooperation. 
507. Following the decision by the Government of 
Cambodia to strengthen and reform its drug control 
system, a new royal decree was issued on 23 June 2006 
to replace the decree of 7 September 1995, on the 
establishment of the National Authority for Combating 
Drugs of Cambodia. With the new decree, the 
secretariat of the National Authority was established as 
an entity in the Ministry of the Interior with its own 
budget and staff. Since then, the resources allocated to 
the secretariat have increased considerably. In 2006, 
the Government initiated the Community Competitive 
Plan against Drug Offences. The objectives of the plan 
include: raising the capacity of law enforcement to 
prevent drug abuse by providing training to law 
enforcement officers; and disseminating information to 
raise the awareness of the community about the 
dangers of drug abuse. 
508. In 2006, the Department of Health of the 
Philippines approved approximately 1,300 drug-testing 
laboratories, which have been utilized to analyse the 
results of random drug testing for employees of 
Government agencies, as well as students. 
509. Several countries in East and South-East Asia, 
including Viet Nam, strengthened their activities 
related to precursor control. Following the examples 
set by other countries in the region, such as Cambodia, 
China, Indonesia, the Lao People’s Democratic 
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Republic, Malaysia, Myanmar, the Philippines and 
Thailand, Viet Nam has drafted a national action plan 
on precursor control to identify and address precursor 
control issues in a more systematic manner. Law 
enforcement agencies in Thailand worked at the 
national and regional levels to control the diversion of 
precursor chemicals, including by becoming involved 
in regional training on precursor control. Since 2004, 
Thailand, in collaboration with the Drug Advisory 
Programme of the Colombo Plan, has hosted and 
conducted an annual training course on precursor 
control for drug law enforcement officers from ASEAN 
member States, as well as China and India. The Board 
encourages China and India to continue to strengthen 
controls over the illicit manufacture of and trafficking 
in precursor chemicals. 
510. Several countries in East and South-East Asia, 
including Malaysia and Viet Nam, introduced measures 
to combat HIV/AIDS. In order to face the problem of 
the growing rate of HIV/AIDS in Malaysia, in 2006, 
the National Strategic Plan on HIV/AIDS 2006-2010 
was launched to provide a framework for the country’s 
response to that threat. The Plan is to integrate 
prevention, treatment and care, with a view to reducing 
the impact of the high prevalence of HIV infection. 
One of the priority areas is reducing HIV infection 
among persons who abuse drugs through the provision 
of education, counselling, testing, medically supervised 
drug substitution, treatment and care programmes for 
such persons. In Viet Nam, the Law on HIV/AIDS 
Prevention and Control, which includes provisions on 
needle exchange programmes and drug substitution 
therapy, entered into effect in January 2007. 
511. In 2007, the Government of Malaysia announced 
its plans to expand its needle exchange programme and 
methadone maintenance therapy to include all states in 
the country. Under the expanded programme, 
15,000   drug abusers would receive methadone 
maintenance therapy and 15,000-25,000 persons who 
abused drugs by injection would be participating in the 
needle exchange programme by 2010. In Viet Nam, the 
Ministry of Health approved a pilot project to provide 
methadone substitution therapy for 700 drug abusers. 
The project is to be completed by the end of 2008. 
512. In 2006, Malaysia strengthened its regulations to 
restrict the number of wholesale outlets selling tablets 
or capsules containing buprenorphine, midazolam, 
zolpidem and zopiclone. 
513. In October 2006, the Financial Action Task Force 
on Money Laundering removed Myanmar from the list 
of countries and territories considered to be not 
cooperating in the efforts to counter money-laundering 
or to have critical deficiencies in their systems for 
countering money-laundering, as the Financial Action 
Task Force had determined that Myanmar had made 
good progress in implementing its system for 
countering money-laundering. 
 
  Cultivation, production, manufacture, 
trafficking and abuse 
 
  Narcotic drugs 
 
514. Cannabis plants continued to be illicitly 
cultivated in countries throughout East and South-East 
Asia, including in Cambodia, Indonesia, the 
Philippines and Thailand. In the Lao People’s 
Democratic Republic, the illicit cultivation of cannabis 
plants remains a problem mainly in the central 
provinces. Such cultivation continued to decline in 
Cambodia. Cannabis plants are illicitly cultivated 
along the borders of Cambodia with the Lao People’s 
Democratic Republic and Thailand. Such plants are 
also illicitly cultivated in some parts of Indonesia, 
particularly in Aceh and, to a lesser extent, Sumatra 
and Java. In the Philippines, over 100 illicit cannabis 
cultivation sites have been identified, including in 
northern Luzon and central and southern Mindanao. 
515. In Indonesia, law enforcement authorities 
eradicated cannabis plants covering 290 hectares of 
land in 2006; over 1 million cannabis plants were 
eradicated, a considerable increase over the figure for 
the previous two years (215,000 cannabis plants in 
2004 and 188,000 in 2005). In many countries, 
significant seizures of cannabis were reported during 
2006. In Malaysia, 2.2 tons of cannabis were seized in 
2006, almost twice the amount seized in 2005. In 
Indonesia over 11.7 tons of cannabis were seized in 
2006. Viet Nam reported having seized more than 
0.6 ton of cannabis in 2006. 
516. Illicit opium poppy cultivation remained at a low 
level throughout East and South-East Asia in 2007. 
Myanmar continued to be the country with the largest 
total area under illicit opium poppy cultivation in the 
region; it was followed by the Lao People’s 
Democratic Republic. 
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517. In Myanmar, 90 per cent of the illicit cultivation 
of opium poppy takes place in Shan State. The total 
area under illicit opium poppy cultivation in Myanmar 
decreased from 130,000 hectares in 1998 to 
21,500    hectares in 2006, but increased to 
27,700  hectares in 2007. That is the first increase 
recorded after several consecutive years of decline. 
The area under illicit opium poppy cultivation in the 
Lao People’s Democratic Republic decreased from 
2,500 hectares in 2006 to 1,500 hectares in 2007, the 
lowest level recorded since 1992. 
518. In 2006, over 2 tons of opium were seized in 
Myanmar, the largest total amount of the substance 
seized in the country in recent years. Viet Nam 
reported the seizure of a total of 184 kg of opium in 
2006, more than triple the amount seized in 2005; the 
majority of the seizures occurred in 25 border 
provinces. Japan seized a total of 28 kg of opium in 
2006, the largest total amount of the substance seized 
in that country in recent years. 
519. In the Hong Kong SAR of China, two illicit 
heroin laboratories were dismantled in 2006. A number 
of States in East and South-East Asia continued to 
report a large total amount of seized heroin. In 2006, 
law enforcement authorities in Viet Nam seized a total 
of 277 kg of heroin. In Cambodia, a total of 21 kg of 
heroin were seized in 2006, almost double the figure 
for 2005 (12 kg). Law enforcement authorities in 
Myanmar detected a new development in trafficking in 
heroin: between April and October 2006, they 
identified four cases of trafficking in heroin by air. In 
the Macao SAR of China, there was an increase in the 
total amount of heroin seized during 2006. The Islamic 
Republic of Iran was the source of 16 of 26 heroin 
consignments seized at their destination, the Hong 
Kong SAR of China. In China, the total amount of 
heroin seized decreased from 11 tons in 2004 and 
9 tons in 2005 to 6 tons in 2006, the lowest level in 
seven years. 
520. Law enforcement authorities in the Hong Kong 
SAR of China uncovered five clandestine laboratories 
involved in the conversion of cocaine hydrochloride to 
“crack” in 2006. In the Republic of Korea, 
approximately 5 kg of cocaine were seized during 
2006, the largest amount seized in four years. 
521. In China (including the Hong Kong SAR and the 
Macao SAR), Indonesia, Malaysia, Myanmar and 
Viet Nam heroin is reported to be the most widely 
abused drug. Of the 800,000 registered drug abusers in 
China, 600,000 abuse heroin. 
522. HIV/AIDS continued to pose a major threat in 
many countries in East and South-East Asia. Of the 
183,733 registered cases of HIV/AIDS in China, 39 per 
cent are attributed to drug abuse. In Viet Nam, over 
12,900 cases of HIV infections in 2006 were attributed 
to drug abuse, 52 per cent of newly detected cases of 
HIV infection were attributed to drug abuse by 
injection and HIV prevalence among drug abusers was 
23 per cent. 
 
  Psychotropic substances 
 
523. An increase in the illicit manufacture of ATS was 
reported in countries throughout East and South-East 
Asia, including in Cambodia, China and Myanmar. 
China dismantled 51 clandestine ATS laboratories in 
the first half of 2006. Laboratories involved in the 
clandestine manufacture of methamphetamine 
continued to be uncovered in countries in East and 
South-East Asia. 
524. In April 2007, for the first time, a laboratory 
involved in the clandestine manufacture of 
methamphetamine was dismantled in Cambodia: an 
estimated 5 tons of precursor chemicals, including 
more than 3 tons of thionyl chloride (a substance 
currently not under international control) and acetone 
and some equipment, were seized at the site, and about 
1 ton of chemicals were uncovered in a warehouse in 
Phnom Penh and 18 suspects were arrested in 
connection with the seizure; the Cambodian authorities 
safely disposed of the seized chemicals with the 
assistance of UNODC. In addition, eight laboratories 
involved in the clandestine manufacture of 
methamphetamine were dismantled in Cambodia 
during 2006. In August 2007, a clandestine 
methamphetamine laboratory was dismantled in Phnom 
Penh; the processing equipment included a machine 
with the capacity to produce 10,000 methamphetamine 
tablets per hour. 
525. In the Philippines, four clandestine 
methamphetamine laboratories were dismantled during 
2006. Law enforcement authorities in Myanmar raided 
two clandestine laboratories in the eastern part of Shan 
State in May 2006 and seized 400,000 tablets of 
methamphetamine, 380 kg of ephedrine, 115 kg of 
phenylacetic acid and some equipment. In Malaysia, 
the authorities dismantled the largest clandestine 
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methamphetamine laboratory ever uncovered in the 
country in April 2007; the first part of the drug 
synthesis had been carried out on an oil palm 
plantation in the southern tip of the country, while the 
finishing stages had taken place in a town west of 
Kuala Lumpur; law enforcement authorities seized 
123 kg of liquid methamphetamine and some cash. In 
July 2006, a clandestine laboratory purportedly 
involved in the illicit manufacture of 
methamphetamine was dismantled in Malaysia; 160 kg 
of methamphetamine were seized at the site. 
526. In several countries in East and South-East Asia, 
the total amount of seized ATS continued to be large. 
During 2006, a total of 1,755,989 tablets of ATS, 
mostly methamphetamine, were seized in the Lao 
People’s Democratic Republic. The smuggling of ATS 
in the form of tablets from Myanmar into China and 
Viet Nam through the Lao People’s Democratic 
Republic remains a problem. Indonesia seized 
approximately 467,000 amphetamine tablets during 
2006, considerably more than the 255,000 tablets 
seized in 2005. In 2006, Viet Nam reported having 
seized a total of 62,870 tablets of ATS. Myanmar 
seized 1.1 million methamphetamine tablets in 
February 2007 alone. Law enforcement authorities 
in   Cambodia continued to report increasing 
seizures   of   methamphetamine tablets: a total of 
428,553 methamphetamine tablets was seized in 2006, 
compared with 338,655 in 2005. In Indonesia, 1,214 kg 
of methamphetamine were seized in 2006, a significant 
increase compared with the 368 kg seized in 2005 and 
the largest total annual amount of seized 
methamphetamine recorded in the country in seven 
years. In the Republic of Korea, the total number of 
seizures of methamphetamine has been steadily 
increasing, nearly doubling between 2005 and 2006. 
Smuggling methamphetamine through the postal 
system was identified as the main method used in the 
Republic of Korea. Law enforcement authorities in the 
Republic of Korea detected 36 cases of trafficking in 
methamphetamine via the Internet in 2006, compared 
with only 10 in 2005. 
527. Countries in East and South-East Asia continued 
to seize large amounts of MDMA. In Indonesia, 
approximately 350,000 MDMA tablets were seized in 
2006, compared with 255,000 in 2005. Over 
242,730 MDMA tablets were seized in Malaysia during 
2006, the largest total annual amount of the substance 
seized in the country in seven years. In Japan, 
approximately 195,300 MDMA tablets were seized in 
2006, a sharp decrease compared with the 
515,483 tablets seized in that country in 2005. Law 
enforcement authorities in Japan seized over 
20,000 tablets of MDMA in December 2006 at Narita 
International Airport. The Republic of Korea seized 
3,000 MDMA tablets in December 2006. In 2006, 
tablets containing alprazolam and lorazepam were 
seized in Myanmar; the tablets originated in Pakistan 
and had been concealed in hand luggage. 
528. In Cambodia, Japan, the Lao People’s Democratic 
Republic, the Philippines and Thailand, 
methamphetamine is the most common drug of abuse. 
Methamphetamine accounts for approximately 80 per 
cent of the drugs abused in Cambodia. The abuse of 
methamphetamine increased in China in 2006. There 
were an estimated 40,000 methamphetamine abusers in 
the Lao People’s Democratic Republic in 2006. The 
abuse of MDMA increased in 2006 in China and 
Viet Nam. 
 
  Precursors  
 
529. Cambodia reported a significant increase in its 
seizures of safrole and safrole-rich oils, which are 
frequently used in the illicit manufacture of MDMA, 
from 570 litres in 2006 to 1,260 litres in 2007. 
 
  Substances not under international control 
 
530. Trafficking in substances not under international 
control continued to be a matter of concern to the 
Governments of several countries in East and South-
East Asia. Approximately 2 tons of ketamine were 
seized in China during 2006. Law enforcement 
authorities in the Hong Kong SAR of China seized 
1 ton of ketamine during 2006. Seizures of ketamine 
also increased in Cambodia during 2006. Law 
enforcement authorities in Myanmar seized over 
3 litres of ketamine hydrochloride in October 2006. An 
increase in seizures of ketamine hydrochloride during 
2006 was reported in the Philippines. A total of 16 kg 
of ketamine from India was seized in Myanmar in June 
2006. Brunei Darussalam reported an increase in 
seizures of dimethylamphetamine, ketamine and 
nimetazepam in 2006. 
531. Countries in East and South-East Asia, including 
Cambodia, China and Japan, continued to note with 
concern the abuse of substances not under international 
control. Non-governmental organizations working with 
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drug abusers in Phnom Penh reported a notable 
increase in ketamine abuse in 2006. During 2006, 
China reported an increase in the abuse of ketamine; in 
particular, the Hong Kong SAR of China noted a 
significant increase in the abuse of ketamine by 
injection. Japan placed ketamine and methylone under 
national control as narcotic drugs in 2007. 
 
  Missions 
 
532. The Board sent a mission to the Republic of 
Korea in October 2007. Through effective drug law 
enforcement, the Government of the Republic of Korea 
has achieved some success in reducing the illicit 
manufacture of methamphetamine on its territory. 
533. Drug abuse is reported to be very limited in the 
Republic of Korea; however, it appears that the 
Government has not recently undertaken a systematic 
and comprehensive assessment of drug abuse and 
instead uses the number of drug-related offenders as an 
indication of the size of the drug abuse problem. The 
Board stresses that the number of drug offenders is an 
imperfect proxy in estimating the extent of the 
problem. Therefore, the Board urges the Government 
to carry out an assessment of drug abuse, involving the 
collection and analysis of data on the incidence, 
prevalence and other characteristics of drug abuse. 
Such an objective assessment will assist the 
Government in developing more targeted drug abuse 
prevention policies and further improve the efficiency 
of programmes for the treatment and rehabilitation of 
drug abusers. 
534. The Republic of Korea has one of the highest 
rates of prescribed stimulants used as anorectics, such 
as phendimetrazine, in the world. The reason for that 
high consumption level has not been established. The 
Board therefore strongly encourages the Government 
to learn more about the reason behind the 
extraordinarily high consumption of stimulants, by, 
inter alia, monitoring and analysing prescription 
patterns more closely. The Government should take the 
initiative in educating the medical profession, as well 
as the public, on the rational use of narcotic drugs and 
psychotropic substances and in promoting sound 
medical prescription practices. 
535. The Government of the Republic of Korea has 
introduced an electronic system for drug import 
authorization with a validation website that, because it 
is not in an official language of the United Nations, is 
of little use to the majority of countries exporting 
internationally controlled drugs to that country. The 
system is also deficient in several other essential 
aspects. The Board urges the Government to suspend 
the electronic system for drug import authorization 
until the problems are resolved. 
536. Precursor chemicals frequently transit the 
Republic of Korea, which is situated close to countries 
where methamphetamine is illegally manufactured. 
There are some indications that the Republic of Korea 
has already been targeted by traffickers of precursors. 
The Board therefore calls on the Government to 
increase its vigilance with regard to precursors, 
particularly those used in the manufacture of 
methamphetamine and other ATS. More efforts should 
be made to examine the legitimate requirements for 
precursors in the country, to seize suspicious shipments 
of precursors and to prosecute traffickers of precursors. 
537. The Board sent a mission to Viet Nam in October 
2007. The Board notes the continued commitment of 
the Government to the eradication of illicit opium 
poppy cultivation. The Board encourages the 
Government to continue its efforts to achieve the goal 
of complete eradication of illicit opium poppy 
cultivation, in order to contribute to the ongoing efforts 
to make ASEAN free of illicit drugs by 2015. 
538. The Board is concerned that the compliance of 
the Government of Viet Nam with its mandatory 
reporting obligations pursuant to the international drug 
control treaties has not been satisfactory, particularly 
with respect to narcotic drugs and psychotropic 
substances. The Board urges the Government to take 
all the steps necessary to enhance coordination and 
cooperation among the institutions and agencies, both 
regulatory and law enforcement, that are responsible 
for drug control issues and to ensure full 
implementation of its treaty obligations and to give 
that matter the highest priority. 
539. The Board notes with concern the high rate of 
relapse among drug abusers in Viet Nam who have 
undergone treatment. The Board reminds the 
Government of the importance of evaluating different 
modalities for the treatment of drug dependence and 
ensuring that the treatment addresses all types of drugs. 
The Board recommends the Government to explore the 
possibility of entering into partnerships with non-
governmental organizations and self-help groups 
working in the field of drug addiction in East and 
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South-East Asia, as such work may be particularly 
effective at the local level, targeting voluntary patients. 
540. The Board urges the Government of Viet Nam to 
continue to cooperate with the Governments of 
neighbouring countries in strengthening regional law 
enforcement activities targeting drug trafficking and 
money-laundering. In that connection, the Board notes 
that in 2005, a decree on money-laundering entered 
into force in Viet Nam. The Board encourages the 
Government to draft and implement legislation against 
money-laundering as soon as possible, with the 
assistance of UNODC and other international entities. 
 
 
  South Asia 
 
 
  Major developments 
 
541. During the past few years, the Board has noted 
that South Asia has been targeted as an area for cocaine 
trafficking. The smuggling of cocaine into India, while 
remaining at a modest level, seems to be organized by 
West African traffickers who exchange South American 
cocaine for South-West Asian heroin destined for illicit 
markets in Europe or North America. International 
drug trafficking syndicates, mostly involving West 
African organized criminal groups, have been using 
India as a major transit country for Europe-bound drug 
consignments and also as a destination country. 
Cocaine seizures in 2007 continued to occur with 
regularity (usually about 1 kg per month). 
542. Trafficking in and abuse of cannabis and heroin 
have increased in countries in South Asia. The porous 
borders between Bangladesh, Bhutan, India and Nepal 
contribute to the cross-border smuggling and 
consequent increased availability of illicit drugs in the 
region. The quantity of heroin entering India from 
Pakistan has increased. Law enforcement agencies in 
the north-western part of India are seizing ever-
increasing quantities of heroin originating in 
Afghanistan and Pakistan and en route to Europe via 
Pakistan and India.  
543. There is evidence that heroin consignments 
destined for Europe are increasingly passing through 
Bangladesh. The most common methods and routes 
used for smuggling heroin into Bangladesh are as 
follows: by courier along a route leading from Pakistan 
to Bangladesh; by commercial vehicle or train along a 
route leading from India to Bangladesh; and by sea via 
the Bay of Bengal or overland by truck or public 
transport along a route leading from Myanmar to 
Bangladesh. It has been reported that Indian heroin is 
increasingly becoming available in Bangladesh.  
544. According to the Maldives-European Community 
Strategy Paper 2007-2013, drug abuse has become a 
serious problem in Maldives, where three quarters of 
the prison inmates are serving sentences for drug 
offences. Unemployed young people are the group 
most vulnerable to drug abuse. 
545. In South Asia, the abuse of heroin and 
pharmaceutical preparations by injection is one of the 
main factors contributing to the spread of HIV/AIDS 
infection. In India, the areas most affected by drug-
related HIV/AIDS infection continue to be the north 
eastern part of the country bordering Myanmar and 
large urban areas; in those areas, there is an extremely 
high incidence of HIV/AIDS among the population. 
The HIV/AIDS situation analysis done in Maldives 
revealed rising levels of drug abuse and addiction. Of 
the persons who abuse drugs in that country, 20-25 per 
cent abuse drugs by injection. Of the persons who 
abuse drugs by injection in Maldives, the majority 
(90 per cent) are male and about 20 per cent are less 
than 20 years of age. The percentage of Maldivian drug 
abusers who have injected drugs increased from 8 per 
cent in 2003 to 29 per cent in 2006. 
546. The smuggling of licitly manufactured 
pharmaceutical preparations, such as codeine-based 
syrups, benzodiazepines and buprenorphine, from India 
into neighbouring countries such as Bangladesh, 
Bhutan, Nepal and Sri Lanka remains a major concern. 
547. Internationally controlled pharmaceutical 
preparations manufactured locally in India are 
increasingly being diverted to some European 
countries and the United States. Each year, the United 
States Customs and Border Protection intercepts in the 
mail system thousands of illegal parcels containing 
pharmaceutical preparations and marked “for personal 
use”. Most of those pharmaceutical preparations appear 
to have been sold illegally over the Internet. 
 
  Regional cooperation 
 
548. A workshop on capacity-building for law 
enforcement officials responsible for investigating 
cases involving money-laundering was held in 
Colombo in January 2007. Senior officials from 
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various investigative agencies in Bangladesh, India, 
Malaysia, Maldives, Pakistan and Sri Lanka 
participated in the workshop. 
549. The fourteenth summit of the South Asian 
Association for Regional Cooperation (SAARC), held 
in New Delhi in April 2007, admitted Afghanistan as a 
new member of SAARC. The Heads of State or 
Government participating in the summit agreed to 
work towards the implementation of the provisions of 
the SAARC conventions to combat transnational 
crimes, counter trafficking in narcotics and 
psychotropic substances and counter trafficking in 
women. 
550. In South Asia, bilateral efforts to combat drug 
trafficking continued. The fourth round of talks at the 
Home/Interior Secretary level between India and 
Pakistan on Terrorism and Drug Trafficking was held 
in New Delhi in July 2007. It was agreed that both 
countries would enhance mutual cooperation to 
effectively combat drug trafficking. They also agreed 
that a memorandum of understanding between their 
drug control agencies would be signed soon. 
551. Bangladesh and Myanmar have signed a bilateral 
agreement to address the problem of trafficking, 
including trafficking in precursors. The agreement 
deals mainly with information exchange and 
intelligence-sharing. 
 
  National legislation, policy and action 
 
552. Under the current drug control legislation in 
Sri Lanka, not all the substances under international 
control are controlled. For example, the current 
legislation does not contain any provision that allows 
for the monitoring of precursors and some 
psychotropic substances to prevent their diversion. The 
Board notes with satisfaction that, in February 2007, 
the Sri Lankan Cabinet ordered the drafting of 
legislation to control precursors. The Board encourages 
the Government of Sri Lanka to ensure that 
the   amended legislation will also take into 
account   provisions of the 1971 Convention, the 
1988 Convention and the 1961 Convention. 
553. The national drug control agency of Sri Lanka 
announced in June 2007 that a rehabilitation 
programme would be in place for drug-dependent 
prison inmates. The announcement came after over 
400 inmates demanded key reforms, including the 
introduction of rehabilitation services at a prison. 
Around 12,000 Sri Lankans are currently serving 
prison sentences for drug-related offences. 
554. In order to involve the population in 
apprehending drug smugglers, the Maldives Customs 
Service decided to give cash awards to those who 
provide assistance in apprehending persons trying to 
smuggle drugs and other contraband into Maldives. 
555. In Bangladesh, a Financial Intelligence Unit was 
formed in March 2007 with technical assistance from 
the United States to combat financial crimes. 
Established within the framework of the amended 
money-laundering prevention ordinance of 2007, the 
Unit will operate as part of the Anti-Money Laundering 
Department of the Bangladesh Bank. 
556. The implementation of the national drug control 
strategy in Bangladesh involves various partners such 
as non-governmental organizations and law 
enforcement agencies; however, proper implementation 
of the drug control strategy is hampered by the lack of 
resources and training. The Board encourages the 
Government of Bangladesh to continue to attach high 
priority to drug control issues and to ensure that all 
partners involved in the implementation of the national 
drug control strategy have the support and resources 
necessary to enable them to carry out their activities. 
557. In Nepal, a comprehensive national narcotics 
control policy drafted by the Ministry of Home Affairs 
was adopted by the Cabinet in 2006. The policy 
consists of strategies for supply control, demand 
reduction, risk reduction, research and development, 
and collaboration and resource mobilization. The 
policy includes provisions for controlling drug 
production, abuse and trafficking. However, there is 
still no legislation in place for the control of 
precursors.  
558. In India, the national policy on demand reduction 
mainly consists of building awareness and educating 
people about the ill effects of drug abuse, taking into 
account the culture-specific aspects of the problem. 
Drug addicts are dealt with through programmes 
involving motivational counselling, treatment, follow-
up and social reintegration. Training in the prevention 
of drug abuse and the rehabilitation of drug addicts is 
made available to service providers. There are 
currently 428 centres that provide counselling, 
detoxification and rehabilitation services for drug 
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addicts; those centres are run by non-governmental 
organizations and funded by the Government.  
559. Drug control officials of the SAARC Drug 
Offences Monitoring Desk based in India and Pakistan 
regularly share information with their counterparts in 
Sri Lanka. The Ministry of Home Affairs of Nepal has 
recently set up a SAARC Drug Offences Monitoring 
Desk at the international airport at Kathmandu. The 
Board encourages the SAARC Drug Offences 
Monitoring Desk in Nepal to increase cooperation with 
its counterparts in India, Pakistan and Sri Lanka and to 
share information on drug control efforts. 
 
  Cultivation, production, manufacture, 
trafficking and abuse 
 
  Narcotic drugs 
 
560. Cannabis continues to be illicitly cultivated and 
abused in most of the countries in South Asia. In 
Sri Lanka, cannabis grows wild and is also illicitly 
cultivated on a total of 500 hectares, mostly in dry 
areas in the eastern and southern provinces of the 
country; the illicitly cultivated cannabis is for use in 
the country. Small quantities of cannabis are also 
cultivated in Bangladesh for local use. About 1-2 tons 
of cannabis are seized yearly in Bangladesh.  
561. In India, large areas of illicitly cultivated opium 
poppy were destroyed in May 2007. Illicit opium 
poppy cultivation is reported to cover thousands of 
hectares in some remote areas of India, including along 
the border with Bangladesh. 
562. In a joint operation conducted in July 2007, the 
Drug Enforcement Unit and the Internal Intelligence 
Department of Maldives, with the assistance of DEA of 
the United States, the Anti-Narcotics Force of Pakistan 
and the Narcotic Bureau of Sri Lanka, seized 7.8 kg of 
heroin. 
563. The geographical nature of Bangladesh, in 
particular its long borders with India and Myanmar, 
makes it particularly suitable for heroin trafficking. 
The Bangladeshi police believe that drugs are 
smuggled out of the country via the provincial airports 
at Sylhet and Chittagong; the seaport of Chittagong 
seems to be the main exit point for drugs leaving the 
country. It was reported that a number of individuals 
have attempted to carry heroin through the 
international airport at Dhaka, on their way from 
Pakistan to Europe. Drug abuse has spread to rural 
areas in Bangladesh. The most frequently abused drug 
is heroin, followed by codeine based cough syrup and 
cannabis. 
564. Pharmaceutical preparations containing narcotic 
drugs, mainly codeine, are widely trafficked and 
abused in South Asia. Codeine-based syrups are 
diverted from the licit market in India and smuggled 
into Bangladesh, where they are abused. 
565. According to research conducted in Sri Lanka in 
2006, people from rural areas seeking jobs in the cities 
are vulnerable to drug abuse. In 2006, 12,551 drug-
related arrests took place; 4 per cent of the persons 
arrested were women. Drug-related arrests increased 
by 6 per cent in 2006, compared with 2005; most of 
those arrested in the western province of the country 
were aged 30 or younger. The drug abuse situation in 
Sri Lanka continues to be stable: it is estimated that 
200,000 persons abuse cannabis and 45,000 persons 
abuse heroin. 
 
  Psychotropic substances 
 
566. The smuggling into Bangladesh, Bhutan, Nepal 
and Sri Lanka of pharmaceutical preparations 
containing psychotropic substances such as 
buprenorphine originating in India continues to be a 
major problem in the countries concerned. The Board 
again calls on the Government of India to reinforce its 
control over the national and international trade in 
psychotropic substances. 
567. In Bangladesh, prescription controls are not 
adequately enforced at the retail level. In addition, 
pharmaceutical preparations are stolen from hospitals 
and pharmacies. The Board urges the Government of 
Bangladesh to strengthen controls over the distribution 
of pharmaceutical preparations at all levels. 
568. In Bangladesh, “Yaba”, a tablet containing 
methamphetamine and caffeine that is widely available 
in South-East Asia, is reported to be gaining popularity 
among young people from middle-class and upper-
middle-class families and in areas near the border with 
Myanmar. 
569. Organized criminal groups are involved in 
trafficking in ATS in India. In 2006, the Narcotics 
Control Bureau and the Central Bureau of Narcotics of 
India dismantled a clandestine ATS laboratory in the 
vicinity of New Delhi. In February 2007, Operation 
Pharma resulted in the dismantling in India of an 
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international drug trafficking operation that had been 
involved in distributing psychotropic substances, 
primarily phentermine, and money-laundering through 
Internet pharmacies. 
570. According to recent seizure data reported by both 
Bangladesh and India, the use of courier services for 
drug trafficking seems to be on the rise. In 2007, drug 
traffickers used Bangladeshi and Indian courier 
services to ship illicit drugs to Canada and South 
Africa. In February 2007, a parcel containing 550 kg of 
ephedrine was seized in a Bangladeshi company 
providing courier services; the parcel was destined for 
Canada. In July 2007, the Narcotics Control Bureau of 
India stopped two parcels containing more than 1 kg of 
heroin in a courier office in New Delhi; one parcel was 
destined for Canada and the other was destined for 
South Africa. 
 
  Missions 
 
571. In February 2007, the Board sent, for the first 
time ever, a mission to Bhutan. For many years, 
information on the drug control situation in Bhutan had 
been lacking. The purpose of the mission was to obtain 
information on how the Government of Bhutan was 
meeting its obligations under the international drug 
control treaties. 
572. The Government of Bhutan has adopted 
comprehensive drug control legislation and has 
established an administrative structure for drug control. 
The Board encourages the Government to continue 
strengthening its administrative structure for drug 
control and ensuring the proper functioning of the 
structure through the provision of adequate human and 
material resources. The Board recommends that the 
Government make the prevention of drug trafficking 
one of the key priorities of law enforcement agencies. 
573. The Board notes that, in Bhutan, there are no 
facilities to provide adequate treatment for drug 
addiction and no reliable data on drug abuse in the 
country. The Board encourages the Government to take 
the necessary measures to address and remedy the 
situation. Those measures should be taken in full 
collaboration with the medical professionals in the 
country. The measures could include the expansion of 
the current facilities in the national hospital for the 
treatment of alcohol abuse so that those facilities could 
be used for the treatment of drug abuse as well. 
574. The Board notes with concern the considerable 
difficulties that Bhutan is facing in controlling the licit 
trade in narcotic drugs and psychotropic substances 
from India. The Board recommends that urgent 
measures be taken to establish control mechanisms in 
that area. 
575. The Board sent a mission to Nepal in March 2007 
to discuss with the Government progress in 
implementing the Board’s recommendations pursuant 
to its previous mission to the country, in 1992. The 
Board notes that Nepal has taken several positive steps 
in recent years to strengthen drug control, including 
acceding to the 1971 Convention in February 2007. 
The Government of Nepal has also made considerable 
effort in the areas of law enforcement and supply 
reduction, for example by the establishment of a 
specialized unit dealing with drug-related offences. 
576. The Board is concerned that, despite the fact that 
Nepal has been a party to the 1988 Convention since 
1991, legislative provisions for the control of 
precursors have yet to be adopted by the Government. 
In view of the geographical location of Nepal, which is 
particularly vulnerable to trafficking in precursors, the 
Board urges the Government to take such measures as 
a matter of priority. The Board is also concerned about 
the lack of legislation to ensure the full implementation 
of the 1971 Convention. The Board urges the 
Government to remedy that situation as well. 
577. The Board, noting the lack of adequate data on 
the abuse of drugs in Nepal, encourages the 
Government to collect such data on a regular basis, 
with the assistance of UNODC, as appropriate. 
 
 
  West Asia 
 
 
  Major developments 
 
578. The illicit cultivation of opium poppy in 
Afghanistan has continued to increase at an alarming 
level, despite the Government’s efforts and the 
assistance provided to the Government by the 
international community over the past five years. In 
2006, the total area under illicit opium poppy 
cultivation in Afghanistan reached 165,000 hectares, an 
increase of 59 per cent compared with 2005. In 2007, 
that figure increased by 17 per cent, to 
193,000 hectares. The estimated crop yield reached a 
record 8,200 tons in 2007, an increase of 34 per cent 
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over the figure for 2006 (6,100 tons). Given that sharp 
increase in potential opium production, the Board is 
seriously concerned that precursor chemicals, acetic 
anhydride in particular, continue to be available for the 
illicit manufacture of heroin in Afghanistan. All 
Governments are reminded that Afghanistan has no 
legitimate need for the substance. 
579. Afghan opiates are smuggled predominantly 
through Iran (Islamic Republic of) and Pakistan and 
countries in Central Asia. Those countries are faced 
with a wide range of problems related to large-scale 
drug trafficking, such as organized crime, corruption 
and relatively high illicit demand for opiates. For 
example, the Islamic Republic of Iran has the highest 
rate of abuse of opiates in the world.  
580. The Board once again urges the Government of 
Afghanistan, as well as the international community, to 
take effective measures to eradicate illicit opium poppy 
cultivation and to ensure that opium poppy growers are 
provided with sustainable, legitimate livelihoods. The 
Board wishes to emphasize that eradication of opium 
poppy cultivation in Afghanistan will require a strong 
political will and determination by the Government of 
Afghanistan and by all the major donors and 
neighbouring countries.  
581. Trafficking in narcotic drugs along the northern 
route, through Central Asia, persists: an estimated 
21 per cent of heroin and morphine of Afghan origin 
passed through Central Asia in 2006. The total amount 
of opium seized in the subregion doubled, mostly 
because of a large increase in the amount of opium 
seized in Tajikistan, Turkmenistan and Uzbekistan, 
countries that share a border 2,300 km long with 
Afghanistan. The increased availability of opiates in 
Central Asia, with its population totalling 60 million, 
resulted in an alarming rise in drug-related crime, the 
abuse of narcotic drugs and the spread of HIV/AIDS. 
582. The southern Caucasus is increasingly being used 
as a transit area for consignments of opiates from 
Afghanistan and, as a result, drug abuse is on the rise 
in that subregion. In view of their long borders with 
Iran (Islamic Republic of), the Russian Federation and 
Turkey and their access to the Black Sea and the 
Caspian Sea, the Board remains concerned that the 
situation with regard to drug trafficking and abuse in 
Armenia, Azerbaijan and Georgia will deteriorate 
further unless increased attention is given to 
information-sharing, more efficient border control and 
regional and national coordination of drug control 
activities.  
583. The abuse of ATS continues to spread in various 
countries in West Asia, including Iran (Islamic 
Republic of), Turkey and several countries on the 
Arabian peninsula. 
 
  Regional cooperation 
 
584. The Governments of Afghanistan, Iran (Islamic 
Republic of) and Pakistan are intensifying their 
regional cooperation. The Governments of Afghanistan 
and Iran (Islamic Republic of) signed a memorandum 
of understanding on counter-narcotics cooperation at a 
meeting held in Kabul in June 2006, pursuant to the 
Kabul Declaration on Good-neighbourly Relations.91 
During a meeting held in June 2007 on strengthening 
border control and activities to deal with the drug 
problem, the Inter-Governmental Technical Committee 
was re-established. 
585. A trilateral ministerial meeting held in Vienna in 
June 2007 brought together high-level officials from 
Afghanistan, Iran (Islamic Republic of) and Pakistan. 
The Board notes with appreciation that the 
representatives of all three countries expressed their 
full commitment to stepping up regional cooperation in 
the form of the Triangular Initiative. The Triangular 
Initiative will lead to the implementation of the 
strategic policy outline, developed by UNODC, 
through joint border projects in Afghanistan, Iran 
(Islamic Republic of) and Pakistan, other exchanges at 
the technical level and regular meetings on policy 
coordination. 
586. The twenty-first conference on anti-narcotics 
policy and strengthening Arab cooperation was held in 
Tunis in June 2007. Representatives of members of the 
League of Arab States attended the conference, which 
was organized by the secretariat of the Council of Arab 
Ministers of the Interior. Participants discussed the 
need to improve efforts to control drugs and counter 
various types of drug-related crime, such as the illegal 
sale of drugs via the Internet and the smuggling of 
drugs by couriers, which had emerged in recent years 
in several Arab countries. The participants adopted 
__________________ 
 91 “Letter dated 24 December 2002 from the Permanent 
Representative of Afghanistan to the United Nations 
addressed to the President of the Security Council” 
(S/2002/1416, annex). 
E/INCB/2007/1  
 
88  
 
recommendations on, among other things, action 
against money-laundering and the financing of 
terrorism and on the creation of additional 
rehabilitation centres for drug abusers. 
587. The Government of Kuwait has intensified its 
participation in regional and international cooperation 
mechanisms in recent years. Representatives of Kuwait 
participated in the Arab Conference for Protecting 
Youth from Drug Abuse, held in Cairo in June 2005, 
the nineteenth Arab conference on combating drugs, 
held in Tunis in July 2005, and the eighth meeting of 
the neighbouring countries of Iraq, held in Istanbul, 
Turkey, in April 2005, which concluded with the 
signing of security cooperation agreements on the 
sharing of information and cooperation to counter drug 
trafficking and organized crime. 
588. Governments of countries in Central Asia are 
increasing their bilateral and multilateral cooperation 
in areas such as reduction of illicit drug supply and 
demand, precursor control, border management, 
countering spread of HIV/AIDS and fighting organized 
crime and money-laundering. They have also been 
participating in various regional projects and 
international operations under the auspices of the 
Commonwealth of Independent States (CIS), the 
Collective Security Treaty Organization (CSTO), the 
Shanghai Cooperation Organization (SCO) and the 
signatories to the 1996 Memorandum of Understanding 
on Subregional Drug Control Cooperation (Azerbaijan, 
Kazakhstan, Kyrgyzstan, the Russian Federation, 
Tajikistan, Turkmenistan and Uzbekistan). Similarly, 
an increasing number of joint programmes are being 
implemented and supported by the United Nations, the 
European Union, the Organization for Security and 
Cooperation in Europe, the World Bank, the World 
Customs Organization, Interpol, the Paris Pact92 Policy 
Consultative Group, the North Atlantic Treaty 
Organization (NATO)-Russia Council, mini-Dublin 
groups and individual Governments. 
589. At a coordination conference held in Astana in 
April 2007, competent national authorities of CIS 
member States adopted a cooperation programme on 
countering organized crime and illicit drug and 
__________________ 
 92 The Paris Pact initiative emerged from the Paris 
Statement (S/2003/641, annex), which had been issued at 
the end of the Conference on Drug Routes from Central 
Asia to Europe, held in Paris on 21 and 22 May 2003. 
precursor trafficking for the period 2008-2010. At the 
Shanghai Cooperation Organization summit held in 
Bishkek in August 2007, heads of SCO member States 
discussed regional security matters and common 
threats, including border control concerns and joint 
action against drug trafficking; the Heads of State of 
Afghanistan, India, Iran (Islamic Republic of), 
Pakistan and Turkmenistan also attended the summit. 
The drug trafficking situation and possible ways to 
expand cooperation among CSTO member States were 
discussed at several high-level meetings and working 
sessions organized by the secretariat of CSTO in 2007.  
590. CSTO member States (Armenia, Belarus, 
Kazakhstan, Kyrgyzstan, Russian Federation, 
Tajikistan and Uzbekistan) are actively involving 
Afghanistan, as well as Interpol and the Governments 
of Azerbaijan, China, Estonia, Finland, Iran (Islamic 
Republic of), Latvia, Lithuania, Mongolia, Poland, 
Ukraine and the United States, in intergovernmental 
operations such as operation Channel, which in 2006 
resulted in the detection of over 9,000 cases related to 
drug trafficking and the seizure of 24 tons of illicit 
drugs, including 774 kg of heroin, 838 kg of “hashish” 
(cannabis resin) and 165 tons of precursors. In 2007, 
the operation resulted in seizures of illicit drugs 
totalling 10.8 tons, including 194 kg of heroin, 4.3 tons 
of opium, 4.8 tons of cannabis and cannabis resin and 
over 223 tons of precursors. 
591. The Governments of Azerbaijan, Kazakhstan, 
Kyrgyzstan, the Russian Federation, Tajikistan, 
Turkmenistan and Uzbekistan continued to cooperate 
in subregional drug control initiatives within the 
framework of the 1996 Memorandum of 
Understanding. The necessary legal and institutional 
basis for establishment of the Central Asia regional 
information and coordination centre has already been 
developed and finalized. All but one of the 
Governments (the Russian Federation) have signed the 
agreement on the establishment of the centre. While 
the centre is expected to be fully operational as soon as 
the agreement is ratified by the parliaments of at least 
four of the countries, a pilot phase of the operation of 
the centre will commence soon. The Board urges the 
Governments involved to support the pilot phase and 
expedite the process of ratification of the agreement 
and to consider including other countries in West Asia 
and the Caucasus, in order to ensure greater 
cooperation in collecting, exchanging and analysing 
drug-related intelligence, organizing and coordinating 
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joint international operations and carrying out other 
supply reduction efforts and training in West Asia. 
592. Under the auspices of the Paris Pact Policy 
Consultative Group, several round-table meetings of 
experts, focusing on drug trafficking routes in Central 
Asia, were held in 2006. The meeting held in Vienna in 
May 2007 focused on the control of precursors used in 
the manufacture of heroin and on the evaluation of 
various international initiatives, such as Operation 
Trans-shipment and Operation Containment. The 
meeting resulted in, among other things, the 
endorsement of the UNODC action plan targeting 
precursors used in heroin manufacture. As follow-up to 
the meeting held in May 2007, a meeting on operations 
targeting the smuggling of acetic anhydride in and 
around Afghanistan was held in Vienna in October 
2007. Under the auspices of the NATO-Russia Council 
pilot project on counter-narcotics training for law 
enforcement personnel from Afghanistan and countries 
in Central Asia, training is being provided by mobile 
teams travelling to those countries, as well as at 
training facilities in the Russian Federation and Turkey. 
593. The European Union continues to implement 
various programmes in Central Asia, such as the 
Central Asian Drug Action Programme, the Border 
Management Programme in Central Asia, and the 
Central Asian Regional Drug Information Network 
(CARDIN), focusing on strengthening capacities at 
main airports and border crossings, improving the 
effectiveness of border control and supporting forensic 
training, HIV prevention in prisons, research into drug 
trafficking, awareness-raising campaigns and the 
training of sniffer dogs. The fifth annual review 
meeting of CARDIN, held in Tashkent in March 2007, 
was attended by national focal points and 
representatives of services for the treatment of abuse 
from Kazakhstan, Kyrgyzstan, Pakistan, Tajikistan and 
Uzbekistan. 
 
  National legislation, policy and action 
 
594. The Counter-Narcotics Trust Fund (CNTF), 
established by the Government of Afghanistan to 
provide funding for drug control, continues to have 
difficulties. As at 30 June 2007, 22.3 million United 
States dollars have been allocated to 27 projects 
in  29 provinces, and US$ 42.3 million (of the 
US$ 74.6 million in pledges) have been received for 
CNTF. The approved projects include 21 projects in the 
area of alternative livelihoods and 2 projects in each of 
the following areas: drug demand reduction, 
institution-building and raising public awareness.  
595. According to the Ministry of Counter Narcotics 
of Afghanistan, the main reasons behind the slow 
progress in the implementation of CNTF projects are 
the limited capacity and resources in the Government 
ministries, conflicting procurement procedures 
between the ministries and the United Nations 
Development Programme and lack of knowledge 
regarding new rules of procurement. In response, 
CNTF launched a project to enhance the capacity of 
the ministries, to fast-track the procurement process 
and to increase the quality and coordination of CNTF 
project proposals.  
596. The Government of Afghanistan implemented 
measures, such as the Good Performance Initiative, 
under which each province that is free of opium poppy 
receives US$ 500,000 in funding for development 
projects and an additional US$ 500,000 if the poppy-
free status is maintained. Provinces in which only a 
small amount of opium poppy is cultivated also receive 
funding. In addition to being compensated for having 
reduced opium poppy cultivation, provincial 
governments are rewarded for having increased their 
eradication efforts. For example, Balkh province has 
been awarded a total of US$ 3 million in recognition of 
its outstanding performance and for maintaining its 
poppy-free status. 
597. In 2006, in a move to strengthen provincial 
institutions, the Ministry of Counter Narcotics of 
Afghanistan established five provincial offices to 
handle all areas of counter-narcotics at the local level. 
Those new provincial offices will implement pilot 
programmes for the development of alternative 
livelihood projects. Within the framework of the 
Afghanistan National Development Strategy,93 a 
national regulatory body was created to supervise the 
import and export of licit drugs. The Government of 
Afghanistan also created, within the Intelligence 
Department of the Counter-Narcotics Police, a unit 
specializing in precursor control.  
__________________ 
 93 “Letter dated 14 February 2006 from the Permanent 
Representative of Afghanistan to the United Nations 
addressed to the President of the Security Council” 
(S/2006/105, annex). 
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598. The Government of Afghanistan has also been 
taking measures to deal with the growing problem of 
drug abuse. By May 2007, the Government had 
established facilities for the treatment of drug abuse in 
17 of the 34 provinces in the country, and another 
8 further centres were being planned for the same year. 
Campaigns for the prevention of drug abuse are 
conducted by religious organizations in Afghanistan, 
and drug abuse prevention has been incorporated in the 
curricula of primary schools. 
599. The Government of the Islamic Republic of Iran 
has adopted general policies on the fight against 
narcotic drugs and, in addition to special treatment 
programmes designed for male drug addicts, has been 
strengthening measures for the provision of treatment 
for female drug addicts. In late 2006, the Government 
opened the first rehabilitation centre for female 
drug   addicts in Tehran, providing facilities for 
3,000  addicts; the centre also includes a kindergarten. 
Two other provinces in the country have similar 
facilities. A drop-in centre for female addicts was 
established in Tehran in March 2007, and the 
Government has announced that it is considering 
proposals for conducting research on the situation of 
female drug addicts in the country.  
600. The Board is concerned that, in Pakistan, the 
Policy Review Board, a committee responsible for the 
coordination of national drug control policy, bringing 
together all the relevant agencies, is not functioning 
properly. A mission of the Board to Pakistan in 2004 
identified the need for improving coordination among 
Government agencies involved in drug control. 
Subsequent to those findings, the Board recommended 
that the Policy Review Board be strengthened 
accordingly. In September 2007, Pakistan promulgated 
legislation against money-laundering in the form of an 
ordinance providing for the establishment of an 
independent financial monitoring unit and a national 
executive committee to combat money-laundering. The 
Government of Pakistan is preparing a draft of the 
national drug control master plan for the period 2008-
2012, which is to be submitted to the Federal Cabinet. 
601. Drug trafficking and abuse are deteriorating on 
the Arabian peninsula. In particular, the Board notes 
that drug control legislation in Palestine needs to be 
examined and updated, with the assistance of UNODC. 
602. Governments of countries in Central Asia have 
continued to improve their national laws, bringing 
them in line with the provisions of the international 
drug control treaties. The parliament of Kyrgyzstan is 
reviewing a draft law that would amend the Narcotic 
Drugs, Psychotropic Substances and Precursors Act of 
the Kyrgyz Republic of 24 April 1998. The amendment 
would enhance the provisions of the Act relating to 
licit drug control, drug abuse prevention and the 
treatment of drug abusers. 
603. In 2006, Kyrgyzstan adopted legislation on 
countering money-laundering and on confiscating 
assets derived from criminal activity; in addition, 
financial intelligence units were established in the 
country. In Uzbekistan, in accordance with the 
presidential decrees issued in 2007, the implementation 
of the main provisions of the law against money-
laundering, which had entered into force in 2005, has 
been suspended until 2013. The Office of the President 
of Tajikistan is preparing a draft law against money-
laundering. 
604. National strategies aimed at preventing the spread 
of HIV/AIDS have been drafted and are in the process 
of being adopted by the Governments of countries in 
Central Asia. Following the adoption of a similar 
programme in Tajikistan in 2006, the Government of 
Uzbekistan is expected to adopt in 2007 a national 
programme for the period 2008-2010 addressing 
HIV/AIDS and the problem of drug abuse. 
605. While implementation of its national programme 
against drug abuse and trafficking in narcotic drugs 
and psychotropic substances, covering the period 2001-
2006, continues, the Government of Azerbaijan is in 
the process of adopting a new programme, covering the 
period 2007-2012. 
606. In 2006, the Government of Georgia created a 
consultative council for drug control policy. The 
council, which includes representatives of the Ministry 
of Health and the Ministry of Internal Affairs, as well 
as non-governmental organizations and medical 
practitioners, has developed a national drug control 
strategy and an action plan, to be implemented in 2007. 
 
  Cultivation, production, manufacture, 
trafficking and abuse 
 
  Narcotic drugs 
 
607. According to the Afghanistan Opium Survey 
2007, in Afghanistan opium poppy cultivation covered 
193,000 hectares in 2007, an increase of 17 per cent 
 E/INCB/2007/1
 
 91 
 
over 2006. A larger share of opium production in 
provinces where yields have traditionally been higher 
resulted in a proportionally larger increase in opium 
production compared with the increase in the total 
cultivated area. As a result, the average opium yields in 
all areas of Afghanistan (42.5 kg per hectare) in 2007 
were also higher than in 2006 (37.0 kg per hectare). 
Given the increase in the total area under illicit opium 
poppy cultivation and the favourable weather 
conditions, Afghanistan produced an extraordinary 
8,200 tons of opium in 2007 (34 per cent more than in 
2006), supplying 93 per cent of the global market for 
opiates. 
608. In south-western Afghanistan, opium poppy 
cultivation has reached an unprecedented level. In 
2007, 70 per cent of the opium poppy cultivation in 
Afghanistan took place in five provinces along that 
country’s border with Pakistan. The province of 
Helmand currently accounts for more than 50 per cent 
of the entire opium production in Afghanistan. 
609. In some areas of Afghanistan opium cultivation 
has diminished. In the northern and central parts of the 
country, illicit opium poppy cultivation was almost 
brought to a halt; in Balkh province, for example, the 
area under opium poppy cultivation fell from 
7,200 hectares in 2006 to nil in 2007. However, the 
Board continues to be concerned that in some areas, 
such as Balkh province, illicit opium poppy cultivation 
is being replaced by the illicit cultivation of cannabis 
plants, which reached 68,850 hectares in 2007. In 
addition, the Board urges the Government to ensure 
that farmers are provided with means for alternative 
livelihoods, which should contribute to the elimination 
of poverty and discourage the illicit cultivation of drug 
crops. 
610. There is a strong link between security conditions 
and illicit opium poppy cultivation in the southern 
provinces of Afghanistan. Information collected by 
UNODC indicates that the overwhelming majority of 
villages with poor security are involved in opium 
poppy cultivation. Drug traffickers and criminal groups 
encourage villagers to grow opium poppy, 
guaranteeing the protection of their opium poppy fields 
and, in some cases, using threats and intimidation to 
force the villagers to engage in illicit opium poppy 
cultivation.  
611. Information released by UNODC in August 2007 
indicates that some 19,000 hectares of opium poppy 
have been eradicated in Afghanistan, 24 per cent more 
than the area eradicated in 2006 (15,300 hectares) and 
280 per cent more than the area eradicated in 2005 
(5,000 hectares). However, taking into account the 
large scale of opium poppy cultivation in Afghanistan 
in 2007, the area eradicated represents only 9 per cent 
of the total area cultivated with opium poppy 
(compared with 8 per cent in 2006). In Helmand, the 
main province in which opium poppy is cultivated, the 
official target set for the eradication of opium poppy 
cultivation was 50 per cent; only a fraction of that area 
was eradicated.  
612. Though eradication efforts in Afghanistan were 
much more intense in 2007 than in 2006, resistance to 
eradication was much more severe. Several security 
incidents, including violent incidents involving armed 
resistance, took place, resulting in over a dozen deaths. 
In areas of the country controlled by the Taliban, 
eradication efforts have had little chance of success. 
613. In the Islamic Republic of Iran, no significant 
illicit cultivation of opium poppy takes place and no 
manufacture of illicit drugs was reported in 2006. As 
the Islamic Republic of Iran has not reported seizures 
of precursor chemicals since 2002 and acetic anhydride 
is manufactured in the country, the Board urges the 
Government to ensure that mechanisms for the control 
of domestic distribution of such chemicals are 
sufficient to prevent their diversion. 
614. The Islamic Republic of Iran continues to seize 
more opiates than any other country in the world. In 
the first half of 2007, a total of 180 tons of opium were 
seized in the Islamic Republic of Iran (an increase of 
37 per cent over the first half of 2006), mainly on that 
country’s eastern border with Afghanistan. While 
opium accounts for 71 per cent of the total amount of 
opiates seized in the Islamic Republic of Iran, in 2007 
heroin seizures almost doubled, seizures of morphine 
increased by 51 per cent and seizures of cannabis 
increased by 22 per cent. Over 50 per cent of the 
inmates in the country’s prisons are reported to have 
been convicted for drug-related crimes. 
615. Pakistan continues to be used as a major transit 
area for Afghan opiates, but to a lesser extent than the 
Islamic Republic of Iran. According to Pakistan 
officials, 35 per cent of illicit opiates of Afghan origin 
are smuggled through Pakistan.  
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616. Government data show a dramatic increase in 
Afghan opiates seized in Pakistan in 2006, the last year 
for which data are available. The total amount of 
seized opiates increased from 25 tons of heroin 
equivalent in 2005 to 36.4 tons of heroin equivalent in 
2006, an increase of 46 per cent. Analysis of seizure 
data suggests that there is increased smuggling of 
Afghan opiates through Pakistan into China. The total 
amount of cannabis resin seized in Pakistan also 
increased, from 93.5 tons in 2005 to 115.4 tons in 
2006, an increase of 23 per cent, partly reflecting an 
increase in cannabis production in Afghanistan. 
617. Until recently, Iraq had been used as a transit area 
for smuggling Afghan heroin through the Islamic 
Republic of Iran into Saudi Arabia and other countries 
in the area of the Persian Gulf. Illicit drug trafficking 
and the risk of illicit cultivation of opium poppy have 
been increasing in some areas with grave security 
problems. Though official data are lacking, it appears 
that drug abuse in Iraq has increased dramatically, 
including among children from relatively affluent 
families. 
618. Some cultivation of opium poppy and cannabis 
takes place in Lebanon, mainly for local use. 
According to the Internal Security Forces of Lebanon, 
approximately 27 hectares of opium and 64 hectares of 
cannabis were eradicated in 2005. In 2006, the 
Government’s eradication efforts resulted in the 
destruction of 380 hectares of illicitly cultivated crops. 
Despite some successes achieved in curtailing drug 
trafficking, heroin, cocaine and psychotropic 
substances, such as MDMA and counterfeit Captagon 
tablets (which nowadays contain mainly amphetamine 
and caffeine instead of fenetylline), are reportedly 
being smuggled through Lebanon into Kuwait, Saudi 
Arabia and the United Arab Emirates, out of Jordan, 
the Syrian Arab Republic and Turkey, as well as from 
countries in Europe and South America. 
619. According to law enforcement authorities in 
Israel, there is a high demand for cannabis, “hashish” 
(cannabis resin), opium, heroin, cocaine and MDMA 
(“ecstasy”) in that country. Police data indicate that, 
while the total amount of cannabis seized is declining, 
the total amount of heroin and cocaine seized is 
increasing and there continues to be a significant 
amount of “ecstasy” seized. In 2005, 12.5 tons of 
cannabis, over 1 ton of cannabis resin, 145 kg of 
heroin, 161 kg of cocaine and 245,000 MDMA tablets 
were seized in Israel. 
620. According to officials in Palestine, cannabis is 
illicitly cultivated both on the West Bank and in the 
Gaza Strip. Drug trafficking is increasing in Palestine, 
as evidenced by the fact that 1 out of 10 cases 
involving serious crime is drug-related. In 2005, 
1.2  tons of opium, 12.9 tons of cannabis and over 
10  kg of heroin and various heroin mixtures were 
seized. 
621. The Syrian Arab Republic is used as a transit 
country for illicit consignments of cannabis, cocaine 
and heroin (mainly from Lebanon and Turkey), 
morphine (from Afghanistan, Iran (Islamic Republic 
of) and Turkey) destined for Jordan and Lebanon, as 
well as counterfeit Captagon tablets (containing mainly 
amphetamine) destined for countries in the area of the 
Persian Gulf. The total amount of drugs seized has 
been increasing in recent years in the Syrian Arab 
Republic. 
622. Cannabis grows wild in Kazakhstan and 
Kyrgyzstan, and small-scale cultivation of opium 
poppy continues to take place in several countries in 
Central Asia and the southern Caucasus. The opium 
produced is mostly used locally or smuggled, on a 
small scale, into the Russian Federation. The 
Governments of those countries should continue their 
efforts aimed at identifying and eradicating illicitly 
cultivated drug crops. 
623. A total of 36.4 tons of drugs were seized in 
Central Asian countries in 2006. That total includes 
27 tons of cannabis, 84 per cent of which was seized in 
Kazakhstan. Opium seizures more than doubled, from 
2.7 tons in 2005 to 5.7 tons in 2006, and a significant 
change in the incidence of seizures of opiates was 
noted throughout Central Asia. While, from 2005 to 
2006, there was a decrease in the share of the opium 
seized in Kazakhstan (from 24 to 11 per cent) and in 
Tajikistan (from 40 to 24 per cent), there was an 
increase in the share of the opium seized in 
Turkmenistan (from 27 to 46 per cent) and Uzbekistan 
(from 4 to 13 per cent). 
624. In 2006, the quantity of heroin seized in Central 
Asia decreased from 3.8 to 3.7 tons. Compared with 
2005, there was a decrease of 11 per cent in the 
quantity of heroin seized in Kazakhstan (from 626 to 
555 kg) and Tajikistan (from 2.3 to 2.1 tons), although 
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those two countries still accounted for 73 per cent of 
the total quantity of heroin seized in countries in 
Central Asia. The quantity of seized heroin increased in 
Kyrgyzstan (by 29 per cent), Turkmenistan (by 11 per 
cent) and Uzbekistan (by 15 per cent). 
625. Turkmenistan, with its extensive borders with 
Afghanistan (745 km), Iran (Islamic Republic of) 
(992  km), Kazakhstan (379 km) and Uzbekistan 
(1,621 km), continues to be used as a transit country 
for Afghan opium and heroin destined for illicit 
markets in the Russian Federation and countries in 
Western Europe. Afghan opiates are smuggled in trucks 
and automobiles, in maritime shipments (on the 
Caspian Sea) and in air cargo through Azerbaijan and 
Turkey. Official statistics released by the Government 
of Turkmenistan indicate that, in 2006, the total 
quantity of seized heroin, opium and cannabis 
exceeded 3 tons, almost tripling the figure for the year 
before. That sharp increase was attributed mainly to an 
increase of 255 per cent in the quantity of opium 
seized. 
626. Uzbekistan continues to be used as a transit 
country for Afghan opiates that are being smuggled 
into the Russian Federation, mainly by road and rail, 
out of Kyrgyzstan and Tajikistan, as well as directly 
out of Afghanistan. In 2006, the total quantity of drugs 
seized in Uzbekistan increased by 70 per cent, mostly 
as a result of an extraordinary increase of 605 per cent 
in the quantity of opium seized, which increased 
significantly from 108 kg in 2005 to 759 kg in 2006. 
The combined quantity of cannabis, opium and heroin 
seized in Kyrgyzstan increased from 2.3 tons in 2005 
to 3 tons in 2006. 
627. The available data suggest that, while the 
quantity of cannabis trafficked through the southern 
Caucasus remains stable, the combined quantity of 
heroin, opium and cocaine is increasing. In 2006, 
531 kg of drugs were seized in Azerbaijan, including 
141 kg of cannabis (down from 150 kg in 2005) and 
49 kg of heroin (up from 13 kg in 2005). However, 
according to some estimates, the total quantity of drugs 
being smuggled through Azerbaijan is approaching 
1,000 tons per year, and Afghan opiates are entering 
the country from the Islamic republic of Iran and 
countries in Central Asia on their way to Georgia, the 
Russian Federation and countries in Western Europe. 
628. The quantity of drugs seized in Armenia, while 
remaining low, has increased. In 2006, a total of 
26.3 kg of narcotic drugs (mostly cannabis) were 
seized, representing an increase of 33 per cent 
compared with the previous year. Due to weak border 
control, drugs appear to be entering Armenia from its 
neighbouring countries: cannabis is entering Armenia 
from Georgia; opium, mainly from the Islamic 
Republic of Iran; heroin, from Iran (Islamic Republic 
of) and Turkey; and buprenorphine (Subutex®), from 
France. 
629. In 2006, drug-related crime increased by 31 per 
cent in Georgia. In addition, trafficking in heroin 
increased (from 2.59 kg in 2005 to 4.8 kg in 2006), 
while the quantity of seized cannabis declined (from 
23.3 kg in 2005 to 11 kg in 2006). The quantity of 
seized buprenorphine (Subutex®) continued to rise in 
Georgia. 
630. The abuse of opiates continues to pose a major 
problem in countries neighbouring Afghanistan and 
even in countries near Afghanistan. Nearly all those 
countries have high rates of drug abuse; the Islamic 
Republic of Iran, for example, has the world’s highest 
abuse rate for opiates: an estimated prevalence rate of 
2.8 per cent. Drug addiction continues to be a growing 
problem in the Islamic Republic of Iran: reportedly 
over 2 million people in the country abuse drugs. 
Pakistan also has a high abuse rate for opiates: the 
estimated prevalence rate among the population 
aged 15-64 in 2006 was 0.7 per cent. Many countries 
in Central Asia have similar levels of drug abuse, with 
heroin abuse having replaced cannabis and opium 
abuse as the main drug problem. In Central Asia, the 
incidence of heroin dependence among registered drug 
abusers ranges from 50 to 80 per cent, the highest rates 
being recorded in Tajikistan and Uzbekistan. 
631. Despite their high estimates of drug abuse, many 
countries in West Asia, including the Islamic Republic 
of Iran, have not collected comprehensive data on drug 
abuse for some years. The Board notes that some 
Governments are taking measures in that area; for 
example, the results of a national drug abuse 
assessment survey carried out in Pakistan in 2006 have 
been recently released. The survey suggests that 77 per 
cent of the 628,000 opioid users in that country abuse 
heroin. The prevalence of drug abuse by injection 
(125,000 persons) was estimated to be about 0.14 per 
cent of the adult population in 2006, which is twice the 
rate in 2002. The Board encourages other Governments 
to follow suit and conduct comprehensive surveys and 
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rapid assessments of the drug abuse situation in their 
countries. 
632. Drug-related crime and drug abuse are growing in 
Palestine. While the smoking of cannabis and the 
injection of heroin have increased significantly in 
recent years, polydrug use and the abuse of over-the-
counter medicines are also spreading. According to the 
available data, 10,000 people in the Gaza Strip and the 
West Bank are registered as drug abusers, and there 
may be another 15,000 drug abusers in Jerusalem. 
There are currently no rehabilitation facilities for drug 
abusers in the West Bank or the Gaza Strip. 
633. Oman is increasingly being used as a transit 
country for illicit drug consignments. Because of the 
porous land borders, cannabis, opium and heroin 
shipments from Afghanistan, Iran (Islamic Republic of) 
and Pakistan are smuggled through Oman. The latest 
statistics indicate that there are over 1,000 individuals 
registered as drug abusers and receiving free treatment 
for drug abuse in Oman. 
634. Cannabis, ephedra, opiates and synthetic drugs 
are abused in Central Asia. Increasing drug addiction 
and a shift from cannabis and opium abuse to heroin 
abuse are common to all countries in the subregion. 
635. In 2006, the number of officially registered 
drug   addicts in Kazakhstan increased by 834 to 
54,411 persons (or 0.5 per cent of the population 
aged  15-64); there has been a continued shift from 
cannabis abuse to opium and heroin abuse. A total of 
7,842 persons in Kyrgyzstan (or 0.2 per cent of the 
adult population) were officially registered drug 
abusers in 2006, an increase of 8 per cent over 2005. 
The number of persons abusing illicit drugs is 
increasing in Tajikistan as well; according to official 
statistics, in 2006, there were 7,865 registered drug 
abusers in the country (or 0.2 per cent of the adult 
population), of which 91 per cent were abusing 
opioids. In Uzbekistan, 19,964 persons (or 0.1 per cent 
of the adult population) were officially registered as 
drug addicts in 2006; according to some estimates, 
80,000 persons in the country abuse heroin by 
injection. No statistics on drug abuse or the spread of 
HIV/AIDS are available for Turkmenistan. 
636. Drug abuse by injection is increasing in many 
countries in West Asia, often contributing to a growing 
HIV problem. It is a major factor behind the spread of 
HIV in Kazakhstan and Uzbekistan, the two countries 
in the region in which the virus has spread the fastest. 
Up to 93 per cent of new cases of HIV infection in 
Tajikistan are related to drug abuse. The same 
phenomenon has been noted in Pakistan and countries 
in the southern Caucasus. 
637. The number of officially registered cases of 
HIV/AIDS in Central Asia increased by 30 per cent, 
from 14,799 cases in 2005 to 19,197 in 2006, drug 
abuse by injection being a major factor contributing to 
that increase. That total includes an increase of 31 per 
cent in Kazakhstan (from 5,657 to 7,402 cases), an 
increase of 30 per cent in Kyrgyzstan (from 826 to 
1,070 cases), an increase of 40 per cent in Tajikistan 
(from 506 to 710 cases) and an increase of 28 per cent 
in Uzbekistan (from 7,810 to 10,015 cases). 
 
  Psychotropic substances 
 
638. In Turkey, the quantity of seized synthetic drugs, 
predominantly MDMA and Captagon (mainly 
amphetamine), increased in 2006 to the highest level 
ever (an increase of 71.6 per cent, compared with 
2005). The quantity of MDMA seized in the country 
continued to increase rapidly, from 94,027 units in 
2002 to 1,457,698 units in 2006. In 2006, the amount 
of Captagon seized also reached the highest level: 
19,971,625 units. According to the Government, 
Turkey is used as a transit country for illicit 
consignments of Captagon, while MDMA is smuggled 
into the country largely to be sold on its growing illicit 
market. 
 
  Precursors 
 
639. The amount of acetic anhydride seized in Turkey 
has increased in recent years, but it remains at a low 
level compared with the large amount of seizures 
before. A total of 5.2 million litres of acetic anhydride 
were seized in 2006, compared with over 18.0 million 
litres in 2002. Although the number of illicit heroin 
laboratories dismantled in the country is decreasing 
and there are indications that Afghan morphine base is 
largely being transformed into heroin before it reaches 
Turkey, the Board calls on the Government of Turkey 
to continue its supply reduction and border control 
measures in order to ensure that no illicit manufacture 
of heroin takes place on its territory. 
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 D. Europe 
 
 
  Major developments 
 
640. After a decade of significant increases, cannabis 
use appears to have stabilized or even declined in most 
Western European countries. However, cannabis 
continues to be the most commonly abused drug in 
Europe. Western Europe remains the largest market for 
cannabis resin in the world. Seizures of cannabis resin 
have decreased in some countries in Europe, a 
development that may be linked to the decline in 
cannabis resin production in Morocco. 
641. Europe is the second largest illicit market for 
cocaine in the world. In most countries in Western 
Europe, particularly those on the Iberian peninsula, a 
significant increase in cocaine seizures has been 
reported. In Portugal, for example, cocaine seizures, 
which were already at a high level, have almost 
doubled. Cocaine is increasingly being smuggled into 
Europe via countries in Western Africa. The abuse of 
cocaine has increased in Western Europe but has 
remained stable in Central and Eastern Europe. The 
Board welcomes the launching of an action plan in 
Spain to address the increasing level of cocaine abuse 
and encourages other States in Europe with high 
prevalence rates to adopt similar measures. 
642. Increased seizures of opiates of Afghan origin in 
the Russian Federation reflect the rise in trafficking in 
opiates in the region. The southern branch of the 
Balkan route, which passes through Istanbul, Sofia, 
Belgrade and Zagreb, is being increasingly used. The 
abuse of opiates has remained stable or declined in 
Western and Central Europe but has reportedly been 
increasing in the Russian Federation and in countries in 
Eastern Europe, as well as in some countries in South-
Eastern Europe along the Balkan route. In Europe, the 
demand for treatment for the abuse of opiates is higher 
in Eastern Europe (61 per cent) than in Western Europe 
(55 per cent). 
643. Europe remains an important source of ATS. The 
illicit manufacture of ATS in South-Eastern and 
Eastern Europe continues to rise. The dismantling of 
laboratories illicitly manufacturing such stimulants has 
been frequently reported in Moldova and Slovakia and 
occasionally reported in Bulgaria, Lithuania and 
Ukraine. The level of MDMA abuse is stable or 
declining in most countries in Western Europe. The 
illicit manufacture and abuse of methamphetamine 
continue to be limited to only a few countries in 
Western and Central Europe (the Czech Republic, 
Estonia, Latvia, Lithuania and parts of Germany). 
644. Over the past few years, the increased drug 
trafficking and abuse in Eastern Europe has contributed 
to an increase in the spread of HIV/AIDS. A significant 
number of new cases of HIV infection are attributable 
to the sharing of drug-injecting equipment or risky 
sexual behaviour resulting from the effects of the 
drugs. One of the fastest-growing HIV epidemics in the 
world is taking place in Eastern Europe.  
 
  Regional cooperation 
 
645. A ministerial conference on the theme new 
signals for drug policies across Europe was organized 
by the Pompidou Group of the Council of Europe in 
Strasbourg, France, in November 2006. The conference 
adopted a six-platform programme against drug abuse 
that focuses on young people. Activities will be 
undertaken under each of the following six platforms 
in the fight against drug abuse and trafficking: 
prevention, treatment, ethics, airports, research and 
criminal justice. One such activity is the MedNET 
Network, initiated by France and the Netherlands, 
which is aimed at facilitating and supporting dialogue, 
cooperation and the exchange and transfer of 
knowledge and experiences between Europe and North 
Africa. As a follow-up to the ministerial conference, an 
online database of European research on drugs was 
launched in January 2007. 
646. An operational body to tackle the smuggling of 
drugs into Europe by sea has been set up within the 
framework of the European Union. In September 2007, 
Ministers of seven European Union member States 
(France, Ireland, Italy, Netherlands, Portugal, Spain 
and United Kingdom) signed an agreement to establish 
the Maritime Analysis and Operation Centre-Narcotics 
(MAOC-N). The mission of MAOC-N is to enhance 
criminal intelligence and coordinate police action on 
the high seas, with a view to intercepting vessels 
carrying cocaine and cannabis. Naval and law 
enforcement bodies will participate in MAOC-N. 
647. In Poland, the 18th International Conference on 
the Reduction of Drug Related Harm was held in 
Warsaw in May 2007. The Conference was organized 
by WHO, UNODC, UNAIDS, the World Bank and the 
Government of Poland. Some 1,200 persons 
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participated in the Conference, representing 
Governments, governmental and non-governmental 
organizations and other institutions from civil society. 
Some of the themes covered at the Conference were 
the provision of training to raise awareness of 
HIV/AIDS, HIV prevention and HIV/AIDS in prisons 
in Central Asia and Eastern Europe. 
648. Representatives of 29 countries participated in 
the Seventh Meeting of Heads of National Drug Law 
Enforcement Agencies, Europe, held in Vienna in June 
2007. The participants examined the current situation 
with respect to regional and subregional cooperation 
aimed at countering drug trafficking and adopted 
recommendations relating to cocaine trafficking in 
Europe, transnational law enforcement investigation 
techniques, criminal groups operating illicit drug 
trafficking networks within Europe and money-
laundering.  
649. The Collaborative Harmonised Amphetamine 
Initiative on amphetamine profiling has been launched 
in the European Union. This initiative aims at 
identifying links between seizures and criminal groups 
through forensic profiling of ATS in different 
laboratories in various member States of the European 
Union. 
650. The customs authorities of the Russian Federation 
regularly participate in the joint international operation 
“Baltic Strike”, aimed at detecting and closing routes 
used for smuggling cocaine on cargo ships travelling 
from Latin American countries to the Russian 
Federation and other countries in Europe. The partners 
of the Russian Federation in the operation are the law 
enforcement and customs authorities of Germany, 
Latvia, Lithuania, Sweden, the United Kingdom and 
the United States. 
651. The Russian Federation, together with Armenia, 
Belarus, Kazakhstan, Kyrgyzstan and Tajikistan, 
participated in several large-scale interdiction 
operations called “Channel” between 2003 and 2006. 
The main goal of the operations was to build an 
enhanced system of collective security to prevent drug 
trafficking in drugs from Afghanistan. The operations 
resulted in substantial seizures of drugs, including 
774 kg of heroin in 2006. 
 
  National legislation, policy and action 
 
652. Results of a Eurobarometer survey published in 
January 2007 indicate that the majority of young 
people in Europe are against the legalization of 
cannabis use. Only one quarter of the citizens of 
European Union member States agree that personal 
consumption of cannabis should be legalized 
throughout Europe, while more than two thirds (68 per 
cent) disagree. 57 per cent of respondents aged 15 to 
24 years expressed their opposition to the legalization 
of personal use of cannabis. It must be noted, however, 
that opinions varied from country to country. In 
Finland (8 per cent), Romania (9 per cent) and Sweden 
(9 per cent), the idea of legalizing personal use of 
cannabis was strongly rejected, whereas 40 per cent of 
respondents in Spain and 49 per cent of respondents in 
the Netherlands felt that personal use of cannabis 
should be legalized throughout Europe. 
653. A report by the European Commission published 
in April 2007 shows that programmes for the exchange 
of needles and syringes are available to drug abusers in 
24 European Union member States; in 15 of those 
member States, such programmes are available 
nationwide. Programmes using methadone and 
buprenorphine for substitution treatments are available 
in all European Union member States, and the 
availability of such programmes has increased over the 
past decade. 
654. UNODC continues to support law enforcement 
operations in Europe. In Albania, UNODC provided in 
2007 examination facilities at the border crossing at 
Qafe Thane, a primary gateway between Albania and 
the former Yugoslav Republic of Macedonia. The new 
refurbished vehicle examination facility at the border 
crossing at Qafe Thane was opened on 26 June 2007.  
655. In March 2007, regulations for drug substitution 
treatment were strengthened in Austria with a view to, 
among other things, limiting the diversion of slow-
release morphine into illicit channels. The number of 
people registered for drug substitution treatment in 
Austria increased continuously in the 10-year period 
1996-2005, from 2,941 to 7,554. The rise in the 
number of drug abusers undergoing substitution 
treatment reflects both an increase in the availability of 
treatment and a possible increase in the abuse of 
opiates. 
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656. In 2006, the Government of Belarus approved its 
national programme against crime for the period 2006-
2010, which includes programmes for the prevention of 
drug abuse and the rehabilitation of drug abusers. 
Under the new national programme, the State Security 
Committee, the State Customs Committee and the 
Ministry of Internal Affairs, the Ministry of Public 
Health and the Ministry of Foreign Affairs will conduct 
their own activities against trafficking in narcotic drugs 
and psychotropic substances. 
657. In Bulgaria, UNODC supports a project aimed at 
strengthening the Anti-Drugs Intelligence Capacity of 
the National Customs Agency of Bulgaria. The project 
began in 2007. 
658. In France, the Ministry of Health adopted in 
November 2006 a plan for the treatment and prevention 
of all forms of addiction for the period 2007-2011. 
About 77 million euros will be spent annually for five 
years to strengthen and coordinate existing facilities 
and further increase resources for the prevention and 
treatment of not only addiction to drugs, but also 
addiction to tobacco, alcohol and gambling. 
659. In Greece, the National Strategy on Drugs 2006-
2012 and the action plan on drugs for the period 2006-
2008 address both demand and supply reduction, with 
special emphasis on preventing and combating 
organized crime. The main goals of the Strategy 
include improving the effectiveness of demand 
reduction activities, increasing access to treatment for 
drug dependence, decreasing drug-related deaths and 
developing alternatives to imprisonment for drug-
dependent offenders. The action plan on drugs sets out 
measures to be taken to achieve the objectives of the 
Strategy.  
660. In Ireland, the Criminal Justice Act 2007 was 
signed into law by the President in May 2007. The Act 
contains a number of changes to the criminal justice 
system, including increased detention powers for the 
Irish police and the introduction of mandatory 
sentencing for a range of offences. Many of the 
changes have been introduced in the context of 
growing concern about drug-related crime.  
661. The Board notes the publication in March 2007 of 
the results of the first survey of prevalence of the use 
of sedatives, tranquillizers and anti-depressants in the 
period 2002-2003 in the Republic of Ireland and 
Northern Ireland of the United Kingdom. The survey 
found that the lifetime prevalence rate of persons 
aged 35-64 (16 per cent) was double that of persons 
aged 15-34 years (8 per cent). A higher prevalence rate 
was found among female respondents than among male 
respondents. In addition, the survey found correlations 
between various indicators of deprivation and higher 
prevalence rates. 
662. In May 2007, the Government of the Netherlands 
submitted to the lower house of Parliament a document 
on the continuation of the policy on synthetic drugs. 
The policy focuses on tighter law enforcement of the 
trade in and production of synthetic drugs, a vigorous 
prevention and information policy and closer 
international cooperation. The policy targets the entire 
chain of criminal activities, starting from the 
production of raw materials to trading in the end 
product. The policy was introduced in 2001; in the 
five-year period that followed, more than 20 million 
tablets of MDMA and thousands of litres of precursors 
were seized by law enforcement agencies in the 
Netherlands. The Government has reported that the 
illicit manufacture of ATS in the Netherlands appears 
to have decreased. 
663. In October 2007, a State Drug Control Committee 
on Additional Measures to Counter Illicit Trade in 
Narcotic Drugs, Psychotropic Substances and 
Precursor Chemicals was established by Presidential 
Decree in the Russian Federation. While the Federal 
Drug Control Service maintains its responsibility of 
coordinating law enforcement activities against illicit 
drug trafficking, the Committee has the mandate to 
monitor and coordinate the decision-making process 
and implementation of executing agencies at all levels 
of the Government. 
664. In the Russian Federation, the Government is 
considering drafting legislation on compulsory 
treatment for drug addicts. The Federal Drug Control 
Service expects that, once adopted, the new law will 
lead to the establishment of special medical centres 
where drug addicts will undergo treatment on the basis 
of a court decision. 
665. In Spain, the number of indictments for 
possession and use of drugs in public places has 
increased steadily since 1997, virtually tripling from 
1996 to 2004. In 2006, there was a record number of 
218,656 indictments, exceeding the total for the 
previous year by 26.3 per cent. Indictments for 
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possession or use of cannabis accounted for more than 
three quarters (77.32 per cent) of the total for 2006. 
666. In June 2007, an action plan against cocaine for 
the period 2007-2010 was introduced by the Minister 
for Health of Spain. The plan is being implemented as 
a response to the significant increase in cocaine abuse 
in that country. Over the past few years, annual 
prevalence of cocaine abuse in Spain has quadrupled 
among teenagers and has doubled among the general 
population. The action plan is aimed at, inter alia, 
reducing cocaine abuse, increasing awareness of the 
risks associated with cocaine abuse and improving 
assistance provided to cocaine abusers. One of the 
central elements of the plan is to dispel wrong 
perceptions about cocaine and to raise awareness of the 
dangers of cocaine abuse. Implementation of the plan 
has already started. The annual cost of the plan is 
estimated at about 7 million euros. 
667. In Sweden, the national action plan on narcotic 
drugs for the period 2006-2010 emphasizes the need to 
identify political priorities and mobilize local resources 
in order to deal with drug-related issues, and it 
underscores the fact that it is important to maintain a 
balance between efforts to reduce both the supply of 
and demand for drugs. The national action plan also 
highlights the importance of involving children and 
their parents in drug abuse prevention activities. 
Surveys carried out by the Swedish National Institute 
of Public Health show that Sweden is one of the 
countries with the lowest lifetime and monthly 
prevalence rates in Europe. 
668. In the United Kingdom, the largest ever public 
consultation on the national drug control strategy was 
launched in July 2007. The consultation is aimed at 
stimulating fresh and constructive ideas on how best to 
reduce the harm caused by drugs. The Government has 
requested the Advisory Council on the Misuse of Drugs 
to review the classification of cannabis, which was 
downgraded some years ago, and to examine national 
policies regarding cannabis in the light of the 
increasing potency of the drug. The consultation 
process will include a series of workshops and events 
in communities, inviting families and current and 
former drug abusers to discuss ways in which the harm 
caused by drug abuse can be reduced further. In 
addition, the Government plans to distribute 
200,000  leaflets about the consultation to police 
stations, libraries and community groups throughout 
the country, in order to spread the word and involve 
people further in what should be a national discussion. 
669. In July 2007, in the United Kingdom, the All 
Party Parliamentary Group on Drug Misuse, a cross-
party group of parliamentarians, launched an inquiry 
into the scale and nature of the abuse of prescription 
and over-the-counter drugs. The inquiry will include an 
in-depth study of an area of drug abuse that is often 
unrecognized, although it affects a large number of 
people. The findings of the inquiry will be published in 
a report in 2008. 
670. In the United Kingdom, an action plan to reduce 
drug-related harm was published in May 2007. The 
action plan sets out the broad streams of action to be 
taken in England to enhance harm reduction activities 
in the area of treatment for drug abuse, with a view to 
reducing the number of drug-related deaths or blood-
borne virus infections among drug abusers. The 
approach to harm reduction combines work aimed 
directly at reducing the number of drug-related deaths 
and blood-borne virus infections with the wider goals 
of preventing drug abuse and encouraging stabilization 
in the treatment and support provided for drug abusers. 
Activities will include a health promotion campaign, 
improving delivery of services and surveillance-related 
activity such as improving the quality of available data 
on drug-related deaths and blood-borne infections. 
Activities will be supported by a dedicated funding 
programme of about 2 million pounds. The action plan 
will be delivered using an integrated approach at the 
national, subnational and local levels. 
 
  Cultivation, production, manufacture, 
trafficking and abuse 
 
  Narcotic drugs 
 
671. Cannabis remains the most prevalent drug in 
Europe. In addition, the region is the largest market in 
the world for cannabis resin. Cultivation of cannabis 
plants is reported in many countries in Western Europe. 
Some 2,000 kg of cannabis grown in the Netherlands 
(“Nederwiet”) were seized in that country in 2005. 
According to the Federal Criminal Police Office 
(BKA) of Germany, the illicit cultivation of cannabis 
plants in professionally equipped indoor sites is 
gaining importance in Germany, where the number of 
confiscated cannabis plants has increased since 2002. 
While initially, the area of Germany near its border 
with the Netherlands played a dominant role, the 
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phenomenon of indoor cultivation of cannabis plants 
appears to have spread to other areas. The Federal 
Police of Belgium reported an increase in seized 
cannabis plants, from 74,140 seized plants in 2005 to 
107,249 in 2006. Cannabis is also cultivated in the 
United Kingdom but the extent of such cultivation is 
unknown.  
672. The illicit cultivation of cannabis plants has also 
been reported in Bulgaria. About one half of the 
cannabis illicitly produced in Bulgaria is destined for 
the illicit market in that country. Polish authorities 
have reported the illicit cultivation of cannabis plants 
in central, south-eastern and western Poland, hidden in 
grain fields, in gardens and in greenhouses; about 
45  per cent of the cannabis produced locally is 
exported, mainly to Western Europe. Albania continues 
to be a major exporter of cannabis. Albanian cannabis 
is smuggled by road through the former Yugoslav 
Republic of Macedonia and Bulgaria to Turkey, as well 
as to Croatia, Bosnia and Herzegovina, Serbia, 
Montenegro, Slovenia and countries in Western 
Europe. 
673. The quantity of cannabis resin seized in Europe 
has decreased, a development that may be linked to a 
decline in cannabis resin production in Morocco. In 
Spain, the country that seizes by far the most cannabis 
resin in the world, the quantity of seized cannabis resin 
declined by 31 per cent from 2005 (669 tons) to 2006 
(459 tons). The drop in seized cannabis resin was even 
more marked in Portugal (70 per cent), where 8 tons 
were seized in 2006, compared with 28 tons in 2005. A 
lower volume of seized cannabis resin was also 
reported in France. In Belgium, however, the Federal 
Police reported a single seizure of 45 tons of cannabis 
resin in February 2007. 
674. According to the French Monitoring Centre for 
Drugs and Drug Addiction (OFDT), cannabis use in 
France has seen a general increase over the past 
15 years. More 18- to 25-year-olds are currently using 
cannabis on a monthly basis than was the case in 2002. 
In addition, the regular use of cannabis (at least 
10 times in the preceding 30 days) saw a significant 
increase from 2000 to 2005 (from 1.7 to 2.7 per cent) 
among persons aged 18 to 64, both men and women. In 
Germany, however, the regular use of cannabis among 
18- and 19-year-olds declined from 6.4 per cent in 
1993 to 4.3 per cent in 2007. 
675. In the UNODC publication World Drug Report 
2007,94 it is noted that Italy and Spain have the highest 
annual prevalence rate for cannabis use in Western 
Europe. Annual prevalence of cannabis use among 
youth and adults in Italy has increased steadily, from 
6.2 per cent in 2001 to 7.1 per cent in 2003 and 
11.2 per cent in 2005. In Spain, however, cannabis use 
remained almost unchanged between 2003 (11.3 per 
cent) and 2005 (11.2 per cent). 
676. In the United Kingdom, both the annual and 
monthly prevalence rates for cannabis are dropping in 
England and Wales. The annual prevalence rate for 
cannabis use among persons aged 16-59 fell from 
10.3 per cent in 1998 to 8.7 per cent in the 
period  2005-2006 and the monthly prevalence rate 
declined from 6.1 per cent to 5.2 per cent over the 
same period. The lowest annual prevalence rates for 
cannabis are reported from Malta, Romania, Bulgaria 
and Greece.  
677. Europe remains the second most common 
destination for cocaine consignments. Already in 2005, 
the quantity of cocaine seized in the region reached an 
all-time high of almost 107 tons, an increase of 48 per 
cent compared with 2004. In 2006, that figure 
increased even further and the trend appears to have 
continued throughout 2007. The quantity of seized 
cocaine has increased significantly in many parts of the 
region. In Spain, the country in which most of the 
cocaine in Europe is seized, the volume of cocaine 
seizures increased (by 2.52 per cent) to 49.6 tons in 
2006. In Portugal, seizures of cocaine increased 
significantly, from 18 tons in 2005 to 34 tons in 2006; 
as a result, Portugal is currently considered to be a 
major European gateway for cocaine. In Ireland, 
cocaine seizures also rose considerably from 2002 to 
2006, from only 17 kg to about 270 kg. The quantity of 
cocaine seized in Germany increased by 59 per cent 
from 2005 (1,079 kg) to 2006 (1,717 kg). Cocaine 
seizures in Switzerland increased significantly (by 
25 per cent) in 2006, to 354 kg, compared with 2005 
(283 kg). Increased cocaine seizures were also reported 
in Finland in 2006, while cocaine seizures declined in 
Austria. 
678. The abuse of “crack” cocaine continues to be 
marginal in all countries in Western Europe, with the 
possible exception of the United Kingdom. Less than 
__________________ 
 94 United Nations publication, Sales No. E.07.XI.5. 
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4 kg of “crack” were seized in Germany in 2006. 
About 98 per cent of the total quantity seized was 
confiscated in Hamburg and Hessen. The cities of 
Hamburg and Frankfurt are used as focal points for the 
traffic in “crack” in Germany. 
679. Over the past few years, cocaine abuse has 
significantly increased in Western and South-Eastern 
Europe and remained stable in Central and Eastern 
Europe. The highest annual prevalence rates for 
cocaine abuse are in Spain (3 per cent), the United 
Kingdom (2.4 per cent) and Italy (2.1 per cent).95 In 
Spain, cocaine abuse has increased significantly over 
the period 1995-2005. According to a household survey 
conducted in Spain in the period 2005-2006, the annual 
prevalence rate for the abuse of cocaine powder among 
the general population increased from 1.8 per cent in 
1995 to 3 per cent in 2005; and the annual prevalence 
for cocaine abuse among minors quadrupled from 1994 
(1.8 percent) to 2004 (7.2 per cent). The Government 
of Spain has taken action to address the problem.  
680. In the United Kingdom, the abuse of cocaine 
powder in England and Wales increased from 2.0 per 
cent in the period 2004-2005 to 2.4 per cent in the 
period 2005-2006. There were 421 drug-related deaths 
in Scotland in 2006, 85 (25 per cent) more than in 
2005. In Italy, the annual prevalence rate for cocaine 
abuse among youth and adults increased steadily from 
1.1 per cent in 2001 to 1.2 per cent in 2003 and 2.1 per 
cent in 2005, reaching a level well above the European 
average of 0.8 per cent. The countries in Western 
Europe with the lowest annual prevalence rates for 
cocaine abuse are Greece (0.1 per cent) and Sweden 
(0.2 per cent). 
681. Virtually all of the heroin on the illicit drug 
markets in Europe originates in Afghanistan. Due to its 
geographical location, Turkey continues to be used as 
the main corridor for heroin consignments destined for 
Europe, serving as a starting point for the Balkan route. 
In addition, heroin continues to be smuggled along the 
so-called “silk route” through Central Asia into the 
Russian Federation, where it is abused locally or 
transported further to European Union member States. 
Heroin is also smuggled along a southern route leading 
__________________ 
 95 The data for the various countries are for different years 
and therefore may not necessarily be comparable in all 
cases. 
from Afghanistan to Pakistan and from there, by air or 
sea, to Europe. 
682. In most countries in Western Europe, the quantity 
of heroin seizures appears to have declined. In 
Portugal, for example, the quantity of seized heroin 
declined by 21 per cent from 2005 (182 kg) to 2006 
(144 kg). In Switzerland, heroin seizures decreased by 
10 per cent from 2005 (256 kg) to 2006 (231 kg). In 
Spain, 471 kg of heroin were seized in 2006, 
representing a significant increase compared with 2002 
(71.57 per cent) and 2005 (170.74 per cent). Increasing 
heroin seizures were also reported in Germany, where 
879 kg of heroin were seized in 2006, 12 per cent more 
than in 2005 (787 kg). 
683. The total number of heroin abusers in Europe is 
estimated at 3.3 million people. Heroin abuse has 
remained largely stable or even declined in Western 
and Central Europe. In France, for example, lifetime 
prevalence of heroin abuse among persons aged 18-44 
remained stable between 1995 and 2005, at 
approximately 1 per cent. In Germany, the number of 
problematic heroin abusers ranges between 78,000 and 
158,000. Heroin is increasingly being smoked in 
Germany. Increasing abuse of opiates has been 
reported in countries in Eastern Europe, particularly in 
member States of the Commonwealth of Independent 
States (CIS) and in countries in South-Eastern Europe 
situated along the Balkan route. In Eastern Europe, 
the   number of heroin abusers is estimated at 
about 1.75 million, or 1.2 per cent of the population  
aged 15-64. 
684. According to the Government of the Russian 
Federation, the total number of registered drug abusers 
was 350,267 as of 1 January 2007. The majority of 
drug abusers (87.7 percent) abuse opiates. In 2006, 
from the total number of patients in treatment for drug 
abuse, 12 percent were infected with HIV. Drug abuse 
by injection continues to be the main route of 
transmission of HIV infection in the Russian 
Federation.  
 
  Psychotropic substances 
 
685. Europe continues to be a major source of 
amphetamines. In Western Europe, the country with the 
highest volume of seizures of amphetamines is the 
Netherlands, followed by the United Kingdom and 
Germany. Seizures of amphetamines have increased 
steadily in Germany; in 2006, they increased by 8 per 
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cent, totalling 723 kg. ATS are also manufactured in 
the Russian Federation, as evidenced by the fact that in 
2006 Russian authorities detected 1,700 facilities used 
to illicitly manufacture synthetic drugs, including 136 
chemical laboratories. 
686. Seizures of MDMA appear to be on the decline in 
Europe. In Spain, the amount of MDMA seized in 2006 
was 16 per cent less than in 2005 and 66 per cent less 
than in 2002, when the amount reached a peak. A total 
of 481,583 units of MDMA were seized in Spain in 
2006, compared with 572,871 units in 2005. In 
Germany, the amount of seized MDMA decreased by 
32 per cent between 2005 and 2006. 
687. Of the seized MDMA tablets for which the origin 
or transit route could be established, by far the largest 
portion came from the Netherlands. As in the case of 
amphetamine, many of the MDMA tablets were on 
their way to Southern and Eastern Europe when they 
were seized. 
688. In the United Kingdom, the largest amphetamine 
market in Europe, annual prevalence of amphetamine 
abuse among the general population has been declining 
steadily since 2000, reflecting intensified prevention 
efforts and supply reduction measures. In Western 
Europe, the abuse of MDMA is highest in an area in 
the United Kingdom (Northern Ireland), where the 
annual prevalence rate is 1.6 per cent; however, that 
rate has declined by 46 per cent since 2000. MDMA 
abuse has also reportedly declined elsewhere in the 
United Kingdom (in England and Wales), as well as in 
Spain. 
 
  Missions 
 
689. A mission of the Board visited Albania in 
November 2007. The Board notes that there has been 
some improvement in the political will and 
commitment of the Government to the objectives of the 
international drug control treaties. The Government’s 
efforts to address the drug problem in the country have 
shown progress and its cooperation with the Board has 
improved since the 2002 mission of the Board to that 
country. The Board notes that Albania has taken some 
steps in recent years to strengthen its drug control 
efforts, but a number of problems continue to exist in 
that area. A national drug control strategy covering the 
period 2004-2010 has been drafted, but its status 
remains unclear. 
690. Over the past few years, Albania has emerged as 
an important segment of the Balkan route. The Board 
notes the efforts made by the Government in 
combating illicit drug production and trafficking. 
However, the Board is concerned that, despite 
successful law enforcement efforts, such as the recent 
moratorium on speedboat traffic along the Albanian 
coast, drug trafficking organizations remain powerful 
and continue to impede drug control efforts in Albania 
and in other countries in Europe. The Board urges the 
Government to curb the influence and activities of 
criminal organizations, including those run by 
Albanian nationals, and to fight corruption at all levels. 
The Board recommends that the Government further 
strengthen its efforts to eliminate the cultivation of 
cannabis plants and drug trafficking in the region.  
691. The Board encourages the competent national 
authorities of Albania to carry out, if necessary with 
assistance from WHO and UNODC, an assessment of 
the drug abuse situation in the country, in order to be 
able to plan and implement appropriate drug control 
measures and to provide a comprehensive drug abuse 
prevention and treatment programme. The Board urges 
the Government of Albania to take all steps necessary 
to enhance coordination and cooperation among 
institutions and agencies that are responsible for drug 
control and to establish and maintain an appropriate 
drug control mechanism in compliance with the 
requirements of the international drug control treaties.  
692. The Board sent a mission to Bosnia and 
Herzegovina in June 2007 to discuss with the 
Government the implementation of the international 
drug control treaties and comprehensive drug control 
legislation, in particular the law on the prevention and 
suppression of the abuse of narcotic drugs, adopted in 
that country in February 2006. The Board notes that 
measures to implement the new legislation have still 
not been adopted by the Government. In particular, the 
implementation of the provisions on creating a national 
inter-ministerial commission for drug control 
coordination, as well as a drug regulatory agency, as 
required under the new legislation, were pending. The 
Board is of the opinion that additional efforts in the 
area of demand reduction are necessary, particularly 
with regard to data collection, as there is currently no 
comprehensive, reliable information regarding the drug 
abuse situation in Bosnia and Herzegovina.  
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693. The Board encourages the Government of Bosnia 
and Herzegovina to implement the new drug control 
legislation without further delay. Such action would 
clarify the respective roles and responsibilities of 
various competent national authorities involved in the 
implementation of the international drug control 
treaties and would allow for effective cooperation with 
the Board, including the submission of reports, in 
accordance with the treaties. The Government is 
invited to create a drug regulatory agency, to prepare a 
comprehensive national strategy on drug abuse and to 
provide adequate resources and training to the 
competent national authorities involved in drug 
control. 
694. In November 2006, a mission of the Board visited 
Lithuania. The Board notes that the Government of 
Lithuania has shown the political commitment and the 
will to deal with drug abuse, drug trafficking and 
organized crime. Apart from the ministries responsible 
for specific areas of drug control, such as the ministries 
of the interior, health, justice, social security and 
education, drug control matters are also handled by the 
parliamentary drug addiction prevention commission. 
The drug control department directly under the 
Government of Lithuania is the main body responsible 
for the implementation of prevention and drug control 
policies. In addition, 60 municipal drug control 
commissions have been established. 
695. In addition to cannabis, the most widespread 
drugs of abuse in Lithuania are amphetamines and 
“ecstasy”. Significant drug abuse is reported to be 
taking place in nightclubs, discos and other 
recreational settings. The main drug problem in 
Lithuania is the increasing abuse of synthetic drugs. 
The illicit market is supplied by clandestine 
manufacture of amphetamines in the country, as well as 
by the smuggling of “ecstasy” into the country, mostly 
from the Netherlands. Amphetamines illicitly 
manufactured in Lithuania are smuggled into Norway 
and Sweden, as well as, more recently, Iceland. The 
Board notes the efforts by the Government to establish 
comprehensive treatment programmes for the treatment 
of drug abuse. 
696. Lithuanian authorities have reported a problem 
involving the use of prescription drugs. The drug 
control department estimates that about 20 per cent of 
the adult population is misusing or abusing 
prescription drugs. The smuggling of flunitrazepam by 
Lithuanian organized criminal groups into 
Scandinavian countries continues. As the diversion of 
flunitrazepam from licit markets has been closed down, 
genuine flunitrazepam tablets have been replaced by 
counterfeit flunitrazepam smuggled through Lithuania. 
With regard to trafficking in precursors, Lithuanian law 
enforcement officers seized significant amounts of 
precursors in 2006, most of which had been smuggled 
out of Belarus and Ukraine (PMK and BMK) and 
destined to be used in the illicit manufacture of 
amphetamines in Lithuania or to be smuggled into 
other countries for the illicit manufacture of MDMA 
(“ecstasy”). The Board recognizes the importance of 
collaboration among neighbouring countries in 
counteracting drug trafficking and the smuggling of 
precursors. 
697. The Board sent a mission to the United Kingdom 
in October 2007, to discuss with the Government, inter 
alia, cooperation in maintaining a global balance 
between the licit supply of and demand for opiate raw 
materials. The mission also examined with the 
authorities steps to be taken to ensure full reporting to 
the Board by the United Kingdom on narcotic drugs 
and psychotropic substances, in accordance with the 
international drug control treaties. The Board trusts 
that the Government will strengthen the human 
resources of the Home Office responsible for collecting 
data and furnishing statistical information to the Board. 
The Government should also ensure adequate 
functioning of the inspection system for licit activities 
with narcotic drugs and psychotropic substances. 
698. The Board welcomes the strong commitment of 
the Government to address the drug problem through 
comprehensive measures against drug abuse and illicit 
drug trafficking. The Government will announce its 
new drug control strategy in early 2008. The Board 
notes that the Government puts major emphasis on the 
prevention of drug abuse and the provision of 
treatment for young drug abusers. The drug control 
policy of the United Kingdom includes harm reduction 
activities. The Board appreciates the commitment of 
the Government to ensuring that such activities are in 
line with the provisions of the international drug 
control treaties and that no facilities where drug 
abusers could abuse with impunity drugs acquired on 
the illicit market would be allowed to operate in the 
United Kingdom.  
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699. The Board notes the vigorous actions taken by the 
law enforcement authorities of the United Kingdom to 
prevent illicit trafficking in narcotic drugs and 
psychotropic substances. The Serious Organised Crime 
Agency, which became operational in 2006, 
endeavours to apply an intelligence-led, holistic 
approach to tackling all forms of organized crime, 
including drug trafficking. The Board invites the 
Government of the United Kingdom to share 
experiences from the work of the Agency with other 
Governments, the Board and relevant international 
organizations. 
700. The United Kingdom participates in the efforts of 
the international community to stop the flow of 
precursors, in particular acetic anhydride, to 
Afghanistan. The Board invites the Government to 
share pertinent information with the Board and to 
support the relevant international initiatives, such as 
the activities under Project Cohesion. 
 
 
 E. Oceania 
 
 
  Major developments 
 
701. The clandestine manufacture of ATS, including 
methamphetamine, continues in Oceania. The island 
States in Oceania, because of their geographical 
remoteness, porous maritime borders and relatively 
weak control measures, are extremely vulnerable to 
exploitation by drug traffickers. In addition, as 
transportation links to Asia, North America and South 
America expand, the countries in Oceania are 
increasingly being used as trans-shipment areas for the 
smuggling of ATS and other illicit drugs of abuse. 
Recent seizures of pseudoephedrine and ephedrine, 
precursor chemicals frequently used in the illicit 
manufacture of ATS, suggest that criminals may be 
turning to smuggling pharmaceutical preparations 
containing precursor chemicals for use in the 
clandestine manufacture of ATS in the region, 
particularly in Australia and New Zealand. The postal 
systems of countries in the region are increasingly 
being used to smuggle psychotropic substances in 
particular and, to a lesser extent, precursor chemicals. 
Trafficking in substances not under international 
control, such as GBL and ketamine, continues to be a 
problem in the region. 
702. The prevalence of abuse of cannabis and ATS in 
Oceania continues to rate among the highest in the 
world, and cannabis continues to be the most abused 
drug in the region. Abuse of cannabis is particularly 
prevalent in Australia, Micronesia (Federated States 
of), New Zealand and Papua New Guinea. A high rate 
of abuse of ATS was reported in countries of the 
region, including Australia and New Zealand. 
 
  Regional cooperation 
 
703. Australia and New Zealand continue to provide 
other countries in Oceania with technical assistance to 
enhance border security. The two countries support the 
Pacific Regional Policing Initiative, which aims to 
improve the effectiveness of policing in small island 
States in Oceania so that they can contribute more to 
regional security. Australian law enforcement 
authorities provided training on the detection, 
dismantling and disruption of syndicates engaged in 
organized transnational crime to police, customs and 
immigration officers from Kiribati, Papua New Guinea, 
Samoa, Tonga and Vanuatu in Apia, Samoa, in 
June  2007. New Zealand, as part of the steering 
committee, has continued to assist in the development 
and promotion of the Customs Asia Pacific 
Enforcement Reporting System, a regional customs 
reporting system and database. Australia launched the 
South Pacific Precursor Control Forum, a regional 
initiative aimed at strengthening cooperation in 
responding to issues related to the diversion of 
precursors and the manufacture of ATS. The Forum, 
which comprises 13 members (countries and regional 
organizations), held a meeting in Sydney, Australia, in 
February 2007 to discuss a strategic plan for the 
region. 
704. In October 2006, law enforcement authorities of 
New Zealand worked with Australian authorities to 
uncover a regional smuggling syndicate, purportedly 
involved in smuggling cocaine from South America 
through New Zealand into Australia. The teamwork 
began in June 2006, when more than 18 kg of cocaine 
were found hidden in a sea cargo shipment destined for 
Australia. In September 2006, authorities in New 
Zealand found another 8 kg of cocaine hidden in a sea 
cargo shipment bound for Australia. Those seizures 
resulted in the identification and arrest of members of 
the syndicate in Australia. 
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  National legislation, policy and action 
 
705. Australia has further strengthened its legislation 
to combat the illicit manufacture of controlled 
substances. In June 2006, the Drug Misuse and 
Trafficking Amendment (Hydroponic Cultivation) Act 
2006 of New South Wales, Australia, made it an 
offence to expose children under the age of 16 to the 
manufacture of illicit drugs or to substances being 
stored for use in such manufacture. In November 2006, 
the Parliament of New South Wales criminalized the 
possession of tabletting machines for the manufacture 
of MDMA under the Crimes and Courts Legislation 
Amendment Act 2006. Similar legislation was 
approved by the Parliament of Queensland in April 
2006 and the Parliament of Victoria in August 2006. 
The Board encourages the other states of Australia to 
review existing legislation and strengthen it, as 
necessary. 
706. In September 2006, the Drug Misuse and 
Trafficking Regulation 2006 of New South Wales 
amended the existing legislation to allow persons who 
abuse drugs by injection to be supplied with sterile 
hypodermic syringes and associated equipment in order 
to prevent the spread of contagious diseases and 
minimize health risks associated with drug abuse by 
injection. The revised regulation also provides for the 
dissemination of information concerning hygienic 
practices in the use of hypodermic syringes to prevent 
the spread of contagious diseases. The Board calls on 
Australia to ensure that such activities are carried out 
in compliance with the provisions of the international 
drug control conventions. 
707. The Drug Misuse and Trafficking Regulation 
2006 of New South Wales gave greater powers to 
police to monitor the diversion of precursor chemicals 
and take action against individuals and companies that 
are not complying with relevant regulations. 
708. In December 2006, the Parliament of New South 
Wales amended existing legislation on the prescription 
of internationally controlled substances. The Poisons 
and Therapeutic Goods Amendment Regulation 2006 
enables the Director-General of the Department of 
Health to allow for electronic prescriptions; enables 
pharmacists to supply restricted medications, including 
internationally controlled substances, to nursing homes 
for use in emergencies; and provides that doctors do 
not require authorization to prescribe buprenorphine if 
it is in the form of transdermal patches. 
709. Following the introduction of more restrictive 
national controls on pseudoephedrine in January 2006, 
Australia enacted further legislation to control the sale 
of that substance. Since April 2006, all medications 
containing pseudoephedrine, such as liquid 
formulations containing more than 800 milligrams of 
pseudoephedrine, and all combination and single 
ingredient products, such as capsules and tablets 
containing more than 720 mg of pseudoephedrine, have 
been rescheduled and can be sold only with a doctor’s 
prescription. 
710. In Australia, the State of Queensland introduced 
in 2006 Project Stop, an online intelligence and sales 
monitoring system. The system enables real-time 
monitoring of sales of pseudoephedrine-based 
medications at retail pharmacy outlets. It helps 
pharmacists to determine, on the basis of recent 
purchases, whether a customer has a legitimate medical 
need for the medication being sought, in addition to 
providing police with intelligence on illicit activities. 
The database, which is currently being used 
successfully in Queensland, will be implemented at the 
national level in 2007. The Board appreciates the 
initiative taken in Queensland and encourages other 
states in Australia to implement the system. 
711. In 2006, the Australian Customs Service opened 
an improved postal screening facility in Melbourne. 
The facility screens all international mail for illicit 
goods, including drugs, using a combination of X-ray 
machines, detector dogs and physical examination.  
712. Other countries in the region have introduced 
additional control measures. In August 2006, the 
Senate of Palau passed a law requiring all elected 
officials to undergo testing for the abuse of illicit 
drugs. 
 
  Cultivation, production, manufacture, 
trafficking and abuse 
 
  Narcotic drugs 
 
713. Cannabis is illicitly cultivated throughout 
Oceania. Although some cannabis from the highlands 
in Papua New Guinea has been smuggled into Australia 
and cannabis seeds have been purchased online from 
the Netherlands through the postal system, most of the 
cannabis found in Australia continues to be from illicit 
cultivation sites in the country. The illicit cultivation of 
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cannabis also continues to be widespread in New 
Zealand. 
714. In Fiji, law enforcement authorities have been 
engaging local communities in the fight against drugs. 
In 2006, several areas of Fiji joined an ongoing effort 
to eradicate the illicit cultivation of cannabis plants. In 
two earlier operations in 2003, law enforcement 
authorities had worked with local communities to 
destroy 6,280 cannabis plants. 
715. In the period 2005-2006, Australian customs 
authorities seized more than 47 kg of cannabis, most of 
which had originated in Papua New Guinea and, to a 
lesser extent, in Canada and the United States. That 
represents a considerable increase compared with the 
total of less than 5 kg seized in the period 2004-2005. 
Most seizures of cannabis in Australia involved small 
quantities of the drug. 
716. South-East Asia remains the main source of the 
heroin that is smuggled into Australia, and demand for 
heroin remained stable in 2006, at a level significantly 
lower than the levels reported prior to 2001. The most 
common method of smuggling heroin into Australia is 
using air couriers from Cambodia and Viet Nam. 
However, in April and May 2006, almost 8 kg of heroin 
from India were intercepted in the postal system in 
164 envelopes, each containing a small quantity of the 
drug. In 2006, four clandestine laboratories used for 
the illicit manufacture of heroin were dismantled in 
Australia, and eight clandestine laboratories used to 
extract morphine from opium poppy seeds were 
dismantled in New Zealand. 
717. In March 2007, Australian law enforcement 
authorities in Sydney seized 141 kg of cocaine that had 
been concealed in an airfreight shipment originating in 
the Hong Kong SAR of China; that was the fifth largest 
seizure of cocaine ever made in Australia. In December 
2006, authorities in New Zealand seized at Auckland 
International Airport approximately 4 kg of cocaine 
from South America; the cocaine was purportedly 
being shipped to Australia via the Cook Islands. 
718. Cannabis remains the most abused drug in 
countries in Oceania, in particular in Australia and 
New Zealand, and the level of cannabis abuse is 
particularly high in Micronesia (Federated States of) 
and Papua New Guinea, each of which has a rate of 
abuse of over 29 per cent. In Australia, however, the 
annual prevalence rate for cannabis abuse decreased by 
37 per cent between 1998 and 2004; currently, 11 per 
cent of the population aged 14 years and older abuse 
cannabis. No significant increase in cannabis abuse has 
been observed in Australia in recent years. 
 
  Psychotropic substances 
 
719. In Australia, the supply of ATS is dominated by 
clandestine manufacture within the country, most of 
which appears to be based in Queensland. Australian 
authorities have linked motorcycle gangs to the illicit 
manufacture of ATS in several states, including New 
South Wales and Queensland. During the period 2005-
2006, 280 clandestine laboratories used for the illicit 
manufacture of ATS were dismantled in Australia. In 
New Zealand, 211 clandestine laboratories purportedly 
used in the illicit manufacture of methamphetamine 
were dismantled in 2006. The number of laboratories 
dismantled in New Zealand has increased for three 
consecutive years, 2006 being the year with the highest 
number ever. Most of the ATS tablets (excluding 
MDMA) that were smuggled into Australia and seized 
in the period 2005-2006 originated in the Netherlands 
and India. Methamphetamine imports originated 
mainly, in descending order, in Canada, the Hong Kong 
SAR of China, mainland China, the Netherlands, the 
United States, Japan, South Africa, Malaysia and 
Thailand. In 2006, 111 kg of methamphetamine were 
seized in New Zealand, 10 times more than the amount 
seized in 2005; most of the seized methamphetamine 
originated in China. 
720. In the period 2005-2006, seven laboratories 
involved in the illicit manufacture of MDMA were 
dismantled in Australia. The main methods used for 
smuggling MDMA into Australia continue to be misuse 
of the postal system and concealment in sea cargo 
shipments. The countries of origin of the seized 
MDMA included Belgium, Canada, France and the 
United Kingdom. In April 2007, law enforcement 
authorities in Sydney, Australia, seized 113 kg of 
MDMA concealed in a shipment of solar hot water 
systems originating in Israel. In 2006, 350 kg of 
MDMA were found in a shipping container of ink 
originating in Canada. 
721. More than 440 seizures of benzodiazepine-based 
sedatives and tranquillizers, most of which was 
detected in the postal system, were reported in 
Australia in the period 2005-2006. The countries of 
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origin included Argentina, India, Pakistan, the 
Philippines and Thailand. 
722. In 2007, the National Drug Law Enforcement 
Research Fund released the results of a study96 that it 
had conducted on the illicit drug markets in Australia, 
focusing on illicit markets for benzodiazepine and 
pharmaceutical preparations containing opioids, their 
abuse and their impact on crime. The study targeted 
three jurisdictions (Melbourne, Hobart and Darwin) in 
which there was evidence of illicit markets for 
prescription drugs. The study found that Melbourne 
appears to have illicit markets for benzodiazepines, 
buprenorphine and morphine. The emergence of those 
illicit markets may be partly attributable to the 
reduction in the supply of heroin, the main illicit drug 
of abuse in that city. The findings suggested that, in 
Hobart and Darwin, there were illicit drug markets, 
primarily for methadone and morphine. The study also 
found that the illicit markets for benzodiazepine and 
pharmaceutical opioids appeared to be supplied mainly 
by small-scale diversion from a number of sources, 
including legitimate prescriptions and forged 
prescriptions, rather than being supplied through theft 
from pharmacies or by diversion from wholesale and 
manufacturing locations, or by other sources such as 
Internet pharmacies and smuggling. The Board notes 
with concern the abuse of prescription pharmaceutical 
drugs in Australia and urges the Government to take 
the necessary steps to address the problem. 
723. The level of abuse of ATS in Australia and New 
Zealand is among the highest in the world. ATS 
continued to be the second most abused drug in 
Australia. New Zealand has reported a recent increase 
in the abuse of methamphetamine and MDMA. There 
is also evidence of the abuse of drugs, including ATS, 
in Fiji and Samoa. 
 
  Precursors 
 
724. In the period 2005-2006, 22 laboratories used for 
the illicit manufacture of precursor chemicals were 
dismantled in Australia, mostly in the state of South 
Australia.  
__________________ 
 96 Craig Fry and others, Benzodiazepine and 
Pharmaceutical Opioid Misuse and Their Relationship 
to Crime: an Examination of Illicit Prescription Drug 
Markets in Melbourne, Hobart and Darwin (Hobart, 
Tasmania, National Drug Law Enforcement Research 
Fund, 2007). 
725. Countries in Oceania continue to report 
significant seizures of pseudoephedrine and ephedrine, 
which are precursor chemicals frequently used in the 
illicit manufacture of ATS. In June 2006, Australia 
reported the seizure of over 2 million tablets 
containing a total of 120 kg of pseudoephedrine, in a 
sea cargo container originating in Indonesia. In 2006, 
seizures of ephedrine and pseudoephedrine continued 
to be reported in Australia. Many of the smuggling 
cases involved the use of the postal system. In May 
2006, 150 kg of pseudoephedrine were seized in New 
Zealand from shipping containers originating in China. 
In addition, several pharmaceutical preparations 
available without prescription and containing 
pseudoephedrine were seized in New Zealand in 
clandestine laboratories purportedly used for the illicit 
manufacture of methamphetamine. In April 2006, 7 kg 
of ephedrine were found in Australia in an air cargo 
shipment originating in South Africa. 
726. In April 2007, Australian law enforcement 
authorities seized in Melbourne 125 kg of phenylacetic 
acid, a precursor chemical frequently used in the illicit 
manufacture of amphetamine. That was among the 
largest seizures of the substance to date in Australia. 
 
  Substances not under international control 
 
727. In 2006, Australian customs authorities seized 
40  shipments of GBL, a precursor of GHB. The 
majority of the shipments were detected in the postal 
system, while a few were concealed in air cargo. For 
example, two consignments of GBL, each containing 
20 litres of the substance, were intercepted in Sydney 
in March 2006 after they had been hidden in air cargo 
from China; the countries of origin of the seized GBL 
included China, Japan, Singapore, South Africa, 
Thailand, the United Kingdom and the United States. 
In addition, eight seizures of ketamine were reported 
for the period 2005-2006, compared with three seizures 
in the period 2004-2005; all eight of the consignments 
of ketamine had been sent using the postal system. 
Countries in the region, including Australia and New 
Zealand, continued to report seizures of small 
quantities of khat in 2006. 
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 IV. Recommendations to Governments, the United Nations and other 
relevant international and regional organizations 
 
 
728. In exercising its mandate to monitor the 
application of the international drug control treaties, 
the Board, on an ongoing basis, examines the 
functioning of the international drug control regime at 
both the national and international levels and makes 
recommendations to Governments and international 
and regional organizations. In the present chapter, the 
Board highlights key recommendations. The Board 
invites all those concerned to examine the 
recommendations and to implement them, as 
appropriate. 
729. Governments and relevant organisations should 
keep the Board informed of the implementation of 
these and other recommendations, as well as 
developments in drug control in their respective 
jurisdictions. 
730. The Board reminds Governments and relevant 
organizations that the recommendations contained in 
chapter I of its annual reports are generally not 
included in chapter IV. The recommendations in both 
chapters should be considered for implementation, as 
appropriate. 
 
 
 A. Recommendations to Governments 
 
 
731. The recommendations to Governments are 
grouped according to the following subject areas: 
treaty adherence; treaty implementation and control 
measures; prevention of illicit drug trafficking and 
abuse; availability and rational use of narcotic drugs 
and psychotropic substances for medical purposes; the 
Internet and smuggling by postal and courier services; 
and smuggling and abuse of counterfeit preparations 
containing narcotic drugs and psychotropic substances. 
 
  Treaty adherence 
 
732. The international drug control treaties, namely 
the 1961 Convention, the 1961 Convention as amended 
by the 1972 Protocol, the 1971 Convention and the 
1988 Convention form the basis of the international 
drug control system. The accession of all States to 
those treaties is a fundamental prerequisite for 
effective drug control worldwide. 
  Recommendation 1: There are a few States 
which are not yet parties to one or more of the 
international drug control treaties. The Board 
reiterates its request to States that are not 
parties to the international drug control 
treaties to take the necessary action to accede 
to those treaties.97 
 
  Treaty implementation and control measures 
 
733. Universal treaty adherence will, however, not be 
sufficient without effective and universal 
implementation of all the provisions of the 
international drug control treaties and the application 
of the necessary control measures by all Governments. 
  Recommendation 2: Timely provision to the 
Board of information required under the 
international drug control conventions is one of 
the key elements of the international drug control 
mechanism. The Board reiterates its request to 
all Governments to furnish in a timely manner 
all statistical reports required under the 
conventions. All Governments are encouraged 
to seek from the Board any information that 
will help them in meeting their reporting 
obligations under the conventions. 
__________________ 
 97  The following States are not parties to the international 
drug control treaties and/or the 1972 Protocol amending 
the 1961 Convention: 
   (a) States not parties to the 1961 Convention as 
amended by the 1972 Protocol or to the 
1961 Convention in its unamended form: Cook Islands, 
Equatorial Guinea, Kiribati, Nauru, Samoa, Timor-Leste, 
Tuvalu and Vanuatu. 
   (b) States not parties to the 1972 Protocol 
amending the 1961 Convention: Afghanistan, Chad and 
Lao People’s Democratic Republic. 
   (c) States not parties to the Convention of 
1971: Cook Islands, Equatorial Guinea, Haiti, Kiribati, 
Liberia, Nauru, Samoa, Solomon Islands, Timor-Leste, 
Tuvalu and Vanuatu. 
   (d) States not parties to the 1988 Convention: 
Equatorial Guinea, Holy See, Kiribati, Marshall Islands, 
Namibia, Nauru, Palau, Papua New Guinea, Solomon 
Islands, Somalia, Timor-Leste and Tuvalu. 
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  Recommendation 3: In some countries, the 
delay in the submission of statistical data to the 
Board is partly the result of Governments 
providing insufficient resources to the authorities 
responsible for the collection and reporting of 
data on licit activities related to narcotic drugs, 
psychotropic substances and precursors. The 
Board urges all Governments to allocate 
adequate resources to their national competent 
authorities to meet their treaty obligations by 
submitting complete statistical data to the 
Board in a timely manner. 
  Recommendation 4: The system of control 
measures laid down in the 1961 Convention 
provides effective protection against attempts at 
the diversion of narcotic drugs from international 
trade into illicit channels. The Board urges all 
Governments to implement fully the system of 
estimates and export authorizations and to 
ensure that exports of narcotic drugs are not 
in excess of the total of the importing country’s 
estimates for those narcotic drugs. 
  Recommendation 5: For Governments that 
did not provide estimates for narcotic drugs for 
2008, the estimates have been established by the 
Board. The Board urges the Governments 
concerned to examine their requirements for 
narcotic drugs for 2008 and furnish their own 
estimates to the Board for confirmation, in 
order to prevent any possible difficulties in 
importing the quantities of narcotic drugs 
required for medical and scientific use in their 
countries.  
  Recommendation 6: In accordance with 
article 19, paragraph 3, of the 1961 Convention, 
Governments may submit supplementary 
estimates for narcotic drugs during the year for 
which the estimates apply. The Board requests 
all Governments to determine their annual 
estimates of requirements for narcotic drugs as 
accurately as possible, so that resort to 
supplementary estimates is reserved for 
unforeseen circumstances or when 
developments in medical treatment, including 
the use of new medications and scientific 
research, result in additional requirements for 
narcotic drugs. 
  Recommendation 7: The practice of 
chewing coca leaves continues in Bolivia and 
Peru. The countries in the region are suffering 
from the illicit manufacture of and trafficking in 
cocaine. The Board calls upon the 
Governments of Bolivia and Peru to initiate 
action without delay with a view to eliminating 
uses of coca leaf, including coca leaf chewing, 
that are contrary to the 1961 Convention. The 
Governments of those countries and Colombia 
should strengthen their efforts against the 
illicit manufacture of and trafficking in 
cocaine. The Board calls on the international 
community to provide assistance to those 
countries towards achieving those objectives.  
  Recommendation 8: The Commission on 
Narcotic Drugs decided in March 2007 to include 
oripavine in Schedule I of the 1961 Convention. 
That decision became effective on the date of 
receipt by each State party of the note verbale of 
the Secretary-General on this matter, dated 
27   June 2007. The Board requests all 
Governments to implement without delay the 
provisions of the 1961 Convention with respect 
to oripavine, including by complying with the 
system of estimates and providing statistical 
reports to the Board. 
  Recommendation 9: A number of 
Governments have for several years not updated 
the assessments of their requirements for 
psychotropic substances. Those earlier 
assessments may no longer reflect their actual 
medical and scientific requirements for 
psychotropic substances, as evidenced by the fact 
that several importing countries continue to issue 
import authorizations for psychotropic substances 
in absence or in excess of the corresponding 
assessments. The Board encourages all 
Governments to ensure that their assessments 
correspond to their actual legitimate needs and 
that no imports exceeding the assessments are 
authorized. 
  Recommendation 10: The system of import 
authorizations for all psychotropic substances has 
proved particularly effective in the identification 
of diversion attempts. The Board reiterates its 
request to all Governments that have not yet 
done so to introduce a system of import and 
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export authorizations for substances in 
Schedules III and IV of the 1971 Convention, 
in accordance with Economic and Social 
Council resolutions 1985/15, 1987/30, 1991/44, 
1993/38 of 27 July 1993 and 1996/30 of 24 July 
1996. 
  Recommendation 11: Diversions of 
psychotropic substances from international trade 
are often attempted using falsified import 
authorizations. The Board invites all 
Governments to continue to pay attention to 
the legitimacy of orders for psychotropic 
substances and, if necessary, to consult with 
the Governments of the importing countries on 
any suspect order prior to approving the 
exports. The Board encourages the national 
competent authorities of exporting countries to 
regularly check import orders against the 
assessments of the actual requirements for 
psychotropic substances of the relevant 
importing countries before authorizing the 
exports.  
  Recommendation 12: Information obtained 
in investigations into seizures or intercepted 
shipments of precursors is important for the 
identification of new trends in illicit drug 
manufacture and trafficking in precursors. The 
Board therefore calls upon all competent 
authorities effecting seizures or intercepting 
shipments of precursors to investigate those 
cases and to inform the Board of the results of 
those investigations. 
  Recommendation 13: The PEN Online 
system has facilitated communication among 
Governments and has been instrumental in 
identifying suspicious transactions and 
preventing diversion. The Board encourages all 
Governments that have not yet done so to 
register for and use the PEN Online system. 
  Recommendation 14: The annual legitimate 
requirements of ephedrine, pseudoephedrine, 
3,4-MDP-2-P and P-2-P have been published in 
the 200698 and 200799 reports of the Board on the 
__________________ 
 98  Precursors and Chemicals Frequently Used in the Illicit 
Manufacture of Narcotic Drugs and Psychotropic 
Substances: Report of the International Narcotics 
Control Board for 2006 …, annex V. 
implementation of article 12 of the 
1988 Convention. In addition, a table showing the 
reported annual legitimate requirements for 
substances frequently used in the manufacture of 
ATS is available on the website of the Board 
(www.incb.org); the table is updated regularly. 
The Board again requests all competent 
authorities to provide information on annual 
legitimate requirements of the above-
mentioned precursor chemicals, to review the 
reported information and to amend it as 
necessary. The Board also invites competent 
authorities to inform the Board of any 
methodologies that they have found useful for 
estimating their national requirements for 
those precursor chemicals.  
  Recommendation 15: Due to inadequate 
precursor control legislation and weaker 
monitoring and control mechanisms in many 
African countries, traffickers have been placing 
orders for precursor chemicals to be delivered to 
countries in Africa, from where the consignments 
are smuggled to the Americas. Moreover, the 
authorities of many African countries do not 
respond to pre-export notifications and to 
inquiries about the legitimacy of shipments of 
precursors in a timely manner. The Board urges 
the Governments of the African countries 
affected by such transit traffic to put in place, 
as a matter of priority, the necessary 
legislative and institutional framework to 
effectively combat the smuggling of precursors 
through their territory. In addition, 
Governments should allocate adequate 
resources for staff development to enable the 
competent authorities to perform their 
regulatory and enforcement roles efficiently. 
In particular, the Board calls on the 
Governments of all countries in Africa to 
strengthen their controls over the import of 
precursors of ATS and the movement of such 
precursors within their territory. Countries 
and territories exporting ephedrine and 
pseudoephedrine are urged to confirm the 
__________________ 
 99  Precursors and Chemicals Frequently Used in the Illicit 
Manufacture of Narcotic Drugs and Psychotropic 
Substances: Report of the International Narcotics 
Control Board for 2007 …, annex V. 
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legitimacy of shipments of ephedrine, 
pseudoephedrine or preparations containing 
those substances to any country before 
approving such shipments. 
  Recommendation 16: The problem of 
diversion of precursor chemicals from domestic 
distribution channels for smuggling to areas 
where drugs are illicitly manufactured continues 
to exist. In order to address the problem, the 
Board recommends that Governments should 
take additional measures to monitor more 
closely the manufacture and domestic 
distribution of precursor chemicals. 
  Recommendation 17: Activities undertaken 
within the framework of Project Prism have 
confirmed that, in most parts of the world, 
traffickers are increasingly trying to obtain large 
amounts of pharmaceutical preparations 
containing ephedrine or pseudoephedrine from 
licit trade at the national and international levels. 
The Board recommends that all Governments 
control pharmaceutical preparations 
containing ephedrine or pseudoephedrine the 
same way as they control the raw chemicals 
ephedrine and pseudoephedrine. At the very 
least, pre-export notifications for shipments of 
such preparations should be sent.  
  Recommendation 18: It is important that the 
Board is provided with detailed information on 
the use of non-scheduled substances in the illicit 
manufacture of ATS so that it may alert all 
relevant competent authorities of the latest trends 
in diversion and trafficking. The Board 
encourages Governments to put in place 
effective mechanisms for identifying and 
investigating suspicious transactions involving 
such non-scheduled substances.  
 
  Prevention of illicit drug trafficking and abuse  
 
734. One of the fundamental objectives of the 
international drug control treaties is to limit to 
legitimate purposes the production, manufacture, 
export, import and distribution of, trade in and use of 
controlled substances and to prevent their diversion 
and abuse.  
  Recommendation 19: The diversion from 
domestic distribution channels and abuse of 
pharmaceutical preparations containing narcotic 
drugs or psychotropic substances pose problems 
in many countries. The Board invites all 
Governments concerned to examine the issue 
of diversion of pharmaceutical preparations 
containing internationally controlled 
substances and to adopt adequate 
countermeasures, as appropriate. The 
Governments are invited to raise awareness in 
their countries about the consequences of the 
abuse of such preparations. 
  Recommendation 20: The diversion from 
licit distribution channels of pharmaceutical 
preparations containing buprenorphine, an opioid 
which is used as analgesic and for the treatment 
of opioid addicts, has become a matter of 
growing concern. The Board calls on all 
Governments to increase their vigilance with 
regard to the diversion and abuse of and 
trafficking in buprenorphine and to inform the 
Board of new developments. The Board 
encourages all Governments concerned to 
consider enhancing existing mechanisms for 
control over that substance, as necessary. 
  Recommendation 21: The Board notes that 
worldwide consumption of methadone has 
significantly increased mostly as a result of the 
growing use of methadone for substitution 
treatment. At the same time, there has been an 
increasing number of reports on the abuse and 
diversion of methadone. The Board requests the 
authorities of countries where methadone is 
used for medical purposes to prevent its 
diversion from licit sources into illicit 
channels.  
  Recommendation 22: Trafficking in and 
abuse of fentanyl and its analogues continue to 
pose a problem in some countries. The Board 
calls upon Governments that reported seizures 
of fentanyl or its analogues to systematically 
collect data on the extent of the problem and 
to adopt measures to counter trafficking in 
and abuse of those drugs, as necessary. The 
Board encourages Governments to ensure that 
forensic laboratories include in their 
programmes the analysis of fentanyl and its 
analogues seized in their countries and to 
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report to the Board on the prevalence of 
fentanyl abuse.  
  Recommendation 23: Abuse of diverted 
pharmaceutical preparations containing fentanyl, 
including used and discarded fentanyl patches, 
has been reported in some countries. The Board 
calls upon the Governments of countries in 
which fentanyl patches are manufactured to 
examine, in cooperation with the 
pharmaceutical industry, possible ways to 
address the issue of the residue of fentanyl in 
used patches without impeding access to an 
otherwise useful medicine. The Board requests 
the Governments of all countries in which 
fentanyl patches are used to adopt measures 
for the disposal of used patches, in order to 
prevent their diversion for abuse. 
  Recommendation 24: The Board notes with 
concern that drug injection rooms continue to 
operate in a small number of countries, mainly in 
Europe. The Board reiterates its position that 
facilities where persons can abuse with impunity 
drugs illegally acquired, contravene the most 
fundamental principle of the international drug 
control conventions: drugs should be used only 
for medical and scientific purposes. The Board 
urges the Governments of countries where 
drug injection rooms are operated for the 
purpose of administering illicitly obtained 
drugs, to close those facilities and to provide 
appropriate evidence-based medical services 
and facilities for the treatment of drug 
abusers.  
  Recommendation 25: In accordance with 
article 38 of the 1961 Convention and article 20 
of the 1971 Convention, parties are required to 
take all practicable measures for the prevention 
of abuse of narcotic drugs and psychotropic 
substances. The Board calls upon all 
Governments that have not yet done so to 
establish a system to regularly assess trends in 
drug abuse in their territory and to establish 
drug demand reduction programmes to 
counter those trends, as necessary. The Board 
also encourages Governments of countries 
with existing drug demand reduction 
programmes, whenever possible and 
appropriate, to share national and local 
experiences with Governments of other 
countries. 
  Recommendation 26: Under the “Data for 
Africa” initiative, UNODC is working with 
Governments of countries in Africa to strengthen 
their data collection and reporting capacities, in 
order to remedy the inadequacy of information on 
drugs and crime in the region. The Board 
encourages the Governments concerned to 
cooperate with UNODC in implementing the 
“Data for Africa” initiative.  
  Recommendation 27: In Commission on 
Narcotic Drugs resolution 50/3, entitled 
“Responding to the threat posed by the abuse and 
diversion of ketamine”, the Commission 
encouraged Member States to consider adopting a 
system of precautionary measures for use by their 
government agencies to facilitate the timely 
detection of the diversion of ketamine. The 
Board calls on all Governments to implement 
Commission resolution 50/3 without delay, to 
inform the Board of their national regulatory 
control measures for ketamine and to provide 
to the Board and to WHO all available 
information on the abuse of ketamine in order 
to assist WHO in its evaluation of 
ketamine  for  possible scheduling under the 
1971 Convention.  
  Recommendation 28: During the past 
several years, the abuse of and trafficking in 
piperazine-derived compounds have been noted. 
In a number of countries, some of those 
substances have already been placed under 
national control. The Board requested WHO in 
March 2007 to consider reviewing piperazine-
derived compounds for possible scheduling under 
the 1971 Convention. The Board urges all 
Governments to provide to WHO and the 
Board any information on the abuse of and 
trafficking in piperazine-derived compounds.  
  Recommendation 29: Rising levels of 
cocaine abuse have been reported in many 
European Countries. The Board encourages the 
Governments concerned to adopt 
comprehensive measures to prevent trafficking 
in and abuse of cocaine.  
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  Recommendation 30: There is a continued 
trend to use Africa for trans-shipment of large 
consignments of cocaine illicitly manufactured in 
South America. The Board encourages 
Governments of countries in Africa and South 
America to further strengthen measures 
against trafficking in cocaine and to improve 
their cooperation in that regard. 
  Recommendation 31: The Board notes with 
grave concern that the level of illicit opium 
poppy cultivation in Afghanistan reached a new 
peak in 2007. The Board wishes to emphasize the 
serious short-term and long-term consequences of 
such cultivation in Afghanistan and elsewhere, 
including the large number of drug-related deaths 
that are occurring in many countries. The Board 
once again urges the Government of 
Afghanistan to meet the commitments made to 
the Board as part of the consultations under 
article 14 of the 1961 Convention and to take 
immediate measures to ensure a significant 
and sustainable reduction in illicit opium 
poppy cultivation. The Board urges the 
international community to increase the 
assistance provided to the Government of 
Afghanistan to address its drug problem, 
particularly with regard to the illicit 
cultivation of opium poppy.  
  Recommendation 32: The Board notes with 
grave concern that corruption is hindering efforts 
to eradicate illicit opium poppy cultivation and to 
strengthen drug control in Afghanistan. The 
Board urges the Government of Afghanistan to 
take appropriate action against corruption and 
to ensure accountability at all levels of 
Government.  
  Recommendation 33: In the light of the 
increased illicit manufacture of heroin in 
Afghanistan, the Board urges the 
Governments of Afghanistan and its 
neighbouring countries to implement measures 
to counter the smuggling of precursor 
chemicals, in particular acetic anhydride, into 
Afghanistan. The Governments of Afghanistan 
and its neighbouring countries should also 
cooperate fully with the Project Cohesion Task 
Force in taking measures to intercept 
consignments of acetic anhydride that are 
being smuggled into Afghanistan. 
 
  Availability and rational use of narcotic drugs 
and psychotropic substances for medical 
purposes 
 
735. A core objective of the international drug control 
treaties is to ensure the availability of narcotic drugs 
and psychotropic substances for medical purposes and 
to promote the rational use of controlled drugs. 
  Recommendation 34: The consumption 
levels of narcotic drugs and psychotropic 
substances continue to differ widely depending 
on the country and region. While such differences 
can sometimes be explained by cultural diversity 
in medical practice and variations in prescription 
patterns, the issue of excessively high or low 
levels of drug consumption merits special 
attention. The Board requests all Governments 
to identify unusual trends in the consumption 
of internationally controlled substances and to 
promote rational use of those substances, 
including the use of opioids for the treatment 
of pain, in accordance with the pertinent 
recommendations of WHO.  
  Recommendation 35: In cooperation with 
the Board, WHO prepared the Access to 
Controlled Medications Programme, which 
addresses, inter alia, causes for underuse of 
opioid analgesics in some countries. The Board 
encourages all Governments concerned to 
cooperate with WHO in the implementation of 
the Access to Controlled Medications 
Programme, with a view to promoting rational 
use of controlled substances by health-care 
professionals, in compliance with current best 
practices and scientific evidence. The Board 
calls on Governments to provide resources to 
WHO for the implementation of the 
Programme. 
  Recommendation 36: Pursuant to 
Commission on Narcotic Drugs 
resolutions 44/15, 45/5, 46/6 and 50/2, the Board 
urges Governments to notify the Board of 
restrictions in their national jurisdictions 
applicable to travellers under medical treatment 
with internationally controlled drugs. The Board 
will disseminate such information on a regular 
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basis. The Board calls on all Governments that 
have not yet done so to inform the Board of 
their current national regulations and 
restrictions applicable to travellers carrying 
medical preparations containing 
internationally controlled substances for 
personal use. Governments should notify the 
Board of any changes in their scope of control 
of narcotic drugs and psychotropic substances 
relevant to travellers under medical treatment 
carrying preparations containing 
internationally controlled substances.  
 
  The Internet and smuggling involving postal 
and courier services 
 
736. In view of the global nature of the problems of 
the illegal sale of pharmaceutical preparations 
containing internationally controlled substances 
through the Internet and the misuse of postal and 
courier services for such smuggling, concerted action 
by the international community is required. In 
particular, there is a need to establish a mechanism that 
will ensure the sharing of experiences and the rapid 
exchange of information on specific cases, as well as 
the standardization of data. 
  Recommendation 37: There is a growing 
number of cases involving the illegal sale by 
Internet pharmacies of pharmaceutical 
preparations containing narcotic drugs or 
psychotropic substances. The Board calls on all 
Governments to accord adequate importance 
to the detection and investigation of such cases 
and to undertake all measures necessary to 
ensure that legislative and regulatory 
provisions are in force in their territory to 
effectively counteract such illegal transactions. 
Governments should also ensure that 
customers of Internet pharmacies are made 
aware of the potential health risk associated 
with consuming pharmaceutical preparations 
obtained from illegal Internet pharmacies. In 
addition, Governments should seek the 
cooperation of professional and consumer 
interest groups in identifying and 
implementing measures to counteract illegal 
activities of Internet pharmacies.  
  Recommendation 38: The Board continues 
to collect information on the activities undertaken 
by Governments to counteract illegal sales of 
pharmaceutical preparations containing 
controlled substances. All Governments are 
encouraged to provide the Board with 
information on national legislation related to 
Internet services and sites, national 
cooperation mechanisms, practical experience 
in the control and investigation of illegal 
Internet pharmacies and contact details of 
national focal points for activities related to 
the issue of illegal Internet pharmacies. 
  Recommendation 39: Some Governments 
have reported to the Board cases involving the 
misuse of courier services for drug smuggling. 
The Board invites all Governments to provide 
it with pertinent information on the smuggling 
of controlled drugs involving the misuse of 
courier services. 
 
  Smuggling and abuse of counterfeit 
preparations containing narcotic drugs and 
psychotropic substances 
 
737. Pharmaceutical preparations containing narcotic 
drugs or psychotropic substances found in the illicit 
traffic are not necessarily always diverted from licit 
manufacture or trade. In some cases, increased demand 
for a specific pharmaceutical preparation containing a 
controlled substance has led to the manufacture of 
counterfeit preparations.  
  Recommendation 40: While the diversion of 
flunitrazepam from both international trade and 
domestic distribution channels continues to exist, 
it appears that the majority of the Rohypnol 
tablets seized nowadays are counterfeit products. 
To accurately assess illicit drug manufacture 
and trafficking trends, the Board encourages 
all Governments that experience problems 
with abuse of Rohypnol tablets to test the 
seized tablets, whenever possible, in order to 
determine if they are counterfeit. The Board 
also encourages those Governments to share 
information on the physical appearance of 
seized tablets with other concerned 
Governments through a profiling network and 
to report their findings to the Board.  
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 B. Recommendations to the United 
Nations Office on Drugs and Crime 
and to the World Health Organization 
 
 
738. UNODC is the primary United Nations entity 
responsible for the provision of technical assistance in 
drug control issues, as well as the coordination of such 
assistance provided by Governments and other 
organizations. The treaty-based function of WHO is to 
provide recommendations, based on medical and 
scientific assessments, regarding changes in the scope 
of control of narcotic drugs under the 1961 Convention 
and the scope of control of psychotropic substances 
under the 1971 Convention. Furthermore, WHO plays 
a key role in supporting the rational use of narcotic 
drugs and psychotropic substances worldwide. 
  Recommendation 41: The Board notes that 
the control of licit activities related to narcotic 
drugs, psychotropic substances and precursors in 
a number of countries remains weak. The Board 
invites UNODC to increase its support to 
Governments in their efforts to implement the 
provisions of the international drug control 
treaties regarding the control of licit activities 
involving internationally controlled 
substances. 
  Recommendation 42: The Board is 
concerned about the steadily increasing trend in 
the diversion and abuse of pharmaceutical 
preparations containing internationally controlled 
substances. The Board invites UNODC to 
support Governments in their efforts to 
monitor consumption trends and prevent the 
diversion and abuse of pharmaceutical 
preparations containing narcotic drugs or 
psychotropic substances (see also the 
corresponding request addressed to 
Governments in recommendation 19 above). 
  Recommendation 43: The Board notes the 
increase in the abuse of and trafficking in 
fentanyl and its analogues and concerned that 
many Governments are still not in a position to 
counteract that problem due to, inter alia, 
inadequate laboratory analysis. The Board 
requests UNODC to support Governments in 
their efforts to include the analysis of fentanyl 
and fentanyl analogues in the programmes of 
their forensic laboratories (see also the 
corresponding request addressed to 
Governments in recommendation 22 above). 
  Recommendation 44: Misuse of the Internet 
and postal and courier services has become an 
important method of obtaining drugs for abuse. 
The Board invites UNODC to develop 
programmes to address the problem of 
illegally operating Internet pharmacies and 
the smuggling of internationally controlled 
substances by mail and to share its experiences 
in the implementation of those programmes 
with the Board. 
  Recommendation 45: Abuse of and 
trafficking in some piperazine-derived 
compounds, such as N-benzylpiperazine (BZP) 
and 1-(3-chlorophenyl)piperazine (mCPP), have 
been reported in many countries. There appear to 
be no current therapeutic uses for those 
compounds. The Board invites WHO to take 
the necessary measures to assess piperazine-
derived compounds in order to determine 
whether to recommend that they be placed 
under international control (see the 
corresponding request addressed to 
Governments in recommendation 28 above).  
 
 
 C. Recommendations to other relevant 
international organizations 
 
 
739. In cases where States require additional 
operational support in specific areas, such as drug law 
enforcement, the Board addresses relevant 
recommendations pertaining to the specific spheres of 
competence of the relevant international and regional 
organizations, including Interpol, UPU, the World 
Customs Organization and the European Union. 
  Recommendation 46: An increase in the 
clandestine manufacture of and trafficking in 
synthetic opioids, such as fentanyl, has been 
noted in some regions. Similarly, reports on 
increasing seizures of ketamine and piperazine-
derived compounds have been received from a 
number of countries. The Board requests 
Interpol and the World Customs Organization 
to share with the Board and with the 
international organizations concerned, such as 
WHO and UNODC, any information they may 
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have on new developments regarding the 
clandestine manufacture of and trafficking in 
synthetic opioids, such as fentanyl, and 
seizures of ketamine and piperazine-derived 
compounds. 
  Recommendation 47: The Board reiterates 
the need to address the problems of illegally 
operating Internet pharmacies and the smuggling 
of controlled substances by mail. The Board 
invites international organizations, in 
particular UPU, Interpol and the World 
Customs Organization, to share with the 
Board relevant experiences gained from any 
programmes they are implementing to address 
the problems of illegally operating Internet 
pharmacies and the smuggling of controlled 
substances by mail (a similar request is 
addressed to UNODC in recommendation 44 
above). 
  Recommendation 48: Technical assistance 
would be required for Bosnia and Herzegovina 
to prepare a comprehensive national strategy 
on drug abuse and to assess the extent and 
nature of the drug problem in the country. 
Such assistance would help the Government to 
fully implement the provisions of the 
international drug control treaties. The Board 
draws the attention of the European Union to 
the need to offer assistance to Bosnia and 
Herzegovina in institution- and 
capacity-building, including the training of 
personnel of the competent authorities 
involved in drug control.  
 
 
 (Signed) (Signed) 
 Philip O. Emafo Sevil Atasoy 
 President  Rapporteur 
 
(Signed) 
Koli Kouame 
Secretary 
 
 Vienna, 16 November 2007 
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Annex I 
 
 
  Regional groupings used in the report of the International 
Narcotics Control Board for 2007 
 
 
 The regional groupings used in the report of the International Narcotics 
Control Board for 2007, together with the States in each of those groupings, are 
listed below. 
Africa 
Algeria 
Angola 
Benin 
Botswana 
Burkina Faso 
Burundi 
Cameroon 
Cape Verde 
Central African Republic 
Chad 
Comoros 
Congo 
Côte d’Ivoire 
Democratic Republic of the Congo 
Djibouti 
Egypt 
Equatorial Guinea 
Eritrea 
Ethiopia 
Gabon 
Gambia 
Ghana 
Guinea 
Guinea-Bissau 
Kenya 
Lesotho 
Liberia  
Libyan Arab Jamahiriya 
Madagascar 
Malawi 
Mali 
Mauritania 
Mauritius 
Morocco 
Mozambique 
Namibia 
Niger 
Nigeria 
Rwanda 
Sao Tome and Principe 
Senegal 
Seychelles 
Sierra Leone 
Somalia 
South Africa 
Sudan 
Swaziland 
Togo 
Tunisia 
Uganda 
United Republic of Tanzania 
Zambia 
Zimbabwe 
Central America and the Caribbean 
Antigua and Barbuda 
Bahamas 
Barbados 
Belize 
Costa Rica 
Cuba 
Dominica 
Dominican Republic 
El Salvador 
Grenada 
Guatemala 
Haiti 
Honduras 
Jamaica 
Nicaragua 
Panama 
Saint Kitts and Nevis 
Saint Lucia 
Saint Vincent and the Grenadines 
Trinidad and Tobago 
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North America 
Canada 
Mexico 
 
United States of America 
South America 
Argentina 
Bolivia 
Brazil 
Chile 
Colombia 
Ecuador 
 
Guyana 
Paraguay 
Peru 
Suriname 
Uruguay 
Venezuela (Bolivarian Republic of) 
 
East and South-East Asia 
Brunei Darussalam 
Cambodia 
China 
Democratic People’s Republic of Korea 
Indonesia 
Japan 
Lao People’s Democratic Republic 
Malaysia 
 
Mongolia 
Myanmar 
Philippines 
Republic of Korea 
Singapore 
Thailand 
Timor-Leste 
Viet Nam 
 
South Asia 
Bangladesh 
Bhutan 
India 
 
Maldives 
Nepal 
Sri Lanka 
 
West Asia 
Afghanistan 
Armenia 
Azerbaijan 
Bahrain 
Georgia 
Iran (Islamic Republic of) 
Iraq 
Israel 
Jordan 
Kazakhstan 
Kuwait 
Kyrgyzstan 
 
Lebanon 
Oman 
Pakistan 
Qatar 
Saudi Arabia 
Syrian Arab Republic 
Tajikistan 
Turkey 
Turkmenistan 
United Arab Emirates 
Uzbekistan 
Yemen 
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Europe 
Albania 
Andorra 
Austria 
Belarus 
Belgium 
Bosnia and Herzegovina 
Bulgaria 
Croatia 
Cyprus 
Czech Republic 
Denmark 
Estonia 
Finland 
France 
Germany 
Greece 
Holy See 
Hungary 
Iceland 
Ireland 
Italy 
Latvia 
Liechtenstein 
 
Lithuania 
Luxembourg 
Malta 
Moldova 
Monaco 
Montenegro 
Netherlands 
Norway 
Poland 
Portugal 
Romania 
Russian Federation 
San Marino 
Serbia 
Slovakia 
Slovenia 
Spain 
Sweden 
Switzerland 
The former Yugoslav Republic of 
  Macedonia 
Ukraine 
United Kingdom of Great Britain 
  and Northern Ireland 
 
Oceania 
Australia 
Cook Islands 
Fiji 
Kiribati 
Marshall Islands 
Micronesia (Federated States of) 
Nauru 
New Zealand 
 
Niue 
Palau 
Papua New Guinea 
Samoa 
Solomon Islands 
Tonga 
Tuvalu 
Vanuatu 
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Annex II 
 
 
  Current membership of the International Narcotics Control 
Board 
 
 
 
  Joseph Bediako Asare 
 
 
 Born in 1942. National of Ghana. Private 
Consultant and Psychiatrist. 
 Medical Academy of Krakow, Poland (1965-
1971); postgraduate training at Graylands and 
Swanbourne Psychiatric Hospitals, Perth, Australia 
(1976-1977); Leicestershire Area Health Authority 
(1977-1980). Senior Registrar in Psychiatry, West 
Berkshire and South Oxford Area Health Authority 
(1981-1982); Chief Psychiatrist, Ghana Health Service; 
specialist in charge at Accra Psychiatric Hospital; 
Chairman, Ghana Chapter, West African College of 
Physicians; Vice-President, West African College of 
Physicians (2000-2004); Advisor to the Ministry of 
Health of Ghana (1984-2004); member of the Narcotics 
Control Board of Ghana (1990-2004); Chairman, 
Subcommittee on Demand Reduction, Narcotics 
Control Board of Ghana (since 1991). Part-time 
lecturer in psychiatry, University of Ghana medical 
school (1991-2004). Faculty Fellow of the 
International Council on Alcohol and Addictions 
training programme on alcohol and drug abuse in 
Benin City, Nigeria (1986 and 1987); President, 
Psychiatric Association of Ghana (1999-2002). 
Member, Royal College of Psychiatrists (1980); 
Fellow, West African College of Psychiatrists; Fellow, 
Ghana College of Physicians and Surgeons. Author of 
numerous works, including: Substance Abuse in 
Ghana; The Problem of Drug Abuse in Ghana: a Guide 
to Parents and Youth (1989); Alcohol Use, Sale and 
Production in Ghana: a Health Perspective (1999); 
Alcohol and Tobacco Abuse in Deheer (1997); 
“Psychiatric co-morbidity of drug abuse”, Assessing 
Standards of Drug Abuse (1993); “Baseline survey of 
the relationship between HIV and substance abuse in 
Ghana” (2004). Recipient of the Grand Medal (Civil 
Division) of Ghana (1997). Participant in numerous 
meetings, including: consultative group that developed 
the manual on assessment standards of care in drug 
abuse treatment (1990-1992); NGO World Forum on 
Drug Demand Reduction, Bangkok (1994); drug 
programme expert meeting, Cleveland, United States 
of America (1995); Drug Expert Forum for Western 
and Central Africa, Cameroon (1995); local expert 
meeting for Western Africa, Dakar (2003). Member of 
the local expert network in West Africa (LENwest) 
(2002-2004).  
 Member of the International Narcotics Control 
Board (since 2005). Member of the Standing 
Committee on Estimates (2006). Chairman of the 
Committee on Finance and Administration (2007). 
 
  Sevil Atasoy 
 
 
 Born in 1949. National of Turkey. Professor of 
Biochemistry and Forensic Science, Istanbul 
University (since 1988). 
 Bachelor of Science in Chemistry (1972), Master 
of Science in Biochemistry (1976) and Doctor of 
Philosophy (Ph.D.) in Biochemistry (1979), Istanbul 
University. Hubert H. Humphrey Fellow, United States 
Information Agency (1995-1996); German Academic 
Exchange Service (DAAD) Fellow (1976, 1978 and 
1994); European Molecular Biology Organization 
Fellow (1985); North Atlantic Treaty Organization 
Fellow (1978). Expert witness in civil and criminal 
courts (since 1980). Director, Institute of Forensic 
Science, Istanbul University (1988-2005). Director, 
Department of Narcotics and Toxicology, Ministry of 
Justice of Turkey (1980-1993). Chairperson, 
Department of Forensic Basic Sciences, Istanbul 
University (1983-1987); Professor of Biochemistry, 
Cerrahpasa School of Medicine, Istanbul University 
(1988-2005); Educational Counsellor, Turkish 
International Academy against Drugs and Organized 
Crime (2000-2005). Guest scientist, School of Public 
Health, University of California, Berkeley, and Drug 
Abuse Research Center, University of California, 
Los Angeles; Department of Genetics, Stanford 
University; Department of Genetics, Emory University; 
California Criminalistics Institute; Federal Bureau of 
Investigation, Virginia; Crime Laboratories, 
Los Angeles Sheriff’s Department; Federal Criminal 
Police (BKA), Wiesbaden, Germany; United Nations 
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Drug Laboratory, Vienna; Ludwig-Maximilian 
University; Munich Institute for Physical Biochemistry 
and Institute of Legal Medicine; Center of Human 
Genetics, Bremen University; Institute of Legal 
Medicine, Muenster University. Recipient of numerous 
awards, including: Rotary International (1993 and 
2001), for the improvement of investigative techniques 
in Turkey. Chairperson, first Regional Symposium on 
Criminalistics (2000); and Chairperson, third European 
Academy of Forensic Science Meeting (2003). 
Member of the Istanbul University Senate (1987-2005) 
and Research Foundation (1987-2002); member of the 
Experts Group on Technical Challenges to the Drug 
Community, United Nations Office on Drugs and 
Crime (UNODC) and Office of National Drug Control 
Policy of the United States (2003 and 2004); member 
of the expert group on risk reduction linked to 
substance use other than by injection, Pompidou Group 
of the Council of Europe (2002); member of the 
Mediterranean Network of the Pompidou Group 
(2001). Member of the Turkish delegation to the 
Commission of Narcotic Drugs (2001 and 2002); the 
special commissions on the improvement of judiciary 
and security affairs, Prime Ministry, VIII. 
Development Plan for the Years 2001-2005, the 
Republic of Turkey Higher Commission on Human 
Rights (1997-1998). Adviser on improving 
investigations and protecting child victims, General 
Command of Gendarmerie Internal Security Units 
(2001-2003); adviser on prevention of violence, suicide 
and drug abuse, Land Forces Command (2000-2004); 
adviser on driving under influence of controlled 
substances, Traffic Accidents Prevention Commission, 
Turkish Grand National Assembly (2000); adviser on 
preventing drug abuse and violence in schools, 
Ministry of National Education (since 1999); adviser 
on drug testing and the improvement of treatment of 
offenders, General Directorate of Correctional 
Facilities, Ministry of Justice (since 1999). Founding 
editor, Turkish Journal of Legal Medicine (1982-1993). 
Member of the scientific board of national and 
international journals, including the International 
Criminal Justice Review, the Turkish Journal on 
Addiction, the Turkish Journal of Forensic Sciences 
and the Croatian Journal of Legal Medicine. Founding 
President, Turkish Society of Forensic Sciences (since 
1998); Honorary Member of the Mediterranean 
Academy of Forensic Sciences (since 2003); member 
of the Standing Committee, European Academy of 
Forensic Sciences (1999-2003). Member of the 
International Society of Forensic Toxicology; the Indo-
Pacific Association of Law, Medicine and Science; the 
European Network of Forensic Science Institutes; the 
International Association of Forensic Toxicologists; the 
American Academy of Forensic Sciences; the 
American Society of Crime Laboratory Directors; the 
Forensic Science Society, United Kingdom of Great 
Britain and Northern Ireland; the American Society of 
Criminology; the Interagency Council on Child Abuse 
and Neglect; and the United Nations Academic 
Council. Participant in projects on illicit drug issues, 
including: Crime Mapping of Drug Offences for the 
Ministry of Home Affairs (1998-2000); Global Study 
of Illicit Drug Markets: Istanbul, Turkey, for the United 
Nations Interregional Crime and Justice Research 
Institute (2000-2001); National Assessment of Nature 
and Extent of Drug Problems in Turkey, for UNODC 
(2002-2003); European School Survey on Alcohol and 
Other Drugs (2002-2003); Modeling the World Heroin 
Market, for the RAND Drug Policy Research Center 
and the Max Planck Institute (2003). Author of over 
130 scientific papers, including papers on drug testing, 
drug chemistry, drug markets, drug-related and drug-
induced crime, drug abuse prevention, clinical and 
forensic toxicology, neuropharmacology, crime scene 
investigation and deoxyribonucleic acid (DNA) 
analysis, including “Excavating Y-chromosome 
haplotype strata in Anatolia”, Human Genetics (2004); 
“DNA fingerprinting of cannabis sativa, accessions 
using RAPD and AFLP markers”, Forensic Science 
International (2003); “H. gamma-vinyl-GABA 
potentiates the severity of naloxone-precipitated 
abstinence signs in morphine-dependent rats”, 
Pharmacological Research (1998). 
 Member of the International Narcotics Control 
Board (since 2005). Member of the Committee on 
Finance and Administration (2006). Second Vice-
President of the Board (2006). Chairman (2006) and 
Member (2007) of the Standing Committee on 
Estimates. Rapporteur of the Board (2007). 
 
  Tatyana Borisovna Dmitrieva 
 
 
 Born in 1951. National of the Russian Federation. 
Director, V. P. Serbsky State Research Centre for 
Social and Forensic Psychiatry (since 1998). Chief 
Expert Psychiatrist, Ministry of Health and Social 
Development of the Russian Federation (2005). 
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 Graduate of the Ivanovskii State Medical Institute 
(1975). Master of Science (1981) and Doctor of 
Medical Sciences (M.D.) (1990). Professor of 
Medicine (since 1993). Head of the Department of 
Psychiatry (1986-1989), Deputy Director of Research 
(1989-1990) and Director (1990-1996), V. P. Serbsky 
State Research Centre for Social and Forensic 
Psychiatry. Minister of Health of the Russian 
Federation (1996-1998). Chairman, Russian Security 
Council Commission on Health Protection (1996-
2000).  
 Member of the Presidium of the Russian 
Academy of Medical Sciences (since 2001); Vice-
Chairman, Russian Society of Psychiatrists (since 
1995); Vice-President, World Association for Social 
Psychiatry Academician; Corresponding Member of 
the Russian Academy of Medical Sciences (since 
1997); member of the Russian Academy of Medical 
Sciences (since 1999). Author of over 350 scientific 
works, recipient of five authors’ certificates for 
inventions and author of three books on drug abuse 
therapy, including Abuse of Psychoactive Substances 
(General and Forensic Psychiatric Practice) (2000) 
and Abuse of Psychoactive Substances: Clinical and 
Legal Aspects (2003). Editor-in-Chief, Russian 
Psychiatric Journal. Editor-in-Chief, Clinical Research 
on Medication in Russia. Member of the editorial 
boards of several Russian and foreign medical journals, 
including the journal Narcology. Member of the 
editorial council, International Medical Journal; and 
member of the editorial council, Siberian Journal of 
Psychiatry and Narcology. Recipient of the Order for 
Services to the Country, fourth class (2001) and third 
class (2006); and the Order of Honour (1995). 
Participant and speaker on psychiatry and drug abuse 
therapy at national and international congresses and 
conferences, including those organized by the World 
Health Organization (WHO), the European Union, the 
Council of Europe, the World Psychiatric Congress and 
the World Psychiatric Association. 
 Member of the International Narcotics Control 
Board (since 2005). Rapporteur of the Board (2006). 
Member (2006) and Chairman (2007) of the Standing 
Committee on Estimates. Second Vice-President of the 
Board (2007). 
 
 
  Philip Onagwele Emafo 
 
 
 Born in 1936. National of Nigeria. 
 Lecturer, Biochemistry, University of Ibadan 
(1969-1971). Lecturer and Senior Lecturer, 
Pharmaceutical Microbiology and Biochemistry, 
University of Benin, Nigeria (1971-1977). Chief 
Pharmacist and Director, Pharmaceutical Services, 
Federal Ministry of Health of Nigeria (1977-1988). 
Chairman, Pharmacists Board of Nigeria (1977-1988). 
Member of the WHO Expert Advisory Panel on the 
International Pharmacopoeia and Pharmaceutical 
Preparations (1979-2003). Rapporteur-General, 
International Conference on Drug Abuse and Illicit 
Trafficking, Vienna (1987). Chairman, Commission on 
Narcotic Drugs at its tenth special session (1988). 
Member of the Secretary-General’s Group of Experts 
on the United Nations Structure for Drug Abuse 
Control (1990). Member of the WHO Expert 
Committee on Drug Dependence (1992, 1994 and 
1998). Consultant to the United Nations International 
Drug Control Programme (1993-1995). Member of the 
ad hoc intergovernmental advisory group established 
by the Commission on Narcotic Drugs to assess 
strengths and weaknesses of global drug control efforts 
(1994). Member of the expert group convened by the 
Secretary-General pursuant to Economic and Social 
Council resolution 1997/37 to review the United 
Nations machinery for drug control (1997-1998). 
Member of the Advisory Group of the International 
Narcotics Control Board to review substances for 
control under article 12 of the United Nations 
Convention against Illicit Traffic in Narcotic Drugs and 
Psychotropic Substances of 1988 (1998-1999). 
Consultant to the Organization of African Unity, Addis 
Ababa (1998-1999). 
 Member of the International Narcotics Control 
Board (since 2000). Member of the Standing 
Committee on Estimates (2000-2004). Rapporteur of 
the Board (2001). First Vice-President of the Board 
(2005). President of the Board (2002, 2003, 2006 and 
2007). 
 
  Hamid Ghodse 
 
 
 Born in 1938. National of the Islamic Republic of 
Iran. Professor of Psychiatry and of International Drug 
Policy, University of London (since 1987). Director, 
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International Centre for Drug Policy, St. George’s 
University of London (since 2003); Medical Director, 
National Clinical Excellence Awards (2006); President, 
European Collaborating Centres for Addiction Studies 
(since 1992); member of the Executive Committee of 
the Federation of Clinical Professors, United Kingdom 
(since 1994); member of the Scientific Committee on 
Tobacco and Health, United Kingdom (since 2000); 
Director of the Board of International Affairs and 
Member of the Council, Royal College of Psychiatrists 
(since 2000); Non-Executive Director, National 
Clinical Assessment Authority of England and 
subsequently patients safety agency (since 2001); 
Chairman, Higher Degrees in Psychiatry, University of 
London (since 2003); member of the Medical Studies 
Committee, University of London (since 2003). 
 Recipient of the following degrees: Doctor of 
Medicine (M.D.), Islamic Republic of Iran (1965); 
Diploma Psychological Medicine (D.P.M.), United 
Kingdom (1974); Doctor of Philosophy (Ph.D.), 
University of London (1976); and Doctor of Science 
(D.Sc.), University of London (2002). Fellow of the 
Royal College of Psychiatrists (F.R.C.Psych.), United 
Kingdom (1985); Fellow of the Royal College of 
Physicians (F.R.C.P.), London (1992); Fellow of the 
Royal College of Physicians of Edinburgh (F.R.C.P.E.), 
Edinburgh (1997); Fellow of the Faculty of Public 
Health Medicine (F.F.P.H.), United Kingdom (1997). 
Member of the WHO Expert Advisory Panel on 
Alcohol and Drug Dependence (since 1979); Adviser, 
Joint Formulary Committee, British National 
Formulary (since 1984); Honorary Consultant 
Psychiatrist, St. George’s and Springfield University 
Hospitals, London (since 1978); Honorary Consultant 
Public Health, Wandsworth Primary Care Trust (since 
1997); Director, Regional Drug Dependence Treatment 
Training and Research Unit, London (1987-1993); 
Director of the Education and Training Unit and of the 
Research, Evaluation and Monitoring Unit and 
Chairman of the Department of Addictive Behaviour 
and Psychological Medicine, St. George’s Hospital 
Medical School, University of London, and Joint 
Faculty of Health Sciences, Kingston University 
(1987-2003). Consultant Psychiatrist, St. Thomas’s 
Teaching Hospital and Medical School, London (1978-
1987); member, rapporteur, chairman and convener of 
various WHO and European Community expert 
committees, review groups and other working groups 
on drug and alcohol dependence; M. S. McLeod 
Visiting Professor, Southern Australia (1990); 
Honorary Professor, Peking University (since 1997). 
Visiting Professor, Keele University, United Kingdom 
(since 2002). Author or editor of over 300 scientific 
books and papers on drug-related issues and 
addictions, including the following books: The Misuse 
of Psychotropic Drugs, London (1981); Psychoactive 
Drugs and Health Problems, Helsinki (1987); 
Psychoactive Drugs: Improving Prescribing Practices, 
Geneva (1988); Substance Abuse and Dependence, 
Guildford (1990); Drug Misuse and Dependence: the 
British and Dutch Response, Lancashire, United 
Kingdom (1990); Misuse of Drugs (3rd ed.), London 
(1997); Drugs and Addictive Behaviour: a Guide to 
Treatment (3rd ed.), Cambridge (2002); Young People 
and Substance Misuse, London (2004); Addiction at 
Workplace, Aldershot (2005). Editor-in-Chief, 
International Psychiatry (since 2002); Editor, 
Substance Misuse Bulletin; member of the Editorial 
Board, International Journal of Social Psychiatry. 
Convener of WHO expert groups on medical education 
(1986), pharmacy education (1987), nurse education 
(1989) and rational prescribing of psychoactive drugs. 
Member of the British Medical Association (since 
1995); member of the Executive Board, Medical 
Council on Alcoholism (since 1997); Honorary 
Secretary/Chairman, Association of Professors of 
Psychiatry of the British Isles (since 1991); Chairman, 
Association of European Professors of Psychiatry; 
Director, National Programme on Substance Abuse 
Deaths (since 1997); member of the International 
Association of Epidemiology (since 1998); member of 
the Institute for Learning and Training in Higher 
Education (since 2001). 
 Member of the International Narcotics Control 
Board (since 1992). Member of the Standing 
Committee on Estimates (1992). President of the Board 
(1993, 1994, 1997, 1998, 2000, 2001, 2004 and 2005). 
 
  Carola Lander 
 
 
 Born in 1941. National of Germany. Former Head 
of the Federal Opium Agency of Germans (1992-2006).  
 Pharmacist, University of Bonn (1968); doctoral 
degree in natural science, University of Berlin (1974); 
Certified Specialist in Public Health (2001). Research 
assistant (1970-1974) and assistant professor (1974-
1979), University of Berlin; person in charge of 
 E/INCB/2007/1
 
 123 
 
pharmaceutical quality control of herbal drugs, Federal 
Institute for Drugs and Medical Devices in Berlin 
(1979-1990); guest professor, Instituto Nacional de 
Controle de Qualidade em Saúde, Rio de Janeiro, 
Brazil (1989); member of the German delegation to the 
Chemical Action Task Force (1990-1991); head of the 
division for the control of manufacturers of narcotic 
drugs, Federal Opium Agency of Germany (1990-
1992); member of the German delegation to the 
Commission on Narcotic Drugs (1990-2006); person 
responsible for submitting statistical returns for 
Germany to the International Narcotics Control Board 
(1992-2006); Chairperson of the federal expert group 
on narcotic drugs (1992-2006); lecturer on drug 
regulatory affairs, University of Bonn (2003-2005). 
Invited speaker at numerous national and some 
international meetings: Conference on Herbal Drugs in 
the Traditional Medicine, Rio de Janeiro, Brazil 
(1989); International Conference on Chemical 
Operations, Rome (1993); International Conference on 
Drug Abuse, Taipei, Taiwan Province of China (2001); 
International Symposium for Scientific Approach on 
Drug Control Strategy, Seoul (2005). Author of 
numerous works including in the areas of research on 
active lipophilic substances in Piper sanctum (three 
publications); research in the field of herbal drugs with 
widespread use in Germany (many lectures and 
16 publications). Co-author (since 1992) of Deutsches 
Betäubungsmittelrecht: Kommentar, an annual 
commentary on German legislation regarding narcotic 
drugs, psychotropic substances and precursors. 
Recipient of a certificate of appreciation for 
outstanding contributions in the field of drug law 
enforcement, awarded by Drug Enforcement 
Administration of the United States of America (1993); 
recipient of a certificate of appreciation awarded by the 
former Yugoslav Republic of Macedonia (1995). 
 Member of the International Narcotics Control 
Board (2007). Member of the Standing Committee on 
Estimates (2007). 
 
  Melvyn Levitsky 
 
 
 Born in 1938. National of the United States. 
Retired Ambassador in the United States Foreign 
Service. Lecturer in Public Policy and International 
Relations and Senior Fellow, International Policy 
Center, Gerald R. Ford School of Public Policy, 
University of Michigan (since 2006). 
 United States diplomat for 35 years, serving as, 
inter alia, Ambassador of the United States to Brazil 
(1994-1998); Assistant Secretary of State for 
International Narcotics Matters (1989-1993); 
Executive Secretary and Special Assistant to the 
Secretary of the United States Department of State 
(1987-1989); Ambassador of the United States to 
Bulgaria (1984-1987); Deputy Director, Voice of 
America (1983-1984); Deputy Assistant Secretary of 
State for Human Rights and Humanitarian Affairs 
(1982-1983); Officer-in-Charge for Bilateral Relations, 
Office of Soviet Union Affairs (1975-1978); Political 
Officer, United States Embassy in Moscow (1973-
1975); Consul, United States consulates in Frankfurt, 
Germany (1963-1965), and Belem, Brazil (1965-1967). 
Professor of International Relations and Public 
Administration, Maxwell School of Citizenship and 
Public Affairs, Syracuse University (1998-2006). 
Recipient of several United States Department of State 
Meritorious and Superior Honor Awards, Presidential 
Meritorious Service Awards and the United States 
Secretary of State’s Distinguished Service Award. 
Member of the Washington Institute of Foreign Affairs, 
the American Academy of Diplomacy and the 
American Foreign Service Association. Member of the 
Advisory Board, Drug Free America Foundation. 
Member of the Institute on Global Drug Policy. 
Member of the Board, Global Panel of the Prague 
Society. Member of the Public-Private Working Group 
on Sale of Controlled Substances via the Internet 
(Harvard University Law School). Distinguished 
Fellow, Daniel Patrick Moynihan Institute of Global 
Affairs, Maxwell School of Citizenship and Public 
Affairs, Syracuse University. Member of the University 
of Michigan Substance Abuse Research Center. Listed 
in Who’s Who in American Politics, Who’s Who in 
American Government and Who’s Who in American 
Education. 
 Member of the International Narcotics Control 
Board (since 2003). Chairman of the Committee on 
Finance and Administration (2004). Chairman of the 
Working Group on Strategy and Priorities (2005). 
 
  Maria Elena Medina-Mora 
 
 
 Born in 1953, National of Mexico. Director, 
Division of Epidemiology and Psychosocial Research, 
National Institute of Psychiatry, Mexico City (since 
1999). Member of the Board of Adjudication and 
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Researcher, National Institute of Health. Researcher, 
National System of Researchers. Member of the 
Colegio Nacional (since 2006). 
 Recipient of a Bachelor of Arts degree (with 
honours) in Psychology (1976) and a Master of Arts 
degree (with honours) in Clinical Psychology (1979), 
Ibero-American University, Mexico; recipient of a 
doctoral degree in Social Psychology, Universidad 
Nacional Autonoma de México (1992). Member of the 
Board of Governors, Universidad Nacional Autonóma 
de México (since 2003). Member of the WHO Expert 
Committee on Addictions (since 1986). Research 
collaborator, WHO project on increasing comparability 
of drug use surveys (1976-1980) Researcher with 
WHO, the International Labour Organization, the 
United Nations Children’s Fund (UNICEF), the 
Addiction Research Foundation, Toronto, Canada, and 
the Alcohol Research Group, California, United States, 
as well as with the National Institute on Alcohol Abuse 
and Alcoholism and the National Institute on Drug 
Abuse of the National Institutes of Health, United 
States. Cooperated with the working group of the 
international board of drug surveillance in developing 
the Lisbon consensus document for drug reporting 
(2000) and with the working group that developed the 
draft Declaration on the Guiding Principles of Drug 
Demand Reduction (1997). Member of the Scientific 
Advisory Committee, Inter-American Drug Abuse 
Control Commission (CICAD). Member of the 
National Academy of Sciences (since 1992), National 
Association of Psychologists of Mexico (since 1991) 
and the National Academy of Medicine (since 1994). 
Member of the Board of Directors, National Institute of 
Public Health (1997-2005) and National Institute on 
Neurology and Neurosurgery (since 2006). Professor at 
the undergraduate and graduate levels and adviser for 
67 Bachelor of Arts, Master of Arts and doctoral theses 
(since 1976). Member of the editorial board of Revista 
de Psicología Social y Personalidad, Salud Mental, 
Revista Mexicana de Psicología and Salud Pública de 
México, Public Psychiatry, Addictions, Hispanic 
Journal of Behavioral Sciences, Addiction Disorders 
and Their Treatment and Revista Brasileira de 
Psiquiatría. Recipient of the “Gerardo Varela” national 
award in public health, for meritorious research (1986); 
the award for professional excellence, presented by the 
Ibero-American University to distinguished former 
alumni (1990); first prize for contributions to research 
in the fields of psychology and health, presented 
during the International Congress on Psychology and 
Health (1990); national prize in psychology, awarded 
by the National Association of Psychologists (1991); 
national prize in psychiatrics, presented by the Camelo 
Foundation (1993); second prize for an article entitled 
“Gender and addictions”, awarded by the United 
Nations Educational, Scientific and Cultural 
Organization, the United Nations International Drug 
Control Programme, the World Bank, WHO and the 
Special Programme for Research and Training in 
Tropical Diseases (1997). Recognized as distinguished 
health professional by the Mexican Society of 
Geography and Statistics (2002) and as honorary 
member by the Sociedad Mexicana de Psicología 
(2006). Recipient of the Woman of the Year Award 
(2006). Author of more than 163 research papers in 
journals and of four books. 
 Member of the International Narcotics Control 
Board (2000-2004 and 2007). Rapporteur (2002) and 
Second Vice-President (2003) of the Board. Member of 
the Standing Committee on Estimates (2000-2004 and 
2007). Chairman of the Standing Committee on 
Estimates (2004). 
 
  Sri Suryawati 
 
 
 Born in 1955. National of Indonesia. Former 
Head of Clinical Pharmacology, Faculty of Medicine, 
Gadjah Mada University, Indonesia. Member of the 
Executive Board of the International Network for the 
Rational Use of Drugs (INRUD), WHO Expert 
Advisory Panel for Medicine Policy and Management. 
Director, Centre for Clinical Pharmacology and 
Medicines Policy Studies, Gadjah Mada University. 
Coordinator, Master Degree Program for Medicine 
Policy and Management, Gadjah Mada University.  
 Specialist in pharmacology (1985); doctoral 
degree in clinical pharmacy (1994). Worked in clinical 
pharmacokinetics and bioequivalence testing (since 
1984), drug evaluation and new drug application (since 
1987) and medicines policy and promoting the quality 
use of medicines (since 1990). Member of the WHO 
Expert Committee on Drug Dependence (2002 and 
2006). Member of the WHO Expert Committee on the 
Selection and Use of Essential Medicines (2002, 2003, 
2005 and 2007). Member of the United Nations 
Millennium Project Task Force on HIV/AIDS, Malaria 
and Tuberculosis and Access to Essential Medicines 
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(Task Force 5) (2001-2005). Supervisor for over 100 
postgraduate theses and research works in the areas of 
medicine policy and management, improving quality 
use of medicines in health facilities, community 
empowerment to improve self-medication, and clinical 
pharmacokinetics (since 1996). International consultant 
in essential medicine programmes and promoting the 
rational use of medicines in Bangladesh (2006-2007), 
Cambodia (2001-2005), China (2006-2007), the Lao 
People’s Democratic Republic (2001-2003), Mongolia 
(2006-2007) and the Philippines (2006-2007). 
International consultant in medicine policy and drug 
evaluation in Cambodia (2003, 2005 and 2007), China 
(2003), Indonesia (2005-2006) and Viet Nam (2003). 
Facilitator in various international training courses in 
medicine policy and promoting the rational use of 
medicines, including: WHO and INRUD courses on 
promoting the rational use of medicines, Yogyakarta, 
Indonesia (1994), Manila (1996), Dhaka (1997), 
New Delhi (1999), Padang, Indonesia (2000), Tehran 
(2002 and 2003), Islamabad and Bhurban, Pakistan 
(2004), and Brunei (2007); the WHO and Management 
Sciences for Health international courses on drugs and 
therapeutics committees, Penang, Malaysia (2001), 
Yogyakarta, Indonesia (2001), Mumbai, India (2002) 
and Brunei (2007); and WHO/Boston University 
international courses on drug policy issues for 
developing countries, Yogyakarta, Indonesia (2002), 
and Tashkent and Samarkand, Uzbekistan (2003). 
Author of numerous lectures presented at international 
conferences, including the following: “Indicator-based 
monitoring strategies to improve drug use in health 
facilities”, Symposium on Rational Drug Use, World 
Conference on Clinical Pharmacology and 
Therapeutics, Florence, Italy (2000); “The role of 
clinical pharmacology in promoting rational drug use 
in developing countries”, World Conference on 
Clinical Pharmacology and Therapeutics, Brisbane, 
Australia (2004); “Strategies to promote quality use of 
medicines: best mix of strategies for improving 
medicine use, case studies from developing countries”, 
National Medicines Symposium, Brisbane, Australia 
(2004); “Decentralization as a challenge to improve the 
quality use of medicine: Indonesia experience”, World 
Conference on Clinical Pharmacology and 
Therapeutics, Brisbane, Australia (2004); “Innovative 
strategies to improve prescribing: the pleasant journey 
from field-test to institutional programs”, World 
Conference on Improving Use of Medicines, Chiang 
Mai, Thailand (2004); “Strategies to improve the use of 
medicines: what makes them effective and 
sustainable?”, EURO Conference: Mastering Anti-
Infective Therapies, Paris (2005); “Irrational use of 
medicines damages health and wastes resources: what 
can we do about it?”, 58th World Health Assembly, 
Geneva (2005); “Problems of medicine use in the 
region”, Asia Social Health Forum, Penang, Malaysia 
(2005). 
 Member of the International Narcotics Control 
Board (2007). 
 
  Camilo Uribe Granja 
 
 
 Born in 1963. National of Colombia. Medical 
Director, Hospital of San Martín (Meta); toxicologist, 
Marly and Palermo clinics; General Director, New 
Clinic Fray Bartolomé de las Casas; consultant, 
National Drug Council. Numerous university teaching 
posts in forensics and clinical toxicology. 
 Medical doctor, School of Medicine, University 
of Our Lady of the Rosary (1989); specialization in 
toxicology, School of Medicine, University of 
Buenos Aires (1990); specialization in occupational 
toxicology (1997), University Teacher’s Certificate 
(1998), diplomas in hospital management (1998) and 
social security administration (1999), University of 
Our Lady of the Rosary; diploma in toxicological 
emergencies, FUNDASALUD (1998); master in social 
services management, Alcala de Enares University 
(2002). Former forensic medical doctor, toxicologist, 
technical coordinator and manager in several hospitals 
and institutions. Scientific Director, Toxicology Clinic, 
Uribe Cualla; Toxicological Assessment Centre; 
Director, Clinical Toxicology, Fray Bartolomé de Las 
Casas Clinic (until 1991); Vice-President, Tropical 
Medicine Institute Corporation “Luis Patiño Camargo” 
(until 1992); Medical Coordinator and Director, 
Emergency National Plan (1993); Director, Health 
Services Management Programme, School of Public 
Administration, College of Public Administration (until 
2000); General Director, National Institute of Drugs 
and Food Administration (2001-2002). Vice-President 
(1988-1990 and 1995-1998) and President (2000-
2003), Latin American Toxicology Association; Vice-
President (2002-2003), International Toxicology 
Federation. Member of the Colombian Association of 
Internal Medicine. Member of the Spanish Association 
of Toxicology. Executive Director, non-governmental 
E/INCB/2007/1  
 
126 
organizations association (until 1998); member of the 
Directive Group of the Cundinamarca’s Medical 
School; member of the Colombian Medical Academy. 
Author of numerous works, including: the chapter on 
benzodiazepines in Therapeutic Compendium of the 
Colombian Internal Medicine Association (1992); 
Criminal intoxication with scopolamine-like 
substances; Handbook on Toxicological Emergency 
Management; Manual on the Treatment of Intoxication 
by Plaguicides (1995); Investigation Protocol “Trauma 
and Alcohol”, Hospital of Kennedy (1993); numerous 
research protocols. Recipient of numerous honours, 
including: honourable mention for services to 
Colombian society in the field of toxicology, First 
International Congress of Toxicology, University of 
Antioquia; distinction by the Latin American 
Association of Toxicology for contributions to the field 
of toxicology (1998). Participant in numerous 
professional conferences and seminars, including 
several meetings of the Latin American Congress of 
Toxicology; National Congress of Toxicology and 
Environmental Protection, Medellín (1999); Seventh 
Colombian Congress of Pharmacology and 
Therapeutics and the first international symposium on 
the theme “Biodiversity as source of new drugs” 
(2001); Congress of Aerial Security in the Colombian 
Caribbean Area (2001); Second National Congress, 
Investigation and Health (2002). 
 Member of the International Narcotics Control 
Board (since 2005). Vice-Chairman of the Standing 
Committee on Estimates (2006 and 2007). Member of 
the Committee on Finance and Administration (2007). 
 
  Brian Watters 
 
 
 Born in 1935. National of Australia. Chairman, 
Australian National Council on Drugs (2005). 
 Arts degree, majoring in medical sociology, 
University of Newcastle, Australia; trained in addiction 
counselling at University of Newcastle; qualified 
psychiatric chaplain. Major in the Salvation Army 
(1975-2000), including work as Commander of the 
Salvation Army’s addiction treatment programme in 
eastern Australia; consultant and media spokesman on 
addiction issues; adviser to the Salvation Army’s 
HIV/AIDS services in eastern Australia; President of 
the Network of Alcohol and Drug Agencies in New 
South Wales; member of New South Wales’ Health 
Minister’s Drug Advisory Council. Patron, “Drug Arm, 
Australia”; Board member, “Drug Free Australia”; 
member of the Leadership Council, International 
Substance Abuse and Addiction Coalition. Member of 
several Australian government committees, including: 
the expert advisory group on sustained release 
naltrexone; the state and national reference groups on 
the Council of Australian Governments “Diversion of 
Offenders” scheme; and the national “Tough on Drugs” 
reference group for non-governmental organization 
treatment grants. Frequent contributor to Australian 
newspapers, magazines and journals, including the 
journal of the National Drug and Alcohol Research 
Centre; several publications, including Drug Dilemma: 
a Way Forward, and contributor to “Prevention, 
demand reduction and treatment: a way forward for 
Australia”, Heroin Crisis (1999). Officer of the Order 
of Australia (2003), for outstanding services in anti-
drug policy development and drug treatment. Keynote 
speaker at national and international conferences, 
including: International Council on Alcohol and 
Addictions, Vienna; European Cities against Drugs, 
Stockholm; Australian Conference on Drugs Strategy, 
Adelaide; International Substance Abuse and Addiction 
Coalition, Madrid. Participant, Commission on 
Narcotic Drugs (2003). Speaker of the National 
Chemical Diversion Conference, Darwin, Australia 
(2005). 
 Member of the International Narcotics Control 
Board (since 2005). Member of the Standing 
Committee on Estimates (2006). First Vice-President 
of the Board (2007). 
 
  Raymond Yans 
 
 
 Born in 1948. National of Belgium.  
 Graduate in Germanic philology and in 
philosophy (1972). Belgian Foreign Service: Attaché, 
Jakarta (1978-1981); Deputy-Mayor of Liège (1982-
1989); Consul, Tokyo (1989-1994); Consul, Chargé 
d’affaires, Luxembourg (1999-2003); Head of the Drug 
Unit, Ministry of Foreign Affairs (1995-1999 and 
2003-2007); Chairman of the Dublin Group (2002-
2006); Chairman of the European Union Drug Policy 
Cooperation Working Group during the Belgian 
Presidency of the European Union; charged with the 
national coordination of the ratification and 
implementation process of the Convention on 
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Psychotropic Substances of 1971 and the United 
Nations Convention against Illicit Traffic in Narcotic 
Drugs and Psychotropic Substances of 1988 (1995-
1998); liaison between the Ministry of Foreign Affairs 
and the National Police for drug liaison officers in 
Belgian embassies (2003-2005); participation in the 
launching by the European Union Joint Action on New 
Synthetic Drugs of an early warning system to alert 
Governments to the appearance of new synthetic drugs 
(1999); active in the creation of the Cooperation 
Mechanism on Drugs between the European Union, 
Latin America and the Caribbean (1997-1999). Author 
of numerous articles, including: “The future of the 
Dublin Group” (2004) and “Is there anything such as a 
European Union Common Drug Policy” (2005). 
Member of the Belgian delegation to the Commission 
on Narcotic Drugs (1995-2007); all the preparatory 
sessions (on amphetamine-type stimulants, precursors, 
judicial cooperation, money-laundering, drug demand 
reduction and alternative development) for the 
twentieth special session of the General Assembly; 
representative of Belgium at the Meeting of Heads of 
National Drug Law Enforcement Agencies, Europe 
(1995-2005); Conference of the International Narcotics 
Control Board on the Control of Psychotropic 
Substances, Strasbourg (1995 and 1998); International 
Conference on Drugs, Dependence and 
Interdependence, Council of Europe, Lisbon (1996); 
European Union Seminar on Best Practices in Drug 
Enforcement by Law Enforcement Authorities, 
Helsinki (1999); Joint European Union/Southern 
African Development Community Conferences on 
Drug Control Cooperation, Mmabatho, South Africa 
(1995) and Gabarone (1998); European Perspectives on 
Policies on Drugs, Oslo (2005); United Nations Office 
on Drugs and Crime/Paris Pact round tables, Brussels 
(2003), Tehran and Istanbul (2005); meetings of the 
Paris Pact Policy Consultative Group, Rome (2003) 
and Vienna (2005); meetings of the High-level 
Dialogue on Drugs between the Andean Community 
and the European Union, the European 
Community/Andean Bilateral Drug Precursors 
Agreements and the European Union/Latin America 
and the Caribbean Coordination and Cooperation 
Mechanism, Lima (2005) and Vienna (2006). 
 Member of the International Narcotics Control 
Board (2007). Member of the Standing Committee on 
Estimates (2007). Member of the Committee on 
Finance and Administration (2007). 
  Yu Xin 
 
 
 Born in 1965. National of China. Clinical 
Professor of Psychiatry, Institute of Mental Health, 
Peking University (since 2004). Licensed Psychiatrist, 
China Medical Association (since 1988). President, 
Chinese Psychiatrist Association (since 2005); 
Chairperson, Credential Committee for Psychiatrists, 
Ministry of Health of China; Vice-President, Chinese 
Society of Psychiatry (since 2006); Vice-President, 
Management Association for Psychiatric Hospitals 
(since 2007); Vice-Chairman, Alzheimer’s Disease, 
China (since 2002). 
 Bachelor of Medicine, Beijing Medical 
University (1988); Fellow in Psychiatry, University of 
Melbourne, Australia (1996-1997); Fellow in 
Substance Abuse, Johns Hopkins University (1998-
1999); Doctor of Medicine (M.D.), Peking University 
(2000); Senior Fellow in Social Medicine, Harvard 
University (2003). Residency in psychiatry (1988-
1993) and Psychiatrist (1993-1998), Institute of Mental 
Health, Beijing Medical University; Head, Associate 
Professor of Psychiatry, Geriatric Psychiatrist, 
Department of Geriatric Psychiatry, Institute of Mental 
Health, Peking University (1999-2001); Assistant 
Director (2000-2001) and Executive Director (2001-
2004), Institute of Mental Health, Peking University. 
Author and co-author of numerous works on various 
topics in psychiatry, such as psychopharmacology, 
early intervention of schizophrenia, mental health and 
HIV/AIDS and drug use, mental health outcome of 
harmful alcohol use, neuropsychology of mental 
disorders, neuroimaging of late life depression, late 
onset psychosis, and assessment, treatment and care for 
dementia. Editor of several textbooks, including 
Geriatric Psychiatry, Textbook of Psychiatry for Asia 
and Psychiatry for Medical Students. Recipient of the 
Outstanding Clinician Award, Beijing Medical 
University, and the Innovation and Creation Award, 
Beijing Medical Professional Union (2004). 
 Member of the International Narcotics Control 
Board (2007). Member of the Standing Committee on 
Estimates (2007). 
 

  
 
 
The role of the International Narcotics Control Board 
 
 
 The International Narcotics Control Board (INCB) is an independent and quasi-judicial control organ, 
established by treaty, for monitoring the implementation of the international drug control treaties. It had 
predecessors under the former drug control treaties as far back as the time of the League of Nations. 
 
Composition 
 
 INCB consists of 13 members who are elected by the Economic and Social Council and who serve in their 
personal capacity, not as government representatives (see annex II of the present publication for the current 
membership). Three members with medical, pharmacological or pharmaceutical experience are elected from a list 
of persons nominated by the World Health Organization (WHO) and 10 members are elected from a list of 
persons nominated by Governments. Members of the Board are persons who, by their competence, impartiality 
and disinterestedness, command general confidence. The Council, in consultation with INCB, makes all 
arrangements necessary to ensure the full technical independence of the Board in carrying out its functions. INCB 
has a secretariat that assists it in the exercise of its treaty-related functions. The INCB secretariat is an 
administrative entity of the United Nations Office on Drugs and Crime, but it reports solely to the Board on 
matters of substance. INCB closely collaborates with the Office in the framework of arrangements approved by 
the Council in its resolution 1991/48. INCB also cooperates with other international bodies concerned with drug 
control, including not only the Council and its Commission on Narcotic Drugs, but also the relevant specialized 
agencies of the United Nations, particularly WHO. It also cooperates with bodies outside the United Nations 
system, especially Interpol and the World Customs Organization. 
 
Functions 
 
 The functions of INCB are laid down in the following treaties: the Single Convention on Narcotic Drugs of 
1961 as amended by the 1972 Protocol; the Convention on Psychotropic Substances of 1971; and the United 
Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988. Broadly 
speaking, INCB deals with the following: 
 (a) As regards the licit manufacture of, trade in and use of drugs, INCB endeavours, in cooperation with 
Governments, to ensure that adequate supplies of drugs are available for medical and scientific uses and that the 
diversion of drugs from licit sources to illicit channels does not occur. INCB also monitors Governments’ control 
over chemicals used in the illicit manufacture of drugs and assists them in preventing the diversion of those 
chemicals into the illicit traffic; 
 (b) As regards the illicit manufacture of, trafficking in and use of drugs, INCB identifies weaknesses in 
national and international control systems and contributes to correcting such situations. INCB is also responsible 
for assessing chemicals used in the illicit manufacture of drugs, in order to determine whether they should be 
placed under international control. 
 In the discharge of its responsibilities, INCB: 
 (a) Administers a system of estimates for narcotic drugs and a voluntary assessment system for 
psychotropic substances and monitors licit activities involving drugs through a statistical returns system, with a 
view to assisting Governments in achieving, inter alia, a balance between supply and demand; 
 (b) Monitors and promotes measures taken by Governments to prevent the diversion of substances 
frequently used in the illicit manufacture of narcotic drugs and psychotropic substances and assesses such 
substances to determine whether there is a need for changes in the scope of control of Tables I and II of the 
1988 Convention; 
 (c) Analyses information provided by Governments, United Nations bodies, specialized agencies or other 
competent international organizations, with a view to ensuring that the provisions of the international drug 
control treaties are adequately carried out by Governments, and recommends remedial measures; 
 (d) Maintains a permanent dialogue with Governments to assist them in complying with their obligations 
under the international drug control treaties and, to that end, recommends, where appropriate, technical or 
financial assistance to be provided. 
 INCB is called upon to ask for explanations in the event of apparent violations of the treaties, to propose 
appropriate remedial measures to Governments that are not fully applying the provisions of the treaties or are 
encountering difficulties in applying them and, where necessary, to assist Governments in overcoming such 
 
 
  
 
difficulties. If, however, INCB notes that the measures necessary to remedy a serious situation have not been 
taken, it may call the matter to the attention of the parties concerned, the Commission on Narcotic Drugs and the 
Economic and Social Council. As a last resort, the treaties empower INCB to recommend to parties that they stop 
importing drugs from a defaulting country, exporting drugs to it or both. In all cases, INCB acts in close 
cooperation with Governments. 
 INCB assists national administrations in meeting their obligations under the conventions. To that end, it 
proposes and participates in regional training seminars and programmes for drug control administrators. 
 
Reports 
 
 The international drug control treaties require INCB to prepare an annual report on its work. The annual 
report contains an analysis of the drug control situation worldwide so that Governments are kept aware of 
existing and potential situations that may endanger the objectives of the international drug control treaties. INCB 
draws the attention of Governments to gaps and weaknesses in national control and in treaty compliance; it also 
makes suggestions and recommendations for improvements at both the national and international levels. The 
annual report is based on information provided by Governments to INCB, United Nations entities and other 
organizations. It also uses information provided through other international organizations, such as Interpol and 
the World Customs Organization, as well as regional organizations. 
 The annual report of INCB is supplemented by detailed technical reports. They contain data on the licit 
movement of narcotic drugs and psychotropic substances required for medical and scientific purposes, together 
with an analysis of those data by INCB. Those data are required for the proper functioning of the system of 
control over the licit movement of narcotic drugs and psychotropic substances, including preventing their 
diversion to illicit channels. Moreover, under the provisions of article 12 of the 1988 Convention, INCB reports 
annually to the Commission on Narcotic Drugs on the implementation of that article. That report, which gives an 
account of the results of the monitoring of precursors and of the chemicals frequently used in the illicit 
manufacture of narcotic drugs and psychotropic substances, is also published as a supplement to the annual 
report. 
 Since 1992, the first chapter of the annual report has been devoted to a specific drug control issue on which 
INCB presents its conclusions and recommendations in order to contribute to policy-related discussions and 
decisions in national, regional and international drug control. The following topics were covered in past annual 
reports: 
 1992:  Legalization of the non-medical use of drugs 
 1993:  The importance of demand reduction 
 1994:  Evaluation of the effectiveness of the international drug control treaties 
 1995:  Giving more priority to combating money-laundering 
 1996:  Drug abuse and the criminal justice system 
 1997:  Preventing drug abuse in an environment of illicit drug promotion 
 1998:  International control of drugs: past, present and future 
 1999:  Freedom from pain and suffering 
 2000:  Overconsumption of internationally controlled drugs 
 2001: Globalization and new technologies: challenges to drug law enforcement in the twenty-first 
  century 
 2002:  Illicit drugs and economic development 
 2003:  Drugs, crime and violence: the microlevel impact 
 2004:  Integration of supply and demand reduction strategies: moving beyond a balanced approach 
 2005: Alternative development and legitimate livelihoods 
 2006: Internationally controlled drugs and the unregulated market 
 Chapter I of the report of the International Narcotics Control Board for 2007 is entitled “The principle of 
proportionality and drug-related offences”. 
 Chapter II presents an analysis of the operation of the international drug control system based primarily on 
information that Governments are required to submit directly to INCB in accordance with the international drug 
control treaties. Its focus is on the worldwide control of all licit activities related to narcotic drugs and 
psychotropic substances, as well as chemicals used in the illicit manufacture of such drugs. 
 Chapter III presents some of the major developments in drug abuse and trafficking and measures by 
Governments to implement the international drug control treaties by addressing those problems. Specific 
comments are made on the drug control situation in each of the countries in which an INCB mission or technical 
visit took place. 
 Chapter IV presents the main recommendations addressed by INCB to Governments, the United Nations 
Office on Drugs and Crime, WHO and other relevant international and regional organizations. 
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